Javascript doit fonctionner ! Activez-le et rechargez cette page.
Le Rézo de JeuxDeMots
• Types de relations
• Types de noeuds
• Consolider
le terme
  Options  
             

  Filtrage type relations : +   - (ex: 4, 12, 18, 36, 444, 555, 777)
  Filtrage valeur :          min   max
  Filtrage type noeuds :   +   - (ex: 4, 6, 8, 9, 10, 12, 18, 36, 444, 555, 777)

  Présentation de sortie :   (ex: -rien-, cloud, nicecloud)
 

'en:Hodgkin lymphoma'
(id=15413897 ; fe=en:Hodgkin lymphoma ; type=1 ; niveau=200 ; luminosité=25 ; somme entrante=27873 creation date=2020-10-17 touchdate=2025-07-23 11:01:15.000)
≈ 1866 relations sortantes

  1. en:Hodgkin lymphoma -- r_associated #0: 226 / 1 -> médecine
    n1=en:Hodgkin lymphoma | n2=médecine | rel=r_associated | relid=0 | w=226
  2. en:Hodgkin lymphoma -- r_associated #0: 210 / 0.929 -> cancer
    n1=en:Hodgkin lymphoma | n2=cancer | rel=r_associated | relid=0 | w=210
  3. en:Hodgkin lymphoma -- r_associated #0: 210 / 0.929 -> cancer de la rate
    n1=en:Hodgkin lymphoma | n2=cancer de la rate | rel=r_associated | relid=0 | w=210
  4. en:Hodgkin lymphoma -- r_associated #0: 210 / 0.929 -> cancer splénique
    n1=en:Hodgkin lymphoma | n2=cancer splénique | rel=r_associated | relid=0 | w=210
  5. en:Hodgkin lymphoma -- r_associated #0: 210 / 0.929 -> en:hodgkin disease
    n1=en:Hodgkin lymphoma | n2=en:hodgkin disease | rel=r_associated | relid=0 | w=210
  6. en:Hodgkin lymphoma -- r_associated #0: 210 / 0.929 -> en:hodgkin lymphoma
    n1=en:Hodgkin lymphoma | n2=en:hodgkin lymphoma | rel=r_associated | relid=0 | w=210
  7. en:Hodgkin lymphoma -- r_associated #0: 210 / 0.929 -> en:malignant splenic neoplasm
    n1=en:Hodgkin lymphoma | n2=en:malignant splenic neoplasm | rel=r_associated | relid=0 | w=210
  8. en:Hodgkin lymphoma -- r_associated #0: 210 / 0.929 -> granulomatose
    n1=en:Hodgkin lymphoma | n2=granulomatose | rel=r_associated | relid=0 | w=210
  9. en:Hodgkin lymphoma -- r_associated #0: 210 / 0.929 -> granulome de hodgkin
    n1=en:Hodgkin lymphoma | n2=granulome de hodgkin | rel=r_associated | relid=0 | w=210
  10. en:Hodgkin lymphoma -- r_associated #0: 210 / 0.929 -> hémopathie maligne
    n1=en:Hodgkin lymphoma | n2=hémopathie maligne | rel=r_associated | relid=0 | w=210
  11. en:Hodgkin lymphoma -- r_associated #0: 210 / 0.929 -> Hodgkin
    n1=en:Hodgkin lymphoma | n2=Hodgkin | rel=r_associated | relid=0 | w=210
  12. en:Hodgkin lymphoma -- r_associated #0: 210 / 0.929 -> lymphocytes B
    n1=en:Hodgkin lymphoma | n2=lymphocytes B | rel=r_associated | relid=0 | w=210
  13. en:Hodgkin lymphoma -- r_associated #0: 210 / 0.929 -> lymphogranulomatose
    n1=en:Hodgkin lymphoma | n2=lymphogranulomatose | rel=r_associated | relid=0 | w=210
  14. en:Hodgkin lymphoma -- r_associated #0: 210 / 0.929 -> lymphogranulomatose maligne
    n1=en:Hodgkin lymphoma | n2=lymphogranulomatose maligne | rel=r_associated | relid=0 | w=210
  15. en:Hodgkin lymphoma -- r_associated #0: 210 / 0.929 -> lymphome
    n1=en:Hodgkin lymphoma | n2=lymphome | rel=r_associated | relid=0 | w=210
  16. en:Hodgkin lymphoma -- r_associated #0: 210 / 0.929 -> lymphome de hodgkin
    n1=en:Hodgkin lymphoma | n2=lymphome de hodgkin | rel=r_associated | relid=0 | w=210
  17. en:Hodgkin lymphoma -- r_associated #0: 210 / 0.929 -> lymphome malin hodgkinien
    n1=en:Hodgkin lymphoma | n2=lymphome malin hodgkinien | rel=r_associated | relid=0 | w=210
  18. en:Hodgkin lymphoma -- r_associated #0: 210 / 0.929 -> maladie
    n1=en:Hodgkin lymphoma | n2=maladie | rel=r_associated | relid=0 | w=210
  19. en:Hodgkin lymphoma -- r_associated #0: 210 / 0.929 -> maladie d'hodgkin
    n1=en:Hodgkin lymphoma | n2=maladie d'hodgkin | rel=r_associated | relid=0 | w=210
  20. en:Hodgkin lymphoma -- r_associated #0: 210 / 0.929 -> maladie de
    n1=en:Hodgkin lymphoma | n2=maladie de | rel=r_associated | relid=0 | w=210
  21. en:Hodgkin lymphoma -- r_associated #0: 210 / 0.929 -> maladie
    (médecine)
    n1=en:Hodgkin lymphoma | n2=maladie
    (médecine)
    | rel=r_associated | relid=0 | w=210
  22. en:Hodgkin lymphoma -- r_associated #0: 210 / 0.929 -> maladies
    n1=en:Hodgkin lymphoma | n2=maladies | rel=r_associated | relid=0 | w=210
  23. en:Hodgkin lymphoma -- r_associated #0: 210 / 0.929 -> maladies d'hodgkin
    n1=en:Hodgkin lymphoma | n2=maladies d'hodgkin | rel=r_associated | relid=0 | w=210
  24. en:Hodgkin lymphoma -- r_associated #0: 210 / 0.929 -> MDH
    n1=en:Hodgkin lymphoma | n2=MDH | rel=r_associated | relid=0 | w=210
  25. en:Hodgkin lymphoma -- r_associated #0: 210 / 0.929 -> médecine spécialisée
    n1=en:Hodgkin lymphoma | n2=médecine spécialisée | rel=r_associated | relid=0 | w=210
  26. en:Hodgkin lymphoma -- r_associated #0: 210 / 0.929 -> paragranulome de hodgkin
    n1=en:Hodgkin lymphoma | n2=paragranulome de hodgkin | rel=r_associated | relid=0 | w=210
  27. en:Hodgkin lymphoma -- r_associated #0: 210 / 0.929 -> processus pathologique
    n1=en:Hodgkin lymphoma | n2=processus pathologique | rel=r_associated | relid=0 | w=210
  28. en:Hodgkin lymphoma -- r_associated #0: 210 / 0.929 -> spécialités médicales
    n1=en:Hodgkin lymphoma | n2=spécialités médicales | rel=r_associated | relid=0 | w=210
  29. en:Hodgkin lymphoma -- r_associated #0: 210 / 0.929 -> tumeur de la rate
    n1=en:Hodgkin lymphoma | n2=tumeur de la rate | rel=r_associated | relid=0 | w=210
  30. en:Hodgkin lymphoma -- r_associated #0: 210 / 0.929 -> tumeur maligne de la rate
    n1=en:Hodgkin lymphoma | n2=tumeur maligne de la rate | rel=r_associated | relid=0 | w=210
  31. en:Hodgkin lymphoma -- r_associated #0: 210 / 0.929 -> tumeur maligne splénique
    n1=en:Hodgkin lymphoma | n2=tumeur maligne splénique | rel=r_associated | relid=0 | w=210
  32. en:Hodgkin lymphoma -- r_associated #0: 210 / 0.929 -> tumeurs de la rate
    n1=en:Hodgkin lymphoma | n2=tumeurs de la rate | rel=r_associated | relid=0 | w=210
  33. en:Hodgkin lymphoma -- r_associated #0: 135 / 0.597 -> type de cancer
    n1=en:Hodgkin lymphoma | n2=type de cancer | rel=r_associated | relid=0 | w=135
  34. en:Hodgkin lymphoma -- r_associated #0: 70 / 0.31 -> lymphome hodgkinien
    n1=en:Hodgkin lymphoma | n2=lymphome hodgkinien | rel=r_associated | relid=0 | w=70
  35. en:Hodgkin lymphoma -- r_associated #0: 65 / 0.288 -> lymphomes hodgkiniens
    n1=en:Hodgkin lymphoma | n2=lymphomes hodgkiniens | rel=r_associated | relid=0 | w=65
  36. en:Hodgkin lymphoma -- r_associated #0: 65 / 0.288 -> sarcome de hodgkin
    n1=en:Hodgkin lymphoma | n2=sarcome de hodgkin | rel=r_associated | relid=0 | w=65
  37. en:Hodgkin lymphoma -- r_associated #0: 65 / 0.288 -> type non précisé maladie de hodgkin
    n1=en:Hodgkin lymphoma | n2=type non précisé maladie de hodgkin | rel=r_associated | relid=0 | w=65
  38. en:Hodgkin lymphoma -- r_associated #0: 58 / 0.257 -> angéite associée à des cancers
    n1=en:Hodgkin lymphoma | n2=angéite associée à des cancers | rel=r_associated | relid=0 | w=58
  39. en:Hodgkin lymphoma -- r_associated #0: 55 / 0.243 -> adénopathie
    n1=en:Hodgkin lymphoma | n2=adénopathie | rel=r_associated | relid=0 | w=55
  40. en:Hodgkin lymphoma -- r_associated #0: 55 / 0.243 -> cancer du système lymphatique
    n1=en:Hodgkin lymphoma | n2=cancer du système lymphatique | rel=r_associated | relid=0 | w=55
  41. en:Hodgkin lymphoma -- r_associated #0: 55 / 0.243 -> cellule de Reed-Sternberg
    n1=en:Hodgkin lymphoma | n2=cellule de Reed-Sternberg | rel=r_associated | relid=0 | w=55
  42. en:Hodgkin lymphoma -- r_associated #0: 55 / 0.243 -> hématologie
    n1=en:Hodgkin lymphoma | n2=hématologie | rel=r_associated | relid=0 | w=55
  43. en:Hodgkin lymphoma -- r_associated #0: 44 / 0.195 -> sarcome hodgkinien (obs)
    n1=en:Hodgkin lymphoma | n2=sarcome hodgkinien (obs) | rel=r_associated | relid=0 | w=44
  44. en:Hodgkin lymphoma -- r_associated #0: 43 / 0.19 -> lymphome hodgkinien, sai
    n1=en:Hodgkin lymphoma | n2=lymphome hodgkinien, sai | rel=r_associated | relid=0 | w=43
  45. en:Hodgkin lymphoma -- r_associated #0: 42 / 0.186 -> 965-966 lymphome de hodgkin
    n1=en:Hodgkin lymphoma | n2=965-966 lymphome de hodgkin | rel=r_associated | relid=0 | w=42
  46. en:Hodgkin lymphoma -- r_associated #0: 41 / 0.181 -> maladie de hodgkin, site non précisé
    n1=en:Hodgkin lymphoma | n2=maladie de hodgkin, site non précisé | rel=r_associated | relid=0 | w=41
  47. en:Hodgkin lymphoma -- r_associated #0: 40 / 0.177 -> hodgkin
    n1=en:Hodgkin lymphoma | n2=hodgkin | rel=r_associated | relid=0 | w=40
  48. en:Hodgkin lymphoma -- r_associated #0: 40 / 0.177 -> Hodgkin (localisations cutanées de la maladie de)
    n1=en:Hodgkin lymphoma | n2=Hodgkin (localisations cutanées de la maladie de) | rel=r_associated | relid=0 | w=40
  49. en:Hodgkin lymphoma -- r_associated #0: 40 / 0.177 -> Hodgkin à prédominance lymphocytaire nodulaire (maladie de)
    n1=en:Hodgkin lymphoma | n2=Hodgkin à prédominance lymphocytaire nodulaire (maladie de) | rel=r_associated | relid=0 | w=40
  50. en:Hodgkin lymphoma -- r_associated #0: 40 / 0.177 -> lymphome hodgkinien médiastinal
    n1=en:Hodgkin lymphoma | n2=lymphome hodgkinien médiastinal | rel=r_associated | relid=0 | w=40
  51. en:Hodgkin lymphoma -- r_associated #0: 40 / 0.177 -> maladie de hodgkin, sai
    n1=en:Hodgkin lymphoma | n2=maladie de hodgkin, sai | rel=r_associated | relid=0 | w=40
  52. en:Hodgkin lymphoma -- r_associated #0: 40 / 0.177 -> paragranulome nodulaire
    n1=en:Hodgkin lymphoma | n2=paragranulome nodulaire | rel=r_associated | relid=0 | w=40
  53. en:Hodgkin lymphoma -- r_associated #0: 40 / 0.177 -> Sternberg (cellule de)
    n1=en:Hodgkin lymphoma | n2=Sternberg (cellule de) | rel=r_associated | relid=0 | w=40
  54. en:Hodgkin lymphoma -- r_associated #0: 35 / 0.155 -> Hodgkin (maladie de)
    n1=en:Hodgkin lymphoma | n2=Hodgkin (maladie de) | rel=r_associated | relid=0 | w=35
  55. en:Hodgkin lymphoma -- r_associated #0: 35 / 0.155 -> lymphome non hodgkinien
    n1=en:Hodgkin lymphoma | n2=lymphome non hodgkinien | rel=r_associated | relid=0 | w=35
  56. en:Hodgkin lymphoma -- r_associated #0: 35 / 0.155 -> maladie de Hodgkin
    n1=en:Hodgkin lymphoma | n2=maladie de Hodgkin | rel=r_associated | relid=0 | w=35
  57. en:Hodgkin lymphoma -- r_associated #0: 34 / 0.15 -> en:malignant lymphogranulomatosis
    n1=en:Hodgkin lymphoma | n2=en:malignant lymphogranulomatosis | rel=r_associated | relid=0 | w=34
  58. en:Hodgkin lymphoma -- r_associated #0: 31 / 0.137 -> en:Hodgkin's disease
    n1=en:Hodgkin lymphoma | n2=en:Hodgkin's disease | rel=r_associated | relid=0 | w=31
  59. en:Hodgkin lymphoma -- r_associated #0: 30 / 0.133 -> en:abdominal tumors (immunodeficiency-associated form)
    n1=en:Hodgkin lymphoma | n2=en:abdominal tumors (immunodeficiency-associated form) | rel=r_associated | relid=0 | w=30
  60. en:Hodgkin lymphoma -- r_associated #0: 30 / 0.133 -> en:acquired deformity of limb
    n1=en:Hodgkin lymphoma | n2=en:acquired deformity of limb | rel=r_associated | relid=0 | w=30
  61. en:Hodgkin lymphoma -- r_associated #0: 30 / 0.133 -> en:adrenal cortex carcinoma
    n1=en:Hodgkin lymphoma | n2=en:adrenal cortex carcinoma | rel=r_associated | relid=0 | w=30
  62. en:Hodgkin lymphoma -- r_associated #0: 30 / 0.133 -> en:alveolar rhabdomyosarcoma
    n1=en:Hodgkin lymphoma | n2=en:alveolar rhabdomyosarcoma | rel=r_associated | relid=0 | w=30
  63. en:Hodgkin lymphoma -- r_associated #0: 30 / 0.133 -> en:ameloblastic fibrosarcoma
    n1=en:Hodgkin lymphoma | n2=en:ameloblastic fibrosarcoma | rel=r_associated | relid=0 | w=30
  64. en:Hodgkin lymphoma -- r_associated #0: 30 / 0.133 -> en:anaplastic large cell lymphoma
    n1=en:Hodgkin lymphoma | n2=en:anaplastic large cell lymphoma | rel=r_associated | relid=0 | w=30
  65. en:Hodgkin lymphoma -- r_associated #0: 30 / 0.133 -> en:anatomic structures
    n1=en:Hodgkin lymphoma | n2=en:anatomic structures | rel=r_associated | relid=0 | w=30
  66. en:Hodgkin lymphoma -- r_associated #0: 30 / 0.133 -> en:angiomyoliposarcoma
    n1=en:Hodgkin lymphoma | n2=en:angiomyoliposarcoma | rel=r_associated | relid=0 | w=30
  67. en:Hodgkin lymphoma -- r_associated #0: 30 / 0.133 -> en:asthma
    n1=en:Hodgkin lymphoma | n2=en:asthma | rel=r_associated | relid=0 | w=30
  68. en:Hodgkin lymphoma -- r_associated #0: 30 / 0.133 -> en:atypical medullary carcinoma
    n1=en:Hodgkin lymphoma | n2=en:atypical medullary carcinoma | rel=r_associated | relid=0 | w=30
  69. en:Hodgkin lymphoma -- r_associated #0: 30 / 0.133 -> en:balanitis
    n1=en:Hodgkin lymphoma | n2=en:balanitis | rel=r_associated | relid=0 | w=30
  70. en:Hodgkin lymphoma -- r_associated #0: 30 / 0.133 -> en:benign urinary system neoplasm
    n1=en:Hodgkin lymphoma | n2=en:benign urinary system neoplasm | rel=r_associated | relid=0 | w=30
  71. en:Hodgkin lymphoma -- r_associated #0: 30 / 0.133 -> en:biliary tract neoplasm
    n1=en:Hodgkin lymphoma | n2=en:biliary tract neoplasm | rel=r_associated | relid=0 | w=30
  72. en:Hodgkin lymphoma -- r_associated #0: 30 / 0.133 -> en:brain neoplasm
    n1=en:Hodgkin lymphoma | n2=en:brain neoplasm | rel=r_associated | relid=0 | w=30
  73. en:Hodgkin lymphoma -- r_associated #0: 30 / 0.133 -> en:cancer alternative therapies
    n1=en:Hodgkin lymphoma | n2=en:cancer alternative therapies | rel=r_associated | relid=0 | w=30
  74. en:Hodgkin lymphoma -- r_associated #0: 30 / 0.133 -> en:cancer of nose
    n1=en:Hodgkin lymphoma | n2=en:cancer of nose | rel=r_associated | relid=0 | w=30
  75. en:Hodgkin lymphoma -- r_associated #0: 30 / 0.133 -> en:carcinoma of lip, oral cavity and pharynx
    n1=en:Hodgkin lymphoma | n2=en:carcinoma of lip, oral cavity and pharynx | rel=r_associated | relid=0 | w=30
  76. en:Hodgkin lymphoma -- r_associated #0: 30 / 0.133 -> en:carcinoma with osteoclast-like giant cells
    n1=en:Hodgkin lymphoma | n2=en:carcinoma with osteoclast-like giant cells | rel=r_associated | relid=0 | w=30
  77. en:Hodgkin lymphoma -- r_associated #0: 30 / 0.133 -> en:cellular morphology
    n1=en:Hodgkin lymphoma | n2=en:cellular morphology | rel=r_associated | relid=0 | w=30
  78. en:Hodgkin lymphoma -- r_associated #0: 30 / 0.133 -> en:cerebral lymphoma
    n1=en:Hodgkin lymphoma | n2=en:cerebral lymphoma | rel=r_associated | relid=0 | w=30
  79. en:Hodgkin lymphoma -- r_associated #0: 30 / 0.133 -> en:chondrosarcoma
    n1=en:Hodgkin lymphoma | n2=en:chondrosarcoma | rel=r_associated | relid=0 | w=30
  80. en:Hodgkin lymphoma -- r_associated #0: 30 / 0.133 -> en:chordoma
    n1=en:Hodgkin lymphoma | n2=en:chordoma | rel=r_associated | relid=0 | w=30
  81. en:Hodgkin lymphoma -- r_associated #0: 30 / 0.133 -> en:chronic lymphocytic leukemia
    n1=en:Hodgkin lymphoma | n2=en:chronic lymphocytic leukemia | rel=r_associated | relid=0 | w=30
  82. en:Hodgkin lymphoma -- r_associated #0: 30 / 0.133 -> en:clip1 wt allele
    n1=en:Hodgkin lymphoma | n2=en:clip1 wt allele | rel=r_associated | relid=0 | w=30
  83. en:Hodgkin lymphoma -- r_associated #0: 30 / 0.133 -> en:coagulopathies and bleeding diatheses (excl thrombocytopenic)
    n1=en:Hodgkin lymphoma | n2=en:coagulopathies and bleeding diatheses (excl thrombocytopenic) | rel=r_associated | relid=0 | w=30
  84. en:Hodgkin lymphoma -- r_associated #0: 30 / 0.133 -> en:colorectal cancer (in some patients)
    n1=en:Hodgkin lymphoma | n2=en:colorectal cancer (in some patients) | rel=r_associated | relid=0 | w=30
  85. en:Hodgkin lymphoma -- r_associated #0: 30 / 0.133 -> en:concussion
    n1=en:Hodgkin lymphoma | n2=en:concussion | rel=r_associated | relid=0 | w=30
  86. en:Hodgkin lymphoma -- r_associated #0: 30 / 0.133 -> en:condylomata acuminata in women
    n1=en:Hodgkin lymphoma | n2=en:condylomata acuminata in women | rel=r_associated | relid=0 | w=30
  87. en:Hodgkin lymphoma -- r_associated #0: 30 / 0.133 -> en:congenital abnormality
    n1=en:Hodgkin lymphoma | n2=en:congenital abnormality | rel=r_associated | relid=0 | w=30
  88. en:Hodgkin lymphoma -- r_associated #0: 30 / 0.133 -> en:congenital anomaly of female genital system
    n1=en:Hodgkin lymphoma | n2=en:congenital anomaly of female genital system | rel=r_associated | relid=0 | w=30
  89. en:Hodgkin lymphoma -- r_associated #0: 30 / 0.133 -> en:congenital mesh qualifier
    n1=en:Hodgkin lymphoma | n2=en:congenital mesh qualifier | rel=r_associated | relid=0 | w=30
  90. en:Hodgkin lymphoma -- r_associated #0: 30 / 0.133 -> en:cutaneous leiomyosarcoma (less common)
    n1=en:Hodgkin lymphoma | n2=en:cutaneous leiomyosarcoma (less common) | rel=r_associated | relid=0 | w=30
  91. en:Hodgkin lymphoma -- r_associated #0: 30 / 0.133 -> en:cyst
    n1=en:Hodgkin lymphoma | n2=en:cyst | rel=r_associated | relid=0 | w=30
  92. en:Hodgkin lymphoma -- r_associated #0: 30 / 0.133 -> en:digestive system neoplasms
    n1=en:Hodgkin lymphoma | n2=en:digestive system neoplasms | rel=r_associated | relid=0 | w=30
  93. en:Hodgkin lymphoma -- r_associated #0: 30 / 0.133 -> en:duct carcinoma, desmoplastic type
    n1=en:Hodgkin lymphoma | n2=en:duct carcinoma, desmoplastic type | rel=r_associated | relid=0 | w=30
  94. en:Hodgkin lymphoma -- r_associated #0: 30 / 0.133 -> en:endocrine neoplasms malignant and unspecified
    n1=en:Hodgkin lymphoma | n2=en:endocrine neoplasms malignant and unspecified | rel=r_associated | relid=0 | w=30
  95. en:Hodgkin lymphoma -- r_associated #0: 30 / 0.133 -> en:environment related neoplasm/cancer
    n1=en:Hodgkin lymphoma | n2=en:environment related neoplasm/cancer | rel=r_associated | relid=0 | w=30
  96. en:Hodgkin lymphoma -- r_associated #0: 30 / 0.133 -> en:esophageal disorder
    n1=en:Hodgkin lymphoma | n2=en:esophageal disorder | rel=r_associated | relid=0 | w=30
  97. en:Hodgkin lymphoma -- r_associated #0: 30 / 0.133 -> en:eye neoplasm
    n1=en:Hodgkin lymphoma | n2=en:eye neoplasm | rel=r_associated | relid=0 | w=30
  98. en:Hodgkin lymphoma -- r_associated #0: 30 / 0.133 -> en:facial nerve palsy
    n1=en:Hodgkin lymphoma | n2=en:facial nerve palsy | rel=r_associated | relid=0 | w=30
  99. en:Hodgkin lymphoma -- r_associated #0: 30 / 0.133 -> en:fibroelastoma
    n1=en:Hodgkin lymphoma | n2=en:fibroelastoma | rel=r_associated | relid=0 | w=30
  100. en:Hodgkin lymphoma -- r_associated #0: 30 / 0.133 -> en:follicular lymphoma
    n1=en:Hodgkin lymphoma | n2=en:follicular lymphoma | rel=r_associated | relid=0 | w=30
  101. en:Hodgkin lymphoma -- r_associated #0: 30 / 0.133 -> en:glioblastoma
    n1=en:Hodgkin lymphoma | n2=en:glioblastoma | rel=r_associated | relid=0 | w=30
  102. en:Hodgkin lymphoma -- r_associated #0: 30 / 0.133 -> en:head and neck paraganglioma
    n1=en:Hodgkin lymphoma | n2=en:head and neck paraganglioma | rel=r_associated | relid=0 | w=30
  103. en:Hodgkin lymphoma -- r_associated #0: 30 / 0.133 -> en:hematopoietic and lymphoid system disorder
    n1=en:Hodgkin lymphoma | n2=en:hematopoietic and lymphoid system disorder | rel=r_associated | relid=0 | w=30
  104. en:Hodgkin lymphoma -- r_associated #0: 30 / 0.133 -> en:hematopoietic and lymphoid tissue
    n1=en:Hodgkin lymphoma | n2=en:hematopoietic and lymphoid tissue | rel=r_associated | relid=0 | w=30
  105. en:Hodgkin lymphoma -- r_associated #0: 30 / 0.133 -> en:hepatocellular carcinoma
    n1=en:Hodgkin lymphoma | n2=en:hepatocellular carcinoma | rel=r_associated | relid=0 | w=30
  106. en:Hodgkin lymphoma -- r_associated #0: 30 / 0.133 -> en:high grade surface osteosarcoma
    n1=en:Hodgkin lymphoma | n2=en:high grade surface osteosarcoma | rel=r_associated | relid=0 | w=30
  107. en:Hodgkin lymphoma -- r_associated #0: 30 / 0.133 -> en:high risk gastrointestinal stromal tumor
    n1=en:Hodgkin lymphoma | n2=en:high risk gastrointestinal stromal tumor | rel=r_associated | relid=0 | w=30
  108. en:Hodgkin lymphoma -- r_associated #0: 30 / 0.133 -> en:histiocytic sarcoma
    n1=en:Hodgkin lymphoma | n2=en:histiocytic sarcoma | rel=r_associated | relid=0 | w=30
  109. en:Hodgkin lymphoma -- r_associated #0: 30 / 0.133 -> en:hodgkin-like post-transplant lymphoproliferative disorder
    n1=en:Hodgkin lymphoma | n2=en:hodgkin-like post-transplant lymphoproliferative disorder | rel=r_associated | relid=0 | w=30
  110. en:Hodgkin lymphoma -- r_associated #0: 30 / 0.133 -> en:hodgkin's disease of intra-abdominal lymph nodes
    n1=en:Hodgkin lymphoma | n2=en:hodgkin's disease of intra-abdominal lymph nodes | rel=r_associated | relid=0 | w=30
  111. en:Hodgkin lymphoma -- r_associated #0: 30 / 0.133 -> en:hodgkin's disease of lymph nodes of axilla and/or upper limb
    n1=en:Hodgkin lymphoma | n2=en:hodgkin's disease of lymph nodes of axilla and/or upper limb | rel=r_associated | relid=0 | w=30
  112. en:Hodgkin lymphoma -- r_associated #0: 30 / 0.133 -> en:hodgkin's disease unclassifiable
    n1=en:Hodgkin lymphoma | n2=en:hodgkin's disease unclassifiable | rel=r_associated | relid=0 | w=30
  113. en:Hodgkin lymphoma -- r_associated #0: 30 / 0.133 -> en:hodgkin's disease, lymphocytic-histiocytic predominance of intra-abdominal lymph nodes
    n1=en:Hodgkin lymphoma | n2=en:hodgkin's disease, lymphocytic-histiocytic predominance of intra-abdominal lymph nodes | rel=r_associated | relid=0 | w=30
  114. en:Hodgkin lymphoma -- r_associated #0: 30 / 0.133 -> en:hodgkin's disease, mixed cellularity of lymph nodes of head, face and neck
    n1=en:Hodgkin lymphoma | n2=en:hodgkin's disease, mixed cellularity of lymph nodes of head, face and neck | rel=r_associated | relid=0 | w=30
  115. en:Hodgkin lymphoma -- r_associated #0: 30 / 0.133 -> en:hodgkin's granuloma of lymph nodes of inguinal region and lower limb
    n1=en:Hodgkin lymphoma | n2=en:hodgkin's granuloma of lymph nodes of inguinal region and lower limb | rel=r_associated | relid=0 | w=30
  116. en:Hodgkin lymphoma -- r_associated #0: 30 / 0.133 -> en:hodgkin's paragranuloma of intrathoracic lymph nodes
    n1=en:Hodgkin lymphoma | n2=en:hodgkin's paragranuloma of intrathoracic lymph nodes | rel=r_associated | relid=0 | w=30
  117. en:Hodgkin lymphoma -- r_associated #0: 30 / 0.133 -> en:hodgkin's sarcoma of lymph nodes of axilla and/or upper limb
    n1=en:Hodgkin lymphoma | n2=en:hodgkin's sarcoma of lymph nodes of axilla and/or upper limb | rel=r_associated | relid=0 | w=30
  118. en:Hodgkin lymphoma -- r_associated #0: 30 / 0.133 -> en:hypersensitivity
    n1=en:Hodgkin lymphoma | n2=en:hypersensitivity | rel=r_associated | relid=0 | w=30
  119. en:Hodgkin lymphoma -- r_associated #0: 30 / 0.133 -> en:immunization
    n1=en:Hodgkin lymphoma | n2=en:immunization | rel=r_associated | relid=0 | w=30
  120. en:Hodgkin lymphoma -- r_associated #0: 30 / 0.133 -> en:immunoproliferative disorders
    n1=en:Hodgkin lymphoma | n2=en:immunoproliferative disorders | rel=r_associated | relid=0 | w=30
  121. en:Hodgkin lymphoma -- r_associated #0: 30 / 0.133 -> en:increased risk for wilms tumor
    n1=en:Hodgkin lymphoma | n2=en:increased risk for wilms tumor | rel=r_associated | relid=0 | w=30
  122. en:Hodgkin lymphoma -- r_associated #0: 30 / 0.133 -> en:increased risk of malignancy (classic feature)
    n1=en:Hodgkin lymphoma | n2=en:increased risk of malignancy (classic feature) | rel=r_associated | relid=0 | w=30
  123. en:Hodgkin lymphoma -- r_associated #0: 30 / 0.133 -> en:increased risk of medulloblastoma (rare)
    n1=en:Hodgkin lymphoma | n2=en:increased risk of medulloblastoma (rare) | rel=r_associated | relid=0 | w=30
  124. en:Hodgkin lymphoma -- r_associated #0: 30 / 0.133 -> en:increased risk of myelodysplastic syndromes
    n1=en:Hodgkin lymphoma | n2=en:increased risk of myelodysplastic syndromes | rel=r_associated | relid=0 | w=30
  125. en:Hodgkin lymphoma -- r_associated #0: 30 / 0.133 -> en:increased susceptibility to cancer
    n1=en:Hodgkin lymphoma | n2=en:increased susceptibility to cancer | rel=r_associated | relid=0 | w=30
  126. en:Hodgkin lymphoma -- r_associated #0: 30 / 0.133 -> en:increased susceptibility to large granular lymphocytic t-cell leukemia
    n1=en:Hodgkin lymphoma | n2=en:increased susceptibility to large granular lymphocytic t-cell leukemia | rel=r_associated | relid=0 | w=30
  127. en:Hodgkin lymphoma -- r_associated #0: 30 / 0.133 -> en:infectious diarrhea/dysentery
    n1=en:Hodgkin lymphoma | n2=en:infectious diarrhea/dysentery | rel=r_associated | relid=0 | w=30
  128. en:Hodgkin lymphoma -- r_associated #0: 30 / 0.133 -> en:inguinal hernia
    n1=en:Hodgkin lymphoma | n2=en:inguinal hernia | rel=r_associated | relid=0 | w=30
  129. en:Hodgkin lymphoma -- r_associated #0: 30 / 0.133 -> en:irritable bowel syndrome
    n1=en:Hodgkin lymphoma | n2=en:irritable bowel syndrome | rel=r_associated | relid=0 | w=30
  130. en:Hodgkin lymphoma -- r_associated #0: 30 / 0.133 -> en:jugulotympanic paraganglioma
    n1=en:Hodgkin lymphoma | n2=en:jugulotympanic paraganglioma | rel=r_associated | relid=0 | w=30
  131. en:Hodgkin lymphoma -- r_associated #0: 30 / 0.133 -> en:klhdc8b, 5-prime utr, +28c-t
    n1=en:Hodgkin lymphoma | n2=en:klhdc8b, 5-prime utr, +28c-t | rel=r_associated | relid=0 | w=30
  132. en:Hodgkin lymphoma -- r_associated #0: 30 / 0.133 -> en:large cell neuroendocrine carcinoma
    n1=en:Hodgkin lymphoma | n2=en:large cell neuroendocrine carcinoma | rel=r_associated | relid=0 | w=30
  133. en:Hodgkin lymphoma -- r_associated #0: 30 / 0.133 -> en:lateral epicondylitis
    n1=en:Hodgkin lymphoma | n2=en:lateral epicondylitis | rel=r_associated | relid=0 | w=30
  134. en:Hodgkin lymphoma -- r_associated #0: 30 / 0.133 -> en:leukemia (both all and aml)
    n1=en:Hodgkin lymphoma | n2=en:leukemia (both all and aml) | rel=r_associated | relid=0 | w=30
  135. en:Hodgkin lymphoma -- r_associated #0: 30 / 0.133 -> en:lipid metabolism disorder
    n1=en:Hodgkin lymphoma | n2=en:lipid metabolism disorder | rel=r_associated | relid=0 | w=30
  136. en:Hodgkin lymphoma -- r_associated #0: 30 / 0.133 -> en:low grade fibromyxoid sarcoma
    n1=en:Hodgkin lymphoma | n2=en:low grade fibromyxoid sarcoma | rel=r_associated | relid=0 | w=30
  137. en:Hodgkin lymphoma -- r_associated #0: 30 / 0.133 -> en:lund
    n1=en:Hodgkin lymphoma | n2=en:lund | rel=r_associated | relid=0 | w=30
  138. en:Hodgkin lymphoma -- r_associated #0: 30 / 0.133 -> en:lupus erythematosus
    n1=en:Hodgkin lymphoma | n2=en:lupus erythematosus | rel=r_associated | relid=0 | w=30
  139. en:Hodgkin lymphoma -- r_associated #0: 30 / 0.133 -> en:lymph node disorder
    n1=en:Hodgkin lymphoma | n2=en:lymph node disorder | rel=r_associated | relid=0 | w=30
  140. en:Hodgkin lymphoma -- r_associated #0: 30 / 0.133 -> en:lymphomatoid papulosis
    n1=en:Hodgkin lymphoma | n2=en:lymphomatoid papulosis | rel=r_associated | relid=0 | w=30
  141. en:Hodgkin lymphoma -- r_associated #0: 30 / 0.133 -> en:lymphosarcoma and reticulosarcoma and other specified malignant tumors of lymphatic tissue
    n1=en:Hodgkin lymphoma | n2=en:lymphosarcoma and reticulosarcoma and other specified malignant tumors of lymphatic tissue | rel=r_associated | relid=0 | w=30
  142. en:Hodgkin lymphoma -- r_associated #0: 30 / 0.133 -> en:macular degeneration
    n1=en:Hodgkin lymphoma | n2=en:macular degeneration | rel=r_associated | relid=0 | w=30
  143. en:Hodgkin lymphoma -- r_associated #0: 30 / 0.133 -> en:malignancy in approximately 10%
    n1=en:Hodgkin lymphoma | n2=en:malignancy in approximately 10% | rel=r_associated | relid=0 | w=30
  144. en:Hodgkin lymphoma -- r_associated #0: 30 / 0.133 -> en:malignant esophageal neoplasm
    n1=en:Hodgkin lymphoma | n2=en:malignant esophageal neoplasm | rel=r_associated | relid=0 | w=30
  145. en:Hodgkin lymphoma -- r_associated #0: 30 / 0.133 -> en:malignant fibrous histiocytoma (in about 35% of patients)
    n1=en:Hodgkin lymphoma | n2=en:malignant fibrous histiocytoma (in about 35% of patients) | rel=r_associated | relid=0 | w=30
  146. en:Hodgkin lymphoma -- r_associated #0: 30 / 0.133 -> en:malignant histiocytosis
    n1=en:Hodgkin lymphoma | n2=en:malignant histiocytosis | rel=r_associated | relid=0 | w=30
  147. en:Hodgkin lymphoma -- r_associated #0: 30 / 0.133 -> en:malignant immunoproliferative neoplasm
    n1=en:Hodgkin lymphoma | n2=en:malignant immunoproliferative neoplasm | rel=r_associated | relid=0 | w=30
  148. en:Hodgkin lymphoma -- r_associated #0: 30 / 0.133 -> en:malignant lymph node neoplasm
    n1=en:Hodgkin lymphoma | n2=en:malignant lymph node neoplasm | rel=r_associated | relid=0 | w=30
  149. en:Hodgkin lymphoma -- r_associated #0: 30 / 0.133 -> en:malignant mixed tumor, chondrosarcomatous type
    n1=en:Hodgkin lymphoma | n2=en:malignant mixed tumor, chondrosarcomatous type | rel=r_associated | relid=0 | w=30
  150. en:Hodgkin lymphoma -- r_associated #0: 30 / 0.133 -> en:malignant muscle neoplasm
    n1=en:Hodgkin lymphoma | n2=en:malignant muscle neoplasm | rel=r_associated | relid=0 | w=30
  151. en:Hodgkin lymphoma -- r_associated #0: 30 / 0.133 -> en:malignant neoplasm after immunosuppressive therapy
    n1=en:Hodgkin lymphoma | n2=en:malignant neoplasm after immunosuppressive therapy | rel=r_associated | relid=0 | w=30
  152. en:Hodgkin lymphoma -- r_associated #0: 30 / 0.133 -> en:malignant neoplasm of colon with rectum
    n1=en:Hodgkin lymphoma | n2=en:malignant neoplasm of colon with rectum | rel=r_associated | relid=0 | w=30
  153. en:Hodgkin lymphoma -- r_associated #0: 30 / 0.133 -> en:malignant neoplasm of pelvis
    n1=en:Hodgkin lymphoma | n2=en:malignant neoplasm of pelvis | rel=r_associated | relid=0 | w=30
  154. en:Hodgkin lymphoma -- r_associated #0: 30 / 0.133 -> en:malignant neuroendocrine neoplasm, epithelial
    n1=en:Hodgkin lymphoma | n2=en:malignant neuroendocrine neoplasm, epithelial | rel=r_associated | relid=0 | w=30
  155. en:Hodgkin lymphoma -- r_associated #0: 30 / 0.133 -> en:malignant odontogenic ghost cell tumor
    n1=en:Hodgkin lymphoma | n2=en:malignant odontogenic ghost cell tumor | rel=r_associated | relid=0 | w=30
  156. en:Hodgkin lymphoma -- r_associated #0: 30 / 0.133 -> en:malignant ovarian neoplasm
    n1=en:Hodgkin lymphoma | n2=en:malignant ovarian neoplasm | rel=r_associated | relid=0 | w=30
  157. en:Hodgkin lymphoma -- r_associated #0: 30 / 0.133 -> en:malignant phyllodes tumor
    n1=en:Hodgkin lymphoma | n2=en:malignant phyllodes tumor | rel=r_associated | relid=0 | w=30
  158. en:Hodgkin lymphoma -- r_associated #0: 30 / 0.133 -> en:malignant solitary fibrous tumor
    n1=en:Hodgkin lymphoma | n2=en:malignant solitary fibrous tumor | rel=r_associated | relid=0 | w=30
  159. en:Hodgkin lymphoma -- r_associated #0: 30 / 0.133 -> en:malignant tumor of unknown origin or ill-defined site
    n1=en:Hodgkin lymphoma | n2=en:malignant tumor of unknown origin or ill-defined site | rel=r_associated | relid=0 | w=30
  160. en:Hodgkin lymphoma -- r_associated #0: 30 / 0.133 -> en:malignant vulvar neoplasm
    n1=en:Hodgkin lymphoma | n2=en:malignant vulvar neoplasm | rel=r_associated | relid=0 | w=30
  161. en:Hodgkin lymphoma -- r_associated #0: 30 / 0.133 -> en:medullary carcinoma with lymphoid stroma
    n1=en:Hodgkin lymphoma | n2=en:medullary carcinoma with lymphoid stroma | rel=r_associated | relid=0 | w=30
  162. en:Hodgkin lymphoma -- r_associated #0: 30 / 0.133 -> en:meningeal melanomatosis
    n1=en:Hodgkin lymphoma | n2=en:meningeal melanomatosis | rel=r_associated | relid=0 | w=30
  163. en:Hodgkin lymphoma -- r_associated #0: 30 / 0.133 -> en:mesenchymal chondrosarcoma
    n1=en:Hodgkin lymphoma | n2=en:mesenchymal chondrosarcoma | rel=r_associated | relid=0 | w=30
  164. en:Hodgkin lymphoma -- r_associated #0: 30 / 0.133 -> en:metastatic neoplasm
    n1=en:Hodgkin lymphoma | n2=en:metastatic neoplasm | rel=r_associated | relid=0 | w=30
  165. en:Hodgkin lymphoma -- r_associated #0: 30 / 0.133 -> en:miscellaneous tumors
    n1=en:Hodgkin lymphoma | n2=en:miscellaneous tumors | rel=r_associated | relid=0 | w=30
  166. en:Hodgkin lymphoma -- r_associated #0: 30 / 0.133 -> en:mixed cellularity classical hodgkin lymphoma, lymph nodes of head, face, and neck
    n1=en:Hodgkin lymphoma | n2=en:mixed cellularity classical hodgkin lymphoma, lymph nodes of head, face, and neck | rel=r_associated | relid=0 | w=30
  167. en:Hodgkin lymphoma -- r_associated #0: 30 / 0.133 -> en:mixed cellularity classical hodgkin lymphoma, spleen
    n1=en:Hodgkin lymphoma | n2=en:mixed cellularity classical hodgkin lymphoma, spleen | rel=r_associated | relid=0 | w=30
  168. en:Hodgkin lymphoma -- r_associated #0: 30 / 0.133 -> en:multiple tumors in 74% of patients
    n1=en:Hodgkin lymphoma | n2=en:multiple tumors in 74% of patients | rel=r_associated | relid=0 | w=30
  169. en:Hodgkin lymphoma -- r_associated #0: 30 / 0.133 -> en:neoplasm, uncertain whether benign or malignant
    n1=en:Hodgkin lymphoma | n2=en:neoplasm, uncertain whether benign or malignant | rel=r_associated | relid=0 | w=30
  170. en:Hodgkin lymphoma -- r_associated #0: 30 / 0.133 -> en:neoplasms, second primary
    n1=en:Hodgkin lymphoma | n2=en:neoplasms, second primary | rel=r_associated | relid=0 | w=30
  171. en:Hodgkin lymphoma -- r_associated #0: 30 / 0.133 -> en:neoplastic lymphocyte
    n1=en:Hodgkin lymphoma | n2=en:neoplastic lymphocyte | rel=r_associated | relid=0 | w=30
  172. en:Hodgkin lymphoma -- r_associated #0: 30 / 0.133 -> en:nervous system neoplasms malignant and unspecified nec
    n1=en:Hodgkin lymphoma | n2=en:nervous system neoplasms malignant and unspecified nec | rel=r_associated | relid=0 | w=30
  173. en:Hodgkin lymphoma -- r_associated #0: 30 / 0.133 -> en:neurasthenia/surmenage
    n1=en:Hodgkin lymphoma | n2=en:neurasthenia/surmenage | rel=r_associated | relid=0 | w=30
  174. en:Hodgkin lymphoma -- r_associated #0: 30 / 0.133 -> en:neuroblastoma, arises anywhere along the sympathetic chain (including intracranially)
    n1=en:Hodgkin lymphoma | n2=en:neuroblastoma, arises anywhere along the sympathetic chain (including intracranially) | rel=r_associated | relid=0 | w=30
  175. en:Hodgkin lymphoma -- r_associated #0: 30 / 0.133 -> en:nodular lymphocyte predominant hodgkin lymphoma, lymph nodes of multiple sites
    n1=en:Hodgkin lymphoma | n2=en:nodular lymphocyte predominant hodgkin lymphoma, lymph nodes of multiple sites | rel=r_associated | relid=0 | w=30
  176. en:Hodgkin lymphoma -- r_associated #0: 30 / 0.133 -> en:non-hematologic malignancy
    n1=en:Hodgkin lymphoma | n2=en:non-hematologic malignancy | rel=r_associated | relid=0 | w=30
  177. en:Hodgkin lymphoma -- r_associated #0: 30 / 0.133 -> en:nonmelanoma skin cancer (in some patients)
    n1=en:Hodgkin lymphoma | n2=en:nonmelanoma skin cancer (in some patients) | rel=r_associated | relid=0 | w=30
  178. en:Hodgkin lymphoma -- r_associated #0: 30 / 0.133 -> en:odontogenic neoplasm
    n1=en:Hodgkin lymphoma | n2=en:odontogenic neoplasm | rel=r_associated | relid=0 | w=30
  179. en:Hodgkin lymphoma -- r_associated #0: 30 / 0.133 -> en:oligodendroglioma
    n1=en:Hodgkin lymphoma | n2=en:oligodendroglioma | rel=r_associated | relid=0 | w=30
  180. en:Hodgkin lymphoma -- r_associated #0: 30 / 0.133 -> en:orthostatic hypotension
    n1=en:Hodgkin lymphoma | n2=en:orthostatic hypotension | rel=r_associated | relid=0 | w=30
  181. en:Hodgkin lymphoma -- r_associated #0: 30 / 0.133 -> en:osteosarcoma and meningioma especially
    n1=en:Hodgkin lymphoma | n2=en:osteosarcoma and meningioma especially | rel=r_associated | relid=0 | w=30
  182. en:Hodgkin lymphoma -- r_associated #0: 30 / 0.133 -> en:other anaemias
    n1=en:Hodgkin lymphoma | n2=en:other anaemias | rel=r_associated | relid=0 | w=30
  183. en:Hodgkin lymphoma -- r_associated #0: 30 / 0.133 -> en:other and unspecified disorders of the circulatory system
    n1=en:Hodgkin lymphoma | n2=en:other and unspecified disorders of the circulatory system | rel=r_associated | relid=0 | w=30
  184. en:Hodgkin lymphoma -- r_associated #0: 30 / 0.133 -> en:other disease male genital including breast
    n1=en:Hodgkin lymphoma | n2=en:other disease male genital including breast | rel=r_associated | relid=0 | w=30
  185. en:Hodgkin lymphoma -- r_associated #0: 30 / 0.133 -> en:other head injury without skull fracture
    n1=en:Hodgkin lymphoma | n2=en:other head injury without skull fracture | rel=r_associated | relid=0 | w=30
  186. en:Hodgkin lymphoma -- r_associated #0: 30 / 0.133 -> en:other/unspecified neoplasm skin
    n1=en:Hodgkin lymphoma | n2=en:other/unspecified neoplasm skin | rel=r_associated | relid=0 | w=30
  187. en:Hodgkin lymphoma -- r_associated #0: 30 / 0.133 -> en:ovarian sex cord-stromal tumor
    n1=en:Hodgkin lymphoma | n2=en:ovarian sex cord-stromal tumor | rel=r_associated | relid=0 | w=30
  188. en:Hodgkin lymphoma -- r_associated #0: 30 / 0.133 -> en:papillary thyroid carcinoma (rare)
    n1=en:Hodgkin lymphoma | n2=en:papillary thyroid carcinoma (rare) | rel=r_associated | relid=0 | w=30
  189. en:Hodgkin lymphoma -- r_associated #0: 30 / 0.133 -> en:papillary transitional cell carcinoma
    n1=en:Hodgkin lymphoma | n2=en:papillary transitional cell carcinoma | rel=r_associated | relid=0 | w=30
  190. en:Hodgkin lymphoma -- r_associated #0: 30 / 0.133 -> en:parkinsonism
    n1=en:Hodgkin lymphoma | n2=en:parkinsonism | rel=r_associated | relid=0 | w=30
  191. en:Hodgkin lymphoma -- r_associated #0: 30 / 0.133 -> en:pediatric adverse events terminology
    n1=en:Hodgkin lymphoma | n2=en:pediatric adverse events terminology | rel=r_associated | relid=0 | w=30
  192. en:Hodgkin lymphoma -- r_associated #0: 30 / 0.133 -> en:pelvic inflammatory disease
    n1=en:Hodgkin lymphoma | n2=en:pelvic inflammatory disease | rel=r_associated | relid=0 | w=30
  193. en:Hodgkin lymphoma -- r_associated #0: 30 / 0.133 -> en:periosteal chondrosarcoma
    n1=en:Hodgkin lymphoma | n2=en:periosteal chondrosarcoma | rel=r_associated | relid=0 | w=30
  194. en:Hodgkin lymphoma -- r_associated #0: 30 / 0.133 -> en:peripheral primitive neuroectodermal tumor
    n1=en:Hodgkin lymphoma | n2=en:peripheral primitive neuroectodermal tumor | rel=r_associated | relid=0 | w=30
  195. en:Hodgkin lymphoma -- r_associated #0: 30 / 0.133 -> en:phyllodes tumor
    n1=en:Hodgkin lymphoma | n2=en:phyllodes tumor | rel=r_associated | relid=0 | w=30
  196. en:Hodgkin lymphoma -- r_associated #0: 30 / 0.133 -> en:plasma cell
    n1=en:Hodgkin lymphoma | n2=en:plasma cell | rel=r_associated | relid=0 | w=30
  197. en:Hodgkin lymphoma -- r_associated #0: 30 / 0.133 -> en:plasma cell neoplasm
    n1=en:Hodgkin lymphoma | n2=en:plasma cell neoplasm | rel=r_associated | relid=0 | w=30
  198. en:Hodgkin lymphoma -- r_associated #0: 30 / 0.133 -> en:polymorphous low grade adenocarcinoma
    n1=en:Hodgkin lymphoma | n2=en:polymorphous low grade adenocarcinoma | rel=r_associated | relid=0 | w=30
  199. en:Hodgkin lymphoma -- r_associated #0: 30 / 0.133 -> en:precursor lymphoblastic leukemia/lymphoma (all subtypes)
    n1=en:Hodgkin lymphoma | n2=en:precursor lymphoblastic leukemia/lymphoma (all subtypes) | rel=r_associated | relid=0 | w=30
  200. en:Hodgkin lymphoma -- r_associated #0: 30 / 0.133 -> en:pregnancy complications, neoplastic
    n1=en:Hodgkin lymphoma | n2=en:pregnancy complications, neoplastic | rel=r_associated | relid=0 | w=30
  201. en:Hodgkin lymphoma -- r_associated #0: 30 / 0.133 -> en:premature birth of newborn
    n1=en:Hodgkin lymphoma | n2=en:premature birth of newborn | rel=r_associated | relid=0 | w=30
  202. en:Hodgkin lymphoma -- r_associated #0: 30 / 0.133 -> en:primary malignant neoplasm of bone
    n1=en:Hodgkin lymphoma | n2=en:primary malignant neoplasm of bone | rel=r_associated | relid=0 | w=30
  203. en:Hodgkin lymphoma -- r_associated #0: 30 / 0.133 -> en:primary malignant neoplasm of unknown site
    n1=en:Hodgkin lymphoma | n2=en:primary malignant neoplasm of unknown site | rel=r_associated | relid=0 | w=30
  204. en:Hodgkin lymphoma -- r_associated #0: 30 / 0.133 -> en:prostate neoplasm
    n1=en:Hodgkin lymphoma | n2=en:prostate neoplasm | rel=r_associated | relid=0 | w=30
  205. en:Hodgkin lymphoma -- r_associated #0: 30 / 0.133 -> en:psammomatous melanotic schwannomas
    n1=en:Hodgkin lymphoma | n2=en:psammomatous melanotic schwannomas | rel=r_associated | relid=0 | w=30
  206. en:Hodgkin lymphoma -- r_associated #0: 30 / 0.133 -> en:pulmonary emphysema
    n1=en:Hodgkin lymphoma | n2=en:pulmonary emphysema | rel=r_associated | relid=0 | w=30
  207. en:Hodgkin lymphoma -- r_associated #0: 30 / 0.133 -> en:reproductive neoplasms female malignant and unspecified
    n1=en:Hodgkin lymphoma | n2=en:reproductive neoplasms female malignant and unspecified | rel=r_associated | relid=0 | w=30
  208. en:Hodgkin lymphoma -- r_associated #0: 30 / 0.133 -> en:rubella infection
    n1=en:Hodgkin lymphoma | n2=en:rubella infection | rel=r_associated | relid=0 | w=30
  209. en:Hodgkin lymphoma -- r_associated #0: 30 / 0.133 -> en:sarcomatoid squamous cell carcinoma
    n1=en:Hodgkin lymphoma | n2=en:sarcomatoid squamous cell carcinoma | rel=r_associated | relid=0 | w=30
  210. en:Hodgkin lymphoma -- r_associated #0: 30 / 0.133 -> en:sebaceous cyst
    n1=en:Hodgkin lymphoma | n2=en:sebaceous cyst | rel=r_associated | relid=0 | w=30
  211. en:Hodgkin lymphoma -- r_associated #0: 30 / 0.133 -> en:second primary malignant neoplasm
    n1=en:Hodgkin lymphoma | n2=en:second primary malignant neoplasm | rel=r_associated | relid=0 | w=30
  212. en:Hodgkin lymphoma -- r_associated #0: 30 / 0.133 -> en:secretory otitis media
    n1=en:Hodgkin lymphoma | n2=en:secretory otitis media | rel=r_associated | relid=0 | w=30
  213. en:Hodgkin lymphoma -- r_associated #0: 30 / 0.133 -> en:sertoli cell carcinoma
    n1=en:Hodgkin lymphoma | n2=en:sertoli cell carcinoma | rel=r_associated | relid=0 | w=30
  214. en:Hodgkin lymphoma -- r_associated #0: 30 / 0.133 -> en:skeletal neoplasms malignant and unspecified
    n1=en:Hodgkin lymphoma | n2=en:skeletal neoplasms malignant and unspecified | rel=r_associated | relid=0 | w=30
  215. en:Hodgkin lymphoma -- r_associated #0: 30 / 0.133 -> en:small cell carcinoma carcinomatosis
    n1=en:Hodgkin lymphoma | n2=en:small cell carcinoma carcinomatosis | rel=r_associated | relid=0 | w=30
  216. en:Hodgkin lymphoma -- r_associated #0: 30 / 0.133 -> en:small cell osteosarcoma
    n1=en:Hodgkin lymphoma | n2=en:small cell osteosarcoma | rel=r_associated | relid=0 | w=30
  217. en:Hodgkin lymphoma -- r_associated #0: 30 / 0.133 -> en:solid papillary carcinoma with invasion
    n1=en:Hodgkin lymphoma | n2=en:solid papillary carcinoma with invasion | rel=r_associated | relid=0 | w=30
  218. en:Hodgkin lymphoma -- r_associated #0: 30 / 0.133 -> en:splenomegaly
    n1=en:Hodgkin lymphoma | n2=en:splenomegaly | rel=r_associated | relid=0 | w=30
  219. en:Hodgkin lymphoma -- r_associated #0: 30 / 0.133 -> en:squamous cell neoplasm
    n1=en:Hodgkin lymphoma | n2=en:squamous cell neoplasm | rel=r_associated | relid=0 | w=30
  220. en:Hodgkin lymphoma -- r_associated #0: 30 / 0.133 -> en:stage i hodgkin lymphoma
    n1=en:Hodgkin lymphoma | n2=en:stage i hodgkin lymphoma | rel=r_associated | relid=0 | w=30
  221. en:Hodgkin lymphoma -- r_associated #0: 30 / 0.133 -> en:stage i lymphocyte-depleted classical hodgkin lymphoma
    n1=en:Hodgkin lymphoma | n2=en:stage i lymphocyte-depleted classical hodgkin lymphoma | rel=r_associated | relid=0 | w=30
  222. en:Hodgkin lymphoma -- r_associated #0: 30 / 0.133 -> en:stage iv lymphocyte-depleted classical hodgkin lymphoma
    n1=en:Hodgkin lymphoma | n2=en:stage iv lymphocyte-depleted classical hodgkin lymphoma | rel=r_associated | relid=0 | w=30
  223. en:Hodgkin lymphoma -- r_associated #0: 30 / 0.133 -> en:starry sky pattern
    n1=en:Hodgkin lymphoma | n2=en:starry sky pattern | rel=r_associated | relid=0 | w=30
  224. en:Hodgkin lymphoma -- r_associated #0: 30 / 0.133 -> en:stromal sarcoma
    n1=en:Hodgkin lymphoma | n2=en:stromal sarcoma | rel=r_associated | relid=0 | w=30
  225. en:Hodgkin lymphoma -- r_associated #0: 30 / 0.133 -> en:superficial injury of ear
    n1=en:Hodgkin lymphoma | n2=en:superficial injury of ear | rel=r_associated | relid=0 | w=30
  226. en:Hodgkin lymphoma -- r_associated #0: 30 / 0.133 -> en:testicular sertoli cell tumor, calcified
    n1=en:Hodgkin lymphoma | n2=en:testicular sertoli cell tumor, calcified | rel=r_associated | relid=0 | w=30
  227. en:Hodgkin lymphoma -- r_associated #0: 30 / 0.133 -> en:thyroid cancer (follicular cell)
    n1=en:Hodgkin lymphoma | n2=en:thyroid cancer (follicular cell) | rel=r_associated | relid=0 | w=30
  228. en:Hodgkin lymphoma -- r_associated #0: 30 / 0.133 -> en:toxemia of pregnancy
    n1=en:Hodgkin lymphoma | n2=en:toxemia of pregnancy | rel=r_associated | relid=0 | w=30
  229. en:Hodgkin lymphoma -- r_associated #0: 30 / 0.133 -> en:toxoplasmosis
    n1=en:Hodgkin lymphoma | n2=en:toxoplasmosis | rel=r_associated | relid=0 | w=30
  230. en:Hodgkin lymphoma -- r_associated #0: 30 / 0.133 -> en:transitional cell carcinoma
    n1=en:Hodgkin lymphoma | n2=en:transitional cell carcinoma | rel=r_associated | relid=0 | w=30
  231. en:Hodgkin lymphoma -- r_associated #0: 30 / 0.133 -> en:uncomplicated hypertension
    n1=en:Hodgkin lymphoma | n2=en:uncomplicated hypertension | rel=r_associated | relid=0 | w=30
  232. en:Hodgkin lymphoma -- r_associated #0: 30 / 0.133 -> en:undifferentiated malignant neoplasm
    n1=en:Hodgkin lymphoma | n2=en:undifferentiated malignant neoplasm | rel=r_associated | relid=0 | w=30
  233. en:Hodgkin lymphoma -- r_associated #0: 30 / 0.133 -> en:undifferentiated sarcoma, not otherwise specified
    n1=en:Hodgkin lymphoma | n2=en:undifferentiated sarcoma, not otherwise specified | rel=r_associated | relid=0 | w=30
  234. en:Hodgkin lymphoma -- r_associated #0: 30 / 0.133 -> en:uterovaginal prolapse
    n1=en:Hodgkin lymphoma | n2=en:uterovaginal prolapse | rel=r_associated | relid=0 | w=30
  235. en:Hodgkin lymphoma -- r_associated #0: 30 / 0.133 -> en:vaginitis/vulvitis nos
    n1=en:Hodgkin lymphoma | n2=en:vaginitis/vulvitis nos | rel=r_associated | relid=0 | w=30
  236. en:Hodgkin lymphoma -- r_associated #0: 30 / 0.133 -> en:varicose vein of lower extremities
    n1=en:Hodgkin lymphoma | n2=en:varicose vein of lower extremities | rel=r_associated | relid=0 | w=30
  237. en:Hodgkin lymphoma -- r_associated #0: 30 / 0.133 -> en:well differentiated malignant neoplasm
    n1=en:Hodgkin lymphoma | n2=en:well differentiated malignant neoplasm | rel=r_associated | relid=0 | w=30
  238. en:Hodgkin lymphoma -- r_associated #0: 30 / 0.133 -> en:whooping cough due to unspecified organism
    n1=en:Hodgkin lymphoma | n2=en:whooping cough due to unspecified organism | rel=r_associated | relid=0 | w=30
  239. en:Hodgkin lymphoma -- r_associated #0: 30 / 0.133 -> stade d'un cancer (détermination du)
    n1=en:Hodgkin lymphoma | n2=stade d'un cancer (détermination du) | rel=r_associated | relid=0 | w=30
  240. en:Hodgkin lymphoma -- r_associated #0: 29 / 0.128 -> en:abnormal pap smear
    n1=en:Hodgkin lymphoma | n2=en:abnormal pap smear | rel=r_associated | relid=0 | w=29
  241. en:Hodgkin lymphoma -- r_associated #0: 29 / 0.128 -> en:acute miliary tuberculosis
    n1=en:Hodgkin lymphoma | n2=en:acute miliary tuberculosis | rel=r_associated | relid=0 | w=29
  242. en:Hodgkin lymphoma -- r_associated #0: 29 / 0.128 -> en:adenocarcinoma in adenomatous polyp
    n1=en:Hodgkin lymphoma | n2=en:adenocarcinoma in adenomatous polyp | rel=r_associated | relid=0 | w=29
  243. en:Hodgkin lymphoma -- r_associated #0: 29 / 0.128 -> en:adnexal and/or skin appendage neoplasm
    n1=en:Hodgkin lymphoma | n2=en:adnexal and/or skin appendage neoplasm | rel=r_associated | relid=0 | w=29
  244. en:Hodgkin lymphoma -- r_associated #0: 29 / 0.128 -> en:adult lymphoma
    n1=en:Hodgkin lymphoma | n2=en:adult lymphoma | rel=r_associated | relid=0 | w=29
  245. en:Hodgkin lymphoma -- r_associated #0: 29 / 0.128 -> en:arrhythmia
    n1=en:Hodgkin lymphoma | n2=en:arrhythmia | rel=r_associated | relid=0 | w=29
  246. en:Hodgkin lymphoma -- r_associated #0: 29 / 0.128 -> en:atopic conjunctivitis
    n1=en:Hodgkin lymphoma | n2=en:atopic conjunctivitis | rel=r_associated | relid=0 | w=29
  247. en:Hodgkin lymphoma -- r_associated #0: 29 / 0.128 -> en:autoimmune lymphoproliferative syndrome-associated lymphoma
    n1=en:Hodgkin lymphoma | n2=en:autoimmune lymphoproliferative syndrome-associated lymphoma | rel=r_associated | relid=0 | w=29
  248. en:Hodgkin lymphoma -- r_associated #0: 29 / 0.128 -> en:b-cell lymphomas
    n1=en:Hodgkin lymphoma | n2=en:b-cell lymphomas | rel=r_associated | relid=0 | w=29
  249. en:Hodgkin lymphoma -- r_associated #0: 29 / 0.128 -> en:basocellular neoplasms develop after second decade
    n1=en:Hodgkin lymphoma | n2=en:basocellular neoplasms develop after second decade | rel=r_associated | relid=0 | w=29
  250. en:Hodgkin lymphoma -- r_associated #0: 29 / 0.128 -> en:bence jones proteins increased
    n1=en:Hodgkin lymphoma | n2=en:bence jones proteins increased | rel=r_associated | relid=0 | w=29
  251. en:Hodgkin lymphoma -- r_associated #0: 29 / 0.128 -> en:benign neoplasm
    n1=en:Hodgkin lymphoma | n2=en:benign neoplasm | rel=r_associated | relid=0 | w=29
  252. en:Hodgkin lymphoma -- r_associated #0: 29 / 0.128 -> en:bone marrow
    n1=en:Hodgkin lymphoma | n2=en:bone marrow | rel=r_associated | relid=0 | w=29
  253. en:Hodgkin lymphoma -- r_associated #0: 29 / 0.128 -> en:bronchogenic carcinoma (some)
    n1=en:Hodgkin lymphoma | n2=en:bronchogenic carcinoma (some) | rel=r_associated | relid=0 | w=29
  254. en:Hodgkin lymphoma -- r_associated #0: 29 / 0.128 -> en:carcinofibroma
    n1=en:Hodgkin lymphoma | n2=en:carcinofibroma | rel=r_associated | relid=0 | w=29
  255. en:Hodgkin lymphoma -- r_associated #0: 29 / 0.128 -> en:carcinogenesis
    n1=en:Hodgkin lymphoma | n2=en:carcinogenesis | rel=r_associated | relid=0 | w=29
  256. en:Hodgkin lymphoma -- r_associated #0: 29 / 0.128 -> en:carcinoma in situ
    n1=en:Hodgkin lymphoma | n2=en:carcinoma in situ | rel=r_associated | relid=0 | w=29
  257. en:Hodgkin lymphoma -- r_associated #0: 29 / 0.128 -> en:carcinosarcoma of skin
    n1=en:Hodgkin lymphoma | n2=en:carcinosarcoma of skin | rel=r_associated | relid=0 | w=29
  258. en:Hodgkin lymphoma -- r_associated #0: 29 / 0.128 -> en:childhood leukemia
    n1=en:Hodgkin lymphoma | n2=en:childhood leukemia | rel=r_associated | relid=0 | w=29
  259. en:Hodgkin lymphoma -- r_associated #0: 29 / 0.128 -> en:chronic myelomonocytic leukemia
    n1=en:Hodgkin lymphoma | n2=en:chronic myelomonocytic leukemia | rel=r_associated | relid=0 | w=29
  260. en:Hodgkin lymphoma -- r_associated #0: 29 / 0.128 -> en:chronic otitis other infection ear
    n1=en:Hodgkin lymphoma | n2=en:chronic otitis other infection ear | rel=r_associated | relid=0 | w=29
  261. en:Hodgkin lymphoma -- r_associated #0: 29 / 0.128 -> en:chronic skin ulcer
    n1=en:Hodgkin lymphoma | n2=en:chronic skin ulcer | rel=r_associated | relid=0 | w=29
  262. en:Hodgkin lymphoma -- r_associated #0: 29 / 0.128 -> en:combined small cell lung carcinoma
    n1=en:Hodgkin lymphoma | n2=en:combined small cell lung carcinoma | rel=r_associated | relid=0 | w=29
  263. en:Hodgkin lymphoma -- r_associated #0: 29 / 0.128 -> en:complex epithelial neoplasm
    n1=en:Hodgkin lymphoma | n2=en:complex epithelial neoplasm | rel=r_associated | relid=0 | w=29
  264. en:Hodgkin lymphoma -- r_associated #0: 29 / 0.128 -> en:congenital urinary system abnormality
    n1=en:Hodgkin lymphoma | n2=en:congenital urinary system abnormality | rel=r_associated | relid=0 | w=29
  265. en:Hodgkin lymphoma -- r_associated #0: 29 / 0.128 -> en:corneal ulcer
    n1=en:Hodgkin lymphoma | n2=en:corneal ulcer | rel=r_associated | relid=0 | w=29
  266. en:Hodgkin lymphoma -- r_associated #0: 29 / 0.128 -> en:death
    n1=en:Hodgkin lymphoma | n2=en:death | rel=r_associated | relid=0 | w=29
  267. en:Hodgkin lymphoma -- r_associated #0: 29 / 0.128 -> en:depressive disorder
    n1=en:Hodgkin lymphoma | n2=en:depressive disorder | rel=r_associated | relid=0 | w=29
  268. en:Hodgkin lymphoma -- r_associated #0: 29 / 0.128 -> en:dislocation
    n1=en:Hodgkin lymphoma | n2=en:dislocation | rel=r_associated | relid=0 | w=29
  269. en:Hodgkin lymphoma -- r_associated #0: 29 / 0.128 -> en:ductal and lobular neoplasms
    n1=en:Hodgkin lymphoma | n2=en:ductal and lobular neoplasms | rel=r_associated | relid=0 | w=29
  270. en:Hodgkin lymphoma -- r_associated #0: 29 / 0.128 -> en:ductal breast carcinoma
    n1=en:Hodgkin lymphoma | n2=en:ductal breast carcinoma | rel=r_associated | relid=0 | w=29
  271. en:Hodgkin lymphoma -- r_associated #0: 29 / 0.128 -> en:dyshidrosis [pompholyx]
    n1=en:Hodgkin lymphoma | n2=en:dyshidrosis [pompholyx] | rel=r_associated | relid=0 | w=29
  272. en:Hodgkin lymphoma -- r_associated #0: 29 / 0.128 -> en:ectopic pregnancy
    n1=en:Hodgkin lymphoma | n2=en:ectopic pregnancy | rel=r_associated | relid=0 | w=29
  273. en:Hodgkin lymphoma -- r_associated #0: 29 / 0.128 -> en:embryonal carcinoma
    n1=en:Hodgkin lymphoma | n2=en:embryonal carcinoma | rel=r_associated | relid=0 | w=29
  274. en:Hodgkin lymphoma -- r_associated #0: 29 / 0.128 -> en:enzymology
    n1=en:Hodgkin lymphoma | n2=en:enzymology | rel=r_associated | relid=0 | w=29
  275. en:Hodgkin lymphoma -- r_associated #0: 29 / 0.128 -> en:epithelioid sarcoma
    n1=en:Hodgkin lymphoma | n2=en:epithelioid sarcoma | rel=r_associated | relid=0 | w=29
  276. en:Hodgkin lymphoma -- r_associated #0: 29 / 0.128 -> en:ewing sarcoma/peripheral primitive neuroectodermal tumor
    n1=en:Hodgkin lymphoma | n2=en:ewing sarcoma/peripheral primitive neuroectodermal tumor | rel=r_associated | relid=0 | w=29
  277. en:Hodgkin lymphoma -- r_associated #0: 29 / 0.128 -> en:fear cancer of blood/lymph organs
    n1=en:Hodgkin lymphoma | n2=en:fear cancer of blood/lymph organs | rel=r_associated | relid=0 | w=29
  278. en:Hodgkin lymphoma -- r_associated #0: 29 / 0.128 -> en:fibroblastic osteosarcoma
    n1=en:Hodgkin lymphoma | n2=en:fibroblastic osteosarcoma | rel=r_associated | relid=0 | w=29
  279. en:Hodgkin lymphoma -- r_associated #0: 29 / 0.128 -> en:fibrous connective tissue neoplasm
    n1=en:Hodgkin lymphoma | n2=en:fibrous connective tissue neoplasm | rel=r_associated | relid=0 | w=29
  280. en:Hodgkin lymphoma -- r_associated #0: 29 / 0.128 -> en:follicular dendritic sarcoma of lymph nodes of multiple sites
    n1=en:Hodgkin lymphoma | n2=en:follicular dendritic sarcoma of lymph nodes of multiple sites | rel=r_associated | relid=0 | w=29
  281. en:Hodgkin lymphoma -- r_associated #0: 29 / 0.128 -> en:foreign body in auditory canal
    n1=en:Hodgkin lymphoma | n2=en:foreign body in auditory canal | rel=r_associated | relid=0 | w=29
  282. en:Hodgkin lymphoma -- r_associated #0: 29 / 0.128 -> en:frequent skin cancer
    n1=en:Hodgkin lymphoma | n2=en:frequent skin cancer | rel=r_associated | relid=0 | w=29
  283. en:Hodgkin lymphoma -- r_associated #0: 29 / 0.128 -> en:genital herpes in men
    n1=en:Hodgkin lymphoma | n2=en:genital herpes in men | rel=r_associated | relid=0 | w=29
  284. en:Hodgkin lymphoma -- r_associated #0: 29 / 0.128 -> en:germ cell tumor
    n1=en:Hodgkin lymphoma | n2=en:germ cell tumor | rel=r_associated | relid=0 | w=29
  285. en:Hodgkin lymphoma -- r_associated #0: 29 / 0.128 -> en:gonorrhea female
    n1=en:Hodgkin lymphoma | n2=en:gonorrhea female | rel=r_associated | relid=0 | w=29
  286. en:Hodgkin lymphoma -- r_associated #0: 29 / 0.128 -> en:heart dimension/size
    n1=en:Hodgkin lymphoma | n2=en:heart dimension/size | rel=r_associated | relid=0 | w=29
  287. en:Hodgkin lymphoma -- r_associated #0: 29 / 0.128 -> en:hemangioblastoma, sporadic cerebellar (e.g., 193300.0007)
    n1=en:Hodgkin lymphoma | n2=en:hemangioblastoma, sporadic cerebellar (e.g., 193300.0007) | rel=r_associated | relid=0 | w=29
  288. en:Hodgkin lymphoma -- r_associated #0: 29 / 0.128 -> en:hematopoietic and lymphoid cell
    n1=en:Hodgkin lymphoma | n2=en:hematopoietic and lymphoid cell | rel=r_associated | relid=0 | w=29
  289. en:Hodgkin lymphoma -- r_associated #0: 29 / 0.128 -> en:hereditary neoplastic syndrome
    n1=en:Hodgkin lymphoma | n2=en:hereditary neoplastic syndrome | rel=r_associated | relid=0 | w=29
  290. en:Hodgkin lymphoma -- r_associated #0: 29 / 0.128 -> en:high grade serous carcinoma
    n1=en:Hodgkin lymphoma | n2=en:high grade serous carcinoma | rel=r_associated | relid=0 | w=29
  291. en:Hodgkin lymphoma -- r_associated #0: 29 / 0.128 -> en:historical aspects qualifier
    n1=en:Hodgkin lymphoma | n2=en:historical aspects qualifier | rel=r_associated | relid=0 | w=29
  292. en:Hodgkin lymphoma -- r_associated #0: 29 / 0.128 -> en:hodgkin lymphoma (category)
    n1=en:Hodgkin lymphoma | n2=en:hodgkin lymphoma (category) | rel=r_associated | relid=0 | w=29
  293. en:Hodgkin lymphoma -- r_associated #0: 29 / 0.128 -> en:hodgkin's disease lymphocyte depletion stage i supradiaphragm
    n1=en:Hodgkin lymphoma | n2=en:hodgkin's disease lymphocyte depletion stage i supradiaphragm | rel=r_associated | relid=0 | w=29
  294. en:Hodgkin lymphoma -- r_associated #0: 29 / 0.128 -> en:hodgkin's disease lymphocyte depletion stage ii supradiaphragm
    n1=en:Hodgkin lymphoma | n2=en:hodgkin's disease lymphocyte depletion stage ii supradiaphragm | rel=r_associated | relid=0 | w=29
  295. en:Hodgkin lymphoma -- r_associated #0: 29 / 0.128 -> en:hodgkin's disease lymphocyte predominance stage i subdiaphragm
    n1=en:Hodgkin lymphoma | n2=en:hodgkin's disease lymphocyte predominance stage i subdiaphragm | rel=r_associated | relid=0 | w=29
  296. en:Hodgkin lymphoma -- r_associated #0: 29 / 0.128 -> en:hodgkin's disease lymphocyte predominance stage ii supradiaphragm
    n1=en:Hodgkin lymphoma | n2=en:hodgkin's disease lymphocyte predominance stage ii supradiaphragm | rel=r_associated | relid=0 | w=29
  297. en:Hodgkin lymphoma -- r_associated #0: 29 / 0.128 -> en:hodgkin's disease, lymphocytic depletion of extranodal and/or solid organ site
    n1=en:Hodgkin lymphoma | n2=en:hodgkin's disease, lymphocytic depletion of extranodal and/or solid organ site | rel=r_associated | relid=0 | w=29
  298. en:Hodgkin lymphoma -- r_associated #0: 29 / 0.128 -> en:hodgkin's disease, lymphocytic depletion of intrapelvic lymph nodes
    n1=en:Hodgkin lymphoma | n2=en:hodgkin's disease, lymphocytic depletion of intrapelvic lymph nodes | rel=r_associated | relid=0 | w=29
  299. en:Hodgkin lymphoma -- r_associated #0: 29 / 0.128 -> en:hodgkin's paragranuloma of lymph nodes of head, face and/or neck
    n1=en:Hodgkin lymphoma | n2=en:hodgkin's paragranuloma of lymph nodes of head, face and/or neck | rel=r_associated | relid=0 | w=29
  300. en:Hodgkin lymphoma -- r_associated #0: 29 / 0.128 -> en:hodgkin's sarcoma of extranodal and/or solid organ site
    n1=en:Hodgkin lymphoma | n2=en:hodgkin's sarcoma of extranodal and/or solid organ site | rel=r_associated | relid=0 | w=29
  301. en:Hodgkin lymphoma -- r_associated #0: 29 / 0.128 -> en:hodgkin's sarcoma of lymph nodes of head, face and neck
    n1=en:Hodgkin lymphoma | n2=en:hodgkin's sarcoma of lymph nodes of head, face and neck | rel=r_associated | relid=0 | w=29
  302. en:Hodgkin lymphoma -- r_associated #0: 29 / 0.128 -> en:hypertrophy of tonsils and adenoids
    n1=en:Hodgkin lymphoma | n2=en:hypertrophy of tonsils and adenoids | rel=r_associated | relid=0 | w=29
  303. en:Hodgkin lymphoma -- r_associated #0: 29 / 0.128 -> en:in urine
    n1=en:Hodgkin lymphoma | n2=en:in urine | rel=r_associated | relid=0 | w=29
  304. en:Hodgkin lymphoma -- r_associated #0: 29 / 0.128 -> en:increased risk of chondrosarcoma (mean age of onset 31 years)
    n1=en:Hodgkin lymphoma | n2=en:increased risk of chondrosarcoma (mean age of onset 31 years) | rel=r_associated | relid=0 | w=29
  305. en:Hodgkin lymphoma -- r_associated #0: 29 / 0.128 -> en:increased risk of pancreatic cancer
    n1=en:Hodgkin lymphoma | n2=en:increased risk of pancreatic cancer | rel=r_associated | relid=0 | w=29
  306. en:Hodgkin lymphoma -- r_associated #0: 29 / 0.128 -> en:increased risk of testicular cancer
    n1=en:Hodgkin lymphoma | n2=en:increased risk of testicular cancer | rel=r_associated | relid=0 | w=29
  307. en:Hodgkin lymphoma -- r_associated #0: 29 / 0.128 -> en:ingrown toenail/other disease of nail
    n1=en:Hodgkin lymphoma | n2=en:ingrown toenail/other disease of nail | rel=r_associated | relid=0 | w=29
  308. en:Hodgkin lymphoma -- r_associated #0: 29 / 0.128 -> en:interdigitating dendritic cell sarcoma
    n1=en:Hodgkin lymphoma | n2=en:interdigitating dendritic cell sarcoma | rel=r_associated | relid=0 | w=29
  309. en:Hodgkin lymphoma -- r_associated #0: 29 / 0.128 -> en:intraocular lymphoma
    n1=en:Hodgkin lymphoma | n2=en:intraocular lymphoma | rel=r_associated | relid=0 | w=29
  310. en:Hodgkin lymphoma -- r_associated #0: 29 / 0.128 -> en:invasive micropapillary breast carcinoma
    n1=en:Hodgkin lymphoma | n2=en:invasive micropapillary breast carcinoma | rel=r_associated | relid=0 | w=29
  311. en:Hodgkin lymphoma -- r_associated #0: 29 / 0.128 -> en:kaposi sarcoma
    n1=en:Hodgkin lymphoma | n2=en:kaposi sarcoma | rel=r_associated | relid=0 | w=29
  312. en:Hodgkin lymphoma -- r_associated #0: 29 / 0.128 -> en:leukemia
    n1=en:Hodgkin lymphoma | n2=en:leukemia | rel=r_associated | relid=0 | w=29
  313. en:Hodgkin lymphoma -- r_associated #0: 29 / 0.128 -> en:leukocyte disorders
    n1=en:Hodgkin lymphoma | n2=en:leukocyte disorders | rel=r_associated | relid=0 | w=29
  314. en:Hodgkin lymphoma -- r_associated #0: 29 / 0.128 -> en:lymphocyte depleted classical hodgkin lymphoma, extranodal and solid organ sites
    n1=en:Hodgkin lymphoma | n2=en:lymphocyte depleted classical hodgkin lymphoma, extranodal and solid organ sites | rel=r_associated | relid=0 | w=29
  315. en:Hodgkin lymphoma -- r_associated #0: 29 / 0.128 -> en:lymphocyte depleted classical hodgkin lymphoma, intrathoracic lymph nodes
    n1=en:Hodgkin lymphoma | n2=en:lymphocyte depleted classical hodgkin lymphoma, intrathoracic lymph nodes | rel=r_associated | relid=0 | w=29
  316. en:Hodgkin lymphoma -- r_associated #0: 29 / 0.128 -> en:lymphocyte depleted classical hodgkin lymphoma, lymph nodes of head, face, and neck
    n1=en:Hodgkin lymphoma | n2=en:lymphocyte depleted classical hodgkin lymphoma, lymph nodes of head, face, and neck | rel=r_associated | relid=0 | w=29
  317. en:Hodgkin lymphoma -- r_associated #0: 29 / 0.128 -> en:lymphocyte depleted classical hodgkin lymphoma, lymph nodes of inguinal region and lower limb
    n1=en:Hodgkin lymphoma | n2=en:lymphocyte depleted classical hodgkin lymphoma, lymph nodes of inguinal region and lower limb | rel=r_associated | relid=0 | w=29
  318. en:Hodgkin lymphoma -- r_associated #0: 29 / 0.128 -> en:lymphocyte predominant type hodgkin's disease
    n1=en:Hodgkin lymphoma | n2=en:lymphocyte predominant type hodgkin's disease | rel=r_associated | relid=0 | w=29
  319. en:Hodgkin lymphoma -- r_associated #0: 29 / 0.128 -> en:lymphocyte-depleted classical hodgkin lymphoma
    n1=en:Hodgkin lymphoma | n2=en:lymphocyte-depleted classical hodgkin lymphoma | rel=r_associated | relid=0 | w=29
  320. en:Hodgkin lymphoma -- r_associated #0: 29 / 0.128 -> en:male germ cell tumors (gct), 2 subtypes -
    n1=en:Hodgkin lymphoma | n2=en:male germ cell tumors (gct), 2 subtypes - | rel=r_associated | relid=0 | w=29
  321. en:Hodgkin lymphoma -- r_associated #0: 29 / 0.128 -> en:malignant (primary) neoplasm, unspecified
    n1=en:Hodgkin lymphoma | n2=en:malignant (primary) neoplasm, unspecified | rel=r_associated | relid=0 | w=29
  322. en:Hodgkin lymphoma -- r_associated #0: 29 / 0.128 -> en:malignant aortic body tumor
    n1=en:Hodgkin lymphoma | n2=en:malignant aortic body tumor | rel=r_associated | relid=0 | w=29
  323. en:Hodgkin lymphoma -- r_associated #0: 29 / 0.128 -> en:malignant eye neoplasm
    n1=en:Hodgkin lymphoma | n2=en:malignant eye neoplasm | rel=r_associated | relid=0 | w=29
  324. en:Hodgkin lymphoma -- r_associated #0: 29 / 0.128 -> en:malignant gastric neoplasm
    n1=en:Hodgkin lymphoma | n2=en:malignant gastric neoplasm | rel=r_associated | relid=0 | w=29
  325. en:Hodgkin lymphoma -- r_associated #0: 29 / 0.128 -> en:malignant genitourinary tract tumor
    n1=en:Hodgkin lymphoma | n2=en:malignant genitourinary tract tumor | rel=r_associated | relid=0 | w=29
  326. en:Hodgkin lymphoma -- r_associated #0: 29 / 0.128 -> en:malignant granulosa cell tumor
    n1=en:Hodgkin lymphoma | n2=en:malignant granulosa cell tumor | rel=r_associated | relid=0 | w=29
  327. en:Hodgkin lymphoma -- r_associated #0: 29 / 0.128 -> en:malignant neoplasm of lower limb
    n1=en:Hodgkin lymphoma | n2=en:malignant neoplasm of lower limb | rel=r_associated | relid=0 | w=29
  328. en:Hodgkin lymphoma -- r_associated #0: 29 / 0.128 -> en:malignant neoplasm of respiratory system
    n1=en:Hodgkin lymphoma | n2=en:malignant neoplasm of respiratory system | rel=r_associated | relid=0 | w=29
  329. en:Hodgkin lymphoma -- r_associated #0: 29 / 0.128 -> en:malignant neoplasm, primary site unknown, so stated
    n1=en:Hodgkin lymphoma | n2=en:malignant neoplasm, primary site unknown, so stated | rel=r_associated | relid=0 | w=29
  330. en:Hodgkin lymphoma -- r_associated #0: 29 / 0.128 -> en:malignant neoplasm: bronchus or lung, unspecified
    n1=en:Hodgkin lymphoma | n2=en:malignant neoplasm: bronchus or lung, unspecified | rel=r_associated | relid=0 | w=29
  331. en:Hodgkin lymphoma -- r_associated #0: 29 / 0.128 -> en:malignant neoplastic disease in pregnancy
    n1=en:Hodgkin lymphoma | n2=en:malignant neoplastic disease in pregnancy | rel=r_associated | relid=0 | w=29
  332. en:Hodgkin lymphoma -- r_associated #0: 29 / 0.128 -> en:malignant pecoma
    n1=en:Hodgkin lymphoma | n2=en:malignant pecoma | rel=r_associated | relid=0 | w=29
  333. en:Hodgkin lymphoma -- r_associated #0: 29 / 0.128 -> en:malignant sebaceous neoplasm
    n1=en:Hodgkin lymphoma | n2=en:malignant sebaceous neoplasm | rel=r_associated | relid=0 | w=29
  334. en:Hodgkin lymphoma -- r_associated #0: 29 / 0.128 -> en:malignant thymus neoplasm
    n1=en:Hodgkin lymphoma | n2=en:malignant thymus neoplasm | rel=r_associated | relid=0 | w=29
  335. en:Hodgkin lymphoma -- r_associated #0: 29 / 0.128 -> en:malignant tumor involving an organ by direct extension from ovary
    n1=en:Hodgkin lymphoma | n2=en:malignant tumor involving an organ by direct extension from ovary | rel=r_associated | relid=0 | w=29
  336. en:Hodgkin lymphoma -- r_associated #0: 29 / 0.128 -> en:malignant white blood cell disorder
    n1=en:Hodgkin lymphoma | n2=en:malignant white blood cell disorder | rel=r_associated | relid=0 | w=29
  337. en:Hodgkin lymphoma -- r_associated #0: 29 / 0.128 -> en:mesonephric adenocarcinoma
    n1=en:Hodgkin lymphoma | n2=en:mesonephric adenocarcinoma | rel=r_associated | relid=0 | w=29
  338. en:Hodgkin lymphoma -- r_associated #0: 29 / 0.128 -> en:mesonephric neoplasm
    n1=en:Hodgkin lymphoma | n2=en:mesonephric neoplasm | rel=r_associated | relid=0 | w=29
  339. en:Hodgkin lymphoma -- r_associated #0: 29 / 0.128 -> en:metaplastic carcinoma
    n1=en:Hodgkin lymphoma | n2=en:metaplastic carcinoma | rel=r_associated | relid=0 | w=29
  340. en:Hodgkin lymphoma -- r_associated #0: 29 / 0.128 -> en:metastatic angiosarcoma
    n1=en:Hodgkin lymphoma | n2=en:metastatic angiosarcoma | rel=r_associated | relid=0 | w=29
  341. en:Hodgkin lymphoma -- r_associated #0: 29 / 0.128 -> en:mixed cellularity classical hodgkin lymphoma, intrathoracic lymph nodes
    n1=en:Hodgkin lymphoma | n2=en:mixed cellularity classical hodgkin lymphoma, intrathoracic lymph nodes | rel=r_associated | relid=0 | w=29
  342. en:Hodgkin lymphoma -- r_associated #0: 29 / 0.128 -> en:mixed glioma
    n1=en:Hodgkin lymphoma | n2=en:mixed glioma | rel=r_associated | relid=0 | w=29
  343. en:Hodgkin lymphoma -- r_associated #0: 29 / 0.128 -> en:moniliasis genital female
    n1=en:Hodgkin lymphoma | n2=en:moniliasis genital female | rel=r_associated | relid=0 | w=29
  344. en:Hodgkin lymphoma -- r_associated #0: 29 / 0.128 -> en:mucosal lentiginous melanoma
    n1=en:Hodgkin lymphoma | n2=en:mucosal lentiginous melanoma | rel=r_associated | relid=0 | w=29
  345. en:Hodgkin lymphoma -- r_associated #0: 29 / 0.128 -> en:mycosis fungoides
    n1=en:Hodgkin lymphoma | n2=en:mycosis fungoides | rel=r_associated | relid=0 | w=29
  346. en:Hodgkin lymphoma -- r_associated #0: 29 / 0.128 -> en:myxoid liposarcoma
    n1=en:Hodgkin lymphoma | n2=en:myxoid liposarcoma | rel=r_associated | relid=0 | w=29
  347. en:Hodgkin lymphoma -- r_associated #0: 29 / 0.128 -> en:neoplasm by site
    n1=en:Hodgkin lymphoma | n2=en:neoplasm by site | rel=r_associated | relid=0 | w=29
  348. en:Hodgkin lymphoma -- r_associated #0: 29 / 0.128 -> en:neoplasm of ocular adnexa
    n1=en:Hodgkin lymphoma | n2=en:neoplasm of ocular adnexa | rel=r_associated | relid=0 | w=29
  349. en:Hodgkin lymphoma -- r_associated #0: 29 / 0.128 -> en:neoplasms of uncertain or unknown behaviour
    n1=en:Hodgkin lymphoma | n2=en:neoplasms of uncertain or unknown behaviour | rel=r_associated | relid=0 | w=29
  350. en:Hodgkin lymphoma -- r_associated #0: 29 / 0.128 -> en:nevi and melanomas
    n1=en:Hodgkin lymphoma | n2=en:nevi and melanomas | rel=r_associated | relid=0 | w=29
  351. en:Hodgkin lymphoma -- r_associated #0: 29 / 0.128 -> en:nodular lymphocyte predominant hodgkin lymphoma, intra-abdominal lymph nodes
    n1=en:Hodgkin lymphoma | n2=en:nodular lymphocyte predominant hodgkin lymphoma, intra-abdominal lymph nodes | rel=r_associated | relid=0 | w=29
  352. en:Hodgkin lymphoma -- r_associated #0: 29 / 0.128 -> en:nodular lymphocyte predominant hodgkin lymphoma, intrathoracic lymph nodes
    n1=en:Hodgkin lymphoma | n2=en:nodular lymphocyte predominant hodgkin lymphoma, intrathoracic lymph nodes | rel=r_associated | relid=0 | w=29
  353. en:Hodgkin lymphoma -- r_associated #0: 29 / 0.128 -> en:nodular sclerosis classical hodgkin lymphoma, intra-abdominal lymph nodes
    n1=en:Hodgkin lymphoma | n2=en:nodular sclerosis classical hodgkin lymphoma, intra-abdominal lymph nodes | rel=r_associated | relid=0 | w=29
  354. en:Hodgkin lymphoma -- r_associated #0: 29 / 0.128 -> en:nodular sclerosis classical hodgkin lymphoma, intrathoracic lymph nodes
    n1=en:Hodgkin lymphoma | n2=en:nodular sclerosis classical hodgkin lymphoma, intrathoracic lymph nodes | rel=r_associated | relid=0 | w=29
  355. en:Hodgkin lymphoma -- r_associated #0: 29 / 0.128 -> en:non-hodgkin lymphoma
    n1=en:Hodgkin lymphoma | n2=en:non-hodgkin lymphoma | rel=r_associated | relid=0 | w=29
  356. en:Hodgkin lymphoma -- r_associated #0: 29 / 0.128 -> en:nonestrogen-dependent cancer
    n1=en:Hodgkin lymphoma | n2=en:nonestrogen-dependent cancer | rel=r_associated | relid=0 | w=29
  357. en:Hodgkin lymphoma -- r_associated #0: 29 / 0.128 -> en:oral cavity carcinoma
    n1=en:Hodgkin lymphoma | n2=en:oral cavity carcinoma | rel=r_associated | relid=0 | w=29
  358. en:Hodgkin lymphoma -- r_associated #0: 29 / 0.128 -> en:oropharyngeal carcinoma
    n1=en:Hodgkin lymphoma | n2=en:oropharyngeal carcinoma | rel=r_associated | relid=0 | w=29
  359. en:Hodgkin lymphoma -- r_associated #0: 29 / 0.128 -> en:other and unspecified types of non-hodgkin lymphoma
    n1=en:Hodgkin lymphoma | n2=en:other and unspecified types of non-hodgkin lymphoma | rel=r_associated | relid=0 | w=29
  360. en:Hodgkin lymphoma -- r_associated #0: 29 / 0.128 -> en:other classical hodgkin lymphoma, intrathoracic lymph nodes
    n1=en:Hodgkin lymphoma | n2=en:other classical hodgkin lymphoma, intrathoracic lymph nodes | rel=r_associated | relid=0 | w=29
  361. en:Hodgkin lymphoma -- r_associated #0: 29 / 0.128 -> en:other classical hodgkin lymphoma, spleen
    n1=en:Hodgkin lymphoma | n2=en:other classical hodgkin lymphoma, spleen | rel=r_associated | relid=0 | w=29
  362. en:Hodgkin lymphoma -- r_associated #0: 29 / 0.128 -> en:other disease of pregnancy/delivery/puerperium
    n1=en:Hodgkin lymphoma | n2=en:other disease of pregnancy/delivery/puerperium | rel=r_associated | relid=0 | w=29
  363. en:Hodgkin lymphoma -- r_associated #0: 29 / 0.128 -> en:other hematologic congenital anomalies
    n1=en:Hodgkin lymphoma | n2=en:other hematologic congenital anomalies | rel=r_associated | relid=0 | w=29
  364. en:Hodgkin lymphoma -- r_associated #0: 29 / 0.128 -> en:other malignant lymphomas, intra-abdominal lymph nodes
    n1=en:Hodgkin lymphoma | n2=en:other malignant lymphomas, intra-abdominal lymph nodes | rel=r_associated | relid=0 | w=29
  365. en:Hodgkin lymphoma -- r_associated #0: 29 / 0.128 -> en:other malignant lymphomas, lymph nodes of inguinal region and lower limb
    n1=en:Hodgkin lymphoma | n2=en:other malignant lymphomas, lymph nodes of inguinal region and lower limb | rel=r_associated | relid=0 | w=29
  366. en:Hodgkin lymphoma -- r_associated #0: 29 / 0.128 -> en:other peripheral neuritis
    n1=en:Hodgkin lymphoma | n2=en:other peripheral neuritis | rel=r_associated | relid=0 | w=29
  367. en:Hodgkin lymphoma -- r_associated #0: 29 / 0.128 -> en:ovarian cystadenoma
    n1=en:Hodgkin lymphoma | n2=en:ovarian cystadenoma | rel=r_associated | relid=0 | w=29
  368. en:Hodgkin lymphoma -- r_associated #0: 29 / 0.128 -> en:pancreatic adenocarcinoma
    n1=en:Hodgkin lymphoma | n2=en:pancreatic adenocarcinoma | rel=r_associated | relid=0 | w=29
  369. en:Hodgkin lymphoma -- r_associated #0: 29 / 0.128 -> en:parasitology
    n1=en:Hodgkin lymphoma | n2=en:parasitology | rel=r_associated | relid=0 | w=29
  370. en:Hodgkin lymphoma -- r_associated #0: 29 / 0.128 -> en:parathyroid gland adenoma
    n1=en:Hodgkin lymphoma | n2=en:parathyroid gland adenoma | rel=r_associated | relid=0 | w=29
  371. en:Hodgkin lymphoma -- r_associated #0: 29 / 0.128 -> en:parosteal osteosarcoma
    n1=en:Hodgkin lymphoma | n2=en:parosteal osteosarcoma | rel=r_associated | relid=0 | w=29
  372. en:Hodgkin lymphoma -- r_associated #0: 29 / 0.128 -> en:pernicious/folate deficiency anemias
    n1=en:Hodgkin lymphoma | n2=en:pernicious/folate deficiency anemias | rel=r_associated | relid=0 | w=29
  373. en:Hodgkin lymphoma -- r_associated #0: 29 / 0.128 -> en:pituitary gland adenoma
    n1=en:Hodgkin lymphoma | n2=en:pituitary gland adenoma | rel=r_associated | relid=0 | w=29
  374. en:Hodgkin lymphoma -- r_associated #0: 29 / 0.128 -> en:plasmacytoma
    n1=en:Hodgkin lymphoma | n2=en:plasmacytoma | rel=r_associated | relid=0 | w=29
  375. en:Hodgkin lymphoma -- r_associated #0: 29 / 0.128 -> en:pneumonia
    n1=en:Hodgkin lymphoma | n2=en:pneumonia | rel=r_associated | relid=0 | w=29
  376. en:Hodgkin lymphoma -- r_associated #0: 29 / 0.128 -> en:polyembryoma
    n1=en:Hodgkin lymphoma | n2=en:polyembryoma | rel=r_associated | relid=0 | w=29
  377. en:Hodgkin lymphoma -- r_associated #0: 29 / 0.128 -> en:possibly increased risk for other cancers
    n1=en:Hodgkin lymphoma | n2=en:possibly increased risk for other cancers | rel=r_associated | relid=0 | w=29
  378. en:Hodgkin lymphoma -- r_associated #0: 29 / 0.128 -> en:primary malignant neoplasm of ill-defined site
    n1=en:Hodgkin lymphoma | n2=en:primary malignant neoplasm of ill-defined site | rel=r_associated | relid=0 | w=29
  379. en:Hodgkin lymphoma -- r_associated #0: 29 / 0.128 -> en:primary malignant neoplasm of spleen
    n1=en:Hodgkin lymphoma | n2=en:primary malignant neoplasm of spleen | rel=r_associated | relid=0 | w=29
  380. en:Hodgkin lymphoma -- r_associated #0: 29 / 0.128 -> en:primary malignant neoplasm of upper limb (disorder)
    n1=en:Hodgkin lymphoma | n2=en:primary malignant neoplasm of upper limb (disorder) | rel=r_associated | relid=0 | w=29
  381. en:Hodgkin lymphoma -- r_associated #0: 29 / 0.128 -> en:psoriasis
    n1=en:Hodgkin lymphoma | n2=en:psoriasis | rel=r_associated | relid=0 | w=29
  382. en:Hodgkin lymphoma -- r_associated #0: 29 / 0.128 -> en:rarely malignant
    n1=en:Hodgkin lymphoma | n2=en:rarely malignant | rel=r_associated | relid=0 | w=29
  383. en:Hodgkin lymphoma -- r_associated #0: 29 / 0.128 -> en:recurrent hodgkin's disease lymphocyte predominance type
    n1=en:Hodgkin lymphoma | n2=en:recurrent hodgkin's disease lymphocyte predominance type | rel=r_associated | relid=0 | w=29
  384. en:Hodgkin lymphoma -- r_associated #0: 29 / 0.128 -> en:refractory anemia with ring sideroblasts
    n1=en:Hodgkin lymphoma | n2=en:refractory anemia with ring sideroblasts | rel=r_associated | relid=0 | w=29
  385. en:Hodgkin lymphoma -- r_associated #0: 29 / 0.128 -> en:refractory cytopenia with multilineage dysplasia and ring sideroblasts
    n1=en:Hodgkin lymphoma | n2=en:refractory cytopenia with multilineage dysplasia and ring sideroblasts | rel=r_associated | relid=0 | w=29
  386. en:Hodgkin lymphoma -- r_associated #0: 29 / 0.128 -> en:refractory hodgkin's disease lymphocyte predominance type
    n1=en:Hodgkin lymphoma | n2=en:refractory hodgkin's disease lymphocyte predominance type | rel=r_associated | relid=0 | w=29
  387. en:Hodgkin lymphoma -- r_associated #0: 29 / 0.128 -> en:renal cell carcinoma, solitary papillary type 2 (about 20% of patients)
    n1=en:Hodgkin lymphoma | n2=en:renal cell carcinoma, solitary papillary type 2 (about 20% of patients) | rel=r_associated | relid=0 | w=29
  388. en:Hodgkin lymphoma -- r_associated #0: 29 / 0.128 -> en:reported colon and other abdominal cancer in relatives
    n1=en:Hodgkin lymphoma | n2=en:reported colon and other abdominal cancer in relatives | rel=r_associated | relid=0 | w=29
  389. en:Hodgkin lymphoma -- r_associated #0: 29 / 0.128 -> en:retinopathy
    n1=en:Hodgkin lymphoma | n2=en:retinopathy | rel=r_associated | relid=0 | w=29
  390. en:Hodgkin lymphoma -- r_associated #0: 29 / 0.128 -> en:rhabdoid tumor
    n1=en:Hodgkin lymphoma | n2=en:rhabdoid tumor | rel=r_associated | relid=0 | w=29
  391. en:Hodgkin lymphoma -- r_associated #0: 29 / 0.128 -> en:rhabdomyosarcoma
    n1=en:Hodgkin lymphoma | n2=en:rhabdomyosarcoma | rel=r_associated | relid=0 | w=29
  392. en:Hodgkin lymphoma -- r_associated #0: 29 / 0.128 -> en:sarcomatoid transitional cell carcinoma
    n1=en:Hodgkin lymphoma | n2=en:sarcomatoid transitional cell carcinoma | rel=r_associated | relid=0 | w=29
  393. en:Hodgkin lymphoma -- r_associated #0: 29 / 0.128 -> en:scabies and other acariases
    n1=en:Hodgkin lymphoma | n2=en:scabies and other acariases | rel=r_associated | relid=0 | w=29
  394. en:Hodgkin lymphoma -- r_associated #0: 29 / 0.128 -> en:sebaceous epithelioma
    n1=en:Hodgkin lymphoma | n2=en:sebaceous epithelioma | rel=r_associated | relid=0 | w=29
  395. en:Hodgkin lymphoma -- r_associated #0: 29 / 0.128 -> en:seborrheic dermatitis
    n1=en:Hodgkin lymphoma | n2=en:seborrheic dermatitis | rel=r_associated | relid=0 | w=29
  396. en:Hodgkin lymphoma -- r_associated #0: 29 / 0.128 -> en:secondary central nervous system hodgkin lymphoma
    n1=en:Hodgkin lymphoma | n2=en:secondary central nervous system hodgkin lymphoma | rel=r_associated | relid=0 | w=29
  397. en:Hodgkin lymphoma -- r_associated #0: 29 / 0.128 -> en:seromucinous carcinoma
    n1=en:Hodgkin lymphoma | n2=en:seromucinous carcinoma | rel=r_associated | relid=0 | w=29
  398. en:Hodgkin lymphoma -- r_associated #0: 29 / 0.128 -> en:sertoli-leydig cell tumor, poorly differentiated
    n1=en:Hodgkin lymphoma | n2=en:sertoli-leydig cell tumor, poorly differentiated | rel=r_associated | relid=0 | w=29
  399. en:Hodgkin lymphoma -- r_associated #0: 29 / 0.128 -> en:skin fibroepithelial basal cell carcinoma
    n1=en:Hodgkin lymphoma | n2=en:skin fibroepithelial basal cell carcinoma | rel=r_associated | relid=0 | w=29
  400. en:Hodgkin lymphoma -- r_associated #0: 29 / 0.128 -> en:small cell sarcoma
    n1=en:Hodgkin lymphoma | n2=en:small cell sarcoma | rel=r_associated | relid=0 | w=29
  401. en:Hodgkin lymphoma -- r_associated #0: 29 / 0.128 -> en:spindle cell sarcoma
    n1=en:Hodgkin lymphoma | n2=en:spindle cell sarcoma | rel=r_associated | relid=0 | w=29
  402. en:Hodgkin lymphoma -- r_associated #0: 29 / 0.128 -> en:spontaneous abortion
    n1=en:Hodgkin lymphoma | n2=en:spontaneous abortion | rel=r_associated | relid=0 | w=29
  403. en:Hodgkin lymphoma -- r_associated #0: 29 / 0.128 -> en:stage iii hodgkin's disease lymphocyte predominance type
    n1=en:Hodgkin lymphoma | n2=en:stage iii hodgkin's disease lymphocyte predominance type | rel=r_associated | relid=0 | w=29
  404. en:Hodgkin lymphoma -- r_associated #0: 29 / 0.128 -> en:steroid cell tumor, malignant
    n1=en:Hodgkin lymphoma | n2=en:steroid cell tumor, malignant | rel=r_associated | relid=0 | w=29
  405. en:Hodgkin lymphoma -- r_associated #0: 29 / 0.128 -> en:surgical aspects
    n1=en:Hodgkin lymphoma | n2=en:surgical aspects | rel=r_associated | relid=0 | w=29
  406. en:Hodgkin lymphoma -- r_associated #0: 29 / 0.128 -> en:swallowed foreign body in digestive system
    n1=en:Hodgkin lymphoma | n2=en:swallowed foreign body in digestive system | rel=r_associated | relid=0 | w=29
  407. en:Hodgkin lymphoma -- r_associated #0: 29 / 0.128 -> en:synovial neoplasm
    n1=en:Hodgkin lymphoma | n2=en:synovial neoplasm | rel=r_associated | relid=0 | w=29
  408. en:Hodgkin lymphoma -- r_associated #0: 29 / 0.128 -> en:t lymphoblastic leukemia/lymphoma
    n1=en:Hodgkin lymphoma | n2=en:t lymphoblastic leukemia/lymphoma | rel=r_associated | relid=0 | w=29
  409. en:Hodgkin lymphoma -- r_associated #0: 29 / 0.128 -> en:taxonomic
    n1=en:Hodgkin lymphoma | n2=en:taxonomic | rel=r_associated | relid=0 | w=29
  410. en:Hodgkin lymphoma -- r_associated #0: 29 / 0.128 -> en:thymus neoplasm
    n1=en:Hodgkin lymphoma | n2=en:thymus neoplasm | rel=r_associated | relid=0 | w=29
  411. en:Hodgkin lymphoma -- r_associated #0: 29 / 0.128 -> en:thyroid gland medullary carcinoma
    n1=en:Hodgkin lymphoma | n2=en:thyroid gland medullary carcinoma | rel=r_associated | relid=0 | w=29
  412. en:Hodgkin lymphoma -- r_associated #0: 29 / 0.128 -> en:thyroid gland neoplasm
    n1=en:Hodgkin lymphoma | n2=en:thyroid gland neoplasm | rel=r_associated | relid=0 | w=29
  413. en:Hodgkin lymphoma -- r_associated #0: 29 / 0.128 -> en:thyroid gland oncocytic adenoma
    n1=en:Hodgkin lymphoma | n2=en:thyroid gland oncocytic adenoma | rel=r_associated | relid=0 | w=29
  414. en:Hodgkin lymphoma -- r_associated #0: 29 / 0.128 -> en:transaminase cell carcinoma
    n1=en:Hodgkin lymphoma | n2=en:transaminase cell carcinoma | rel=r_associated | relid=0 | w=29
  415. en:Hodgkin lymphoma -- r_associated #0: 29 / 0.128 -> en:tumor cells, benign
    n1=en:Hodgkin lymphoma | n2=en:tumor cells, benign | rel=r_associated | relid=0 | w=29
  416. en:Hodgkin lymphoma -- r_associated #0: 29 / 0.128 -> en:tumor necrosis factor receptor superfamily member 8
    n1=en:Hodgkin lymphoma | n2=en:tumor necrosis factor receptor superfamily member 8 | rel=r_associated | relid=0 | w=29
  417. en:Hodgkin lymphoma -- r_associated #0: 29 / 0.128 -> en:undifferentiated (embryonal) sarcoma
    n1=en:Hodgkin lymphoma | n2=en:undifferentiated (embryonal) sarcoma | rel=r_associated | relid=0 | w=29
  418. en:Hodgkin lymphoma -- r_associated #0: 29 / 0.128 -> en:undifferentiated pleomorphic sarcoma with osteoclast-like giant cells
    n1=en:Hodgkin lymphoma | n2=en:undifferentiated pleomorphic sarcoma with osteoclast-like giant cells | rel=r_associated | relid=0 | w=29
  419. en:Hodgkin lymphoma -- r_associated #0: 29 / 0.128 -> en:unresectable malignant neoplasm
    n1=en:Hodgkin lymphoma | n2=en:unresectable malignant neoplasm | rel=r_associated | relid=0 | w=29
  420. en:Hodgkin lymphoma -- r_associated #0: 29 / 0.128 -> en:vaccine-induced fibrosarcoma
    n1=en:Hodgkin lymphoma | n2=en:vaccine-induced fibrosarcoma | rel=r_associated | relid=0 | w=29
  421. en:Hodgkin lymphoma -- r_associated #0: 28 / 0.124 -> en:acute lymphadenitis
    n1=en:Hodgkin lymphoma | n2=en:acute lymphadenitis | rel=r_associated | relid=0 | w=28
  422. en:Hodgkin lymphoma -- r_associated #0: 28 / 0.124 -> en:acute lymphoblastic leukemia (in 1 patient)
    n1=en:Hodgkin lymphoma | n2=en:acute lymphoblastic leukemia (in 1 patient) | rel=r_associated | relid=0 | w=28
  423. en:Hodgkin lymphoma -- r_associated #0: 28 / 0.124 -> en:acute monoblastic leukemia
    n1=en:Hodgkin lymphoma | n2=en:acute monoblastic leukemia | rel=r_associated | relid=0 | w=28
  424. en:Hodgkin lymphoma -- r_associated #0: 28 / 0.124 -> en:acute myocardial infarction
    n1=en:Hodgkin lymphoma | n2=en:acute myocardial infarction | rel=r_associated | relid=0 | w=28
  425. en:Hodgkin lymphoma -- r_associated #0: 28 / 0.124 -> en:adrenal glands are most common site
    n1=en:Hodgkin lymphoma | n2=en:adrenal glands are most common site | rel=r_associated | relid=0 | w=28
  426. en:Hodgkin lymphoma -- r_associated #0: 28 / 0.124 -> en:advanced malignant neoplasm
    n1=en:Hodgkin lymphoma | n2=en:advanced malignant neoplasm | rel=r_associated | relid=0 | w=28
  427. en:Hodgkin lymphoma -- r_associated #0: 28 / 0.124 -> en:aids-related lymphoma
    n1=en:Hodgkin lymphoma | n2=en:aids-related lymphoma | rel=r_associated | relid=0 | w=28
  428. en:Hodgkin lymphoma -- r_associated #0: 28 / 0.124 -> en:ampulla of vater adenocarcinoma
    n1=en:Hodgkin lymphoma | n2=en:ampulla of vater adenocarcinoma | rel=r_associated | relid=0 | w=28
  429. en:Hodgkin lymphoma -- r_associated #0: 28 / 0.124 -> en:anal carcinoma
    n1=en:Hodgkin lymphoma | n2=en:anal carcinoma | rel=r_associated | relid=0 | w=28
  430. en:Hodgkin lymphoma -- r_associated #0: 28 / 0.124 -> en:anaphylaxis (non medication)
    n1=en:Hodgkin lymphoma | n2=en:anaphylaxis (non medication) | rel=r_associated | relid=0 | w=28
  431. en:Hodgkin lymphoma -- r_associated #0: 28 / 0.124 -> en:anaplastic (malignant) meningioma
    n1=en:Hodgkin lymphoma | n2=en:anaplastic (malignant) meningioma | rel=r_associated | relid=0 | w=28
  432. en:Hodgkin lymphoma -- r_associated #0: 28 / 0.124 -> en:associated with other malignancies
    n1=en:Hodgkin lymphoma | n2=en:associated with other malignancies | rel=r_associated | relid=0 | w=28
  433. en:Hodgkin lymphoma -- r_associated #0: 28 / 0.124 -> en:astrocytoma
    n1=en:Hodgkin lymphoma | n2=en:astrocytoma | rel=r_associated | relid=0 | w=28
  434. en:Hodgkin lymphoma -- r_associated #0: 28 / 0.124 -> en:atherosclerosis excluding heart/brain
    n1=en:Hodgkin lymphoma | n2=en:atherosclerosis excluding heart/brain | rel=r_associated | relid=0 | w=28
  435. en:Hodgkin lymphoma -- r_associated #0: 28 / 0.124 -> en:atypical teratoid/rhabdoid tumor
    n1=en:Hodgkin lymphoma | n2=en:atypical teratoid/rhabdoid tumor | rel=r_associated | relid=0 | w=28
  436. en:Hodgkin lymphoma -- r_associated #0: 28 / 0.124 -> en:b-cell lymphoma, unclassifiable, with features intermediate between diffuse large b-cell lymphoma and classical hodgkin lymphoma
    n1=en:Hodgkin lymphoma | n2=en:b-cell lymphoma, unclassifiable, with features intermediate between diffuse large b-cell lymphoma and classical hodgkin lymphoma | rel=r_associated | relid=0 | w=28
  437. en:Hodgkin lymphoma -- r_associated #0: 28 / 0.124 -> en:basaloid carcinoma
    n1=en:Hodgkin lymphoma | n2=en:basaloid carcinoma | rel=r_associated | relid=0 | w=28
  438. en:Hodgkin lymphoma -- r_associated #0: 28 / 0.124 -> en:benign digestive system neoplasm
    n1=en:Hodgkin lymphoma | n2=en:benign digestive system neoplasm | rel=r_associated | relid=0 | w=28
  439. en:Hodgkin lymphoma -- r_associated #0: 28 / 0.124 -> en:benign genitourinary tract neoplasm
    n1=en:Hodgkin lymphoma | n2=en:benign genitourinary tract neoplasm | rel=r_associated | relid=0 | w=28
  440. en:Hodgkin lymphoma -- r_associated #0: 28 / 0.124 -> en:benign soft tissue neoplasm
    n1=en:Hodgkin lymphoma | n2=en:benign soft tissue neoplasm | rel=r_associated | relid=0 | w=28
  441. en:Hodgkin lymphoma -- r_associated #0: 28 / 0.124 -> en:benign teratoma
    n1=en:Hodgkin lymphoma | n2=en:benign teratoma | rel=r_associated | relid=0 | w=28
  442. en:Hodgkin lymphoma -- r_associated #0: 28 / 0.124 -> en:benign tumors of the eye, heart, and lungs
    n1=en:Hodgkin lymphoma | n2=en:benign tumors of the eye, heart, and lungs | rel=r_associated | relid=0 | w=28
  443. en:Hodgkin lymphoma -- r_associated #0: 28 / 0.124 -> en:biphasic mesothelioma
    n1=en:Hodgkin lymphoma | n2=en:biphasic mesothelioma | rel=r_associated | relid=0 | w=28
  444. en:Hodgkin lymphoma -- r_associated #0: 28 / 0.124 -> en:bladder carcinoma
    n1=en:Hodgkin lymphoma | n2=en:bladder carcinoma | rel=r_associated | relid=0 | w=28
  445. en:Hodgkin lymphoma -- r_associated #0: 28 / 0.124 -> en:bladder urothelial carcinoma
    n1=en:Hodgkin lymphoma | n2=en:bladder urothelial carcinoma | rel=r_associated | relid=0 | w=28
  446. en:Hodgkin lymphoma -- r_associated #0: 28 / 0.124 -> en:bone marrow disorder
    n1=en:Hodgkin lymphoma | n2=en:bone marrow disorder | rel=r_associated | relid=0 | w=28
  447. en:Hodgkin lymphoma -- r_associated #0: 28 / 0.124 -> en:breast disorder in pregnancy/puerperium other
    n1=en:Hodgkin lymphoma | n2=en:breast disorder in pregnancy/puerperium other | rel=r_associated | relid=0 | w=28
  448. en:Hodgkin lymphoma -- r_associated #0: 28 / 0.124 -> en:carcinosarcoma, embryonal
    n1=en:Hodgkin lymphoma | n2=en:carcinosarcoma, embryonal | rel=r_associated | relid=0 | w=28
  449. en:Hodgkin lymphoma -- r_associated #0: 28 / 0.124 -> en:centroblastic lymphoma
    n1=en:Hodgkin lymphoma | n2=en:centroblastic lymphoma | rel=r_associated | relid=0 | w=28
  450. en:Hodgkin lymphoma -- r_associated #0: 28 / 0.124 -> en:cervical neoplasm
    n1=en:Hodgkin lymphoma | n2=en:cervical neoplasm | rel=r_associated | relid=0 | w=28
  451. en:Hodgkin lymphoma -- r_associated #0: 28 / 0.124 -> en:chemically induced
    n1=en:Hodgkin lymphoma | n2=en:chemically induced | rel=r_associated | relid=0 | w=28
  452. en:Hodgkin lymphoma -- r_associated #0: 28 / 0.124 -> en:chemotherapy
    n1=en:Hodgkin lymphoma | n2=en:chemotherapy | rel=r_associated | relid=0 | w=28
  453. en:Hodgkin lymphoma -- r_associated #0: 28 / 0.124 -> en:childhood brain neoplasm
    n1=en:Hodgkin lymphoma | n2=en:childhood brain neoplasm | rel=r_associated | relid=0 | w=28
  454. en:Hodgkin lymphoma -- r_associated #0: 28 / 0.124 -> en:childhood malignant neoplasm
    n1=en:Hodgkin lymphoma | n2=en:childhood malignant neoplasm | rel=r_associated | relid=0 | w=28
  455. en:Hodgkin lymphoma -- r_associated #0: 28 / 0.124 -> en:chronic internal knee derangement
    n1=en:Hodgkin lymphoma | n2=en:chronic internal knee derangement | rel=r_associated | relid=0 | w=28
  456. en:Hodgkin lymphoma -- r_associated #0: 28 / 0.124 -> en:clear cell chondrosarcoma
    n1=en:Hodgkin lymphoma | n2=en:clear cell chondrosarcoma | rel=r_associated | relid=0 | w=28
  457. en:Hodgkin lymphoma -- r_associated #0: 28 / 0.124 -> en:clear cell sarcoma of the kidney
    n1=en:Hodgkin lymphoma | n2=en:clear cell sarcoma of the kidney | rel=r_associated | relid=0 | w=28
  458. en:Hodgkin lymphoma -- r_associated #0: 28 / 0.124 -> en:colon carcinoma
    n1=en:Hodgkin lymphoma | n2=en:colon carcinoma | rel=r_associated | relid=0 | w=28
  459. en:Hodgkin lymphoma -- r_associated #0: 28 / 0.124 -> en:complex mixed and stromal neoplasms
    n1=en:Hodgkin lymphoma | n2=en:complex mixed and stromal neoplasms | rel=r_associated | relid=0 | w=28
  460. en:Hodgkin lymphoma -- r_associated #0: 28 / 0.124 -> en:complication aspects
    n1=en:Hodgkin lymphoma | n2=en:complication aspects | rel=r_associated | relid=0 | w=28
  461. en:Hodgkin lymphoma -- r_associated #0: 28 / 0.124 -> en:compound eye
    n1=en:Hodgkin lymphoma | n2=en:compound eye | rel=r_associated | relid=0 | w=28
  462. en:Hodgkin lymphoma -- r_associated #0: 28 / 0.124 -> en:cryptosporidiosis
    n1=en:Hodgkin lymphoma | n2=en:cryptosporidiosis | rel=r_associated | relid=0 | w=28
  463. en:Hodgkin lymphoma -- r_associated #0: 28 / 0.124 -> en:diffuse embryoma
    n1=en:Hodgkin lymphoma | n2=en:diffuse embryoma | rel=r_associated | relid=0 | w=28
  464. en:Hodgkin lymphoma -- r_associated #0: 28 / 0.124 -> en:dysplasia with neoplasia
    n1=en:Hodgkin lymphoma | n2=en:dysplasia with neoplasia | rel=r_associated | relid=0 | w=28
  465. en:Hodgkin lymphoma -- r_associated #0: 28 / 0.124 -> en:ear neoplasm
    n1=en:Hodgkin lymphoma | n2=en:ear neoplasm | rel=r_associated | relid=0 | w=28
  466. en:Hodgkin lymphoma -- r_associated #0: 28 / 0.124 -> en:embryologic
    n1=en:Hodgkin lymphoma | n2=en:embryologic | rel=r_associated | relid=0 | w=28
  467. en:Hodgkin lymphoma -- r_associated #0: 28 / 0.124 -> en:embryonal tumor with multilayered rosettes, c19mc-altered
    n1=en:Hodgkin lymphoma | n2=en:embryonal tumor with multilayered rosettes, c19mc-altered | rel=r_associated | relid=0 | w=28
  468. en:Hodgkin lymphoma -- r_associated #0: 28 / 0.124 -> en:epithelial-myoepithelial carcinoma
    n1=en:Hodgkin lymphoma | n2=en:epithelial-myoepithelial carcinoma | rel=r_associated | relid=0 | w=28
  469. en:Hodgkin lymphoma -- r_associated #0: 28 / 0.124 -> en:epithelioid mesothelioma
    n1=en:Hodgkin lymphoma | n2=en:epithelioid mesothelioma | rel=r_associated | relid=0 | w=28
  470. en:Hodgkin lymphoma -- r_associated #0: 28 / 0.124 -> en:extrarenal rhabdoid tumor
    n1=en:Hodgkin lymphoma | n2=en:extrarenal rhabdoid tumor | rel=r_associated | relid=0 | w=28
  471. en:Hodgkin lymphoma -- r_associated #0: 28 / 0.124 -> en:fibroblastic liposarcoma
    n1=en:Hodgkin lymphoma | n2=en:fibroblastic liposarcoma | rel=r_associated | relid=0 | w=28
  472. en:Hodgkin lymphoma -- r_associated #0: 28 / 0.124 -> en:fibrohistiocytic neoplasm
    n1=en:Hodgkin lymphoma | n2=en:fibrohistiocytic neoplasm | rel=r_associated | relid=0 | w=28
  473. en:Hodgkin lymphoma -- r_associated #0: 28 / 0.124 -> en:fracture hand/foot bones
    n1=en:Hodgkin lymphoma | n2=en:fracture hand/foot bones | rel=r_associated | relid=0 | w=28
  474. en:Hodgkin lymphoma -- r_associated #0: 28 / 0.124 -> en:ganglion joint/tendon
    n1=en:Hodgkin lymphoma | n2=en:ganglion joint/tendon | rel=r_associated | relid=0 | w=28
  475. en:Hodgkin lymphoma -- r_associated #0: 28 / 0.124 -> en:gastric cancer, diffuse type, poorly differentiated, high-grade submucosal lesions
    n1=en:Hodgkin lymphoma | n2=en:gastric cancer, diffuse type, poorly differentiated, high-grade submucosal lesions | rel=r_associated | relid=0 | w=28
  476. en:Hodgkin lymphoma -- r_associated #0: 28 / 0.124 -> en:germ cell and gonadal stromal cell neoplasms (all subtypes)
    n1=en:Hodgkin lymphoma | n2=en:germ cell and gonadal stromal cell neoplasms (all subtypes) | rel=r_associated | relid=0 | w=28
  477. en:Hodgkin lymphoma -- r_associated #0: 28 / 0.124 -> en:giant cell astrocytoma
    n1=en:Hodgkin lymphoma | n2=en:giant cell astrocytoma | rel=r_associated | relid=0 | w=28
  478. en:Hodgkin lymphoma -- r_associated #0: 28 / 0.124 -> en:giant cell sarcoma (except of bone, m-92503)
    n1=en:Hodgkin lymphoma | n2=en:giant cell sarcoma (except of bone, m-92503) | rel=r_associated | relid=0 | w=28
  479. en:Hodgkin lymphoma -- r_associated #0: 28 / 0.124 -> en:gonadoblastoma
    n1=en:Hodgkin lymphoma | n2=en:gonadoblastoma | rel=r_associated | relid=0 | w=28
  480. en:Hodgkin lymphoma -- r_associated #0: 28 / 0.124 -> en:granular cell tumors and alveolar soft part sarcomas
    n1=en:Hodgkin lymphoma | n2=en:granular cell tumors and alveolar soft part sarcomas | rel=r_associated | relid=0 | w=28
  481. en:Hodgkin lymphoma -- r_associated #0: 28 / 0.124 -> en:granulocytic sarcoma
    n1=en:Hodgkin lymphoma | n2=en:granulocytic sarcoma | rel=r_associated | relid=0 | w=28
  482. en:Hodgkin lymphoma -- r_associated #0: 28 / 0.124 -> en:haematological disorders nec
    n1=en:Hodgkin lymphoma | n2=en:haematological disorders nec | rel=r_associated | relid=0 | w=28
  483. en:Hodgkin lymphoma -- r_associated #0: 28 / 0.124 -> en:hepatoblastoma
    n1=en:Hodgkin lymphoma | n2=en:hepatoblastoma | rel=r_associated | relid=0 | w=28
  484. en:Hodgkin lymphoma -- r_associated #0: 28 / 0.124 -> en:hepatomegaly
    n1=en:Hodgkin lymphoma | n2=en:hepatomegaly | rel=r_associated | relid=0 | w=28
  485. en:Hodgkin lymphoma -- r_associated #0: 28 / 0.124 -> en:hiv/aids in women
    n1=en:Hodgkin lymphoma | n2=en:hiv/aids in women | rel=r_associated | relid=0 | w=28
  486. en:Hodgkin lymphoma -- r_associated #0: 28 / 0.124 -> en:hodgkin's disease, lymphocytic depletion of lymph nodes of axilla and/or upper limb
    n1=en:Hodgkin lymphoma | n2=en:hodgkin's disease, lymphocytic depletion of lymph nodes of axilla and/or upper limb | rel=r_associated | relid=0 | w=28
  487. en:Hodgkin lymphoma -- r_associated #0: 28 / 0.124 -> en:hodgkin's disease, lymphocytic depletion of spleen
    n1=en:Hodgkin lymphoma | n2=en:hodgkin's disease, lymphocytic depletion of spleen | rel=r_associated | relid=0 | w=28
  488. en:Hodgkin lymphoma -- r_associated #0: 28 / 0.124 -> en:hodgkin's disease, nodular sclerosis of intrapelvic lymph nodes
    n1=en:Hodgkin lymphoma | n2=en:hodgkin's disease, nodular sclerosis of intrapelvic lymph nodes | rel=r_associated | relid=0 | w=28
  489. en:Hodgkin lymphoma -- r_associated #0: 28 / 0.124 -> en:hodgkin's sarcoma of lymph nodes of inguinal region and lower limb
    n1=en:Hodgkin lymphoma | n2=en:hodgkin's sarcoma of lymph nodes of inguinal region and lower limb | rel=r_associated | relid=0 | w=28
  490. en:Hodgkin lymphoma -- r_associated #0: 28 / 0.124 -> en:hodgkin's sarcoma of spleen
    n1=en:Hodgkin lymphoma | n2=en:hodgkin's sarcoma of spleen | rel=r_associated | relid=0 | w=28
  491. en:Hodgkin lymphoma -- r_associated #0: 28 / 0.124 -> en:hypereosinophilic syndrome
    n1=en:Hodgkin lymphoma | n2=en:hypereosinophilic syndrome | rel=r_associated | relid=0 | w=28
  492. en:Hodgkin lymphoma -- r_associated #0: 28 / 0.124 -> en:hypoglycemia
    n1=en:Hodgkin lymphoma | n2=en:hypoglycemia | rel=r_associated | relid=0 | w=28
  493. en:Hodgkin lymphoma -- r_associated #0: 28 / 0.124 -> en:imaginal discs
    n1=en:Hodgkin lymphoma | n2=en:imaginal discs | rel=r_associated | relid=0 | w=28
  494. en:Hodgkin lymphoma -- r_associated #0: 28 / 0.124 -> en:immune system disorder
    n1=en:Hodgkin lymphoma | n2=en:immune system disorder | rel=r_associated | relid=0 | w=28
  495. en:Hodgkin lymphoma -- r_associated #0: 28 / 0.124 -> en:immunology aspects
    n1=en:Hodgkin lymphoma | n2=en:immunology aspects | rel=r_associated | relid=0 | w=28
  496. en:Hodgkin lymphoma -- r_associated #0: 28 / 0.124 -> en:impetigo
    n1=en:Hodgkin lymphoma | n2=en:impetigo | rel=r_associated | relid=0 | w=28
  497. en:Hodgkin lymphoma -- r_associated #0: 28 / 0.124 -> en:in cerebrospinal fluid
    n1=en:Hodgkin lymphoma | n2=en:in cerebrospinal fluid | rel=r_associated | relid=0 | w=28
  498. en:Hodgkin lymphoma -- r_associated #0: 28 / 0.124 -> en:increase in blood pressure
    n1=en:Hodgkin lymphoma | n2=en:increase in blood pressure | rel=r_associated | relid=0 | w=28
  499. en:Hodgkin lymphoma -- r_associated #0: 28 / 0.124 -> en:increased risk for hematologic cancer, particularly acute myeloid leukemia
    n1=en:Hodgkin lymphoma | n2=en:increased risk for hematologic cancer, particularly acute myeloid leukemia | rel=r_associated | relid=0 | w=28
  500. en:Hodgkin lymphoma -- r_associated #0: 28 / 0.124 -> en:increased risk for lymphoma hodgkin disease
    n1=en:Hodgkin lymphoma | n2=en:increased risk for lymphoma hodgkin disease | rel=r_associated | relid=0 | w=28
  501. en:Hodgkin lymphoma -- r_associated #0: 28 / 0.124 -> en:increased risk in heterozygotes
    n1=en:Hodgkin lymphoma | n2=en:increased risk in heterozygotes | rel=r_associated | relid=0 | w=28
  502. en:Hodgkin lymphoma -- r_associated #0: 28 / 0.124 -> en:increased risk of meningioma
    n1=en:Hodgkin lymphoma | n2=en:increased risk of meningioma | rel=r_associated | relid=0 | w=28
  503. en:Hodgkin lymphoma -- r_associated #0: 28 / 0.124 -> en:index tumor
    n1=en:Hodgkin lymphoma | n2=en:index tumor | rel=r_associated | relid=0 | w=28
  504. en:Hodgkin lymphoma -- r_associated #0: 28 / 0.124 -> en:infantile fibrosarcoma
    n1=en:Hodgkin lymphoma | n2=en:infantile fibrosarcoma | rel=r_associated | relid=0 | w=28
  505. en:Hodgkin lymphoma -- r_associated #0: 28 / 0.124 -> en:infiltrating carcinoma with ductal and lobular features
    n1=en:Hodgkin lymphoma | n2=en:infiltrating carcinoma with ductal and lobular features | rel=r_associated | relid=0 | w=28
  506. en:Hodgkin lymphoma -- r_associated #0: 28 / 0.124 -> en:kaposi sarcoma (1 patient)
    n1=en:Hodgkin lymphoma | n2=en:kaposi sarcoma (1 patient) | rel=r_associated | relid=0 | w=28
  507. en:Hodgkin lymphoma -- r_associated #0: 28 / 0.124 -> en:leukemic infiltrate of kidney
    n1=en:Hodgkin lymphoma | n2=en:leukemic infiltrate of kidney | rel=r_associated | relid=0 | w=28
  508. en:Hodgkin lymphoma -- r_associated #0: 28 / 0.124 -> en:leukocyte
    n1=en:Hodgkin lymphoma | n2=en:leukocyte | rel=r_associated | relid=0 | w=28
  509. en:Hodgkin lymphoma -- r_associated #0: 28 / 0.124 -> en:lipoma
    n1=en:Hodgkin lymphoma | n2=en:lipoma | rel=r_associated | relid=0 | w=28
  510. en:Hodgkin lymphoma -- r_associated #0: 28 / 0.124 -> en:low grade myofibroblastic sarcoma
    n1=en:Hodgkin lymphoma | n2=en:low grade myofibroblastic sarcoma | rel=r_associated | relid=0 | w=28
  511. en:Hodgkin lymphoma -- r_associated #0: 28 / 0.124 -> en:lymphocyte depleted classical hodgkin lymphoma, lymph nodes of multiple sites
    n1=en:Hodgkin lymphoma | n2=en:lymphocyte depleted classical hodgkin lymphoma, lymph nodes of multiple sites | rel=r_associated | relid=0 | w=28
  512. en:Hodgkin lymphoma -- r_associated #0: 28 / 0.124 -> en:lymphocyte depleted classical hodgkin lymphoma, spleen
    n1=en:Hodgkin lymphoma | n2=en:lymphocyte depleted classical hodgkin lymphoma, spleen | rel=r_associated | relid=0 | w=28
  513. en:Hodgkin lymphoma -- r_associated #0: 28 / 0.124 -> en:lymphocyte-rich classical hodgkin lymphoma, lymph nodes of head, face, and neck
    n1=en:Hodgkin lymphoma | n2=en:lymphocyte-rich classical hodgkin lymphoma, lymph nodes of head, face, and neck | rel=r_associated | relid=0 | w=28
  514. en:Hodgkin lymphoma -- r_associated #0: 28 / 0.124 -> en:lymphocyte-rich classical hodgkin lymphoma, unspecified site
    n1=en:Hodgkin lymphoma | n2=en:lymphocyte-rich classical hodgkin lymphoma, unspecified site | rel=r_associated | relid=0 | w=28
  515. en:Hodgkin lymphoma -- r_associated #0: 28 / 0.124 -> en:lymphoma
    n1=en:Hodgkin lymphoma | n2=en:lymphoma | rel=r_associated | relid=0 | w=28
  516. en:Hodgkin lymphoma -- r_associated #0: 28 / 0.124 -> en:lymphoma by site
    n1=en:Hodgkin lymphoma | n2=en:lymphoma by site | rel=r_associated | relid=0 | w=28
  517. en:Hodgkin lymphoma -- r_associated #0: 28 / 0.124 -> en:malignant adrenal gland neoplasm
    n1=en:Hodgkin lymphoma | n2=en:malignant adrenal gland neoplasm | rel=r_associated | relid=0 | w=28
  518. en:Hodgkin lymphoma -- r_associated #0: 28 / 0.124 -> en:malignant breast neoplasm
    n1=en:Hodgkin lymphoma | n2=en:malignant breast neoplasm | rel=r_associated | relid=0 | w=28
  519. en:Hodgkin lymphoma -- r_associated #0: 28 / 0.124 -> en:malignant glioma
    n1=en:Hodgkin lymphoma | n2=en:malignant glioma | rel=r_associated | relid=0 | w=28
  520. en:Hodgkin lymphoma -- r_associated #0: 28 / 0.124 -> en:malignant lymphadenopathy
    n1=en:Hodgkin lymphoma | n2=en:malignant lymphadenopathy | rel=r_associated | relid=0 | w=28
  521. en:Hodgkin lymphoma -- r_associated #0: 28 / 0.124 -> en:malignant neoplasm (morphology)
    n1=en:Hodgkin lymphoma | n2=en:malignant neoplasm (morphology) | rel=r_associated | relid=0 | w=28
  522. en:Hodgkin lymphoma -- r_associated #0: 28 / 0.124 -> en:malignant neoplasm associated with aids
    n1=en:Hodgkin lymphoma | n2=en:malignant neoplasm associated with aids | rel=r_associated | relid=0 | w=28
  523. en:Hodgkin lymphoma -- r_associated #0: 28 / 0.124 -> en:malignant neoplasm associated with transplant organ
    n1=en:Hodgkin lymphoma | n2=en:malignant neoplasm associated with transplant organ | rel=r_associated | relid=0 | w=28
  524. en:Hodgkin lymphoma -- r_associated #0: 28 / 0.124 -> en:malignant neoplasm by grade
    n1=en:Hodgkin lymphoma | n2=en:malignant neoplasm by grade | rel=r_associated | relid=0 | w=28
  525. en:Hodgkin lymphoma -- r_associated #0: 28 / 0.124 -> en:malignant neoplasm of other and ill-defined sites: other ill-defined sites
    n1=en:Hodgkin lymphoma | n2=en:malignant neoplasm of other and ill-defined sites: other ill-defined sites | rel=r_associated | relid=0 | w=28
  526. en:Hodgkin lymphoma -- r_associated #0: 28 / 0.124 -> en:malignant neoplasm of skeletal system
    n1=en:Hodgkin lymphoma | n2=en:malignant neoplasm of skeletal system | rel=r_associated | relid=0 | w=28
  527. en:Hodgkin lymphoma -- r_associated #0: 28 / 0.124 -> en:malignant neoplasm, overlapping lesion of digestive system
    n1=en:Hodgkin lymphoma | n2=en:malignant neoplasm, overlapping lesion of digestive system | rel=r_associated | relid=0 | w=28
  528. en:Hodgkin lymphoma -- r_associated #0: 28 / 0.124 -> en:malignant peripheral nerve sheath tumor
    n1=en:Hodgkin lymphoma | n2=en:malignant peripheral nerve sheath tumor | rel=r_associated | relid=0 | w=28
  529. en:Hodgkin lymphoma -- r_associated #0: 28 / 0.124 -> en:malignant prostate neoplasm
    n1=en:Hodgkin lymphoma | n2=en:malignant prostate neoplasm | rel=r_associated | relid=0 | w=28
  530. en:Hodgkin lymphoma -- r_associated #0: 28 / 0.124 -> en:malignant sex cord-stromal tumor
    n1=en:Hodgkin lymphoma | n2=en:malignant sex cord-stromal tumor | rel=r_associated | relid=0 | w=28
  531. en:Hodgkin lymphoma -- r_associated #0: 28 / 0.124 -> en:malignant thoracic neoplasm
    n1=en:Hodgkin lymphoma | n2=en:malignant thoracic neoplasm | rel=r_associated | relid=0 | w=28
  532. en:Hodgkin lymphoma -- r_associated #0: 28 / 0.124 -> en:malignant trophoblastic teratoma
    n1=en:Hodgkin lymphoma | n2=en:malignant trophoblastic teratoma | rel=r_associated | relid=0 | w=28
  533. en:Hodgkin lymphoma -- r_associated #0: 28 / 0.124 -> en:malignant urinary system neoplasm
    n1=en:Hodgkin lymphoma | n2=en:malignant urinary system neoplasm | rel=r_associated | relid=0 | w=28
  534. en:Hodgkin lymphoma -- r_associated #0: 28 / 0.124 -> en:malignant vaginal neoplasm
    n1=en:Hodgkin lymphoma | n2=en:malignant vaginal neoplasm | rel=r_associated | relid=0 | w=28
  535. en:Hodgkin lymphoma -- r_associated #0: 28 / 0.124 -> en:mature b-cell non-hodgkin lymphoma
    n1=en:Hodgkin lymphoma | n2=en:mature b-cell non-hodgkin lymphoma | rel=r_associated | relid=0 | w=28
  536. en:Hodgkin lymphoma -- r_associated #0: 28 / 0.124 -> en:meningitis/encephalitis
    n1=en:Hodgkin lymphoma | n2=en:meningitis/encephalitis | rel=r_associated | relid=0 | w=28
  537. en:Hodgkin lymphoma -- r_associated #0: 28 / 0.124 -> en:minimal deviation malignant melanoma
    n1=en:Hodgkin lymphoma | n2=en:minimal deviation malignant melanoma | rel=r_associated | relid=0 | w=28
  538. en:Hodgkin lymphoma -- r_associated #0: 28 / 0.124 -> en:mixed liposarcoma
    n1=en:Hodgkin lymphoma | n2=en:mixed liposarcoma | rel=r_associated | relid=0 | w=28
  539. en:Hodgkin lymphoma -- r_associated #0: 28 / 0.124 -> en:morphology
    n1=en:Hodgkin lymphoma | n2=en:morphology | rel=r_associated | relid=0 | w=28
  540. en:Hodgkin lymphoma -- r_associated #0: 28 / 0.124 -> en:muscle tumors (all subtypes)
    n1=en:Hodgkin lymphoma | n2=en:muscle tumors (all subtypes) | rel=r_associated | relid=0 | w=28
  541. en:Hodgkin lymphoma -- r_associated #0: 28 / 0.124 -> en:myeloproliferative neoplasm
    n1=en:Hodgkin lymphoma | n2=en:myeloproliferative neoplasm | rel=r_associated | relid=0 | w=28
  542. en:Hodgkin lymphoma -- r_associated #0: 28 / 0.124 -> en:nci ctep simplified disease classification terminology
    n1=en:Hodgkin lymphoma | n2=en:nci ctep simplified disease classification terminology | rel=r_associated | relid=0 | w=28
  543. en:Hodgkin lymphoma -- r_associated #0: 28 / 0.124 -> en:neoplasm of unspecified nature of endocrine glands and other parts of nervous system
    n1=en:Hodgkin lymphoma | n2=en:neoplasm of unspecified nature of endocrine glands and other parts of nervous system | rel=r_associated | relid=0 | w=28
  544. en:Hodgkin lymphoma -- r_associated #0: 28 / 0.124 -> en:neoplasms, adnexal and skin appendage
    n1=en:Hodgkin lymphoma | n2=en:neoplasms, adnexal and skin appendage | rel=r_associated | relid=0 | w=28
  545. en:Hodgkin lymphoma -- r_associated #0: 28 / 0.124 -> en:neoplasms, cystic, mucinous, and serous
    n1=en:Hodgkin lymphoma | n2=en:neoplasms, cystic, mucinous, and serous | rel=r_associated | relid=0 | w=28
  546. en:Hodgkin lymphoma -- r_associated #0: 28 / 0.124 -> en:neoplasms, hormone-dependent
    n1=en:Hodgkin lymphoma | n2=en:neoplasms, hormone-dependent | rel=r_associated | relid=0 | w=28
  547. en:Hodgkin lymphoma -- r_associated #0: 28 / 0.124 -> en:nerve sheath neoplasm
    n1=en:Hodgkin lymphoma | n2=en:nerve sheath neoplasm | rel=r_associated | relid=0 | w=28
  548. en:Hodgkin lymphoma -- r_associated #0: 28 / 0.124 -> en:neural tissue tumors
    n1=en:Hodgkin lymphoma | n2=en:neural tissue tumors | rel=r_associated | relid=0 | w=28
  549. en:Hodgkin lymphoma -- r_associated #0: 28 / 0.124 -> en:nevus and/or melanoma
    n1=en:Hodgkin lymphoma | n2=en:nevus and/or melanoma | rel=r_associated | relid=0 | w=28
  550. en:Hodgkin lymphoma -- r_associated #0: 28 / 0.124 -> en:no disease
    n1=en:Hodgkin lymphoma | n2=en:no disease | rel=r_associated | relid=0 | w=28
  551. en:Hodgkin lymphoma -- r_associated #0: 28 / 0.124 -> en:nodular lymphocyte predominant hodgkin lymphoma, spleen
    n1=en:Hodgkin lymphoma | n2=en:nodular lymphocyte predominant hodgkin lymphoma, spleen | rel=r_associated | relid=0 | w=28
  552. en:Hodgkin lymphoma -- r_associated #0: 28 / 0.124 -> en:nodular sclerosis classical hodgkin lymphoma, intrapelvic lymph nodes
    n1=en:Hodgkin lymphoma | n2=en:nodular sclerosis classical hodgkin lymphoma, intrapelvic lymph nodes | rel=r_associated | relid=0 | w=28
  553. en:Hodgkin lymphoma -- r_associated #0: 28 / 0.124 -> en:nodular sclerosis classical hodgkin lymphoma, lymph nodes of inguinal region and lower limb
    n1=en:Hodgkin lymphoma | n2=en:nodular sclerosis classical hodgkin lymphoma, lymph nodes of inguinal region and lower limb | rel=r_associated | relid=0 | w=28
  554. en:Hodgkin lymphoma -- r_associated #0: 28 / 0.124 -> en:nodular sclerosis classical hodgkin lymphoma, unspecified site
    n1=en:Hodgkin lymphoma | n2=en:nodular sclerosis classical hodgkin lymphoma, unspecified site | rel=r_associated | relid=0 | w=28
  555. en:Hodgkin lymphoma -- r_associated #0: 28 / 0.124 -> en:olfactory neurogenic tumor
    n1=en:Hodgkin lymphoma | n2=en:olfactory neurogenic tumor | rel=r_associated | relid=0 | w=28
  556. en:Hodgkin lymphoma -- r_associated #0: 28 / 0.124 -> en:optic glioma (19%)
    n1=en:Hodgkin lymphoma | n2=en:optic glioma (19%) | rel=r_associated | relid=0 | w=28
  557. en:Hodgkin lymphoma -- r_associated #0: 28 / 0.124 -> en:optic nerve glioma
    n1=en:Hodgkin lymphoma | n2=en:optic nerve glioma | rel=r_associated | relid=0 | w=28
  558. en:Hodgkin lymphoma -- r_associated #0: 28 / 0.124 -> en:osteoporosis
    n1=en:Hodgkin lymphoma | n2=en:osteoporosis | rel=r_associated | relid=0 | w=28
  559. en:Hodgkin lymphoma -- r_associated #0: 28 / 0.124 -> en:other arterial obstructive/peripheral vascular disease
    n1=en:Hodgkin lymphoma | n2=en:other arterial obstructive/peripheral vascular disease | rel=r_associated | relid=0 | w=28
  560. en:Hodgkin lymphoma -- r_associated #0: 28 / 0.124 -> en:other auditory injuries
    n1=en:Hodgkin lymphoma | n2=en:other auditory injuries | rel=r_associated | relid=0 | w=28
  561. en:Hodgkin lymphoma -- r_associated #0: 28 / 0.124 -> en:other classical hodgkin lymphoma, lymph nodes of multiple sites
    n1=en:Hodgkin lymphoma | n2=en:other classical hodgkin lymphoma, lymph nodes of multiple sites | rel=r_associated | relid=0 | w=28
  562. en:Hodgkin lymphoma -- r_associated #0: 28 / 0.124 -> en:other complications of the puerperium
    n1=en:Hodgkin lymphoma | n2=en:other complications of the puerperium | rel=r_associated | relid=0 | w=28
  563. en:Hodgkin lymphoma -- r_associated #0: 28 / 0.124 -> en:other congenital malformations of eye
    n1=en:Hodgkin lymphoma | n2=en:other congenital malformations of eye | rel=r_associated | relid=0 | w=28
  564. en:Hodgkin lymphoma -- r_associated #0: 28 / 0.124 -> en:other endocrine or metabolic congenital anomalies
    n1=en:Hodgkin lymphoma | n2=en:other endocrine or metabolic congenital anomalies | rel=r_associated | relid=0 | w=28
  565. en:Hodgkin lymphoma -- r_associated #0: 28 / 0.124 -> en:other female genital malignant neoplasms
    n1=en:Hodgkin lymphoma | n2=en:other female genital malignant neoplasms | rel=r_associated | relid=0 | w=28
  566. en:Hodgkin lymphoma -- r_associated #0: 28 / 0.124 -> en:other infectious diseases
    n1=en:Hodgkin lymphoma | n2=en:other infectious diseases | rel=r_associated | relid=0 | w=28
  567. en:Hodgkin lymphoma -- r_associated #0: 28 / 0.124 -> en:other malignant lymphomas, lymph nodes of axilla and upper limb
    n1=en:Hodgkin lymphoma | n2=en:other malignant lymphomas, lymph nodes of axilla and upper limb | rel=r_associated | relid=0 | w=28
  568. en:Hodgkin lymphoma -- r_associated #0: 28 / 0.124 -> en:other malignant lymphomas, lymph nodes of head, face, and neck
    n1=en:Hodgkin lymphoma | n2=en:other malignant lymphomas, lymph nodes of head, face, and neck | rel=r_associated | relid=0 | w=28
  569. en:Hodgkin lymphoma -- r_associated #0: 28 / 0.124 -> en:other symptom lymph gland(s)
    n1=en:Hodgkin lymphoma | n2=en:other symptom lymph gland(s) | rel=r_associated | relid=0 | w=28
  570. en:Hodgkin lymphoma -- r_associated #0: 28 / 0.124 -> en:other viral diseases
    n1=en:Hodgkin lymphoma | n2=en:other viral diseases | rel=r_associated | relid=0 | w=28
  571. en:Hodgkin lymphoma -- r_associated #0: 28 / 0.124 -> en:overlapping malignant neoplasm of ill-defined site
    n1=en:Hodgkin lymphoma | n2=en:overlapping malignant neoplasm of ill-defined site | rel=r_associated | relid=0 | w=28
  572. en:Hodgkin lymphoma -- r_associated #0: 28 / 0.124 -> en:overweight
    n1=en:Hodgkin lymphoma | n2=en:overweight | rel=r_associated | relid=0 | w=28
  573. en:Hodgkin lymphoma -- r_associated #0: 28 / 0.124 -> en:paragangliomas, head and neck (31%)
    n1=en:Hodgkin lymphoma | n2=en:paragangliomas, head and neck (31%) | rel=r_associated | relid=0 | w=28
  574. en:Hodgkin lymphoma -- r_associated #0: 28 / 0.124 -> en:paraneoplastic sps is associated with breast cancer and other malignancies
    n1=en:Hodgkin lymphoma | n2=en:paraneoplastic sps is associated with breast cancer and other malignancies | rel=r_associated | relid=0 | w=28
  575. en:Hodgkin lymphoma -- r_associated #0: 28 / 0.124 -> en:paraneoplastic syndrome
    n1=en:Hodgkin lymphoma | n2=en:paraneoplastic syndrome | rel=r_associated | relid=0 | w=28
  576. en:Hodgkin lymphoma -- r_associated #0: 28 / 0.124 -> en:parathyroid disease rare
    n1=en:Hodgkin lymphoma | n2=en:parathyroid disease rare | rel=r_associated | relid=0 | w=28
  577. en:Hodgkin lymphoma -- r_associated #0: 28 / 0.124 -> en:parotid gland monomorphic adenoma
    n1=en:Hodgkin lymphoma | n2=en:parotid gland monomorphic adenoma | rel=r_associated | relid=0 | w=28
  578. en:Hodgkin lymphoma -- r_associated #0: 28 / 0.124 -> en:pleomorphic liposarcoma
    n1=en:Hodgkin lymphoma | n2=en:pleomorphic liposarcoma | rel=r_associated | relid=0 | w=28
  579. en:Hodgkin lymphoma -- r_associated #0: 28 / 0.124 -> en:pleurisy with pleural effusion
    n1=en:Hodgkin lymphoma | n2=en:pleurisy with pleural effusion | rel=r_associated | relid=0 | w=28
  580. en:Hodgkin lymphoma -- r_associated #0: 28 / 0.124 -> en:predisposition to uv-induced malignancies
    n1=en:Hodgkin lymphoma | n2=en:predisposition to uv-induced malignancies | rel=r_associated | relid=0 | w=28
  581. en:Hodgkin lymphoma -- r_associated #0: 28 / 0.124 -> en:primary malignant neoplasm of independent multiple sites
    n1=en:Hodgkin lymphoma | n2=en:primary malignant neoplasm of independent multiple sites | rel=r_associated | relid=0 | w=28
  582. en:Hodgkin lymphoma -- r_associated #0: 28 / 0.124 -> en:primary malignant neoplasm of respiratory tract
    n1=en:Hodgkin lymphoma | n2=en:primary malignant neoplasm of respiratory tract | rel=r_associated | relid=0 | w=28
  583. en:Hodgkin lymphoma -- r_associated #0: 28 / 0.124 -> en:reed-sternberg cell
    n1=en:Hodgkin lymphoma | n2=en:reed-sternberg cell | rel=r_associated | relid=0 | w=28
  584. en:Hodgkin lymphoma -- r_associated #0: 28 / 0.124 -> en:seminoma
    n1=en:Hodgkin lymphoma | n2=en:seminoma | rel=r_associated | relid=0 | w=28
  585. en:Hodgkin lymphoma -- r_associated #0: 28 / 0.124 -> en:sertoli-leydig cell ovarian tumors may occur
    n1=en:Hodgkin lymphoma | n2=en:sertoli-leydig cell ovarian tumors may occur | rel=r_associated | relid=0 | w=28
  586. en:Hodgkin lymphoma -- r_associated #0: 28 / 0.124 -> en:sex cord-stromal tumor
    n1=en:Hodgkin lymphoma | n2=en:sex cord-stromal tumor | rel=r_associated | relid=0 | w=28
  587. en:Hodgkin lymphoma -- r_associated #0: 28 / 0.124 -> en:signet ring cell carcinoma
    n1=en:Hodgkin lymphoma | n2=en:signet ring cell carcinoma | rel=r_associated | relid=0 | w=28
  588. en:Hodgkin lymphoma -- r_associated #0: 28 / 0.124 -> en:skin basosquamous cell carcinoma
    n1=en:Hodgkin lymphoma | n2=en:skin basosquamous cell carcinoma | rel=r_associated | relid=0 | w=28
  589. en:Hodgkin lymphoma -- r_associated #0: 28 / 0.124 -> en:small cell carcinoma
    n1=en:Hodgkin lymphoma | n2=en:small cell carcinoma | rel=r_associated | relid=0 | w=28
  590. en:Hodgkin lymphoma -- r_associated #0: 28 / 0.124 -> en:small cell carcinoma of the ovary, hypercalcemic type
    n1=en:Hodgkin lymphoma | n2=en:small cell carcinoma of the ovary, hypercalcemic type | rel=r_associated | relid=0 | w=28
  591. en:Hodgkin lymphoma -- r_associated #0: 28 / 0.124 -> en:small cell carcinoma, fusiform cell type
    n1=en:Hodgkin lymphoma | n2=en:small cell carcinoma, fusiform cell type | rel=r_associated | relid=0 | w=28
  592. en:Hodgkin lymphoma -- r_associated #0: 28 / 0.124 -> en:spiradenocarcinoma
    n1=en:Hodgkin lymphoma | n2=en:spiradenocarcinoma | rel=r_associated | relid=0 | w=28
  593. en:Hodgkin lymphoma -- r_associated #0: 28 / 0.124 -> en:splenic hodgkin lymphoma
    n1=en:Hodgkin lymphoma | n2=en:splenic hodgkin lymphoma | rel=r_associated | relid=0 | w=28
  594. en:Hodgkin lymphoma -- r_associated #0: 28 / 0.124 -> en:strabismus
    n1=en:Hodgkin lymphoma | n2=en:strabismus | rel=r_associated | relid=0 | w=28
  595. en:Hodgkin lymphoma -- r_associated #0: 28 / 0.124 -> en:sweat gland adenocarcinoma
    n1=en:Hodgkin lymphoma | n2=en:sweat gland adenocarcinoma | rel=r_associated | relid=0 | w=28
  596. en:Hodgkin lymphoma -- r_associated #0: 28 / 0.124 -> en:syphilis male
    n1=en:Hodgkin lymphoma | n2=en:syphilis male | rel=r_associated | relid=0 | w=28
  597. en:Hodgkin lymphoma -- r_associated #0: 28 / 0.124 -> en:teratoid medulloepithelioma
    n1=en:Hodgkin lymphoma | n2=en:teratoid medulloepithelioma | rel=r_associated | relid=0 | w=28
  598. en:Hodgkin lymphoma -- r_associated #0: 28 / 0.124 -> en:therapy-related myelodysplastic syndrome
    n1=en:Hodgkin lymphoma | n2=en:therapy-related myelodysplastic syndrome | rel=r_associated | relid=0 | w=28
  599. en:Hodgkin lymphoma -- r_associated #0: 28 / 0.124 -> en:thyroid gland carcinoma
    n1=en:Hodgkin lymphoma | n2=en:thyroid gland carcinoma | rel=r_associated | relid=0 | w=28
  600. en:Hodgkin lymphoma -- r_associated #0: 28 / 0.124 -> en:thyrotoxicosis [hyperthyroidism]
    n1=en:Hodgkin lymphoma | n2=en:thyrotoxicosis [hyperthyroidism] | rel=r_associated | relid=0 | w=28
  601. en:Hodgkin lymphoma -- r_associated #0: 28 / 0.124 -> en:type 2 autoimmune lymphoproliferative syndrome
    n1=en:Hodgkin lymphoma | n2=en:type 2 autoimmune lymphoproliferative syndrome | rel=r_associated | relid=0 | w=28
  602. en:Hodgkin lymphoma -- r_associated #0: 28 / 0.124 -> en:vertiginous syndrome
    n1=en:Hodgkin lymphoma | n2=en:vertiginous syndrome | rel=r_associated | relid=0 | w=28
  603. en:Hodgkin lymphoma -- r_associated #0: 28 / 0.124 -> en:virus-related lymphoma
    n1=en:Hodgkin lymphoma | n2=en:virus-related lymphoma | rel=r_associated | relid=0 | w=28
  604. en:Hodgkin lymphoma -- r_associated #0: 27 / 0.119 -> en:abnormal results investigation nos
    n1=en:Hodgkin lymphoma | n2=en:abnormal results investigation nos | rel=r_associated | relid=0 | w=27
  605. en:Hodgkin lymphoma -- r_associated #0: 27 / 0.119 -> en:acne
    n1=en:Hodgkin lymphoma | n2=en:acne | rel=r_associated | relid=0 | w=27
  606. en:Hodgkin lymphoma -- r_associated #0: 27 / 0.119 -> en:acute bronchitis and bronchiolitis
    n1=en:Hodgkin lymphoma | n2=en:acute bronchitis and bronchiolitis | rel=r_associated | relid=0 | w=27
  607. en:Hodgkin lymphoma -- r_associated #0: 27 / 0.119 -> en:acute myeloid leukemia
    n1=en:Hodgkin lymphoma | n2=en:acute myeloid leukemia | rel=r_associated | relid=0 | w=27
  608. en:Hodgkin lymphoma -- r_associated #0: 27 / 0.119 -> en:adenocarcinoma
    n1=en:Hodgkin lymphoma | n2=en:adenocarcinoma | rel=r_associated | relid=0 | w=27
  609. en:Hodgkin lymphoma -- r_associated #0: 27 / 0.119 -> en:adenocarcinoma (some)
    n1=en:Hodgkin lymphoma | n2=en:adenocarcinoma (some) | rel=r_associated | relid=0 | w=27
  610. en:Hodgkin lymphoma -- r_associated #0: 27 / 0.119 -> en:adnexal carcinoma
    n1=en:Hodgkin lymphoma | n2=en:adnexal carcinoma | rel=r_associated | relid=0 | w=27
  611. en:Hodgkin lymphoma -- r_associated #0: 27 / 0.119 -> en:alveolar cell carcinoma (some)
    n1=en:Hodgkin lymphoma | n2=en:alveolar cell carcinoma (some) | rel=r_associated | relid=0 | w=27
  612. en:Hodgkin lymphoma -- r_associated #0: 27 / 0.119 -> en:anaemias nonhaemolytic and marrow depression
    n1=en:Hodgkin lymphoma | n2=en:anaemias nonhaemolytic and marrow depression | rel=r_associated | relid=0 | w=27
  613. en:Hodgkin lymphoma -- r_associated #0: 27 / 0.119 -> en:aplastic anemia
    n1=en:Hodgkin lymphoma | n2=en:aplastic anemia | rel=r_associated | relid=0 | w=27
  614. en:Hodgkin lymphoma -- r_associated #0: 27 / 0.119 -> en:atrial fibrillation and flutter
    n1=en:Hodgkin lymphoma | n2=en:atrial fibrillation and flutter | rel=r_associated | relid=0 | w=27
  615. en:Hodgkin lymphoma -- r_associated #0: 27 / 0.119 -> en:autoimmune disease
    n1=en:Hodgkin lymphoma | n2=en:autoimmune disease | rel=r_associated | relid=0 | w=27
  616. en:Hodgkin lymphoma -- r_associated #0: 27 / 0.119 -> en:b-cell non-hodgkin lymphoma
    n1=en:Hodgkin lymphoma | n2=en:b-cell non-hodgkin lymphoma | rel=r_associated | relid=0 | w=27
  617. en:Hodgkin lymphoma -- r_associated #0: 27 / 0.119 -> en:balloon cell melanoma
    n1=en:Hodgkin lymphoma | n2=en:balloon cell melanoma | rel=r_associated | relid=0 | w=27
  618. en:Hodgkin lymphoma -- r_associated #0: 27 / 0.119 -> en:basal cell neoplasm
    n1=en:Hodgkin lymphoma | n2=en:basal cell neoplasm | rel=r_associated | relid=0 | w=27
  619. en:Hodgkin lymphoma -- r_associated #0: 27 / 0.119 -> en:benign female breast neoplasm
    n1=en:Hodgkin lymphoma | n2=en:benign female breast neoplasm | rel=r_associated | relid=0 | w=27
  620. en:Hodgkin lymphoma -- r_associated #0: 27 / 0.119 -> en:biopsy
    n1=en:Hodgkin lymphoma | n2=en:biopsy | rel=r_associated | relid=0 | w=27
  621. en:Hodgkin lymphoma -- r_associated #0: 27 / 0.119 -> en:blood, blood forming organs, lymphatics, spleen
    n1=en:Hodgkin lymphoma | n2=en:blood, blood forming organs, lymphatics, spleen | rel=r_associated | relid=0 | w=27
  622. en:Hodgkin lymphoma -- r_associated #0: 27 / 0.119 -> en:bone sarcoma
    n1=en:Hodgkin lymphoma | n2=en:bone sarcoma | rel=r_associated | relid=0 | w=27
  623. en:Hodgkin lymphoma -- r_associated #0: 27 / 0.119 -> en:breast lymphoma
    n1=en:Hodgkin lymphoma | n2=en:breast lymphoma | rel=r_associated | relid=0 | w=27
  624. en:Hodgkin lymphoma -- r_associated #0: 27 / 0.119 -> en:breast neoplasm
    n1=en:Hodgkin lymphoma | n2=en:breast neoplasm | rel=r_associated | relid=0 | w=27
  625. en:Hodgkin lymphoma -- r_associated #0: 27 / 0.119 -> en:breast neoplasms malignant and unspecified (incl nipple)
    n1=en:Hodgkin lymphoma | n2=en:breast neoplasms malignant and unspecified (incl nipple) | rel=r_associated | relid=0 | w=27
  626. en:Hodgkin lymphoma -- r_associated #0: 27 / 0.119 -> en:carcinoma
    n1=en:Hodgkin lymphoma | n2=en:carcinoma | rel=r_associated | relid=0 | w=27
  627. en:Hodgkin lymphoma -- r_associated #0: 27 / 0.119 -> en:carotid body tumors (most common location)
    n1=en:Hodgkin lymphoma | n2=en:carotid body tumors (most common location) | rel=r_associated | relid=0 | w=27
  628. en:Hodgkin lymphoma -- r_associated #0: 27 / 0.119 -> en:carpal tunnel syndrome
    n1=en:Hodgkin lymphoma | n2=en:carpal tunnel syndrome | rel=r_associated | relid=0 | w=27
  629. en:Hodgkin lymphoma -- r_associated #0: 27 / 0.119 -> en:central nervous system lymphoma
    n1=en:Hodgkin lymphoma | n2=en:central nervous system lymphoma | rel=r_associated | relid=0 | w=27
  630. en:Hodgkin lymphoma -- r_associated #0: 27 / 0.119 -> en:central nervous system neoplasm
    n1=en:Hodgkin lymphoma | n2=en:central nervous system neoplasm | rel=r_associated | relid=0 | w=27
  631. en:Hodgkin lymphoma -- r_associated #0: 27 / 0.119 -> en:cervical carcinoma
    n1=en:Hodgkin lymphoma | n2=en:cervical carcinoma | rel=r_associated | relid=0 | w=27
  632. en:Hodgkin lymphoma -- r_associated #0: 27 / 0.119 -> en:childhood hodgkin lymphoma
    n1=en:Hodgkin lymphoma | n2=en:childhood hodgkin lymphoma | rel=r_associated | relid=0 | w=27
  633. en:Hodgkin lymphoma -- r_associated #0: 27 / 0.119 -> en:childhood immunization
    n1=en:Hodgkin lymphoma | n2=en:childhood immunization | rel=r_associated | relid=0 | w=27
  634. en:Hodgkin lymphoma -- r_associated #0: 27 / 0.119 -> en:chondroblastoma, malignant
    n1=en:Hodgkin lymphoma | n2=en:chondroblastoma, malignant | rel=r_associated | relid=0 | w=27
  635. en:Hodgkin lymphoma -- r_associated #0: 27 / 0.119 -> en:chromaffin cell neoplasm
    n1=en:Hodgkin lymphoma | n2=en:chromaffin cell neoplasm | rel=r_associated | relid=0 | w=27
  636. en:Hodgkin lymphoma -- r_associated #0: 27 / 0.119 -> en:chronic lymphocytic leukemia, b-cell, susceptibility to
    n1=en:Hodgkin lymphoma | n2=en:chronic lymphocytic leukemia, b-cell, susceptibility to | rel=r_associated | relid=0 | w=27
  637. en:Hodgkin lymphoma -- r_associated #0: 27 / 0.119 -> en:classical hodgkin lymphoma
    n1=en:Hodgkin lymphoma | n2=en:classical hodgkin lymphoma | rel=r_associated | relid=0 | w=27
  638. en:Hodgkin lymphoma -- r_associated #0: 27 / 0.119 -> en:confirmation of pregnancy
    n1=en:Hodgkin lymphoma | n2=en:confirmation of pregnancy | rel=r_associated | relid=0 | w=27
  639. en:Hodgkin lymphoma -- r_associated #0: 27 / 0.119 -> en:congenital anomaly of male genital system
    n1=en:Hodgkin lymphoma | n2=en:congenital anomaly of male genital system | rel=r_associated | relid=0 | w=27
  640. en:Hodgkin lymphoma -- r_associated #0: 27 / 0.119 -> en:conventional osteosarcoma
    n1=en:Hodgkin lymphoma | n2=en:conventional osteosarcoma | rel=r_associated | relid=0 | w=27
  641. en:Hodgkin lymphoma -- r_associated #0: 27 / 0.119 -> en:cutaneous melanoma
    n1=en:Hodgkin lymphoma | n2=en:cutaneous melanoma | rel=r_associated | relid=0 | w=27
  642. en:Hodgkin lymphoma -- r_associated #0: 27 / 0.119 -> en:cystic partially differentiated nephroblastoma
    n1=en:Hodgkin lymphoma | n2=en:cystic partially differentiated nephroblastoma | rel=r_associated | relid=0 | w=27
  643. en:Hodgkin lymphoma -- r_associated #0: 27 / 0.119 -> en:desmoplastic small round cell tumor
    n1=en:Hodgkin lymphoma | n2=en:desmoplastic small round cell tumor | rel=r_associated | relid=0 | w=27
  644. en:Hodgkin lymphoma -- r_associated #0: 27 / 0.119 -> en:diaper dermatitis
    n1=en:Hodgkin lymphoma | n2=en:diaper dermatitis | rel=r_associated | relid=0 | w=27
  645. en:Hodgkin lymphoma -- r_associated #0: 27 / 0.119 -> en:disease of mouth/tongue/lips
    n1=en:Hodgkin lymphoma | n2=en:disease of mouth/tongue/lips | rel=r_associated | relid=0 | w=27
  646. en:Hodgkin lymphoma -- r_associated #0: 27 / 0.119 -> en:duodenal carcinoid
    n1=en:Hodgkin lymphoma | n2=en:duodenal carcinoid | rel=r_associated | relid=0 | w=27
  647. en:Hodgkin lymphoma -- r_associated #0: 27 / 0.119 -> en:duodenal carcinoma
    n1=en:Hodgkin lymphoma | n2=en:duodenal carcinoma | rel=r_associated | relid=0 | w=27
  648. en:Hodgkin lymphoma -- r_associated #0: 27 / 0.119 -> en:eccrine porocarcinoma
    n1=en:Hodgkin lymphoma | n2=en:eccrine porocarcinoma | rel=r_associated | relid=0 | w=27
  649. en:Hodgkin lymphoma -- r_associated #0: 27 / 0.119 -> en:ependymoma
    n1=en:Hodgkin lymphoma | n2=en:ependymoma | rel=r_associated | relid=0 | w=27
  650. en:Hodgkin lymphoma -- r_associated #0: 27 / 0.119 -> en:epididymo-orchitis
    n1=en:Hodgkin lymphoma | n2=en:epididymo-orchitis | rel=r_associated | relid=0 | w=27
  651. en:Hodgkin lymphoma -- r_associated #0: 27 / 0.119 -> en:epithelioid leiomyosarcoma
    n1=en:Hodgkin lymphoma | n2=en:epithelioid leiomyosarcoma | rel=r_associated | relid=0 | w=27
  652. en:Hodgkin lymphoma -- r_associated #0: 27 / 0.119 -> en:fascial fibrosarcoma
    n1=en:Hodgkin lymphoma | n2=en:fascial fibrosarcoma | rel=r_associated | relid=0 | w=27
  653. en:Hodgkin lymphoma -- r_associated #0: 27 / 0.119 -> en:fibroid/myoma (uterus/cervix)
    n1=en:Hodgkin lymphoma | n2=en:fibroid/myoma (uterus/cervix) | rel=r_associated | relid=0 | w=27
  654. en:Hodgkin lymphoma -- r_associated #0: 27 / 0.119 -> en:fibrosarcoma of connective tissue
    n1=en:Hodgkin lymphoma | n2=en:fibrosarcoma of connective tissue | rel=r_associated | relid=0 | w=27
  655. en:Hodgkin lymphoma -- r_associated #0: 27 / 0.119 -> en:follicular neoplasm
    n1=en:Hodgkin lymphoma | n2=en:follicular neoplasm | rel=r_associated | relid=0 | w=27
  656. en:Hodgkin lymphoma -- r_associated #0: 27 / 0.119 -> en:ganglioneuroma
    n1=en:Hodgkin lymphoma | n2=en:ganglioneuroma | rel=r_associated | relid=0 | w=27
  657. en:Hodgkin lymphoma -- r_associated #0: 27 / 0.119 -> en:gastrointestinal neoplasms malignant and unspecified
    n1=en:Hodgkin lymphoma | n2=en:gastrointestinal neoplasms malignant and unspecified | rel=r_associated | relid=0 | w=27
  658. en:Hodgkin lymphoma -- r_associated #0: 27 / 0.119 -> en:glycosuria, renal
    n1=en:Hodgkin lymphoma | n2=en:glycosuria, renal | rel=r_associated | relid=0 | w=27
  659. en:Hodgkin lymphoma -- r_associated #0: 27 / 0.119 -> en:goiter
    n1=en:Hodgkin lymphoma | n2=en:goiter | rel=r_associated | relid=0 | w=27
  660. en:Hodgkin lymphoma -- r_associated #0: 27 / 0.119 -> en:growth hormone-producing pituitary gland neoplasm
    n1=en:Hodgkin lymphoma | n2=en:growth hormone-producing pituitary gland neoplasm | rel=r_associated | relid=0 | w=27
  661. en:Hodgkin lymphoma -- r_associated #0: 27 / 0.119 -> en:heart murmur
    n1=en:Hodgkin lymphoma | n2=en:heart murmur | rel=r_associated | relid=0 | w=27
  662. en:Hodgkin lymphoma -- r_associated #0: 27 / 0.119 -> en:hematopoietic and lymphoid system neoplasm
    n1=en:Hodgkin lymphoma | n2=en:hematopoietic and lymphoid system neoplasm | rel=r_associated | relid=0 | w=27
  663. en:Hodgkin lymphoma -- r_associated #0: 27 / 0.119 -> en:hemophagocytic lymphohistiocytosis (in some patients)
    n1=en:Hodgkin lymphoma | n2=en:hemophagocytic lymphohistiocytosis (in some patients) | rel=r_associated | relid=0 | w=27
  664. en:Hodgkin lymphoma -- r_associated #0: 27 / 0.119 -> en:hiatal hernia
    n1=en:Hodgkin lymphoma | n2=en:hiatal hernia | rel=r_associated | relid=0 | w=27
  665. en:Hodgkin lymphoma -- r_associated #0: 27 / 0.119 -> en:hip osteoarthritis
    n1=en:Hodgkin lymphoma | n2=en:hip osteoarthritis | rel=r_associated | relid=0 | w=27
  666. en:Hodgkin lymphoma -- r_associated #0: 27 / 0.119 -> en:hodgkin disease, x-linked pseudoautosomal
    n1=en:Hodgkin lymphoma | n2=en:hodgkin disease, x-linked pseudoautosomal | rel=r_associated | relid=0 | w=27
  667. en:Hodgkin lymphoma -- r_associated #0: 27 / 0.119 -> en:hodgkin lymphoma, unspecified, lymph nodes of axilla and upper limb
    n1=en:Hodgkin lymphoma | n2=en:hodgkin lymphoma, unspecified, lymph nodes of axilla and upper limb | rel=r_associated | relid=0 | w=27
  668. en:Hodgkin lymphoma -- r_associated #0: 27 / 0.119 -> en:hodgkin's disease lymphocyte predominance stage i site unspec
    n1=en:Hodgkin lymphoma | n2=en:hodgkin's disease lymphocyte predominance stage i site unspec | rel=r_associated | relid=0 | w=27
  669. en:Hodgkin lymphoma -- r_associated #0: 27 / 0.119 -> en:hodgkin's disease, lymphocytic depletion of intra-abdominal lymph nodes
    n1=en:Hodgkin lymphoma | n2=en:hodgkin's disease, lymphocytic depletion of intra-abdominal lymph nodes | rel=r_associated | relid=0 | w=27
  670. en:Hodgkin lymphoma -- r_associated #0: 27 / 0.119 -> en:hodgkin's disease, lymphocytic-histiocytic predominance of lymph nodes of head, face and neck
    n1=en:Hodgkin lymphoma | n2=en:hodgkin's disease, lymphocytic-histiocytic predominance of lymph nodes of head, face and neck | rel=r_associated | relid=0 | w=27
  671. en:Hodgkin lymphoma -- r_associated #0: 27 / 0.119 -> en:hodgkin's disease, mixed cellularity of lymph nodes of inguinal region and lower limb
    n1=en:Hodgkin lymphoma | n2=en:hodgkin's disease, mixed cellularity of lymph nodes of inguinal region and lower limb | rel=r_associated | relid=0 | w=27
  672. en:Hodgkin lymphoma -- r_associated #0: 27 / 0.119 -> en:hodgkin's paragranuloma involving spleen
    n1=en:Hodgkin lymphoma | n2=en:hodgkin's paragranuloma involving spleen | rel=r_associated | relid=0 | w=27
  673. en:Hodgkin lymphoma -- r_associated #0: 27 / 0.119 -> en:hodgkin's paragranuloma of intra-abdominal lymph nodes
    n1=en:Hodgkin lymphoma | n2=en:hodgkin's paragranuloma of intra-abdominal lymph nodes | rel=r_associated | relid=0 | w=27
  674. en:Hodgkin lymphoma -- r_associated #0: 27 / 0.119 -> en:hodgkin's paragranuloma of lymph nodes of inguinal region and/or lower limb
    n1=en:Hodgkin lymphoma | n2=en:hodgkin's paragranuloma of lymph nodes of inguinal region and/or lower limb | rel=r_associated | relid=0 | w=27
  675. en:Hodgkin lymphoma -- r_associated #0: 27 / 0.119 -> en:hodgkin's paragranuloma of lymph nodes of multiple sites
    n1=en:Hodgkin lymphoma | n2=en:hodgkin's paragranuloma of lymph nodes of multiple sites | rel=r_associated | relid=0 | w=27
  676. en:Hodgkin lymphoma -- r_associated #0: 27 / 0.119 -> en:hodgkin's sarcoma of intrathoracic lymph nodes
    n1=en:Hodgkin lymphoma | n2=en:hodgkin's sarcoma of intrathoracic lymph nodes | rel=r_associated | relid=0 | w=27
  677. en:Hodgkin lymphoma -- r_associated #0: 27 / 0.119 -> en:hodgkin's sarcoma, unspecified site, extranodal and solid organ sites
    n1=en:Hodgkin lymphoma | n2=en:hodgkin's sarcoma, unspecified site, extranodal and solid organ sites | rel=r_associated | relid=0 | w=27
  678. en:Hodgkin lymphoma -- r_associated #0: 27 / 0.119 -> en:immunodeficiency-related malignant neoplasm
    n1=en:Hodgkin lymphoma | n2=en:immunodeficiency-related malignant neoplasm | rel=r_associated | relid=0 | w=27
  679. en:Hodgkin lymphoma -- r_associated #0: 27 / 0.119 -> en:in blood
    n1=en:Hodgkin lymphoma | n2=en:in blood | rel=r_associated | relid=0 | w=27
  680. en:Hodgkin lymphoma -- r_associated #0: 27 / 0.119 -> en:increased risk for cancer
    n1=en:Hodgkin lymphoma | n2=en:increased risk for cancer | rel=r_associated | relid=0 | w=27
  681. en:Hodgkin lymphoma -- r_associated #0: 27 / 0.119 -> en:increased risk for embryonal tumors
    n1=en:Hodgkin lymphoma | n2=en:increased risk for embryonal tumors | rel=r_associated | relid=0 | w=27
  682. en:Hodgkin lymphoma -- r_associated #0: 27 / 0.119 -> en:increased risk for multiple myeloma
    n1=en:Hodgkin lymphoma | n2=en:increased risk for multiple myeloma | rel=r_associated | relid=0 | w=27
  683. en:Hodgkin lymphoma -- r_associated #0: 27 / 0.119 -> en:increased risk of breast cancer in women
    n1=en:Hodgkin lymphoma | n2=en:increased risk of breast cancer in women | rel=r_associated | relid=0 | w=27
  684. en:Hodgkin lymphoma -- r_associated #0: 27 / 0.119 -> en:increased susceptibility to carcinomas, especially cancers related to cutaneous viral infections
    n1=en:Hodgkin lymphoma | n2=en:increased susceptibility to carcinomas, especially cancers related to cutaneous viral infections | rel=r_associated | relid=0 | w=27
  685. en:Hodgkin lymphoma -- r_associated #0: 27 / 0.119 -> en:invasive ductal and lobular carcinoma in situ
    n1=en:Hodgkin lymphoma | n2=en:invasive ductal and lobular carcinoma in situ | rel=r_associated | relid=0 | w=27
  686. en:Hodgkin lymphoma -- r_associated #0: 27 / 0.119 -> en:invertebrate cuticle
    n1=en:Hodgkin lymphoma | n2=en:invertebrate cuticle | rel=r_associated | relid=0 | w=27
  687. en:Hodgkin lymphoma -- r_associated #0: 27 / 0.119 -> en:kawasaki disease
    n1=en:Hodgkin lymphoma | n2=en:kawasaki disease | rel=r_associated | relid=0 | w=27
  688. en:Hodgkin lymphoma -- r_associated #0: 27 / 0.119 -> en:latex allergy
    n1=en:Hodgkin lymphoma | n2=en:latex allergy | rel=r_associated | relid=0 | w=27
  689. en:Hodgkin lymphoma -- r_associated #0: 27 / 0.119 -> en:liver carcinoma
    n1=en:Hodgkin lymphoma | n2=en:liver carcinoma | rel=r_associated | relid=0 | w=27
  690. en:Hodgkin lymphoma -- r_associated #0: 27 / 0.119 -> en:low incidence of plexiform neurofibromas
    n1=en:Hodgkin lymphoma | n2=en:low incidence of plexiform neurofibromas | rel=r_associated | relid=0 | w=27
  691. en:Hodgkin lymphoma -- r_associated #0: 27 / 0.119 -> en:lymphocyte-rich classical hodgkin lymphoma
    n1=en:Hodgkin lymphoma | n2=en:lymphocyte-rich classical hodgkin lymphoma | rel=r_associated | relid=0 | w=27
  692. en:Hodgkin lymphoma -- r_associated #0: 27 / 0.119 -> en:lymphocyte-rich classical hodgkin lymphoma, lymph nodes of axilla and upper limb
    n1=en:Hodgkin lymphoma | n2=en:lymphocyte-rich classical hodgkin lymphoma, lymph nodes of axilla and upper limb | rel=r_associated | relid=0 | w=27
  693. en:Hodgkin lymphoma -- r_associated #0: 27 / 0.119 -> en:malignant bone neoplasm
    n1=en:Hodgkin lymphoma | n2=en:malignant bone neoplasm | rel=r_associated | relid=0 | w=27
  694. en:Hodgkin lymphoma -- r_associated #0: 27 / 0.119 -> en:malignant immunoproliferative diseases and certain other b-cell lymphomas
    n1=en:Hodgkin lymphoma | n2=en:malignant immunoproliferative diseases and certain other b-cell lymphomas | rel=r_associated | relid=0 | w=27
  695. en:Hodgkin lymphoma -- r_associated #0: 27 / 0.119 -> en:malignant intestinal neoplasm
    n1=en:Hodgkin lymphoma | n2=en:malignant intestinal neoplasm | rel=r_associated | relid=0 | w=27
  696. en:Hodgkin lymphoma -- r_associated #0: 27 / 0.119 -> en:malignant melanoma in giant pigmented nevus
    n1=en:Hodgkin lymphoma | n2=en:malignant melanoma in giant pigmented nevus | rel=r_associated | relid=0 | w=27
  697. en:Hodgkin lymphoma -- r_associated #0: 27 / 0.119 -> en:malignant melanoma in precancerous melanosis
    n1=en:Hodgkin lymphoma | n2=en:malignant melanoma in precancerous melanosis | rel=r_associated | relid=0 | w=27
  698. en:Hodgkin lymphoma -- r_associated #0: 27 / 0.119 -> en:malignant mesenchymoma
    n1=en:Hodgkin lymphoma | n2=en:malignant mesenchymoma | rel=r_associated | relid=0 | w=27
  699. en:Hodgkin lymphoma -- r_associated #0: 27 / 0.119 -> en:malignant mixed tumor, carcinomatous type
    n1=en:Hodgkin lymphoma | n2=en:malignant mixed tumor, carcinomatous type | rel=r_associated | relid=0 | w=27
  700. en:Hodgkin lymphoma -- r_associated #0: 27 / 0.119 -> en:malignant neoplasm of other specified sites
    n1=en:Hodgkin lymphoma | n2=en:malignant neoplasm of other specified sites | rel=r_associated | relid=0 | w=27
  701. en:Hodgkin lymphoma -- r_associated #0: 27 / 0.119 -> en:malignant neoplasm of upper limb nos
    n1=en:Hodgkin lymphoma | n2=en:malignant neoplasm of upper limb nos | rel=r_associated | relid=0 | w=27
  702. en:Hodgkin lymphoma -- r_associated #0: 27 / 0.119 -> en:malignant neoplasms of ill-defined, secondary and unspecified sites
    n1=en:Hodgkin lymphoma | n2=en:malignant neoplasms of ill-defined, secondary and unspecified sites | rel=r_associated | relid=0 | w=27
  703. en:Hodgkin lymphoma -- r_associated #0: 27 / 0.119 -> en:malignant neoplasms, stated or presumed to be primary, of lymphoid, haematopoietic and related tissue
    n1=en:Hodgkin lymphoma | n2=en:malignant neoplasms, stated or presumed to be primary, of lymphoid, haematopoietic and related tissue | rel=r_associated | relid=0 | w=27
  704. en:Hodgkin lymphoma -- r_associated #0: 27 / 0.119 -> en:malignant neuroendocrine tumor
    n1=en:Hodgkin lymphoma | n2=en:malignant neuroendocrine tumor | rel=r_associated | relid=0 | w=27
  705. en:Hodgkin lymphoma -- r_associated #0: 27 / 0.119 -> en:malignant ossifying fibromyxoid tumor
    n1=en:Hodgkin lymphoma | n2=en:malignant ossifying fibromyxoid tumor | rel=r_associated | relid=0 | w=27
  706. en:Hodgkin lymphoma -- r_associated #0: 27 / 0.119 -> en:malignant soft tissue neoplasm
    n1=en:Hodgkin lymphoma | n2=en:malignant soft tissue neoplasm | rel=r_associated | relid=0 | w=27
  707. en:Hodgkin lymphoma -- r_associated #0: 27 / 0.119 -> en:malignant thyroid gland neoplasm
    n1=en:Hodgkin lymphoma | n2=en:malignant thyroid gland neoplasm | rel=r_associated | relid=0 | w=27
  708. en:Hodgkin lymphoma -- r_associated #0: 27 / 0.119 -> en:malignant triton tumor
    n1=en:Hodgkin lymphoma | n2=en:malignant triton tumor | rel=r_associated | relid=0 | w=27
  709. en:Hodgkin lymphoma -- r_associated #0: 27 / 0.119 -> en:malignant tumor involving an organ by direct extension from endometrium
    n1=en:Hodgkin lymphoma | n2=en:malignant tumor involving an organ by direct extension from endometrium | rel=r_associated | relid=0 | w=27
  710. en:Hodgkin lymphoma -- r_associated #0: 27 / 0.119 -> en:malignant type ab thymoma
    n1=en:Hodgkin lymphoma | n2=en:malignant type ab thymoma | rel=r_associated | relid=0 | w=27
  711. en:Hodgkin lymphoma -- r_associated #0: 27 / 0.119 -> en:mast cell
    n1=en:Hodgkin lymphoma | n2=en:mast cell | rel=r_associated | relid=0 | w=27
  712. en:Hodgkin lymphoma -- r_associated #0: 27 / 0.119 -> en:mature lymphocyte
    n1=en:Hodgkin lymphoma | n2=en:mature lymphocyte | rel=r_associated | relid=0 | w=27
  713. en:Hodgkin lymphoma -- r_associated #0: 27 / 0.119 -> en:melanoma
    n1=en:Hodgkin lymphoma | n2=en:melanoma | rel=r_associated | relid=0 | w=27
  714. en:Hodgkin lymphoma -- r_associated #0: 27 / 0.119 -> en:migraine
    n1=en:Hodgkin lymphoma | n2=en:migraine | rel=r_associated | relid=0 | w=27
  715. en:Hodgkin lymphoma -- r_associated #0: 27 / 0.119 -> en:minimal residual disease
    n1=en:Hodgkin lymphoma | n2=en:minimal residual disease | rel=r_associated | relid=0 | w=27
  716. en:Hodgkin lymphoma -- r_associated #0: 27 / 0.119 -> en:miscellaneous bone tumors
    n1=en:Hodgkin lymphoma | n2=en:miscellaneous bone tumors | rel=r_associated | relid=0 | w=27
  717. en:Hodgkin lymphoma -- r_associated #0: 27 / 0.119 -> en:mixed cellularity classical hodgkin lymphoma, lymph nodes of multiple sites
    n1=en:Hodgkin lymphoma | n2=en:mixed cellularity classical hodgkin lymphoma, lymph nodes of multiple sites | rel=r_associated | relid=0 | w=27
  718. en:Hodgkin lymphoma -- r_associated #0: 27 / 0.119 -> en:multiple malignancy
    n1=en:Hodgkin lymphoma | n2=en:multiple malignancy | rel=r_associated | relid=0 | w=27
  719. en:Hodgkin lymphoma -- r_associated #0: 27 / 0.119 -> en:myelodysplastic syndrome, no icd-o subtype
    n1=en:Hodgkin lymphoma | n2=en:myelodysplastic syndrome, no icd-o subtype | rel=r_associated | relid=0 | w=27
  720. en:Hodgkin lymphoma -- r_associated #0: 27 / 0.119 -> en:myeloid cell
    n1=en:Hodgkin lymphoma | n2=en:myeloid cell | rel=r_associated | relid=0 | w=27
  721. en:Hodgkin lymphoma -- r_associated #0: 27 / 0.119 -> en:neoplasm of uncertain malignant potential
    n1=en:Hodgkin lymphoma | n2=en:neoplasm of uncertain malignant potential | rel=r_associated | relid=0 | w=27
  722. en:Hodgkin lymphoma -- r_associated #0: 27 / 0.119 -> en:no cancer despite harboring complete deletions of the tp53 gene
    n1=en:Hodgkin lymphoma | n2=en:no cancer despite harboring complete deletions of the tp53 gene | rel=r_associated | relid=0 | w=27
  723. en:Hodgkin lymphoma -- r_associated #0: 27 / 0.119 -> en:nodular lymphocyte predominant hodgkin lymphoma
    n1=en:Hodgkin lymphoma | n2=en:nodular lymphocyte predominant hodgkin lymphoma | rel=r_associated | relid=0 | w=27
  724. en:Hodgkin lymphoma -- r_associated #0: 27 / 0.119 -> en:nodular lymphocyte predominant hodgkin lymphoma, extranodal and solid organ sites
    n1=en:Hodgkin lymphoma | n2=en:nodular lymphocyte predominant hodgkin lymphoma, extranodal and solid organ sites | rel=r_associated | relid=0 | w=27
  725. en:Hodgkin lymphoma -- r_associated #0: 27 / 0.119 -> en:nodular lymphocyte predominant hodgkin lymphoma, lymph nodes of inguinal region and lower limb
    n1=en:Hodgkin lymphoma | n2=en:nodular lymphocyte predominant hodgkin lymphoma, lymph nodes of inguinal region and lower limb | rel=r_associated | relid=0 | w=27
  726. en:Hodgkin lymphoma -- r_associated #0: 27 / 0.119 -> en:nodular sclerosis classical hodgkin lymphoma, lymph nodes of axilla and upper limb
    n1=en:Hodgkin lymphoma | n2=en:nodular sclerosis classical hodgkin lymphoma, lymph nodes of axilla and upper limb | rel=r_associated | relid=0 | w=27
  727. en:Hodgkin lymphoma -- r_associated #0: 27 / 0.119 -> en:nonseminomatous germ cell tumor
    n1=en:Hodgkin lymphoma | n2=en:nonseminomatous germ cell tumor | rel=r_associated | relid=0 | w=27
  728. en:Hodgkin lymphoma -- r_associated #0: 27 / 0.119 -> en:nursing therapy
    n1=en:Hodgkin lymphoma | n2=en:nursing therapy | rel=r_associated | relid=0 | w=27
  729. en:Hodgkin lymphoma -- r_associated #0: 27 / 0.119 -> en:nutritional management
    n1=en:Hodgkin lymphoma | n2=en:nutritional management | rel=r_associated | relid=0 | w=27
  730. en:Hodgkin lymphoma -- r_associated #0: 27 / 0.119 -> en:oropharyngeal squamous cell carcinoma
    n1=en:Hodgkin lymphoma | n2=en:oropharyngeal squamous cell carcinoma | rel=r_associated | relid=0 | w=27
  731. en:Hodgkin lymphoma -- r_associated #0: 27 / 0.119 -> en:osseous and chondromatous neoplasms
    n1=en:Hodgkin lymphoma | n2=en:osseous and chondromatous neoplasms | rel=r_associated | relid=0 | w=27
  732. en:Hodgkin lymphoma -- r_associated #0: 27 / 0.119 -> en:other benign neoplasm of skin, unspecified
    n1=en:Hodgkin lymphoma | n2=en:other benign neoplasm of skin, unspecified | rel=r_associated | relid=0 | w=27
  733. en:Hodgkin lymphoma -- r_associated #0: 27 / 0.119 -> en:other dermatologic congenital anomalies
    n1=en:Hodgkin lymphoma | n2=en:other dermatologic congenital anomalies | rel=r_associated | relid=0 | w=27
  734. en:Hodgkin lymphoma -- r_associated #0: 27 / 0.119 -> en:other diseases female genital system
    n1=en:Hodgkin lymphoma | n2=en:other diseases female genital system | rel=r_associated | relid=0 | w=27
  735. en:Hodgkin lymphoma -- r_associated #0: 27 / 0.119 -> en:other hematological abnormality
    n1=en:Hodgkin lymphoma | n2=en:other hematological abnormality | rel=r_associated | relid=0 | w=27
  736. en:Hodgkin lymphoma -- r_associated #0: 27 / 0.119 -> en:other lymphomas, unspecified site, extranodal and solid organ sites
    n1=en:Hodgkin lymphoma | n2=en:other lymphomas, unspecified site, extranodal and solid organ sites | rel=r_associated | relid=0 | w=27
  737. en:Hodgkin lymphoma -- r_associated #0: 27 / 0.119 -> en:other malignant neoplasms of lymphoid and histiocytic tissue
    n1=en:Hodgkin lymphoma | n2=en:other malignant neoplasms of lymphoid and histiocytic tissue | rel=r_associated | relid=0 | w=27
  738. en:Hodgkin lymphoma -- r_associated #0: 27 / 0.119 -> en:other psychoses
    n1=en:Hodgkin lymphoma | n2=en:other psychoses | rel=r_associated | relid=0 | w=27
  739. en:Hodgkin lymphoma -- r_associated #0: 27 / 0.119 -> en:otitis externa
    n1=en:Hodgkin lymphoma | n2=en:otitis externa | rel=r_associated | relid=0 | w=27
  740. en:Hodgkin lymphoma -- r_associated #0: 27 / 0.119 -> en:overlapping malignant neoplasm of lip, oral cavity and pharynx
    n1=en:Hodgkin lymphoma | n2=en:overlapping malignant neoplasm of lip, oral cavity and pharynx | rel=r_associated | relid=0 | w=27
  741. en:Hodgkin lymphoma -- r_associated #0: 27 / 0.119 -> en:pancreatoblastoma
    n1=en:Hodgkin lymphoma | n2=en:pancreatoblastoma | rel=r_associated | relid=0 | w=27
  742. en:Hodgkin lymphoma -- r_associated #0: 27 / 0.119 -> en:paraganglioma and/or glomus tumor
    n1=en:Hodgkin lymphoma | n2=en:paraganglioma and/or glomus tumor | rel=r_associated | relid=0 | w=27
  743. en:Hodgkin lymphoma -- r_associated #0: 27 / 0.119 -> en:paraneoplastic sps is associated with autoantibodies to amphiphysin (amph, 600418)
    n1=en:Hodgkin lymphoma | n2=en:paraneoplastic sps is associated with autoantibodies to amphiphysin (amph, 600418) | rel=r_associated | relid=0 | w=27
  744. en:Hodgkin lymphoma -- r_associated #0: 27 / 0.119 -> en:parathyroid gland carcinoma
    n1=en:Hodgkin lymphoma | n2=en:parathyroid gland carcinoma | rel=r_associated | relid=0 | w=27
  745. en:Hodgkin lymphoma -- r_associated #0: 27 / 0.119 -> en:parotid oncocytomas
    n1=en:Hodgkin lymphoma | n2=en:parotid oncocytomas | rel=r_associated | relid=0 | w=27
  746. en:Hodgkin lymphoma -- r_associated #0: 27 / 0.119 -> en:perinatal mortality
    n1=en:Hodgkin lymphoma | n2=en:perinatal mortality | rel=r_associated | relid=0 | w=27
  747. en:Hodgkin lymphoma -- r_associated #0: 27 / 0.119 -> en:periosteal fibrosarcoma
    n1=en:Hodgkin lymphoma | n2=en:periosteal fibrosarcoma | rel=r_associated | relid=0 | w=27
  748. en:Hodgkin lymphoma -- r_associated #0: 27 / 0.119 -> en:periosteal osteosarcoma
    n1=en:Hodgkin lymphoma | n2=en:periosteal osteosarcoma | rel=r_associated | relid=0 | w=27
  749. en:Hodgkin lymphoma -- r_associated #0: 27 / 0.119 -> en:pilonidal cyst/fistula
    n1=en:Hodgkin lymphoma | n2=en:pilonidal cyst/fistula | rel=r_associated | relid=0 | w=27
  750. en:Hodgkin lymphoma -- r_associated #0: 27 / 0.119 -> en:plasma cell neoplasms (all subtypes)
    n1=en:Hodgkin lymphoma | n2=en:plasma cell neoplasms (all subtypes) | rel=r_associated | relid=0 | w=27
  751. en:Hodgkin lymphoma -- r_associated #0: 27 / 0.119 -> en:poisoning by medical agent
    n1=en:Hodgkin lymphoma | n2=en:poisoning by medical agent | rel=r_associated | relid=0 | w=27
  752. en:Hodgkin lymphoma -- r_associated #0: 27 / 0.119 -> en:possibly increased risk of cancer
    n1=en:Hodgkin lymphoma | n2=en:possibly increased risk of cancer | rel=r_associated | relid=0 | w=27
  753. en:Hodgkin lymphoma -- r_associated #0: 27 / 0.119 -> en:primary malignant neoplasm of head
    n1=en:Hodgkin lymphoma | n2=en:primary malignant neoplasm of head | rel=r_associated | relid=0 | w=27
  754. en:Hodgkin lymphoma -- r_associated #0: 27 / 0.119 -> en:primary malignant neoplasm of lower limb
    n1=en:Hodgkin lymphoma | n2=en:primary malignant neoplasm of lower limb | rel=r_associated | relid=0 | w=27
  755. en:Hodgkin lymphoma -- r_associated #0: 27 / 0.119 -> en:propensity to tumor development
    n1=en:Hodgkin lymphoma | n2=en:propensity to tumor development | rel=r_associated | relid=0 | w=27
  756. en:Hodgkin lymphoma -- r_associated #0: 27 / 0.119 -> en:prostatitis/seminal vesiculitis
    n1=en:Hodgkin lymphoma | n2=en:prostatitis/seminal vesiculitis | rel=r_associated | relid=0 | w=27
  757. en:Hodgkin lymphoma -- r_associated #0: 27 / 0.119 -> en:pseudoglandular squamous cell carcinoma
    n1=en:Hodgkin lymphoma | n2=en:pseudoglandular squamous cell carcinoma | rel=r_associated | relid=0 | w=27
  758. en:Hodgkin lymphoma -- r_associated #0: 27 / 0.119 -> en:psychological aspect of cancer
    n1=en:Hodgkin lymphoma | n2=en:psychological aspect of cancer | rel=r_associated | relid=0 | w=27
  759. en:Hodgkin lymphoma -- r_associated #0: 27 / 0.119 -> en:puerperal infection/sepsis
    n1=en:Hodgkin lymphoma | n2=en:puerperal infection/sepsis | rel=r_associated | relid=0 | w=27
  760. en:Hodgkin lymphoma -- r_associated #0: 27 / 0.119 -> en:radiation-related neoplasm
    n1=en:Hodgkin lymphoma | n2=en:radiation-related neoplasm | rel=r_associated | relid=0 | w=27
  761. en:Hodgkin lymphoma -- r_associated #0: 27 / 0.119 -> en:recurrent malignant neoplasm
    n1=en:Hodgkin lymphoma | n2=en:recurrent malignant neoplasm | rel=r_associated | relid=0 | w=27
  762. en:Hodgkin lymphoma -- r_associated #0: 27 / 0.119 -> en:refractory malignant neoplasm
    n1=en:Hodgkin lymphoma | n2=en:refractory malignant neoplasm | rel=r_associated | relid=0 | w=27
  763. en:Hodgkin lymphoma -- r_associated #0: 27 / 0.119 -> en:regressing melanoma
    n1=en:Hodgkin lymphoma | n2=en:regressing melanoma | rel=r_associated | relid=0 | w=27
  764. en:Hodgkin lymphoma -- r_associated #0: 27 / 0.119 -> en:renal cell carcinoma, usually clear cell type
    n1=en:Hodgkin lymphoma | n2=en:renal cell carcinoma, usually clear cell type | rel=r_associated | relid=0 | w=27
  765. en:Hodgkin lymphoma -- r_associated #0: 27 / 0.119 -> en:reproductive and genitourinary neoplasms gender unspecified nec
    n1=en:Hodgkin lymphoma | n2=en:reproductive and genitourinary neoplasms gender unspecified nec | rel=r_associated | relid=0 | w=27
  766. en:Hodgkin lymphoma -- r_associated #0: 27 / 0.119 -> en:respiratory and mediastinal neoplasms benign (excl mesotheliomas)
    n1=en:Hodgkin lymphoma | n2=en:respiratory and mediastinal neoplasms benign (excl mesotheliomas) | rel=r_associated | relid=0 | w=27
  767. en:Hodgkin lymphoma -- r_associated #0: 27 / 0.119 -> en:retinoblastoma
    n1=en:Hodgkin lymphoma | n2=en:retinoblastoma | rel=r_associated | relid=0 | w=27
  768. en:Hodgkin lymphoma -- r_associated #0: 27 / 0.119 -> en:secondary malignant neoplasm
    n1=en:Hodgkin lymphoma | n2=en:secondary malignant neoplasm | rel=r_associated | relid=0 | w=27
  769. en:Hodgkin lymphoma -- r_associated #0: 27 / 0.119 -> en:small intestine carcinoid
    n1=en:Hodgkin lymphoma | n2=en:small intestine carcinoid | rel=r_associated | relid=0 | w=27
  770. en:Hodgkin lymphoma -- r_associated #0: 27 / 0.119 -> en:soft tissue sarcoma
    n1=en:Hodgkin lymphoma | n2=en:soft tissue sarcoma | rel=r_associated | relid=0 | w=27
  771. en:Hodgkin lymphoma -- r_associated #0: 27 / 0.119 -> en:spindle cell melanoma
    n1=en:Hodgkin lymphoma | n2=en:spindle cell melanoma | rel=r_associated | relid=0 | w=27
  772. en:Hodgkin lymphoma -- r_associated #0: 27 / 0.119 -> en:spongioneuroblastoma
    n1=en:Hodgkin lymphoma | n2=en:spongioneuroblastoma | rel=r_associated | relid=0 | w=27
  773. en:Hodgkin lymphoma -- r_associated #0: 27 / 0.119 -> en:sprain and strain of ankle
    n1=en:Hodgkin lymphoma | n2=en:sprain and strain of ankle | rel=r_associated | relid=0 | w=27
  774. en:Hodgkin lymphoma -- r_associated #0: 27 / 0.119 -> en:stage ii subdiaphragmatic hodgkin lymphoma
    n1=en:Hodgkin lymphoma | n2=en:stage ii subdiaphragmatic hodgkin lymphoma | rel=r_associated | relid=0 | w=27
  775. en:Hodgkin lymphoma -- r_associated #0: 27 / 0.119 -> en:stage iv hodgkin lymphoma
    n1=en:Hodgkin lymphoma | n2=en:stage iv hodgkin lymphoma | rel=r_associated | relid=0 | w=27
  776. en:Hodgkin lymphoma -- r_associated #0: 27 / 0.119 -> en:strep throat/scarlet fever
    n1=en:Hodgkin lymphoma | n2=en:strep throat/scarlet fever | rel=r_associated | relid=0 | w=27
  777. en:Hodgkin lymphoma -- r_associated #0: 27 / 0.119 -> en:symptom blood/lymph organs
    n1=en:Hodgkin lymphoma | n2=en:symptom blood/lymph organs | rel=r_associated | relid=0 | w=27
  778. en:Hodgkin lymphoma -- r_associated #0: 27 / 0.119 -> en:synovial-like neoplasm
    n1=en:Hodgkin lymphoma | n2=en:synovial-like neoplasm | rel=r_associated | relid=0 | w=27
  779. en:Hodgkin lymphoma -- r_associated #0: 27 / 0.119 -> en:testicular sertoli cell tumor
    n1=en:Hodgkin lymphoma | n2=en:testicular sertoli cell tumor | rel=r_associated | relid=0 | w=27
  780. en:Hodgkin lymphoma -- r_associated #0: 27 / 0.119 -> en:throat cancer
    n1=en:Hodgkin lymphoma | n2=en:throat cancer | rel=r_associated | relid=0 | w=27
  781. en:Hodgkin lymphoma -- r_associated #0: 27 / 0.119 -> en:thyroglossal duct cyst
    n1=en:Hodgkin lymphoma | n2=en:thyroglossal duct cyst | rel=r_associated | relid=0 | w=27
  782. en:Hodgkin lymphoma -- r_associated #0: 27 / 0.119 -> en:trichoepitheliomas may rarely show malignant transformation to basal cell carcinoma
    n1=en:Hodgkin lymphoma | n2=en:trichoepitheliomas may rarely show malignant transformation to basal cell carcinoma | rel=r_associated | relid=0 | w=27
  783. en:Hodgkin lymphoma -- r_associated #0: 27 / 0.119 -> en:type b spindle cell melanoma
    n1=en:Hodgkin lymphoma | n2=en:type b spindle cell melanoma | rel=r_associated | relid=0 | w=27
  784. en:Hodgkin lymphoma -- r_associated #0: 27 / 0.119 -> en:uveal melanoma
    n1=en:Hodgkin lymphoma | n2=en:uveal melanoma | rel=r_associated | relid=0 | w=27
  785. en:Hodgkin lymphoma -- r_associated #0: 27 / 0.119 -> en:vibrissae
    n1=en:Hodgkin lymphoma | n2=en:vibrissae | rel=r_associated | relid=0 | w=27
  786. en:Hodgkin lymphoma -- r_associated #0: 27 / 0.119 -> en:viral hepatitis
    n1=en:Hodgkin lymphoma | n2=en:viral hepatitis | rel=r_associated | relid=0 | w=27
  787. en:Hodgkin lymphoma -- r_associated #0: 27 / 0.119 -> en:white blood cell abnormality
    n1=en:Hodgkin lymphoma | n2=en:white blood cell abnormality | rel=r_associated | relid=0 | w=27
  788. en:Hodgkin lymphoma -- r_associated #0: 26 / 0.115 -> en:acinar cell carcinoma
    n1=en:Hodgkin lymphoma | n2=en:acinar cell carcinoma | rel=r_associated | relid=0 | w=26
  789. en:Hodgkin lymphoma -- r_associated #0: 26 / 0.115 -> en:acquired deformity of spine
    n1=en:Hodgkin lymphoma | n2=en:acquired deformity of spine | rel=r_associated | relid=0 | w=26
  790. en:Hodgkin lymphoma -- r_associated #0: 26 / 0.115 -> en:acute tonsillitis
    n1=en:Hodgkin lymphoma | n2=en:acute tonsillitis | rel=r_associated | relid=0 | w=26
  791. en:Hodgkin lymphoma -- r_associated #0: 26 / 0.115 -> en:addison's disease
    n1=en:Hodgkin lymphoma | n2=en:addison's disease | rel=r_associated | relid=0 | w=26
  792. en:Hodgkin lymphoma -- r_associated #0: 26 / 0.115 -> en:adenosquamous carcinoma
    n1=en:Hodgkin lymphoma | n2=en:adenosquamous carcinoma | rel=r_associated | relid=0 | w=26
  793. en:Hodgkin lymphoma -- r_associated #0: 26 / 0.115 -> en:adrenal gland pheochromocytoma
    n1=en:Hodgkin lymphoma | n2=en:adrenal gland pheochromocytoma | rel=r_associated | relid=0 | w=26
  794. en:Hodgkin lymphoma -- r_associated #0: 26 / 0.115 -> en:alpha heavy chain disease
    n1=en:Hodgkin lymphoma | n2=en:alpha heavy chain disease | rel=r_associated | relid=0 | w=26
  795. en:Hodgkin lymphoma -- r_associated #0: 26 / 0.115 -> en:amelanotic melanoma
    n1=en:Hodgkin lymphoma | n2=en:amelanotic melanoma | rel=r_associated | relid=0 | w=26
  796. en:Hodgkin lymphoma -- r_associated #0: 26 / 0.115 -> en:ameloblastic odontosarcoma
    n1=en:Hodgkin lymphoma | n2=en:ameloblastic odontosarcoma | rel=r_associated | relid=0 | w=26
  797. en:Hodgkin lymphoma -- r_associated #0: 26 / 0.115 -> en:anaplastic malignant neoplasm
    n1=en:Hodgkin lymphoma | n2=en:anaplastic malignant neoplasm | rel=r_associated | relid=0 | w=26
  798. en:Hodgkin lymphoma -- r_associated #0: 26 / 0.115 -> en:angioimmunoblastic t-cell lymphoma
    n1=en:Hodgkin lymphoma | n2=en:angioimmunoblastic t-cell lymphoma | rel=r_associated | relid=0 | w=26
  799. en:Hodgkin lymphoma -- r_associated #0: 26 / 0.115 -> en:angiolipoma
    n1=en:Hodgkin lymphoma | n2=en:angiolipoma | rel=r_associated | relid=0 | w=26
  800. en:Hodgkin lymphoma -- r_associated #0: 26 / 0.115 -> en:angiomyosarcoma
    n1=en:Hodgkin lymphoma | n2=en:angiomyosarcoma | rel=r_associated | relid=0 | w=26
  801. en:Hodgkin lymphoma -- r_associated #0: 26 / 0.115 -> en:animal bite
    n1=en:Hodgkin lymphoma | n2=en:animal bite | rel=r_associated | relid=0 | w=26
  802. en:Hodgkin lymphoma -- r_associated #0: 26 / 0.115 -> en:autoimmune lymphoproliferative syndrome
    n1=en:Hodgkin lymphoma | n2=en:autoimmune lymphoproliferative syndrome | rel=r_associated | relid=0 | w=26
  803. en:Hodgkin lymphoma -- r_associated #0: 26 / 0.115 -> en:basal cell nevus
    n1=en:Hodgkin lymphoma | n2=en:basal cell nevus | rel=r_associated | relid=0 | w=26
  804. en:Hodgkin lymphoma -- r_associated #0: 26 / 0.115 -> en:benign female reproductive system neoplasm
    n1=en:Hodgkin lymphoma | n2=en:benign female reproductive system neoplasm | rel=r_associated | relid=0 | w=26
  805. en:Hodgkin lymphoma -- r_associated #0: 26 / 0.115 -> en:benign male reproductive system neoplasm
    n1=en:Hodgkin lymphoma | n2=en:benign male reproductive system neoplasm | rel=r_associated | relid=0 | w=26
  806. en:Hodgkin lymphoma -- r_associated #0: 26 / 0.115 -> en:benign skin neoplasm
    n1=en:Hodgkin lymphoma | n2=en:benign skin neoplasm | rel=r_associated | relid=0 | w=26
  807. en:Hodgkin lymphoma -- r_associated #0: 26 / 0.115 -> en:blood vessel neoplasm
    n1=en:Hodgkin lymphoma | n2=en:blood vessel neoplasm | rel=r_associated | relid=0 | w=26
  808. en:Hodgkin lymphoma -- r_associated #0: 26 / 0.115 -> en:bone marrow transplantation
    n1=en:Hodgkin lymphoma | n2=en:bone marrow transplantation | rel=r_associated | relid=0 | w=26
  809. en:Hodgkin lymphoma -- r_associated #0: 26 / 0.115 -> en:brain morphology
    n1=en:Hodgkin lymphoma | n2=en:brain morphology | rel=r_associated | relid=0 | w=26
  810. en:Hodgkin lymphoma -- r_associated #0: 26 / 0.115 -> en:carcinoid tumor
    n1=en:Hodgkin lymphoma | n2=en:carcinoid tumor | rel=r_associated | relid=0 | w=26
  811. en:Hodgkin lymphoma -- r_associated #0: 26 / 0.115 -> en:carcinoma of bone, connective tissue, skin and breast
    n1=en:Hodgkin lymphoma | n2=en:carcinoma of bone, connective tissue, skin and breast | rel=r_associated | relid=0 | w=26
  812. en:Hodgkin lymphoma -- r_associated #0: 26 / 0.115 -> en:carotid body paraganglioma
    n1=en:Hodgkin lymphoma | n2=en:carotid body paraganglioma | rel=r_associated | relid=0 | w=26
  813. en:Hodgkin lymphoma -- r_associated #0: 26 / 0.115 -> en:carotid body tumors (most common)
    n1=en:Hodgkin lymphoma | n2=en:carotid body tumors (most common) | rel=r_associated | relid=0 | w=26
  814. en:Hodgkin lymphoma -- r_associated #0: 26 / 0.115 -> en:central nervous system embryonal neoplasm
    n1=en:Hodgkin lymphoma | n2=en:central nervous system embryonal neoplasm | rel=r_associated | relid=0 | w=26
  815. en:Hodgkin lymphoma -- r_associated #0: 26 / 0.115 -> en:childhood lymphoma
    n1=en:Hodgkin lymphoma | n2=en:childhood lymphoma | rel=r_associated | relid=0 | w=26
  816. en:Hodgkin lymphoma -- r_associated #0: 26 / 0.115 -> en:choriocarcinoma
    n1=en:Hodgkin lymphoma | n2=en:choriocarcinoma | rel=r_associated | relid=0 | w=26
  817. en:Hodgkin lymphoma -- r_associated #0: 26 / 0.115 -> en:choriocarcinoma combined with other germ cell elements
    n1=en:Hodgkin lymphoma | n2=en:choriocarcinoma combined with other germ cell elements | rel=r_associated | relid=0 | w=26
  818. en:Hodgkin lymphoma -- r_associated #0: 26 / 0.115 -> en:cluster headache
    n1=en:Hodgkin lymphoma | n2=en:cluster headache | rel=r_associated | relid=0 | w=26
  819. en:Hodgkin lymphoma -- r_associated #0: 26 / 0.115 -> en:contusion/hemorrhage eye
    n1=en:Hodgkin lymphoma | n2=en:contusion/hemorrhage eye | rel=r_associated | relid=0 | w=26
  820. en:Hodgkin lymphoma -- r_associated #0: 26 / 0.115 -> en:dedifferentiated liposarcoma
    n1=en:Hodgkin lymphoma | n2=en:dedifferentiated liposarcoma | rel=r_associated | relid=0 | w=26
  821. en:Hodgkin lymphoma -- r_associated #0: 26 / 0.115 -> en:digestive system carcinoma
    n1=en:Hodgkin lymphoma | n2=en:digestive system carcinoma | rel=r_associated | relid=0 | w=26
  822. en:Hodgkin lymphoma -- r_associated #0: 26 / 0.115 -> en:digestive system lymphoma
    n1=en:Hodgkin lymphoma | n2=en:digestive system lymphoma | rel=r_associated | relid=0 | w=26
  823. en:Hodgkin lymphoma -- r_associated #0: 26 / 0.115 -> en:ebv-induced b-cell lymphoma
    n1=en:Hodgkin lymphoma | n2=en:ebv-induced b-cell lymphoma | rel=r_associated | relid=0 | w=26
  824. en:Hodgkin lymphoma -- r_associated #0: 26 / 0.115 -> en:embryonal neoplasm
    n1=en:Hodgkin lymphoma | n2=en:embryonal neoplasm | rel=r_associated | relid=0 | w=26
  825. en:Hodgkin lymphoma -- r_associated #0: 26 / 0.115 -> en:embryonal rhabdomyosarcoma
    n1=en:Hodgkin lymphoma | n2=en:embryonal rhabdomyosarcoma | rel=r_associated | relid=0 | w=26
  826. en:Hodgkin lymphoma -- r_associated #0: 26 / 0.115 -> en:endocrine system cancer
    n1=en:Hodgkin lymphoma | n2=en:endocrine system cancer | rel=r_associated | relid=0 | w=26
  827. en:Hodgkin lymphoma -- r_associated #0: 26 / 0.115 -> en:endometrial adenocarcinoma
    n1=en:Hodgkin lymphoma | n2=en:endometrial adenocarcinoma | rel=r_associated | relid=0 | w=26
  828. en:Hodgkin lymphoma -- r_associated #0: 26 / 0.115 -> en:epithelioid trophoblastic tumor
    n1=en:Hodgkin lymphoma | n2=en:epithelioid trophoblastic tumor | rel=r_associated | relid=0 | w=26
  829. en:Hodgkin lymphoma -- r_associated #0: 26 / 0.115 -> en:esophageal carcinoma
    n1=en:Hodgkin lymphoma | n2=en:esophageal carcinoma | rel=r_associated | relid=0 | w=26
  830. en:Hodgkin lymphoma -- r_associated #0: 26 / 0.115 -> en:extraskeletal osteosarcoma
    n1=en:Hodgkin lymphoma | n2=en:extraskeletal osteosarcoma | rel=r_associated | relid=0 | w=26
  831. en:Hodgkin lymphoma -- r_associated #0: 26 / 0.115 -> en:family history of hodgkin's disease
    n1=en:Hodgkin lymphoma | n2=en:family history of hodgkin's disease | rel=r_associated | relid=0 | w=26
  832. en:Hodgkin lymphoma -- r_associated #0: 26 / 0.115 -> en:fibroblastic/myofibroblastic tumors (all subtypes)
    n1=en:Hodgkin lymphoma | n2=en:fibroblastic/myofibroblastic tumors (all subtypes) | rel=r_associated | relid=0 | w=26
  833. en:Hodgkin lymphoma -- r_associated #0: 26 / 0.115 -> en:fibromatous neoplasm
    n1=en:Hodgkin lymphoma | n2=en:fibromatous neoplasm | rel=r_associated | relid=0 | w=26
  834. en:Hodgkin lymphoma -- r_associated #0: 26 / 0.115 -> en:gastric adenocarcinoma
    n1=en:Hodgkin lymphoma | n2=en:gastric adenocarcinoma | rel=r_associated | relid=0 | w=26
  835. en:Hodgkin lymphoma -- r_associated #0: 26 / 0.115 -> en:gastric carcinoma
    n1=en:Hodgkin lymphoma | n2=en:gastric carcinoma | rel=r_associated | relid=0 | w=26
  836. en:Hodgkin lymphoma -- r_associated #0: 26 / 0.115 -> en:gastroenteritis presumed infectious
    n1=en:Hodgkin lymphoma | n2=en:gastroenteritis presumed infectious | rel=r_associated | relid=0 | w=26
  837. en:Hodgkin lymphoma -- r_associated #0: 26 / 0.115 -> en:genetic aspects
    n1=en:Hodgkin lymphoma | n2=en:genetic aspects | rel=r_associated | relid=0 | w=26
  838. en:Hodgkin lymphoma -- r_associated #0: 26 / 0.115 -> en:genital cancer
    n1=en:Hodgkin lymphoma | n2=en:genital cancer | rel=r_associated | relid=0 | w=26
  839. en:Hodgkin lymphoma -- r_associated #0: 26 / 0.115 -> en:genital tract lymphoma
    n1=en:Hodgkin lymphoma | n2=en:genital tract lymphoma | rel=r_associated | relid=0 | w=26
  840. en:Hodgkin lymphoma -- r_associated #0: 26 / 0.115 -> en:germinoma
    n1=en:Hodgkin lymphoma | n2=en:germinoma | rel=r_associated | relid=0 | w=26
  841. en:Hodgkin lymphoma -- r_associated #0: 26 / 0.115 -> en:glaucoma
    n1=en:Hodgkin lymphoma | n2=en:glaucoma | rel=r_associated | relid=0 | w=26
  842. en:Hodgkin lymphoma -- r_associated #0: 26 / 0.115 -> en:glomerulonephritis/nephrosis
    n1=en:Hodgkin lymphoma | n2=en:glomerulonephritis/nephrosis | rel=r_associated | relid=0 | w=26
  843. en:Hodgkin lymphoma -- r_associated #0: 26 / 0.115 -> en:granulomatous slack skin disease
    n1=en:Hodgkin lymphoma | n2=en:granulomatous slack skin disease | rel=r_associated | relid=0 | w=26
  844. en:Hodgkin lymphoma -- r_associated #0: 26 / 0.115 -> en:haematopoietic neoplasms (excl leukaemias and lymphomas)
    n1=en:Hodgkin lymphoma | n2=en:haematopoietic neoplasms (excl leukaemias and lymphomas) | rel=r_associated | relid=0 | w=26
  845. en:Hodgkin lymphoma -- r_associated #0: 26 / 0.115 -> en:hamartoma
    n1=en:Hodgkin lymphoma | n2=en:hamartoma | rel=r_associated | relid=0 | w=26
  846. en:Hodgkin lymphoma -- r_associated #0: 26 / 0.115 -> en:hemangiomas and lymphangiomas of any site
    n1=en:Hodgkin lymphoma | n2=en:hemangiomas and lymphangiomas of any site | rel=r_associated | relid=0 | w=26
  847. en:Hodgkin lymphoma -- r_associated #0: 26 / 0.115 -> en:hematopoietic and lymphatic system
    n1=en:Hodgkin lymphoma | n2=en:hematopoietic and lymphatic system | rel=r_associated | relid=0 | w=26
  848. en:Hodgkin lymphoma -- r_associated #0: 26 / 0.115 -> en:hemoglobinopathy
    n1=en:Hodgkin lymphoma | n2=en:hemoglobinopathy | rel=r_associated | relid=0 | w=26
  849. en:Hodgkin lymphoma -- r_associated #0: 26 / 0.115 -> en:hereditary malignant neoplasm
    n1=en:Hodgkin lymphoma | n2=en:hereditary malignant neoplasm | rel=r_associated | relid=0 | w=26
  850. en:Hodgkin lymphoma -- r_associated #0: 26 / 0.115 -> en:herpes zoster
    n1=en:Hodgkin lymphoma | n2=en:herpes zoster | rel=r_associated | relid=0 | w=26
  851. en:Hodgkin lymphoma -- r_associated #0: 26 / 0.115 -> en:hiv/aids
    n1=en:Hodgkin lymphoma | n2=en:hiv/aids | rel=r_associated | relid=0 | w=26
  852. en:Hodgkin lymphoma -- r_associated #0: 26 / 0.115 -> en:hodgkin lymphoma, unspecified, lymph nodes of head, face, and neck
    n1=en:Hodgkin lymphoma | n2=en:hodgkin lymphoma, unspecified, lymph nodes of head, face, and neck | rel=r_associated | relid=0 | w=26
  853. en:Hodgkin lymphoma -- r_associated #0: 26 / 0.115 -> en:hodgkin's disease lymphocyte depletion stage ii subdiaphragm
    n1=en:Hodgkin lymphoma | n2=en:hodgkin's disease lymphocyte depletion stage ii subdiaphragm | rel=r_associated | relid=0 | w=26
  854. en:Hodgkin lymphoma -- r_associated #0: 26 / 0.115 -> en:hodgkin's disease, lymphocytic-histiocytic predominance of intrapelvic lymph nodes
    n1=en:Hodgkin lymphoma | n2=en:hodgkin's disease, lymphocytic-histiocytic predominance of intrapelvic lymph nodes | rel=r_associated | relid=0 | w=26
  855. en:Hodgkin lymphoma -- r_associated #0: 26 / 0.115 -> en:hodgkin's disease, nodular sclerosis of lymph nodes of head, face and neck
    n1=en:Hodgkin lymphoma | n2=en:hodgkin's disease, nodular sclerosis of lymph nodes of head, face and neck | rel=r_associated | relid=0 | w=26
  856. en:Hodgkin lymphoma -- r_associated #0: 26 / 0.115 -> en:hodgkin's granuloma of intrathoracic lymph nodes
    n1=en:Hodgkin lymphoma | n2=en:hodgkin's granuloma of intrathoracic lymph nodes | rel=r_associated | relid=0 | w=26
  857. en:Hodgkin lymphoma -- r_associated #0: 26 / 0.115 -> en:hodgkin's granuloma of spleen
    n1=en:Hodgkin lymphoma | n2=en:hodgkin's granuloma of spleen | rel=r_associated | relid=0 | w=26
  858. en:Hodgkin lymphoma -- r_associated #0: 26 / 0.115 -> en:hodgkin's granuloma, unspecified site, extranodal and solid organ sites
    n1=en:Hodgkin lymphoma | n2=en:hodgkin's granuloma, unspecified site, extranodal and solid organ sites | rel=r_associated | relid=0 | w=26
  859. en:Hodgkin lymphoma -- r_associated #0: 26 / 0.115 -> en:Hodgkin's lymphoma
    n1=en:Hodgkin lymphoma | n2=en:Hodgkin's lymphoma | rel=r_associated | relid=0 | w=26
  860. en:Hodgkin lymphoma -- r_associated #0: 26 / 0.115 -> en:hodgkin's paragranuloma of lymph nodes of axilla and/or upper limb
    n1=en:Hodgkin lymphoma | n2=en:hodgkin's paragranuloma of lymph nodes of axilla and/or upper limb | rel=r_associated | relid=0 | w=26
  861. en:Hodgkin lymphoma -- r_associated #0: 26 / 0.115 -> en:hormone related neoplasm/cancer
    n1=en:Hodgkin lymphoma | n2=en:hormone related neoplasm/cancer | rel=r_associated | relid=0 | w=26
  862. en:Hodgkin lymphoma -- r_associated #0: 26 / 0.115 -> en:hypothalamic neoplasm
    n1=en:Hodgkin lymphoma | n2=en:hypothalamic neoplasm | rel=r_associated | relid=0 | w=26
  863. en:Hodgkin lymphoma -- r_associated #0: 26 / 0.115 -> en:immune system
    n1=en:Hodgkin lymphoma | n2=en:immune system | rel=r_associated | relid=0 | w=26
  864. en:Hodgkin lymphoma -- r_associated #0: 26 / 0.115 -> en:increased incidence of rectosigmoid cancer
    n1=en:Hodgkin lymphoma | n2=en:increased incidence of rectosigmoid cancer | rel=r_associated | relid=0 | w=26
  865. en:Hodgkin lymphoma -- r_associated #0: 26 / 0.115 -> en:increased risk of malignancy
    n1=en:Hodgkin lymphoma | n2=en:increased risk of malignancy | rel=r_associated | relid=0 | w=26
  866. en:Hodgkin lymphoma -- r_associated #0: 26 / 0.115 -> en:influenza (proven) without pneumonia
    n1=en:Hodgkin lymphoma | n2=en:influenza (proven) without pneumonia | rel=r_associated | relid=0 | w=26
  867. en:Hodgkin lymphoma -- r_associated #0: 26 / 0.115 -> en:intraductal papillary adenocarcinoma with invasion
    n1=en:Hodgkin lymphoma | n2=en:intraductal papillary adenocarcinoma with invasion | rel=r_associated | relid=0 | w=26
  868. en:Hodgkin lymphoma -- r_associated #0: 26 / 0.115 -> en:jak2 wt allele
    n1=en:Hodgkin lymphoma | n2=en:jak2 wt allele | rel=r_associated | relid=0 | w=26
  869. en:Hodgkin lymphoma -- r_associated #0: 26 / 0.115 -> en:laryngeal neoplasm
    n1=en:Hodgkin lymphoma | n2=en:laryngeal neoplasm | rel=r_associated | relid=0 | w=26
  870. en:Hodgkin lymphoma -- r_associated #0: 26 / 0.115 -> en:leiomyosarcoma
    n1=en:Hodgkin lymphoma | n2=en:leiomyosarcoma | rel=r_associated | relid=0 | w=26
  871. en:Hodgkin lymphoma -- r_associated #0: 26 / 0.115 -> en:low-grade neuroendocrine carcinoma (submandibular glands, salivary glands, maxillary sinus, nasal cavity)
    n1=en:Hodgkin lymphoma | n2=en:low-grade neuroendocrine carcinoma (submandibular glands, salivary glands, maxillary sinus, nasal cavity) | rel=r_associated | relid=0 | w=26
  872. en:Hodgkin lymphoma -- r_associated #0: 26 / 0.115 -> en:lung
    n1=en:Hodgkin lymphoma | n2=en:lung | rel=r_associated | relid=0 | w=26
  873. en:Hodgkin lymphoma -- r_associated #0: 26 / 0.115 -> en:lymph node neoplasm
    n1=en:Hodgkin lymphoma | n2=en:lymph node neoplasm | rel=r_associated | relid=0 | w=26
  874. en:Hodgkin lymphoma -- r_associated #0: 26 / 0.115 -> en:lymphatic vessel neoplasm
    n1=en:Hodgkin lymphoma | n2=en:lymphatic vessel neoplasm | rel=r_associated | relid=0 | w=26
  875. en:Hodgkin lymphoma -- r_associated #0: 26 / 0.115 -> en:lymphocyte-rich classical hodgkin lymphoma, lymph nodes of inguinal region and lower limb
    n1=en:Hodgkin lymphoma | n2=en:lymphocyte-rich classical hodgkin lymphoma, lymph nodes of inguinal region and lower limb | rel=r_associated | relid=0 | w=26
  876. en:Hodgkin lymphoma -- r_associated #0: 26 / 0.115 -> en:malaria
    n1=en:Hodgkin lymphoma | n2=en:malaria | rel=r_associated | relid=0 | w=26
  877. en:Hodgkin lymphoma -- r_associated #0: 26 / 0.115 -> en:malignant cervical neoplasm
    n1=en:Hodgkin lymphoma | n2=en:malignant cervical neoplasm | rel=r_associated | relid=0 | w=26
  878. en:Hodgkin lymphoma -- r_associated #0: 26 / 0.115 -> en:malignant fibromatous neoplasm
    n1=en:Hodgkin lymphoma | n2=en:malignant fibromatous neoplasm | rel=r_associated | relid=0 | w=26
  879. en:Hodgkin lymphoma -- r_associated #0: 26 / 0.115 -> en:malignant glomus tumor
    n1=en:Hodgkin lymphoma | n2=en:malignant glomus tumor | rel=r_associated | relid=0 | w=26
  880. en:Hodgkin lymphoma -- r_associated #0: 26 / 0.115 -> en:malignant granular cell tumor
    n1=en:Hodgkin lymphoma | n2=en:malignant granular cell tumor | rel=r_associated | relid=0 | w=26
  881. en:Hodgkin lymphoma -- r_associated #0: 26 / 0.115 -> en:malignant leydig cell tumor
    n1=en:Hodgkin lymphoma | n2=en:malignant leydig cell tumor | rel=r_associated | relid=0 | w=26
  882. en:Hodgkin lymphoma -- r_associated #0: 26 / 0.115 -> en:malignant lung neoplasm
    n1=en:Hodgkin lymphoma | n2=en:malignant lung neoplasm | rel=r_associated | relid=0 | w=26
  883. en:Hodgkin lymphoma -- r_associated #0: 26 / 0.115 -> en:malignant neoplasm of gartner's duct
    n1=en:Hodgkin lymphoma | n2=en:malignant neoplasm of gartner's duct | rel=r_associated | relid=0 | w=26
  884. en:Hodgkin lymphoma -- r_associated #0: 26 / 0.115 -> en:malignant neoplasm of lip, oral cavity and pharynx
    n1=en:Hodgkin lymphoma | n2=en:malignant neoplasm of lip, oral cavity and pharynx | rel=r_associated | relid=0 | w=26
  885. en:Hodgkin lymphoma -- r_associated #0: 26 / 0.115 -> en:malignant ovarian thecoma
    n1=en:Hodgkin lymphoma | n2=en:malignant ovarian thecoma | rel=r_associated | relid=0 | w=26
  886. en:Hodgkin lymphoma -- r_associated #0: 26 / 0.115 -> en:malignant pancreatic neoplasm
    n1=en:Hodgkin lymphoma | n2=en:malignant pancreatic neoplasm | rel=r_associated | relid=0 | w=26
  887. en:Hodgkin lymphoma -- r_associated #0: 26 / 0.115 -> en:malignant peripheral nerve sheath tumor with perineurial differentiation
    n1=en:Hodgkin lymphoma | n2=en:malignant peripheral nerve sheath tumor with perineurial differentiation | rel=r_associated | relid=0 | w=26
  888. en:Hodgkin lymphoma -- r_associated #0: 26 / 0.115 -> en:malignant salivary gland neoplasm
    n1=en:Hodgkin lymphoma | n2=en:malignant salivary gland neoplasm | rel=r_associated | relid=0 | w=26
  889. en:Hodgkin lymphoma -- r_associated #0: 26 / 0.115 -> en:malignant skin neoplasm
    n1=en:Hodgkin lymphoma | n2=en:malignant skin neoplasm | rel=r_associated | relid=0 | w=26
  890. en:Hodgkin lymphoma -- r_associated #0: 26 / 0.115 -> en:malignant solid tumor
    n1=en:Hodgkin lymphoma | n2=en:malignant solid tumor | rel=r_associated | relid=0 | w=26
  891. en:Hodgkin lymphoma -- r_associated #0: 26 / 0.115 -> en:malignant tumor of nerve sheath origin
    n1=en:Hodgkin lymphoma | n2=en:malignant tumor of nerve sheath origin | rel=r_associated | relid=0 | w=26
  892. en:Hodgkin lymphoma -- r_associated #0: 26 / 0.115 -> en:malignant type b2 thymoma
    n1=en:Hodgkin lymphoma | n2=en:malignant type b2 thymoma | rel=r_associated | relid=0 | w=26
  893. en:Hodgkin lymphoma -- r_associated #0: 26 / 0.115 -> en:medulloblastoma
    n1=en:Hodgkin lymphoma | n2=en:medulloblastoma | rel=r_associated | relid=0 | w=26
  894. en:Hodgkin lymphoma -- r_associated #0: 26 / 0.115 -> en:melanoma arising from blue nevus
    n1=en:Hodgkin lymphoma | n2=en:melanoma arising from blue nevus | rel=r_associated | relid=0 | w=26
  895. en:Hodgkin lymphoma -- r_associated #0: 26 / 0.115 -> en:meningeal sarcomatosis
    n1=en:Hodgkin lymphoma | n2=en:meningeal sarcomatosis | rel=r_associated | relid=0 | w=26
  896. en:Hodgkin lymphoma -- r_associated #0: 26 / 0.115 -> en:meningioma
    n1=en:Hodgkin lymphoma | n2=en:meningioma | rel=r_associated | relid=0 | w=26
  897. en:Hodgkin lymphoma -- r_associated #0: 26 / 0.115 -> en:mesothelioma (malignant, clinical disorder) (disorder)
    n1=en:Hodgkin lymphoma | n2=en:mesothelioma (malignant, clinical disorder) (disorder) | rel=r_associated | relid=0 | w=26
  898. en:Hodgkin lymphoma -- r_associated #0: 26 / 0.115 -> en:metastasis to lymph node from squamous cell carcinoma
    n1=en:Hodgkin lymphoma | n2=en:metastasis to lymph node from squamous cell carcinoma | rel=r_associated | relid=0 | w=26
  899. en:Hodgkin lymphoma -- r_associated #0: 26 / 0.115 -> en:micropapillary transitional cell carcinoma
    n1=en:Hodgkin lymphoma | n2=en:micropapillary transitional cell carcinoma | rel=r_associated | relid=0 | w=26
  900. en:Hodgkin lymphoma -- r_associated #0: 26 / 0.115 -> en:miscellaneous soft tissue tumors (all subtypes)
    n1=en:Hodgkin lymphoma | n2=en:miscellaneous soft tissue tumors (all subtypes) | rel=r_associated | relid=0 | w=26
  901. en:Hodgkin lymphoma -- r_associated #0: 26 / 0.115 -> en:mixed cellularity classical hodgkin lymphoma, intrapelvic lymph nodes
    n1=en:Hodgkin lymphoma | n2=en:mixed cellularity classical hodgkin lymphoma, intrapelvic lymph nodes | rel=r_associated | relid=0 | w=26
  902. en:Hodgkin lymphoma -- r_associated #0: 26 / 0.115 -> en:mucoepidermoid tumor
    n1=en:Hodgkin lymphoma | n2=en:mucoepidermoid tumor | rel=r_associated | relid=0 | w=26
  903. en:Hodgkin lymphoma -- r_associated #0: 26 / 0.115 -> en:multiple congenital anomalies
    n1=en:Hodgkin lymphoma | n2=en:multiple congenital anomalies | rel=r_associated | relid=0 | w=26
  904. en:Hodgkin lymphoma -- r_associated #0: 26 / 0.115 -> en:multiple trauma/internal injury
    n1=en:Hodgkin lymphoma | n2=en:multiple trauma/internal injury | rel=r_associated | relid=0 | w=26
  905. en:Hodgkin lymphoma -- r_associated #0: 26 / 0.115 -> en:multiple tumors in 28% of patients
    n1=en:Hodgkin lymphoma | n2=en:multiple tumors in 28% of patients | rel=r_associated | relid=0 | w=26
  906. en:Hodgkin lymphoma -- r_associated #0: 26 / 0.115 -> en:myeloliposarcoma
    n1=en:Hodgkin lymphoma | n2=en:myeloliposarcoma | rel=r_associated | relid=0 | w=26
  907. en:Hodgkin lymphoma -- r_associated #0: 26 / 0.115 -> en:myxoid chondrosarcoma
    n1=en:Hodgkin lymphoma | n2=en:myxoid chondrosarcoma | rel=r_associated | relid=0 | w=26
  908. en:Hodgkin lymphoma -- r_associated #0: 26 / 0.115 -> en:myxoma
    n1=en:Hodgkin lymphoma | n2=en:myxoma | rel=r_associated | relid=0 | w=26
  909. en:Hodgkin lymphoma -- r_associated #0: 26 / 0.115 -> en:myxomatous neoplasm
    n1=en:Hodgkin lymphoma | n2=en:myxomatous neoplasm | rel=r_associated | relid=0 | w=26
  910. en:Hodgkin lymphoma -- r_associated #0: 26 / 0.115 -> en:neoplasm of uncertain behavior of endocrine glands and nervous system
    n1=en:Hodgkin lymphoma | n2=en:neoplasm of uncertain behavior of endocrine glands and nervous system | rel=r_associated | relid=0 | w=26
  911. en:Hodgkin lymphoma -- r_associated #0: 26 / 0.115 -> en:neoplasms, multiple primary
    n1=en:Hodgkin lymphoma | n2=en:neoplasms, multiple primary | rel=r_associated | relid=0 | w=26
  912. en:Hodgkin lymphoma -- r_associated #0: 26 / 0.115 -> en:neuroepithelioma
    n1=en:Hodgkin lymphoma | n2=en:neuroepithelioma | rel=r_associated | relid=0 | w=26
  913. en:Hodgkin lymphoma -- r_associated #0: 26 / 0.115 -> en:nodular melanoma
    n1=en:Hodgkin lymphoma | n2=en:nodular melanoma | rel=r_associated | relid=0 | w=26
  914. en:Hodgkin lymphoma -- r_associated #0: 26 / 0.115 -> en:nodular sclerosis classical hodgkin lymphoma, cellular phase
    n1=en:Hodgkin lymphoma | n2=en:nodular sclerosis classical hodgkin lymphoma, cellular phase | rel=r_associated | relid=0 | w=26
  915. en:Hodgkin lymphoma -- r_associated #0: 26 / 0.115 -> en:non-rheum heart valve disease
    n1=en:Hodgkin lymphoma | n2=en:non-rheum heart valve disease | rel=r_associated | relid=0 | w=26
  916. en:Hodgkin lymphoma -- r_associated #0: 26 / 0.115 -> en:normal delivery deadborn
    n1=en:Hodgkin lymphoma | n2=en:normal delivery deadborn | rel=r_associated | relid=0 | w=26
  917. en:Hodgkin lymphoma -- r_associated #0: 26 / 0.115 -> en:other classical hodgkin lymphoma, intrapelvic lymph nodes
    n1=en:Hodgkin lymphoma | n2=en:other classical hodgkin lymphoma, intrapelvic lymph nodes | rel=r_associated | relid=0 | w=26
  918. en:Hodgkin lymphoma -- r_associated #0: 26 / 0.115 -> en:other diseases of ear/mastoid
    n1=en:Hodgkin lymphoma | n2=en:other diseases of ear/mastoid | rel=r_associated | relid=0 | w=26
  919. en:Hodgkin lymphoma -- r_associated #0: 26 / 0.115 -> en:other forms of chronic ischaemic heart disease
    n1=en:Hodgkin lymphoma | n2=en:other forms of chronic ischaemic heart disease | rel=r_associated | relid=0 | w=26
  920. en:Hodgkin lymphoma -- r_associated #0: 26 / 0.115 -> en:other forms of heart disease
    n1=en:Hodgkin lymphoma | n2=en:other forms of heart disease | rel=r_associated | relid=0 | w=26
  921. en:Hodgkin lymphoma -- r_associated #0: 26 / 0.115 -> en:other musculoskeletal disorder
    n1=en:Hodgkin lymphoma | n2=en:other musculoskeletal disorder | rel=r_associated | relid=0 | w=26
  922. en:Hodgkin lymphoma -- r_associated #0: 26 / 0.115 -> en:other neurologic injuries
    n1=en:Hodgkin lymphoma | n2=en:other neurologic injuries | rel=r_associated | relid=0 | w=26
  923. en:Hodgkin lymphoma -- r_associated #0: 26 / 0.115 -> en:other non-obstetrical conditions
    n1=en:Hodgkin lymphoma | n2=en:other non-obstetrical conditions | rel=r_associated | relid=0 | w=26
  924. en:Hodgkin lymphoma -- r_associated #0: 26 / 0.115 -> en:other osteoarthritis
    n1=en:Hodgkin lymphoma | n2=en:other osteoarthritis | rel=r_associated | relid=0 | w=26
  925. en:Hodgkin lymphoma -- r_associated #0: 26 / 0.115 -> en:other viral disease with exanthems
    n1=en:Hodgkin lymphoma | n2=en:other viral disease with exanthems | rel=r_associated | relid=0 | w=26
  926. en:Hodgkin lymphoma -- r_associated #0: 26 / 0.115 -> en:overlapping malignant neoplasm of gastrointestinal tract
    n1=en:Hodgkin lymphoma | n2=en:overlapping malignant neoplasm of gastrointestinal tract | rel=r_associated | relid=0 | w=26
  927. en:Hodgkin lymphoma -- r_associated #0: 26 / 0.115 -> en:paraganglioma
    n1=en:Hodgkin lymphoma | n2=en:paraganglioma | rel=r_associated | relid=0 | w=26
  928. en:Hodgkin lymphoma -- r_associated #0: 26 / 0.115 -> en:pediculosis/other skin infestation
    n1=en:Hodgkin lymphoma | n2=en:pediculosis/other skin infestation | rel=r_associated | relid=0 | w=26
  929. en:Hodgkin lymphoma -- r_associated #0: 26 / 0.115 -> en:phagocytic cell
    n1=en:Hodgkin lymphoma | n2=en:phagocytic cell | rel=r_associated | relid=0 | w=26
  930. en:Hodgkin lymphoma -- r_associated #0: 26 / 0.115 -> en:pheochromocytomas, adrenal (28%)
    n1=en:Hodgkin lymphoma | n2=en:pheochromocytomas, adrenal (28%) | rel=r_associated | relid=0 | w=26
  931. en:Hodgkin lymphoma -- r_associated #0: 26 / 0.115 -> en:poorly differentiated carcinoma
    n1=en:Hodgkin lymphoma | n2=en:poorly differentiated carcinoma | rel=r_associated | relid=0 | w=26
  932. en:Hodgkin lymphoma -- r_associated #0: 26 / 0.115 -> en:primary malignant germ cell neoplasm
    n1=en:Hodgkin lymphoma | n2=en:primary malignant germ cell neoplasm | rel=r_associated | relid=0 | w=26
  933. en:Hodgkin lymphoma -- r_associated #0: 26 / 0.115 -> en:primary malignant neoplasm of back
    n1=en:Hodgkin lymphoma | n2=en:primary malignant neoplasm of back | rel=r_associated | relid=0 | w=26
  934. en:Hodgkin lymphoma -- r_associated #0: 26 / 0.115 -> en:primary malignant neoplasm of ear, nose and/or throat
    n1=en:Hodgkin lymphoma | n2=en:primary malignant neoplasm of ear, nose and/or throat | rel=r_associated | relid=0 | w=26
  935. en:Hodgkin lymphoma -- r_associated #0: 26 / 0.115 -> en:primary undifferentiated large cell carcinoma
    n1=en:Hodgkin lymphoma | n2=en:primary undifferentiated large cell carcinoma | rel=r_associated | relid=0 | w=26
  936. en:Hodgkin lymphoma -- r_associated #0: 26 / 0.115 -> en:pulmonary tuberculosis
    n1=en:Hodgkin lymphoma | n2=en:pulmonary tuberculosis | rel=r_associated | relid=0 | w=26
  937. en:Hodgkin lymphoma -- r_associated #0: 26 / 0.115 -> en:refractory anemia
    n1=en:Hodgkin lymphoma | n2=en:refractory anemia | rel=r_associated | relid=0 | w=26
  938. en:Hodgkin lymphoma -- r_associated #0: 26 / 0.115 -> en:renal cell carcinoma
    n1=en:Hodgkin lymphoma | n2=en:renal cell carcinoma | rel=r_associated | relid=0 | w=26
  939. en:Hodgkin lymphoma -- r_associated #0: 26 / 0.115 -> en:reticuloendothelial system
    n1=en:Hodgkin lymphoma | n2=en:reticuloendothelial system | rel=r_associated | relid=0 | w=26
  940. en:Hodgkin lymphoma -- r_associated #0: 26 / 0.115 -> en:schizophrenia
    n1=en:Hodgkin lymphoma | n2=en:schizophrenia | rel=r_associated | relid=0 | w=26
  941. en:Hodgkin lymphoma -- r_associated #0: 26 / 0.115 -> en:screening for prostate cancer
    n1=en:Hodgkin lymphoma | n2=en:screening for prostate cancer | rel=r_associated | relid=0 | w=26
  942. en:Hodgkin lymphoma -- r_associated #0: 26 / 0.115 -> en:seizure disorder
    n1=en:Hodgkin lymphoma | n2=en:seizure disorder | rel=r_associated | relid=0 | w=26
  943. en:Hodgkin lymphoma -- r_associated #0: 26 / 0.115 -> en:skin appendage tumors may show malignant transformation
    n1=en:Hodgkin lymphoma | n2=en:skin appendage tumors may show malignant transformation | rel=r_associated | relid=0 | w=26
  944. en:Hodgkin lymphoma -- r_associated #0: 26 / 0.115 -> en:skin metatypical carcinoma
    n1=en:Hodgkin lymphoma | n2=en:skin metatypical carcinoma | rel=r_associated | relid=0 | w=26
  945. en:Hodgkin lymphoma -- r_associated #0: 26 / 0.115 -> en:small cell intermediate cell carcinoma
    n1=en:Hodgkin lymphoma | n2=en:small cell intermediate cell carcinoma | rel=r_associated | relid=0 | w=26
  946. en:Hodgkin lymphoma -- r_associated #0: 26 / 0.115 -> en:squamous cell carcinoma
    n1=en:Hodgkin lymphoma | n2=en:squamous cell carcinoma | rel=r_associated | relid=0 | w=26
  947. en:Hodgkin lymphoma -- r_associated #0: 26 / 0.115 -> en:squamous cell carcinoma in area of palmoplantar keratoderma (rare)
    n1=en:Hodgkin lymphoma | n2=en:squamous cell carcinoma in area of palmoplantar keratoderma (rare) | rel=r_associated | relid=0 | w=26
  948. en:Hodgkin lymphoma -- r_associated #0: 26 / 0.115 -> en:squamous epitheliomas, multiple
    n1=en:Hodgkin lymphoma | n2=en:squamous epitheliomas, multiple | rel=r_associated | relid=0 | w=26
  949. en:Hodgkin lymphoma -- r_associated #0: 26 / 0.115 -> en:suicide attempt
    n1=en:Hodgkin lymphoma | n2=en:suicide attempt | rel=r_associated | relid=0 | w=26
  950. en:Hodgkin lymphoma -- r_associated #0: 26 / 0.115 -> en:telangiectatic osteosarcoma
    n1=en:Hodgkin lymphoma | n2=en:telangiectatic osteosarcoma | rel=r_associated | relid=0 | w=26
  951. en:Hodgkin lymphoma -- r_associated #0: 26 / 0.115 -> en:teratoid tumor, atypical
    n1=en:Hodgkin lymphoma | n2=en:teratoid tumor, atypical | rel=r_associated | relid=0 | w=26
  952. en:Hodgkin lymphoma -- r_associated #0: 26 / 0.115 -> en:therapy-related malignant neoplasm
    n1=en:Hodgkin lymphoma | n2=en:therapy-related malignant neoplasm | rel=r_associated | relid=0 | w=26
  953. en:Hodgkin lymphoma -- r_associated #0: 26 / 0.115 -> en:thymoma type b3
    n1=en:Hodgkin lymphoma | n2=en:thymoma type b3 | rel=r_associated | relid=0 | w=26
  954. en:Hodgkin lymphoma -- r_associated #0: 26 / 0.115 -> en:thyroid gland oncocytic neoplasm
    n1=en:Hodgkin lymphoma | n2=en:thyroid gland oncocytic neoplasm | rel=r_associated | relid=0 | w=26
  955. en:Hodgkin lymphoma -- r_associated #0: 26 / 0.115 -> en:transient cerebral ischemia
    n1=en:Hodgkin lymphoma | n2=en:transient cerebral ischemia | rel=r_associated | relid=0 | w=26
  956. en:Hodgkin lymphoma -- r_associated #0: 26 / 0.115 -> en:trophoblastic tumor
    n1=en:Hodgkin lymphoma | n2=en:trophoblastic tumor | rel=r_associated | relid=0 | w=26
  957. en:Hodgkin lymphoma -- r_associated #0: 26 / 0.115 -> en:tumors of the sympathetic nervous system (5 to 10%)
    n1=en:Hodgkin lymphoma | n2=en:tumors of the sympathetic nervous system (5 to 10%) | rel=r_associated | relid=0 | w=26
  958. en:Hodgkin lymphoma -- r_associated #0: 26 / 0.115 -> en:type b lymphomatoid papulosis
    n1=en:Hodgkin lymphoma | n2=en:type b lymphomatoid papulosis | rel=r_associated | relid=0 | w=26
  959. en:Hodgkin lymphoma -- r_associated #0: 26 / 0.115 -> en:urinary system neoplasm
    n1=en:Hodgkin lymphoma | n2=en:urinary system neoplasm | rel=r_associated | relid=0 | w=26
  960. en:Hodgkin lymphoma -- r_associated #0: 26 / 0.115 -> en:vagus nerve paraganglioma
    n1=en:Hodgkin lymphoma | n2=en:vagus nerve paraganglioma | rel=r_associated | relid=0 | w=26
  961. en:Hodgkin lymphoma -- r_associated #0: 26 / 0.115 -> en:verrucous carcinoma
    n1=en:Hodgkin lymphoma | n2=en:verrucous carcinoma | rel=r_associated | relid=0 | w=26
  962. en:Hodgkin lymphoma -- r_associated #0: 26 / 0.115 -> en:well differentiated liposarcoma
    n1=en:Hodgkin lymphoma | n2=en:well differentiated liposarcoma | rel=r_associated | relid=0 | w=26
  963. en:Hodgkin lymphoma -- r_associated #0: 26 / 0.115 -> en:x-linked dyskeratosis congenita
    n1=en:Hodgkin lymphoma | n2=en:x-linked dyskeratosis congenita | rel=r_associated | relid=0 | w=26
  964. en:Hodgkin lymphoma -- r_associated #0: 25 / 0.111 -> en:acoustic schwannoma
    n1=en:Hodgkin lymphoma | n2=en:acoustic schwannoma | rel=r_associated | relid=0 | w=25
  965. en:Hodgkin lymphoma -- r_associated #0: 25 / 0.111 -> en:acute lymphoblastic leukemia
    n1=en:Hodgkin lymphoma | n2=en:acute lymphoblastic leukemia | rel=r_associated | relid=0 | w=25
  966. en:Hodgkin lymphoma -- r_associated #0: 25 / 0.111 -> en:acute monocytic leukemia
    n1=en:Hodgkin lymphoma | n2=en:acute monocytic leukemia | rel=r_associated | relid=0 | w=25
  967. en:Hodgkin lymphoma -- r_associated #0: 25 / 0.111 -> en:air sac
    n1=en:Hodgkin lymphoma | n2=en:air sac | rel=r_associated | relid=0 | w=25
  968. en:Hodgkin lymphoma -- r_associated #0: 25 / 0.111 -> en:alveolar soft part sarcoma
    n1=en:Hodgkin lymphoma | n2=en:alveolar soft part sarcoma | rel=r_associated | relid=0 | w=25
  969. en:Hodgkin lymphoma -- r_associated #0: 25 / 0.111 -> en:antigen presenting cell
    n1=en:Hodgkin lymphoma | n2=en:antigen presenting cell | rel=r_associated | relid=0 | w=25
  970. en:Hodgkin lymphoma -- r_associated #0: 25 / 0.111 -> en:argentaffin cell
    n1=en:Hodgkin lymphoma | n2=en:argentaffin cell | rel=r_associated | relid=0 | w=25
  971. en:Hodgkin lymphoma -- r_associated #0: 25 / 0.111 -> en:askin tumor
    n1=en:Hodgkin lymphoma | n2=en:askin tumor | rel=r_associated | relid=0 | w=25
  972. en:Hodgkin lymphoma -- r_associated #0: 25 / 0.111 -> en:aspects of radionuclide imaging
    n1=en:Hodgkin lymphoma | n2=en:aspects of radionuclide imaging | rel=r_associated | relid=0 | w=25
  973. en:Hodgkin lymphoma -- r_associated #0: 25 / 0.111 -> en:benign neoplasm of male genital organ
    n1=en:Hodgkin lymphoma | n2=en:benign neoplasm of male genital organ | rel=r_associated | relid=0 | w=25
  974. en:Hodgkin lymphoma -- r_associated #0: 25 / 0.111 -> en:body system/site cancer
    n1=en:Hodgkin lymphoma | n2=en:body system/site cancer | rel=r_associated | relid=0 | w=25
  975. en:Hodgkin lymphoma -- r_associated #0: 25 / 0.111 -> en:boil/abscess nose
    n1=en:Hodgkin lymphoma | n2=en:boil/abscess nose | rel=r_associated | relid=0 | w=25
  976. en:Hodgkin lymphoma -- r_associated #0: 25 / 0.111 -> en:burkitt lymphoma (b-cell lymphoma)
    n1=en:Hodgkin lymphoma | n2=en:burkitt lymphoma (b-cell lymphoma) | rel=r_associated | relid=0 | w=25
  977. en:Hodgkin lymphoma -- r_associated #0: 25 / 0.111 -> en:cancer-related condition
    n1=en:Hodgkin lymphoma | n2=en:cancer-related condition | rel=r_associated | relid=0 | w=25
  978. en:Hodgkin lymphoma -- r_associated #0: 25 / 0.111 -> en:cholecystitis with cholelithiasis
    n1=en:Hodgkin lymphoma | n2=en:cholecystitis with cholelithiasis | rel=r_associated | relid=0 | w=25
  979. en:Hodgkin lymphoma -- r_associated #0: 25 / 0.111 -> en:chondroblastic osteosarcoma
    n1=en:Hodgkin lymphoma | n2=en:chondroblastic osteosarcoma | rel=r_associated | relid=0 | w=25
  980. en:Hodgkin lymphoma -- r_associated #0: 25 / 0.111 -> en:chronic myelogenous leukemia, bcr-abl1 positive
    n1=en:Hodgkin lymphoma | n2=en:chronic myelogenous leukemia, bcr-abl1 positive | rel=r_associated | relid=0 | w=25
  981. en:Hodgkin lymphoma -- r_associated #0: 25 / 0.111 -> en:clear cell sarcoma of soft tissue
    n1=en:Hodgkin lymphoma | n2=en:clear cell sarcoma of soft tissue | rel=r_associated | relid=0 | w=25
  982. en:Hodgkin lymphoma -- r_associated #0: 25 / 0.111 -> en:colon polyp
    n1=en:Hodgkin lymphoma | n2=en:colon polyp | rel=r_associated | relid=0 | w=25
  983. en:Hodgkin lymphoma -- r_associated #0: 25 / 0.111 -> en:congenital ear anomaly nos (disorder)
    n1=en:Hodgkin lymphoma | n2=en:congenital ear anomaly nos (disorder) | rel=r_associated | relid=0 | w=25
  984. en:Hodgkin lymphoma -- r_associated #0: 25 / 0.111 -> en:connective and soft tissue injury
    n1=en:Hodgkin lymphoma | n2=en:connective and soft tissue injury | rel=r_associated | relid=0 | w=25
  985. en:Hodgkin lymphoma -- r_associated #0: 25 / 0.111 -> en:cutaneous lymphoma
    n1=en:Hodgkin lymphoma | n2=en:cutaneous lymphoma | rel=r_associated | relid=0 | w=25
  986. en:Hodgkin lymphoma -- r_associated #0: 25 / 0.111 -> en:dedifferentiated chondrosarcoma
    n1=en:Hodgkin lymphoma | n2=en:dedifferentiated chondrosarcoma | rel=r_associated | relid=0 | w=25
  987. en:Hodgkin lymphoma -- r_associated #0: 25 / 0.111 -> en:dementia senile/alzheimer
    n1=en:Hodgkin lymphoma | n2=en:dementia senile/alzheimer | rel=r_associated | relid=0 | w=25
  988. en:Hodgkin lymphoma -- r_associated #0: 25 / 0.111 -> en:dendritic cell system structure
    n1=en:Hodgkin lymphoma | n2=en:dendritic cell system structure | rel=r_associated | relid=0 | w=25
  989. en:Hodgkin lymphoma -- r_associated #0: 25 / 0.111 -> en:digestive system neoplasm
    n1=en:Hodgkin lymphoma | n2=en:digestive system neoplasm | rel=r_associated | relid=0 | w=25
  990. en:Hodgkin lymphoma -- r_associated #0: 25 / 0.111 -> en:digital papillary eccrine carcinoma
    n1=en:Hodgkin lymphoma | n2=en:digital papillary eccrine carcinoma | rel=r_associated | relid=0 | w=25
  991. en:Hodgkin lymphoma -- r_associated #0: 25 / 0.111 -> en:dysgerminoma
    n1=en:Hodgkin lymphoma | n2=en:dysgerminoma | rel=r_associated | relid=0 | w=25
  992. en:Hodgkin lymphoma -- r_associated #0: 25 / 0.111 -> en:early-onset hepatocellular carcinoma
    n1=en:Hodgkin lymphoma | n2=en:early-onset hepatocellular carcinoma | rel=r_associated | relid=0 | w=25
  993. en:Hodgkin lymphoma -- r_associated #0: 25 / 0.111 -> en:eccrine adenocarcinoma
    n1=en:Hodgkin lymphoma | n2=en:eccrine adenocarcinoma | rel=r_associated | relid=0 | w=25
  994. en:Hodgkin lymphoma -- r_associated #0: 25 / 0.111 -> en:endometrial stromal sarcoma - category
    n1=en:Hodgkin lymphoma | n2=en:endometrial stromal sarcoma - category | rel=r_associated | relid=0 | w=25
  995. en:Hodgkin lymphoma -- r_associated #0: 25 / 0.111 -> en:epidemiologic
    n1=en:Hodgkin lymphoma | n2=en:epidemiologic | rel=r_associated | relid=0 | w=25
  996. en:Hodgkin lymphoma -- r_associated #0: 25 / 0.111 -> en:epithelial neoplasm
    n1=en:Hodgkin lymphoma | n2=en:epithelial neoplasm | rel=r_associated | relid=0 | w=25
  997. en:Hodgkin lymphoma -- r_associated #0: 25 / 0.111 -> en:female genital injuries
    n1=en:Hodgkin lymphoma | n2=en:female genital injuries | rel=r_associated | relid=0 | w=25
  998. en:Hodgkin lymphoma -- r_associated #0: 25 / 0.111 -> en:femur fracture
    n1=en:Hodgkin lymphoma | n2=en:femur fracture | rel=r_associated | relid=0 | w=25
  999. en:Hodgkin lymphoma -- r_associated #0: 25 / 0.111 -> en:follicular dendritic cell sarcoma
    n1=en:Hodgkin lymphoma | n2=en:follicular dendritic cell sarcoma | rel=r_associated | relid=0 | w=25
  1000. en:Hodgkin lymphoma -- r_associated #0: 25 / 0.111 -> en:gene mutation-related cancer
    n1=en:Hodgkin lymphoma | n2=en:gene mutation-related cancer | rel=r_associated | relid=0 | w=25
  1001. en:Hodgkin lymphoma -- r_associated #0: 25 / 0.111 -> en:gestational trophoblastic tumor
    n1=en:Hodgkin lymphoma | n2=en:gestational trophoblastic tumor | rel=r_associated | relid=0 | w=25
  1002. en:Hodgkin lymphoma -- r_associated #0: 25 / 0.111 -> en:hiv/aids and pregnancy
    n1=en:Hodgkin lymphoma | n2=en:hiv/aids and pregnancy | rel=r_associated | relid=0 | w=25
  1003. en:Hodgkin lymphoma -- r_associated #0: 25 / 0.111 -> en:hodgkin lymphoma, unspecified, lymph nodes of multiple sites
    n1=en:Hodgkin lymphoma | n2=en:hodgkin lymphoma, unspecified, lymph nodes of multiple sites | rel=r_associated | relid=0 | w=25
  1004. en:Hodgkin lymphoma -- r_associated #0: 25 / 0.111 -> en:hodgkin's disease lymphocyte depletion stage i site unspecified
    n1=en:Hodgkin lymphoma | n2=en:hodgkin's disease lymphocyte depletion stage i site unspecified | rel=r_associated | relid=0 | w=25
  1005. en:Hodgkin lymphoma -- r_associated #0: 25 / 0.111 -> en:hodgkin's disease lymphocyte depletion stage i subdiaphragm
    n1=en:Hodgkin lymphoma | n2=en:hodgkin's disease lymphocyte depletion stage i subdiaphragm | rel=r_associated | relid=0 | w=25
  1006. en:Hodgkin lymphoma -- r_associated #0: 25 / 0.111 -> en:hodgkin's disease, lymphocytic depletion of lymph nodes of head, face and neck
    n1=en:Hodgkin lymphoma | n2=en:hodgkin's disease, lymphocytic depletion of lymph nodes of head, face and neck | rel=r_associated | relid=0 | w=25
  1007. en:Hodgkin lymphoma -- r_associated #0: 25 / 0.111 -> en:hodgkin's disease, nodular sclerosis of intra-abdominal lymph nodes
    n1=en:Hodgkin lymphoma | n2=en:hodgkin's disease, nodular sclerosis of intra-abdominal lymph nodes | rel=r_associated | relid=0 | w=25
  1008. en:Hodgkin lymphoma -- r_associated #0: 25 / 0.111 -> en:immunological synapses
    n1=en:Hodgkin lymphoma | n2=en:immunological synapses | rel=r_associated | relid=0 | w=25
  1009. en:Hodgkin lymphoma -- r_associated #0: 25 / 0.111 -> en:increased malignancy risk, especially lymphoma and skin neoplasm
    n1=en:Hodgkin lymphoma | n2=en:increased malignancy risk, especially lymphoma and skin neoplasm | rel=r_associated | relid=0 | w=25
  1010. en:Hodgkin lymphoma -- r_associated #0: 25 / 0.111 -> en:increased susceptibility to b-cell lymphoma
    n1=en:Hodgkin lymphoma | n2=en:increased susceptibility to b-cell lymphoma | rel=r_associated | relid=0 | w=25
  1011. en:Hodgkin lymphoma -- r_associated #0: 25 / 0.111 -> en:infections of musculoskeletal system
    n1=en:Hodgkin lymphoma | n2=en:infections of musculoskeletal system | rel=r_associated | relid=0 | w=25
  1012. en:Hodgkin lymphoma -- r_associated #0: 25 / 0.111 -> en:islet cell tumor
    n1=en:Hodgkin lymphoma | n2=en:islet cell tumor | rel=r_associated | relid=0 | w=25
  1013. en:Hodgkin lymphoma -- r_associated #0: 25 / 0.111 -> en:langerhans cell sarcoma
    n1=en:Hodgkin lymphoma | n2=en:langerhans cell sarcoma | rel=r_associated | relid=0 | w=25
  1014. en:Hodgkin lymphoma -- r_associated #0: 25 / 0.111 -> en:large cell carcinoma
    n1=en:Hodgkin lymphoma | n2=en:large cell carcinoma | rel=r_associated | relid=0 | w=25
  1015. en:Hodgkin lymphoma -- r_associated #0: 25 / 0.111 -> en:late effect of trauma
    n1=en:Hodgkin lymphoma | n2=en:late effect of trauma | rel=r_associated | relid=0 | w=25
  1016. en:Hodgkin lymphoma -- r_associated #0: 25 / 0.111 -> en:liposarcoma of connective tissue
    n1=en:Hodgkin lymphoma | n2=en:liposarcoma of connective tissue | rel=r_associated | relid=0 | w=25
  1017. en:Hodgkin lymphoma -- r_associated #0: 25 / 0.111 -> en:liver neoplasms
    n1=en:Hodgkin lymphoma | n2=en:liver neoplasms | rel=r_associated | relid=0 | w=25
  1018. en:Hodgkin lymphoma -- r_associated #0: 25 / 0.111 -> en:low grade central osteosarcoma
    n1=en:Hodgkin lymphoma | n2=en:low grade central osteosarcoma | rel=r_associated | relid=0 | w=25
  1019. en:Hodgkin lymphoma -- r_associated #0: 25 / 0.111 -> en:low grade serous carcinoma
    n1=en:Hodgkin lymphoma | n2=en:low grade serous carcinoma | rel=r_associated | relid=0 | w=25
  1020. en:Hodgkin lymphoma -- r_associated #0: 25 / 0.111 -> en:lymphocyte depleted classical hodgkin lymphoma, intra-abdominal lymph nodes
    n1=en:Hodgkin lymphoma | n2=en:lymphocyte depleted classical hodgkin lymphoma, intra-abdominal lymph nodes | rel=r_associated | relid=0 | w=25
  1021. en:Hodgkin lymphoma -- r_associated #0: 25 / 0.111 -> en:lymphocyte depleted classical hodgkin lymphoma, intrapelvic lymph nodes
    n1=en:Hodgkin lymphoma | n2=en:lymphocyte depleted classical hodgkin lymphoma, intrapelvic lymph nodes | rel=r_associated | relid=0 | w=25
  1022. en:Hodgkin lymphoma -- r_associated #0: 25 / 0.111 -> en:lymphoid system structure
    n1=en:Hodgkin lymphoma | n2=en:lymphoid system structure | rel=r_associated | relid=0 | w=25
  1023. en:Hodgkin lymphoma -- r_associated #0: 25 / 0.111 -> en:lymphoma by stage
    n1=en:Hodgkin lymphoma | n2=en:lymphoma by stage | rel=r_associated | relid=0 | w=25
  1024. en:Hodgkin lymphoma -- r_associated #0: 25 / 0.111 -> en:lymphomas nec
    n1=en:Hodgkin lymphoma | n2=en:lymphomas nec | rel=r_associated | relid=0 | w=25
  1025. en:Hodgkin lymphoma -- r_associated #0: 25 / 0.111 -> en:male breast carcinoma
    n1=en:Hodgkin lymphoma | n2=en:male breast carcinoma | rel=r_associated | relid=0 | w=25
  1026. en:Hodgkin lymphoma -- r_associated #0: 25 / 0.111 -> en:malignant carotid body paraganglioma
    n1=en:Hodgkin lymphoma | n2=en:malignant carotid body paraganglioma | rel=r_associated | relid=0 | w=25
  1027. en:Hodgkin lymphoma -- r_associated #0: 25 / 0.111 -> en:malignant epithelial neoplasms (all subtypes)
    n1=en:Hodgkin lymphoma | n2=en:malignant epithelial neoplasms (all subtypes) | rel=r_associated | relid=0 | w=25
  1028. en:Hodgkin lymphoma -- r_associated #0: 25 / 0.111 -> en:malignant kidney neoplasm
    n1=en:Hodgkin lymphoma | n2=en:malignant kidney neoplasm | rel=r_associated | relid=0 | w=25
  1029. en:Hodgkin lymphoma -- r_associated #0: 25 / 0.111 -> en:malignant lymphoma of thyroid gland
    n1=en:Hodgkin lymphoma | n2=en:malignant lymphoma of thyroid gland | rel=r_associated | relid=0 | w=25
  1030. en:Hodgkin lymphoma -- r_associated #0: 25 / 0.111 -> en:malignant lymphomas, nos or diffuse
    n1=en:Hodgkin lymphoma | n2=en:malignant lymphomas, nos or diffuse | rel=r_associated | relid=0 | w=25
  1031. en:Hodgkin lymphoma -- r_associated #0: 25 / 0.111 -> en:malignant neoplasm of anorectum
    n1=en:Hodgkin lymphoma | n2=en:malignant neoplasm of anorectum | rel=r_associated | relid=0 | w=25
  1032. en:Hodgkin lymphoma -- r_associated #0: 25 / 0.111 -> en:malignant neoplasm of connective tissue
    n1=en:Hodgkin lymphoma | n2=en:malignant neoplasm of connective tissue | rel=r_associated | relid=0 | w=25
  1033. en:Hodgkin lymphoma -- r_associated #0: 25 / 0.111 -> en:malignant neoplasm of multiple primary sites
    n1=en:Hodgkin lymphoma | n2=en:malignant neoplasm of multiple primary sites | rel=r_associated | relid=0 | w=25
  1034. en:Hodgkin lymphoma -- r_associated #0: 25 / 0.111 -> en:malignant neoplasm of thoracic vertebral column
    n1=en:Hodgkin lymphoma | n2=en:malignant neoplasm of thoracic vertebral column | rel=r_associated | relid=0 | w=25
  1035. en:Hodgkin lymphoma -- r_associated #0: 25 / 0.111 -> en:malignant neoplasm other/unspecified
    n1=en:Hodgkin lymphoma | n2=en:malignant neoplasm other/unspecified | rel=r_associated | relid=0 | w=25
  1036. en:Hodgkin lymphoma -- r_associated #0: 25 / 0.111 -> en:malignant neoplasms of respiratory and intrathoracic organs
    n1=en:Hodgkin lymphoma | n2=en:malignant neoplasms of respiratory and intrathoracic organs | rel=r_associated | relid=0 | w=25
  1037. en:Hodgkin lymphoma -- r_associated #0: 25 / 0.111 -> en:malignant odontogenic neoplasm
    n1=en:Hodgkin lymphoma | n2=en:malignant odontogenic neoplasm | rel=r_associated | relid=0 | w=25
  1038. en:Hodgkin lymphoma -- r_associated #0: 25 / 0.111 -> en:malignant spindle cell neoplasm
    n1=en:Hodgkin lymphoma | n2=en:malignant spindle cell neoplasm | rel=r_associated | relid=0 | w=25
  1039. en:Hodgkin lymphoma -- r_associated #0: 25 / 0.111 -> en:malignant tumor involving an organ by direct extension from uterine cervix
    n1=en:Hodgkin lymphoma | n2=en:malignant tumor involving an organ by direct extension from uterine cervix | rel=r_associated | relid=0 | w=25
  1040. en:Hodgkin lymphoma -- r_associated #0: 25 / 0.111 -> en:malignant tumor involving an organ by direct extension from vagina
    n1=en:Hodgkin lymphoma | n2=en:malignant tumor involving an organ by direct extension from vagina | rel=r_associated | relid=0 | w=25
  1041. en:Hodgkin lymphoma -- r_associated #0: 25 / 0.111 -> en:malignant tumor, clear cell type
    n1=en:Hodgkin lymphoma | n2=en:malignant tumor, clear cell type | rel=r_associated | relid=0 | w=25
  1042. en:Hodgkin lymphoma -- r_associated #0: 25 / 0.111 -> en:malignant tumor, small cell type
    n1=en:Hodgkin lymphoma | n2=en:malignant tumor, small cell type | rel=r_associated | relid=0 | w=25
  1043. en:Hodgkin lymphoma -- r_associated #0: 25 / 0.111 -> en:mast cell malignancy
    n1=en:Hodgkin lymphoma | n2=en:mast cell malignancy | rel=r_associated | relid=0 | w=25
  1044. en:Hodgkin lymphoma -- r_associated #0: 25 / 0.111 -> en:medulloepithelioma
    n1=en:Hodgkin lymphoma | n2=en:medulloepithelioma | rel=r_associated | relid=0 | w=25
  1045. en:Hodgkin lymphoma -- r_associated #0: 25 / 0.111 -> en:metachronous malignant neoplasm
    n1=en:Hodgkin lymphoma | n2=en:metachronous malignant neoplasm | rel=r_associated | relid=0 | w=25
  1046. en:Hodgkin lymphoma -- r_associated #0: 25 / 0.111 -> en:metastasis to lymph node from adenocarcinoma
    n1=en:Hodgkin lymphoma | n2=en:metastasis to lymph node from adenocarcinoma | rel=r_associated | relid=0 | w=25
  1047. en:Hodgkin lymphoma -- r_associated #0: 25 / 0.111 -> en:metastatic lymphoma in the heart
    n1=en:Hodgkin lymphoma | n2=en:metastatic lymphoma in the heart | rel=r_associated | relid=0 | w=25
  1048. en:Hodgkin lymphoma -- r_associated #0: 25 / 0.111 -> en:mixed acinar-ductal carcinoma
    n1=en:Hodgkin lymphoma | n2=en:mixed acinar-ductal carcinoma | rel=r_associated | relid=0 | w=25
  1049. en:Hodgkin lymphoma -- r_associated #0: 25 / 0.111 -> en:mixed type rhabdomyosarcoma
    n1=en:Hodgkin lymphoma | n2=en:mixed type rhabdomyosarcoma | rel=r_associated | relid=0 | w=25
  1050. en:Hodgkin lymphoma -- r_associated #0: 25 / 0.111 -> en:multiple tumors
    n1=en:Hodgkin lymphoma | n2=en:multiple tumors | rel=r_associated | relid=0 | w=25
  1051. en:Hodgkin lymphoma -- r_associated #0: 25 / 0.111 -> en:myelodysplastic syndrome
    n1=en:Hodgkin lymphoma | n2=en:myelodysplastic syndrome | rel=r_associated | relid=0 | w=25
  1052. en:Hodgkin lymphoma -- r_associated #0: 25 / 0.111 -> en:myelodysplastic syndrome with isolated del(5q)
    n1=en:Hodgkin lymphoma | n2=en:myelodysplastic syndrome with isolated del(5q) | rel=r_associated | relid=0 | w=25
  1053. en:Hodgkin lymphoma -- r_associated #0: 25 / 0.111 -> en:myeloid leukemia
    n1=en:Hodgkin lymphoma | n2=en:myeloid leukemia | rel=r_associated | relid=0 | w=25
  1054. en:Hodgkin lymphoma -- r_associated #0: 25 / 0.111 -> en:myxosarcoma
    n1=en:Hodgkin lymphoma | n2=en:myxosarcoma | rel=r_associated | relid=0 | w=25
  1055. en:Hodgkin lymphoma -- r_associated #0: 25 / 0.111 -> en:neoplasm
    n1=en:Hodgkin lymphoma | n2=en:neoplasm | rel=r_associated | relid=0 | w=25
  1056. en:Hodgkin lymphoma -- r_associated #0: 25 / 0.111 -> en:neoplasm of unspecified nature of other genitourinary organs
    n1=en:Hodgkin lymphoma | n2=en:neoplasm of unspecified nature of other genitourinary organs | rel=r_associated | relid=0 | w=25
  1057. en:Hodgkin lymphoma -- r_associated #0: 25 / 0.111 -> en:neoplastic hematopoietic and lymphoid cell
    n1=en:Hodgkin lymphoma | n2=en:neoplastic hematopoietic and lymphoid cell | rel=r_associated | relid=0 | w=25
  1058. en:Hodgkin lymphoma -- r_associated #0: 25 / 0.111 -> en:neurofibroma
    n1=en:Hodgkin lymphoma | n2=en:neurofibroma | rel=r_associated | relid=0 | w=25
  1059. en:Hodgkin lymphoma -- r_associated #0: 25 / 0.111 -> en:nodular sclerosis classical hodgkin lymphoma
    n1=en:Hodgkin lymphoma | n2=en:nodular sclerosis classical hodgkin lymphoma | rel=r_associated | relid=0 | w=25
  1060. en:Hodgkin lymphoma -- r_associated #0: 25 / 0.111 -> en:nodular sclerosis classical hodgkin lymphoma, lymph nodes of head, face, and neck
    n1=en:Hodgkin lymphoma | n2=en:nodular sclerosis classical hodgkin lymphoma, lymph nodes of head, face, and neck | rel=r_associated | relid=0 | w=25
  1061. en:Hodgkin lymphoma -- r_associated #0: 25 / 0.111 -> en:nodular sclerosis classical hodgkin lymphoma, lymph nodes of multiple sites
    n1=en:Hodgkin lymphoma | n2=en:nodular sclerosis classical hodgkin lymphoma, lymph nodes of multiple sites | rel=r_associated | relid=0 | w=25
  1062. en:Hodgkin lymphoma -- r_associated #0: 25 / 0.111 -> en:non-gonococcal urethritis
    n1=en:Hodgkin lymphoma | n2=en:non-gonococcal urethritis | rel=r_associated | relid=0 | w=25
  1063. en:Hodgkin lymphoma -- r_associated #0: 25 / 0.111 -> en:non-keratinizing sinonasal squamous cell carcinoma
    n1=en:Hodgkin lymphoma | n2=en:non-keratinizing sinonasal squamous cell carcinoma | rel=r_associated | relid=0 | w=25
  1064. en:Hodgkin lymphoma -- r_associated #0: 25 / 0.111 -> en:non-small cell carcinoma
    n1=en:Hodgkin lymphoma | n2=en:non-small cell carcinoma | rel=r_associated | relid=0 | w=25
  1065. en:Hodgkin lymphoma -- r_associated #0: 25 / 0.111 -> en:normal delivery liveborn
    n1=en:Hodgkin lymphoma | n2=en:normal delivery liveborn | rel=r_associated | relid=0 | w=25
  1066. en:Hodgkin lymphoma -- r_associated #0: 25 / 0.111 -> en:osteoarthritis, knee
    n1=en:Hodgkin lymphoma | n2=en:osteoarthritis, knee | rel=r_associated | relid=0 | w=25
  1067. en:Hodgkin lymphoma -- r_associated #0: 25 / 0.111 -> en:other benign neoplasm female genital
    n1=en:Hodgkin lymphoma | n2=en:other benign neoplasm female genital | rel=r_associated | relid=0 | w=25
  1068. en:Hodgkin lymphoma -- r_associated #0: 25 / 0.111 -> en:other classical hodgkin lymphoma, intra-abdominal lymph nodes
    n1=en:Hodgkin lymphoma | n2=en:other classical hodgkin lymphoma, intra-abdominal lymph nodes | rel=r_associated | relid=0 | w=25
  1069. en:Hodgkin lymphoma -- r_associated #0: 25 / 0.111 -> en:other digestive system injuries
    n1=en:Hodgkin lymphoma | n2=en:other digestive system injuries | rel=r_associated | relid=0 | w=25
  1070. en:Hodgkin lymphoma -- r_associated #0: 25 / 0.111 -> en:other disorders of the skin and subcutaneous tissue
    n1=en:Hodgkin lymphoma | n2=en:other disorders of the skin and subcutaneous tissue | rel=r_associated | relid=0 | w=25
  1071. en:Hodgkin lymphoma -- r_associated #0: 25 / 0.111 -> en:other hematologic disorders
    n1=en:Hodgkin lymphoma | n2=en:other hematologic disorders | rel=r_associated | relid=0 | w=25
  1072. en:Hodgkin lymphoma -- r_associated #0: 25 / 0.111 -> en:other hematologic injuries
    n1=en:Hodgkin lymphoma | n2=en:other hematologic injuries | rel=r_associated | relid=0 | w=25
  1073. en:Hodgkin lymphoma -- r_associated #0: 25 / 0.111 -> en:other leukaemias of specified cell type
    n1=en:Hodgkin lymphoma | n2=en:other leukaemias of specified cell type | rel=r_associated | relid=0 | w=25
  1074. en:Hodgkin lymphoma -- r_associated #0: 25 / 0.111 -> en:other male genital malignant neoplasm
    n1=en:Hodgkin lymphoma | n2=en:other male genital malignant neoplasm | rel=r_associated | relid=0 | w=25
  1075. en:Hodgkin lymphoma -- r_associated #0: 25 / 0.111 -> en:other malignant lymphomas, lymph nodes of multiple sites
    n1=en:Hodgkin lymphoma | n2=en:other malignant lymphomas, lymph nodes of multiple sites | rel=r_associated | relid=0 | w=25
  1076. en:Hodgkin lymphoma -- r_associated #0: 25 / 0.111 -> en:other neurotic disorders
    n1=en:Hodgkin lymphoma | n2=en:other neurotic disorders | rel=r_associated | relid=0 | w=25
  1077. en:Hodgkin lymphoma -- r_associated #0: 25 / 0.111 -> en:other ocular injuries
    n1=en:Hodgkin lymphoma | n2=en:other ocular injuries | rel=r_associated | relid=0 | w=25
  1078. en:Hodgkin lymphoma -- r_associated #0: 25 / 0.111 -> en:other organic psychosis
    n1=en:Hodgkin lymphoma | n2=en:other organic psychosis | rel=r_associated | relid=0 | w=25
  1079. en:Hodgkin lymphoma -- r_associated #0: 25 / 0.111 -> en:paget disease and intraductal carcinoma of the breast
    n1=en:Hodgkin lymphoma | n2=en:paget disease and intraductal carcinoma of the breast | rel=r_associated | relid=0 | w=25
  1080. en:Hodgkin lymphoma -- r_associated #0: 25 / 0.111 -> en:papillary neoplasm
    n1=en:Hodgkin lymphoma | n2=en:papillary neoplasm | rel=r_associated | relid=0 | w=25
  1081. en:Hodgkin lymphoma -- r_associated #0: 25 / 0.111 -> en:paraganglioma, catecholamine-secreting
    n1=en:Hodgkin lymphoma | n2=en:paraganglioma, catecholamine-secreting | rel=r_associated | relid=0 | w=25
  1082. en:Hodgkin lymphoma -- r_associated #0: 25 / 0.111 -> en:periampullary carcinoma nos
    n1=en:Hodgkin lymphoma | n2=en:periampullary carcinoma nos | rel=r_associated | relid=0 | w=25
  1083. en:Hodgkin lymphoma -- r_associated #0: 25 / 0.111 -> en:pheochromocytoma, adrenal (53%)
    n1=en:Hodgkin lymphoma | n2=en:pheochromocytoma, adrenal (53%) | rel=r_associated | relid=0 | w=25
  1084. en:Hodgkin lymphoma -- r_associated #0: 25 / 0.111 -> en:physiopathological
    n1=en:Hodgkin lymphoma | n2=en:physiopathological | rel=r_associated | relid=0 | w=25
  1085. en:Hodgkin lymphoma -- r_associated #0: 25 / 0.111 -> en:pigmentation
    n1=en:Hodgkin lymphoma | n2=en:pigmentation | rel=r_associated | relid=0 | w=25
  1086. en:Hodgkin lymphoma -- r_associated #0: 25 / 0.111 -> en:pituitary gland neoplasm
    n1=en:Hodgkin lymphoma | n2=en:pituitary gland neoplasm | rel=r_associated | relid=0 | w=25
  1087. en:Hodgkin lymphoma -- r_associated #0: 25 / 0.111 -> en:premenstrual tension
    n1=en:Hodgkin lymphoma | n2=en:premenstrual tension | rel=r_associated | relid=0 | w=25
  1088. en:Hodgkin lymphoma -- r_associated #0: 25 / 0.111 -> en:primary malignant neoplasm
    n1=en:Hodgkin lymphoma | n2=en:primary malignant neoplasm | rel=r_associated | relid=0 | w=25
  1089. en:Hodgkin lymphoma -- r_associated #0: 25 / 0.111 -> en:primary malignant neoplasm of gastrointestinal tract
    n1=en:Hodgkin lymphoma | n2=en:primary malignant neoplasm of gastrointestinal tract | rel=r_associated | relid=0 | w=25
  1090. en:Hodgkin lymphoma -- r_associated #0: 25 / 0.111 -> en:primary malignant neoplasm of paraganglion
    n1=en:Hodgkin lymphoma | n2=en:primary malignant neoplasm of paraganglion | rel=r_associated | relid=0 | w=25
  1091. en:Hodgkin lymphoma -- r_associated #0: 25 / 0.111 -> en:primary malignant neoplasm of sweat gland
    n1=en:Hodgkin lymphoma | n2=en:primary malignant neoplasm of sweat gland | rel=r_associated | relid=0 | w=25
  1092. en:Hodgkin lymphoma -- r_associated #0: 25 / 0.111 -> en:purpura/coagulation defects/abnormal platelets
    n1=en:Hodgkin lymphoma | n2=en:purpura/coagulation defects/abnormal platelets | rel=r_associated | relid=0 | w=25
  1093. en:Hodgkin lymphoma -- r_associated #0: 25 / 0.111 -> en:recurrent hodgkin lymphoma
    n1=en:Hodgkin lymphoma | n2=en:recurrent hodgkin lymphoma | rel=r_associated | relid=0 | w=25
  1094. en:Hodgkin lymphoma -- r_associated #0: 25 / 0.111 -> en:renal and urinary tract neoplasms malignant and unspecified
    n1=en:Hodgkin lymphoma | n2=en:renal and urinary tract neoplasms malignant and unspecified | rel=r_associated | relid=0 | w=25
  1095. en:Hodgkin lymphoma -- r_associated #0: 25 / 0.111 -> en:rheumatic heart disease
    n1=en:Hodgkin lymphoma | n2=en:rheumatic heart disease | rel=r_associated | relid=0 | w=25
  1096. en:Hodgkin lymphoma -- r_associated #0: 25 / 0.111 -> en:rhinitis seasonal
    n1=en:Hodgkin lymphoma | n2=en:rhinitis seasonal | rel=r_associated | relid=0 | w=25
  1097. en:Hodgkin lymphoma -- r_associated #0: 25 / 0.111 -> en:roentgenographic
    n1=en:Hodgkin lymphoma | n2=en:roentgenographic | rel=r_associated | relid=0 | w=25
  1098. en:Hodgkin lymphoma -- r_associated #0: 25 / 0.111 -> en:sertoli cell tumor
    n1=en:Hodgkin lymphoma | n2=en:sertoli cell tumor | rel=r_associated | relid=0 | w=25
  1099. en:Hodgkin lymphoma -- r_associated #0: 25 / 0.111 -> en:skin cancer susceptibility
    n1=en:Hodgkin lymphoma | n2=en:skin cancer susceptibility | rel=r_associated | relid=0 | w=25
  1100. en:Hodgkin lymphoma -- r_associated #0: 25 / 0.111 -> en:skin carcinoma
    n1=en:Hodgkin lymphoma | n2=en:skin carcinoma | rel=r_associated | relid=0 | w=25
  1101. en:Hodgkin lymphoma -- r_associated #0: 25 / 0.111 -> en:small intestinal carcinoma
    n1=en:Hodgkin lymphoma | n2=en:small intestinal carcinoma | rel=r_associated | relid=0 | w=25
  1102. en:Hodgkin lymphoma -- r_associated #0: 25 / 0.111 -> en:soft tissue neoplasms malignant and unspecified
    n1=en:Hodgkin lymphoma | n2=en:soft tissue neoplasms malignant and unspecified | rel=r_associated | relid=0 | w=25
  1103. en:Hodgkin lymphoma -- r_associated #0: 25 / 0.111 -> en:splenic rupture
    n1=en:Hodgkin lymphoma | n2=en:splenic rupture | rel=r_associated | relid=0 | w=25
  1104. en:Hodgkin lymphoma -- r_associated #0: 25 / 0.111 -> en:stage i subdiaphragmatic hodgkin lymphoma
    n1=en:Hodgkin lymphoma | n2=en:stage i subdiaphragmatic hodgkin lymphoma | rel=r_associated | relid=0 | w=25
  1105. en:Hodgkin lymphoma -- r_associated #0: 25 / 0.111 -> en:superficial spreading melanoma
    n1=en:Hodgkin lymphoma | n2=en:superficial spreading melanoma | rel=r_associated | relid=0 | w=25
  1106. en:Hodgkin lymphoma -- r_associated #0: 25 / 0.111 -> en:tachycardia, paroxysmal
    n1=en:Hodgkin lymphoma | n2=en:tachycardia, paroxysmal | rel=r_associated | relid=0 | w=25
  1107. en:Hodgkin lymphoma -- r_associated #0: 25 / 0.111 -> en:thyroid gland spindle cell tumor with thymus-like differentiation
    n1=en:Hodgkin lymphoma | n2=en:thyroid gland spindle cell tumor with thymus-like differentiation | rel=r_associated | relid=0 | w=25
  1108. en:Hodgkin lymphoma -- r_associated #0: 25 / 0.111 -> en:trichilemmocarcinoma
    n1=en:Hodgkin lymphoma | n2=en:trichilemmocarcinoma | rel=r_associated | relid=0 | w=25
  1109. en:Hodgkin lymphoma -- r_associated #0: 25 / 0.111 -> en:type 1a autoimmune lymphoproliferative syndrome
    n1=en:Hodgkin lymphoma | n2=en:type 1a autoimmune lymphoproliferative syndrome | rel=r_associated | relid=0 | w=25
  1110. en:Hodgkin lymphoma -- r_associated #0: 25 / 0.111 -> en:undifferentiated pleomorphic sarcoma
    n1=en:Hodgkin lymphoma | n2=en:undifferentiated pleomorphic sarcoma | rel=r_associated | relid=0 | w=25
  1111. en:Hodgkin lymphoma -- r_associated #0: 25 / 0.111 -> en:unexplained abnormal blood test
    n1=en:Hodgkin lymphoma | n2=en:unexplained abnormal blood test | rel=r_associated | relid=0 | w=25
  1112. en:Hodgkin lymphoma -- r_associated #0: 25 / 0.111 -> en:unilateral vestibular schwannoma
    n1=en:Hodgkin lymphoma | n2=en:unilateral vestibular schwannoma | rel=r_associated | relid=0 | w=25
  1113. en:Hodgkin lymphoma -- r_associated #0: 25 / 0.111 -> en:veterinary aspects
    n1=en:Hodgkin lymphoma | n2=en:veterinary aspects | rel=r_associated | relid=0 | w=25
  1114. en:Hodgkin lymphoma -- r_associated #0: 25 / 0.111 -> en:viral infection
    n1=en:Hodgkin lymphoma | n2=en:viral infection | rel=r_associated | relid=0 | w=25
  1115. en:Hodgkin lymphoma -- r_associated #0: 25 / 0.111 -> en:viruses
    n1=en:Hodgkin lymphoma | n2=en:viruses | rel=r_associated | relid=0 | w=25
  1116. en:Hodgkin lymphoma -- r_associated #0: 25 / 0.111 -> en:yolk sac tumor
    n1=en:Hodgkin lymphoma | n2=en:yolk sac tumor | rel=r_associated | relid=0 | w=25
  1117. en:Hodgkin lymphoma -- r_associated #0: 24 / 0.106 -> en:abnormal urine test result
    n1=en:Hodgkin lymphoma | n2=en:abnormal urine test result | rel=r_associated | relid=0 | w=24
  1118. en:Hodgkin lymphoma -- r_associated #0: 24 / 0.106 -> en:acinar cell neoplasm
    n1=en:Hodgkin lymphoma | n2=en:acinar cell neoplasm | rel=r_associated | relid=0 | w=24
  1119. en:Hodgkin lymphoma -- r_associated #0: 24 / 0.106 -> en:acral lentiginous melanoma
    n1=en:Hodgkin lymphoma | n2=en:acral lentiginous melanoma | rel=r_associated | relid=0 | w=24
  1120. en:Hodgkin lymphoma -- r_associated #0: 24 / 0.106 -> en:acute leukemia
    n1=en:Hodgkin lymphoma | n2=en:acute leukemia | rel=r_associated | relid=0 | w=24
  1121. en:Hodgkin lymphoma -- r_associated #0: 24 / 0.106 -> en:acute megakaryoblastic leukemia
    n1=en:Hodgkin lymphoma | n2=en:acute megakaryoblastic leukemia | rel=r_associated | relid=0 | w=24
  1122. en:Hodgkin lymphoma -- r_associated #0: 24 / 0.106 -> en:acute nasopharyngitis
    n1=en:Hodgkin lymphoma | n2=en:acute nasopharyngitis | rel=r_associated | relid=0 | w=24
  1123. en:Hodgkin lymphoma -- r_associated #0: 24 / 0.106 -> en:acute otitis media/myringitis
    n1=en:Hodgkin lymphoma | n2=en:acute otitis media/myringitis | rel=r_associated | relid=0 | w=24
  1124. en:Hodgkin lymphoma -- r_associated #0: 24 / 0.106 -> en:adenocarcinoma in villous adenoma
    n1=en:Hodgkin lymphoma | n2=en:adenocarcinoma in villous adenoma | rel=r_associated | relid=0 | w=24
  1125. en:Hodgkin lymphoma -- r_associated #0: 24 / 0.106 -> en:adenoid cystic carcinoma
    n1=en:Hodgkin lymphoma | n2=en:adenoid cystic carcinoma | rel=r_associated | relid=0 | w=24
  1126. en:Hodgkin lymphoma -- r_associated #0: 24 / 0.106 -> en:adenoma and/or adenocarcinoma
    n1=en:Hodgkin lymphoma | n2=en:adenoma and/or adenocarcinoma | rel=r_associated | relid=0 | w=24
  1127. en:Hodgkin lymphoma -- r_associated #0: 24 / 0.106 -> en:adult hodgkin lymphoma
    n1=en:Hodgkin lymphoma | n2=en:adult hodgkin lymphoma | rel=r_associated | relid=0 | w=24
  1128. en:Hodgkin lymphoma -- r_associated #0: 24 / 0.106 -> en:adverse effect medical agent proper dose
    n1=en:Hodgkin lymphoma | n2=en:adverse effect medical agent proper dose | rel=r_associated | relid=0 | w=24
  1129. en:Hodgkin lymphoma -- r_associated #0: 24 / 0.106 -> en:all other perinatal morbidity
    n1=en:Hodgkin lymphoma | n2=en:all other perinatal morbidity | rel=r_associated | relid=0 | w=24
  1130. en:Hodgkin lymphoma -- r_associated #0: 24 / 0.106 -> en:anal fissure/perianal abscess
    n1=en:Hodgkin lymphoma | n2=en:anal fissure/perianal abscess | rel=r_associated | relid=0 | w=24
  1131. en:Hodgkin lymphoma -- r_associated #0: 24 / 0.106 -> en:benign prostatic hyperplasia
    n1=en:Hodgkin lymphoma | n2=en:benign prostatic hyperplasia | rel=r_associated | relid=0 | w=24
  1132. en:Hodgkin lymphoma -- r_associated #0: 24 / 0.106 -> en:bilateral malignant neoplasm
    n1=en:Hodgkin lymphoma | n2=en:bilateral malignant neoplasm | rel=r_associated | relid=0 | w=24
  1133. en:Hodgkin lymphoma -- r_associated #0: 24 / 0.106 -> en:blindness all degrees/types
    n1=en:Hodgkin lymphoma | n2=en:blindness all degrees/types | rel=r_associated | relid=0 | w=24
  1134. en:Hodgkin lymphoma -- r_associated #0: 24 / 0.106 -> en:breast neoplasms benign (incl nipple)
    n1=en:Hodgkin lymphoma | n2=en:breast neoplasms benign (incl nipple) | rel=r_associated | relid=0 | w=24
  1135. en:Hodgkin lymphoma -- r_associated #0: 24 / 0.106 -> en:carcinoma ex pleomorphic adenoma
    n1=en:Hodgkin lymphoma | n2=en:carcinoma ex pleomorphic adenoma | rel=r_associated | relid=0 | w=24
  1136. en:Hodgkin lymphoma -- r_associated #0: 24 / 0.106 -> en:cardiovascular neoplasm
    n1=en:Hodgkin lymphoma | n2=en:cardiovascular neoplasm | rel=r_associated | relid=0 | w=24
  1137. en:Hodgkin lymphoma -- r_associated #0: 24 / 0.106 -> en:chronic bronchitis/bronchiectasis
    n1=en:Hodgkin lymphoma | n2=en:chronic bronchitis/bronchiectasis | rel=r_associated | relid=0 | w=24
  1138. en:Hodgkin lymphoma -- r_associated #0: 24 / 0.106 -> en:chronic enteritis/ulcerative colitis
    n1=en:Hodgkin lymphoma | n2=en:chronic enteritis/ulcerative colitis | rel=r_associated | relid=0 | w=24
  1139. en:Hodgkin lymphoma -- r_associated #0: 24 / 0.106 -> en:chronic leukemia
    n1=en:Hodgkin lymphoma | n2=en:chronic leukemia | rel=r_associated | relid=0 | w=24
  1140. en:Hodgkin lymphoma -- r_associated #0: 24 / 0.106 -> en:chronic monocytic leukemia
    n1=en:Hodgkin lymphoma | n2=en:chronic monocytic leukemia | rel=r_associated | relid=0 | w=24
  1141. en:Hodgkin lymphoma -- r_associated #0: 24 / 0.106 -> en:clip1 gene
    n1=en:Hodgkin lymphoma | n2=en:clip1 gene | rel=r_associated | relid=0 | w=24
  1142. en:Hodgkin lymphoma -- r_associated #0: 24 / 0.106 -> en:colon adenocarcinoma
    n1=en:Hodgkin lymphoma | n2=en:colon adenocarcinoma | rel=r_associated | relid=0 | w=24
  1143. en:Hodgkin lymphoma -- r_associated #0: 24 / 0.106 -> en:colorectal carcinoma
    n1=en:Hodgkin lymphoma | n2=en:colorectal carcinoma | rel=r_associated | relid=0 | w=24
  1144. en:Hodgkin lymphoma -- r_associated #0: 24 / 0.106 -> en:complement
    n1=en:Hodgkin lymphoma | n2=en:complement | rel=r_associated | relid=0 | w=24
  1145. en:Hodgkin lymphoma -- r_associated #0: 24 / 0.106 -> en:complication of surgical and medical care, unspecified
    n1=en:Hodgkin lymphoma | n2=en:complication of surgical and medical care, unspecified | rel=r_associated | relid=0 | w=24
  1146. en:Hodgkin lymphoma -- r_associated #0: 24 / 0.106 -> en:composite lymphoma
    n1=en:Hodgkin lymphoma | n2=en:composite lymphoma | rel=r_associated | relid=0 | w=24
  1147. en:Hodgkin lymphoma -- r_associated #0: 24 / 0.106 -> en:congenital anomalies of mother
    n1=en:Hodgkin lymphoma | n2=en:congenital anomalies of mother | rel=r_associated | relid=0 | w=24
  1148. en:Hodgkin lymphoma -- r_associated #0: 24 / 0.106 -> en:cystic, mucinous and/or serous neoplasm
    n1=en:Hodgkin lymphoma | n2=en:cystic, mucinous and/or serous neoplasm | rel=r_associated | relid=0 | w=24
  1149. en:Hodgkin lymphoma -- r_associated #0: 24 / 0.106 -> en:dermatophytosis
    n1=en:Hodgkin lymphoma | n2=en:dermatophytosis | rel=r_associated | relid=0 | w=24
  1150. en:Hodgkin lymphoma -- r_associated #0: 24 / 0.106 -> en:diagnosis/diseases component
    n1=en:Hodgkin lymphoma | n2=en:diagnosis/diseases component | rel=r_associated | relid=0 | w=24
  1151. en:Hodgkin lymphoma -- r_associated #0: 24 / 0.106 -> en:disseminated malignant neoplasm, unspecified
    n1=en:Hodgkin lymphoma | n2=en:disseminated malignant neoplasm, unspecified | rel=r_associated | relid=0 | w=24
  1152. en:Hodgkin lymphoma -- r_associated #0: 24 / 0.106 -> en:ductal, lobular and/or medullary neoplasm
    n1=en:Hodgkin lymphoma | n2=en:ductal, lobular and/or medullary neoplasm | rel=r_associated | relid=0 | w=24
  1153. en:Hodgkin lymphoma -- r_associated #0: 24 / 0.106 -> en:encapsulated papillary carcinoma with invasion
    n1=en:Hodgkin lymphoma | n2=en:encapsulated papillary carcinoma with invasion | rel=r_associated | relid=0 | w=24
  1154. en:Hodgkin lymphoma -- r_associated #0: 24 / 0.106 -> en:endometrial carcinoma
    n1=en:Hodgkin lymphoma | n2=en:endometrial carcinoma | rel=r_associated | relid=0 | w=24
  1155. en:Hodgkin lymphoma -- r_associated #0: 24 / 0.106 -> en:ewing sarcoma
    n1=en:Hodgkin lymphoma | n2=en:ewing sarcoma | rel=r_associated | relid=0 | w=24
  1156. en:Hodgkin lymphoma -- r_associated #0: 24 / 0.106 -> en:fibroepithelial neoplasm
    n1=en:Hodgkin lymphoma | n2=en:fibroepithelial neoplasm | rel=r_associated | relid=0 | w=24
  1157. en:Hodgkin lymphoma -- r_associated #0: 24 / 0.106 -> en:foreign body nose/larynx/bronchus
    n1=en:Hodgkin lymphoma | n2=en:foreign body nose/larynx/bronchus | rel=r_associated | relid=0 | w=24
  1158. en:Hodgkin lymphoma -- r_associated #0: 24 / 0.106 -> en:fracture of radius and ulna
    n1=en:Hodgkin lymphoma | n2=en:fracture of radius and ulna | rel=r_associated | relid=0 | w=24
  1159. en:Hodgkin lymphoma -- r_associated #0: 24 / 0.106 -> en:gammopathy
    n1=en:Hodgkin lymphoma | n2=en:gammopathy | rel=r_associated | relid=0 | w=24
  1160. en:Hodgkin lymphoma -- r_associated #0: 24 / 0.106 -> en:gonorrhea male
    n1=en:Hodgkin lymphoma | n2=en:gonorrhea male | rel=r_associated | relid=0 | w=24
  1161. en:Hodgkin lymphoma -- r_associated #0: 24 / 0.106 -> en:grade 2 nodular sclerosis classical hodgkin lymphoma
    n1=en:Hodgkin lymphoma | n2=en:grade 2 nodular sclerosis classical hodgkin lymphoma | rel=r_associated | relid=0 | w=24
  1162. en:Hodgkin lymphoma -- r_associated #0: 24 / 0.106 -> en:head or neck cancer
    n1=en:Hodgkin lymphoma | n2=en:head or neck cancer | rel=r_associated | relid=0 | w=24
  1163. en:Hodgkin lymphoma -- r_associated #0: 24 / 0.106 -> en:hematopoietic and lymphoid cell neoplasm
    n1=en:Hodgkin lymphoma | n2=en:hematopoietic and lymphoid cell neoplasm | rel=r_associated | relid=0 | w=24
  1164. en:Hodgkin lymphoma -- r_associated #0: 24 / 0.106 -> en:hereditary hemolytic anemia
    n1=en:Hodgkin lymphoma | n2=en:hereditary hemolytic anemia | rel=r_associated | relid=0 | w=24
  1165. en:Hodgkin lymphoma -- r_associated #0: 24 / 0.106 -> en:herpes simplex infections
    n1=en:Hodgkin lymphoma | n2=en:herpes simplex infections | rel=r_associated | relid=0 | w=24
  1166. en:Hodgkin lymphoma -- r_associated #0: 24 / 0.106 -> en:high risk pregnancy
    n1=en:Hodgkin lymphoma | n2=en:high risk pregnancy | rel=r_associated | relid=0 | w=24
  1167. en:Hodgkin lymphoma -- r_associated #0: 24 / 0.106 -> en:histiocytic disorders, malignant
    n1=en:Hodgkin lymphoma | n2=en:histiocytic disorders, malignant | rel=r_associated | relid=0 | w=24
  1168. en:Hodgkin lymphoma -- r_associated #0: 24 / 0.106 -> en:history of hodgkin lymphoma
    n1=en:Hodgkin lymphoma | n2=en:history of hodgkin lymphoma | rel=r_associated | relid=0 | w=24
  1169. en:Hodgkin lymphoma -- r_associated #0: 24 / 0.106 -> en:hiv/aids medicines
    n1=en:Hodgkin lymphoma | n2=en:hiv/aids medicines | rel=r_associated | relid=0 | w=24
  1170. en:Hodgkin lymphoma -- r_associated #0: 24 / 0.106 -> en:hodgkin disease, y-linked pseudoautosomal
    n1=en:Hodgkin lymphoma | n2=en:hodgkin disease, y-linked pseudoautosomal | rel=r_associated | relid=0 | w=24
  1171. en:Hodgkin lymphoma -- r_associated #0: 24 / 0.106 -> en:hodgkin lymphoma during pregnancy
    n1=en:Hodgkin lymphoma | n2=en:hodgkin lymphoma during pregnancy | rel=r_associated | relid=0 | w=24
  1172. en:Hodgkin lymphoma -- r_associated #0: 24 / 0.106 -> en:hodgkin lymphoma, lymphocyte depletion, diffuse fibrosis
    n1=en:Hodgkin lymphoma | n2=en:hodgkin lymphoma, lymphocyte depletion, diffuse fibrosis | rel=r_associated | relid=0 | w=24
  1173. en:Hodgkin lymphoma -- r_associated #0: 24 / 0.106 -> en:hodgkin lymphoma, unspecified, intrathoracic lymph nodes
    n1=en:Hodgkin lymphoma | n2=en:hodgkin lymphoma, unspecified, intrathoracic lymph nodes | rel=r_associated | relid=0 | w=24
  1174. en:Hodgkin lymphoma -- r_associated #0: 24 / 0.106 -> en:hodgkin lymphoma, unspecified, spleen
    n1=en:Hodgkin lymphoma | n2=en:hodgkin lymphoma, unspecified, spleen | rel=r_associated | relid=0 | w=24
  1175. en:Hodgkin lymphoma -- r_associated #0: 24 / 0.106 -> en:hodgkin's disease lymphocyte predominance stage i supradiaphragm
    n1=en:Hodgkin lymphoma | n2=en:hodgkin's disease lymphocyte predominance stage i supradiaphragm | rel=r_associated | relid=0 | w=24
  1176. en:Hodgkin lymphoma -- r_associated #0: 24 / 0.106 -> en:hodgkin's disease nec
    n1=en:Hodgkin lymphoma | n2=en:hodgkin's disease nec | rel=r_associated | relid=0 | w=24
  1177. en:Hodgkin lymphoma -- r_associated #0: 24 / 0.106 -> en:hodgkin's disease of lymph nodes of head, face and/or neck
    n1=en:Hodgkin lymphoma | n2=en:hodgkin's disease of lymph nodes of head, face and/or neck | rel=r_associated | relid=0 | w=24
  1178. en:Hodgkin lymphoma -- r_associated #0: 24 / 0.106 -> en:hodgkin's disease, lymphocytic depletion of intrathoracic lymph nodes
    n1=en:Hodgkin lymphoma | n2=en:hodgkin's disease, lymphocytic depletion of intrathoracic lymph nodes | rel=r_associated | relid=0 | w=24
  1179. en:Hodgkin lymphoma -- r_associated #0: 24 / 0.106 -> en:hodgkin's disease, mixed cellularity of intra-abdominal lymph nodes
    n1=en:Hodgkin lymphoma | n2=en:hodgkin's disease, mixed cellularity of intra-abdominal lymph nodes | rel=r_associated | relid=0 | w=24
  1180. en:Hodgkin lymphoma -- r_associated #0: 24 / 0.106 -> en:hodgkin's disease, mixed cellularity of intrathoracic lymph nodes
    n1=en:Hodgkin lymphoma | n2=en:hodgkin's disease, mixed cellularity of intrathoracic lymph nodes | rel=r_associated | relid=0 | w=24
  1181. en:Hodgkin lymphoma -- r_associated #0: 24 / 0.106 -> en:hodgkin's disease, nodular sclerosis of intrathoracic lymph nodes
    n1=en:Hodgkin lymphoma | n2=en:hodgkin's disease, nodular sclerosis of intrathoracic lymph nodes | rel=r_associated | relid=0 | w=24
  1182. en:Hodgkin lymphoma -- r_associated #0: 24 / 0.106 -> en:hodgkin's granuloma of intrapelvic lymph nodes
    n1=en:Hodgkin lymphoma | n2=en:hodgkin's granuloma of intrapelvic lymph nodes | rel=r_associated | relid=0 | w=24
  1183. en:Hodgkin lymphoma -- r_associated #0: 24 / 0.106 -> en:hodgkin's granuloma of lymph nodes of axilla and/or upper limb
    n1=en:Hodgkin lymphoma | n2=en:hodgkin's granuloma of lymph nodes of axilla and/or upper limb | rel=r_associated | relid=0 | w=24
  1184. en:Hodgkin lymphoma -- r_associated #0: 24 / 0.106 -> en:hodgkin's paragranuloma
    n1=en:Hodgkin lymphoma | n2=en:hodgkin's paragranuloma | rel=r_associated | relid=0 | w=24
  1185. en:Hodgkin lymphoma -- r_associated #0: 24 / 0.106 -> en:hodgkin's sarcoma of intra-abdominal lymph nodes
    n1=en:Hodgkin lymphoma | n2=en:hodgkin's sarcoma of intra-abdominal lymph nodes | rel=r_associated | relid=0 | w=24
  1186. en:Hodgkin lymphoma -- r_associated #0: 24 / 0.106 -> en:hodgkin's sarcoma of intrapelvic lymph nodes
    n1=en:Hodgkin lymphoma | n2=en:hodgkin's sarcoma of intrapelvic lymph nodes | rel=r_associated | relid=0 | w=24
  1187. en:Hodgkin lymphoma -- r_associated #0: 24 / 0.106 -> en:hodgkin's sarcoma of lymph nodes of multiple sites
    n1=en:Hodgkin lymphoma | n2=en:hodgkin's sarcoma of lymph nodes of multiple sites | rel=r_associated | relid=0 | w=24
  1188. en:Hodgkin lymphoma -- r_associated #0: 24 / 0.106 -> en:ileal, cecal, ovarian, and breast tumors, occasionally (endemic form)
    n1=en:Hodgkin lymphoma | n2=en:ileal, cecal, ovarian, and breast tumors, occasionally (endemic form) | rel=r_associated | relid=0 | w=24
  1189. en:Hodgkin lymphoma -- r_associated #0: 24 / 0.106 -> en:infectious mononucleosis
    n1=en:Hodgkin lymphoma | n2=en:infectious mononucleosis | rel=r_associated | relid=0 | w=24
  1190. en:Hodgkin lymphoma -- r_associated #0: 24 / 0.106 -> en:injuries complicating pregnancy
    n1=en:Hodgkin lymphoma | n2=en:injuries complicating pregnancy | rel=r_associated | relid=0 | w=24
  1191. en:Hodgkin lymphoma -- r_associated #0: 24 / 0.106 -> en:large cell lung carcinoma with rhabdoid phenotype
    n1=en:Hodgkin lymphoma | n2=en:large cell lung carcinoma with rhabdoid phenotype | rel=r_associated | relid=0 | w=24
  1192. en:Hodgkin lymphoma -- r_associated #0: 24 / 0.106 -> en:laryngeal carcinoma
    n1=en:Hodgkin lymphoma | n2=en:laryngeal carcinoma | rel=r_associated | relid=0 | w=24
  1193. en:Hodgkin lymphoma -- r_associated #0: 24 / 0.106 -> en:leukemia (category)
    n1=en:Hodgkin lymphoma | n2=en:leukemia (category) | rel=r_associated | relid=0 | w=24
  1194. en:Hodgkin lymphoma -- r_associated #0: 24 / 0.106 -> en:lobular breast carcinoma
    n1=en:Hodgkin lymphoma | n2=en:lobular breast carcinoma | rel=r_associated | relid=0 | w=24
  1195. en:Hodgkin lymphoma -- r_associated #0: 24 / 0.106 -> en:lymphangiosarcoma
    n1=en:Hodgkin lymphoma | n2=en:lymphangiosarcoma | rel=r_associated | relid=0 | w=24
  1196. en:Hodgkin lymphoma -- r_associated #0: 24 / 0.106 -> en:lymphoblastic lymphoma
    n1=en:Hodgkin lymphoma | n2=en:lymphoblastic lymphoma | rel=r_associated | relid=0 | w=24
  1197. en:Hodgkin lymphoma -- r_associated #0: 24 / 0.106 -> en:lymphocyte
    n1=en:Hodgkin lymphoma | n2=en:lymphocyte | rel=r_associated | relid=0 | w=24
  1198. en:Hodgkin lymphoma -- r_associated #0: 24 / 0.106 -> en:lymphocyte depleted classical hodgkin lymphoma, lymph nodes of axilla and upper limb
    n1=en:Hodgkin lymphoma | n2=en:lymphocyte depleted classical hodgkin lymphoma, lymph nodes of axilla and upper limb | rel=r_associated | relid=0 | w=24
  1199. en:Hodgkin lymphoma -- r_associated #0: 24 / 0.106 -> en:lymphocyte-rich classical hodgkin lymphoma, intra-abdominal lymph nodes
    n1=en:Hodgkin lymphoma | n2=en:lymphocyte-rich classical hodgkin lymphoma, intra-abdominal lymph nodes | rel=r_associated | relid=0 | w=24
  1200. en:Hodgkin lymphoma -- r_associated #0: 24 / 0.106 -> en:lymphocyte-rich classical hodgkin lymphoma, spleen
    n1=en:Hodgkin lymphoma | n2=en:lymphocyte-rich classical hodgkin lymphoma, spleen | rel=r_associated | relid=0 | w=24
  1201. en:Hodgkin lymphoma -- r_associated #0: 24 / 0.106 -> en:lymphoid organ structure
    n1=en:Hodgkin lymphoma | n2=en:lymphoid organ structure | rel=r_associated | relid=0 | w=24
  1202. en:Hodgkin lymphoma -- r_associated #0: 24 / 0.106 -> en:lymphoma (in some patients)
    n1=en:Hodgkin lymphoma | n2=en:lymphoma (in some patients) | rel=r_associated | relid=0 | w=24
  1203. en:Hodgkin lymphoma -- r_associated #0: 24 / 0.106 -> en:lymphoma of pelvis
    n1=en:Hodgkin lymphoma | n2=en:lymphoma of pelvis | rel=r_associated | relid=0 | w=24
  1204. en:Hodgkin lymphoma -- r_associated #0: 24 / 0.106 -> en:malignant central nervous system neoplasm
    n1=en:Hodgkin lymphoma | n2=en:malignant central nervous system neoplasm | rel=r_associated | relid=0 | w=24
  1205. en:Hodgkin lymphoma -- r_associated #0: 24 / 0.106 -> en:malignant extra-adrenal paraganglioma
    n1=en:Hodgkin lymphoma | n2=en:malignant extra-adrenal paraganglioma | rel=r_associated | relid=0 | w=24
  1206. en:Hodgkin lymphoma -- r_associated #0: 24 / 0.106 -> en:malignant giant cell neoplasm
    n1=en:Hodgkin lymphoma | n2=en:malignant giant cell neoplasm | rel=r_associated | relid=0 | w=24
  1207. en:Hodgkin lymphoma -- r_associated #0: 24 / 0.106 -> en:malignant head and neck neoplasm
    n1=en:Hodgkin lymphoma | n2=en:malignant head and neck neoplasm | rel=r_associated | relid=0 | w=24
  1208. en:Hodgkin lymphoma -- r_associated #0: 24 / 0.106 -> en:malignant mast cell neoplasm
    n1=en:Hodgkin lymphoma | n2=en:malignant mast cell neoplasm | rel=r_associated | relid=0 | w=24
  1209. en:Hodgkin lymphoma -- r_associated #0: 24 / 0.106 -> en:malignant neoplasm musculoskeletal
    n1=en:Hodgkin lymphoma | n2=en:malignant neoplasm musculoskeletal | rel=r_associated | relid=0 | w=24
  1210. en:Hodgkin lymphoma -- r_associated #0: 24 / 0.106 -> en:malignant neoplasm of digestive organs and peritoneum
    n1=en:Hodgkin lymphoma | n2=en:malignant neoplasm of digestive organs and peritoneum | rel=r_associated | relid=0 | w=24
  1211. en:Hodgkin lymphoma -- r_associated #0: 24 / 0.106 -> en:malignant neoplasm of genitourinary organ
    n1=en:Hodgkin lymphoma | n2=en:malignant neoplasm of genitourinary organ | rel=r_associated | relid=0 | w=24
  1212. en:Hodgkin lymphoma -- r_associated #0: 24 / 0.106 -> en:malignant neoplasms, stated or presumed to be primary, of specified sites, except of lymphoid, haematopoietic and related tissue
    n1=en:Hodgkin lymphoma | n2=en:malignant neoplasms, stated or presumed to be primary, of specified sites, except of lymphoid, haematopoietic and related tissue | rel=r_associated | relid=0 | w=24
  1213. en:Hodgkin lymphoma -- r_associated #0: 24 / 0.106 -> en:malignant thymoma
    n1=en:Hodgkin lymphoma | n2=en:malignant thymoma | rel=r_associated | relid=0 | w=24
  1214. en:Hodgkin lymphoma -- r_associated #0: 24 / 0.106 -> en:malignant tumor involving an organ by direct extension from bladder
    n1=en:Hodgkin lymphoma | n2=en:malignant tumor involving an organ by direct extension from bladder | rel=r_associated | relid=0 | w=24
  1215. en:Hodgkin lymphoma -- r_associated #0: 24 / 0.106 -> en:malignant type a thymoma
    n1=en:Hodgkin lymphoma | n2=en:malignant type a thymoma | rel=r_associated | relid=0 | w=24
  1216. en:Hodgkin lymphoma -- r_associated #0: 24 / 0.106 -> en:mammary ductal fibroadenoma
    n1=en:Hodgkin lymphoma | n2=en:mammary ductal fibroadenoma | rel=r_associated | relid=0 | w=24
  1217. en:Hodgkin lymphoma -- r_associated #0: 24 / 0.106 -> en:melanocytic neoplasm
    n1=en:Hodgkin lymphoma | n2=en:melanocytic neoplasm | rel=r_associated | relid=0 | w=24
  1218. en:Hodgkin lymphoma -- r_associated #0: 24 / 0.106 -> en:metabolic aspects
    n1=en:Hodgkin lymphoma | n2=en:metabolic aspects | rel=r_associated | relid=0 | w=24
  1219. en:Hodgkin lymphoma -- r_associated #0: 24 / 0.106 -> en:metastatic malignant neoplasm of unknown primary origin
    n1=en:Hodgkin lymphoma | n2=en:metastatic malignant neoplasm of unknown primary origin | rel=r_associated | relid=0 | w=24
  1220. en:Hodgkin lymphoma -- r_associated #0: 24 / 0.106 -> en:mixed cellularity classical hodgkin lymphoma, extranodal and solid organ sites
    n1=en:Hodgkin lymphoma | n2=en:mixed cellularity classical hodgkin lymphoma, extranodal and solid organ sites | rel=r_associated | relid=0 | w=24
  1221. en:Hodgkin lymphoma -- r_associated #0: 24 / 0.106 -> en:mixed germ cell tumor
    n1=en:Hodgkin lymphoma | n2=en:mixed germ cell tumor | rel=r_associated | relid=0 | w=24
  1222. en:Hodgkin lymphoma -- r_associated #0: 24 / 0.106 -> en:molluscum contagiosum
    n1=en:Hodgkin lymphoma | n2=en:molluscum contagiosum | rel=r_associated | relid=0 | w=24
  1223. en:Hodgkin lymphoma -- r_associated #0: 24 / 0.106 -> en:monomorphic cells, medium-sized, with round nuclei, multiple nucleoli, and moderate amount of cytoplasm
    n1=en:Hodgkin lymphoma | n2=en:monomorphic cells, medium-sized, with round nuclei, multiple nucleoli, and moderate amount of cytoplasm | rel=r_associated | relid=0 | w=24
  1224. en:Hodgkin lymphoma -- r_associated #0: 24 / 0.106 -> en:mucin-producing adenocarcinoma
    n1=en:Hodgkin lymphoma | n2=en:mucin-producing adenocarcinoma | rel=r_associated | relid=0 | w=24
  1225. en:Hodgkin lymphoma -- r_associated #0: 24 / 0.106 -> en:multiple bilateral renal angiomyolipoma
    n1=en:Hodgkin lymphoma | n2=en:multiple bilateral renal angiomyolipoma | rel=r_associated | relid=0 | w=24
  1226. en:Hodgkin lymphoma -- r_associated #0: 24 / 0.106 -> en:multiple sclerosis
    n1=en:Hodgkin lymphoma | n2=en:multiple sclerosis | rel=r_associated | relid=0 | w=24
  1227. en:Hodgkin lymphoma -- r_associated #0: 24 / 0.106 -> en:myocardial rhabdomyoma
    n1=en:Hodgkin lymphoma | n2=en:myocardial rhabdomyoma | rel=r_associated | relid=0 | w=24
  1228. en:Hodgkin lymphoma -- r_associated #0: 24 / 0.106 -> en:myomatous neoplasm
    n1=en:Hodgkin lymphoma | n2=en:myomatous neoplasm | rel=r_associated | relid=0 | w=24
  1229. en:Hodgkin lymphoma -- r_associated #0: 24 / 0.106 -> en:myosarcoma
    n1=en:Hodgkin lymphoma | n2=en:myosarcoma | rel=r_associated | relid=0 | w=24
  1230. en:Hodgkin lymphoma -- r_associated #0: 24 / 0.106 -> en:myxedema
    n1=en:Hodgkin lymphoma | n2=en:myxedema | rel=r_associated | relid=0 | w=24
  1231. en:Hodgkin lymphoma -- r_associated #0: 24 / 0.106 -> en:myxoid leiomyosarcoma
    n1=en:Hodgkin lymphoma | n2=en:myxoid leiomyosarcoma | rel=r_associated | relid=0 | w=24
  1232. en:Hodgkin lymphoma -- r_associated #0: 24 / 0.106 -> en:neoplasm by morphology
    n1=en:Hodgkin lymphoma | n2=en:neoplasm by morphology | rel=r_associated | relid=0 | w=24
  1233. en:Hodgkin lymphoma -- r_associated #0: 24 / 0.106 -> en:neoplasm by special category
    n1=en:Hodgkin lymphoma | n2=en:neoplasm by special category | rel=r_associated | relid=0 | w=24
  1234. en:Hodgkin lymphoma -- r_associated #0: 24 / 0.106 -> en:neoplasm of uncertain behavior of other and unspecified sites and tissues
    n1=en:Hodgkin lymphoma | n2=en:neoplasm of uncertain behavior of other and unspecified sites and tissues | rel=r_associated | relid=0 | w=24
  1235. en:Hodgkin lymphoma -- r_associated #0: 24 / 0.106 -> en:neoplasm of uncertain behavior, site unspecified
    n1=en:Hodgkin lymphoma | n2=en:neoplasm of uncertain behavior, site unspecified | rel=r_associated | relid=0 | w=24
  1236. en:Hodgkin lymphoma -- r_associated #0: 24 / 0.106 -> en:neoplasm of unspecified nature of bone, soft tissue, and skin
    n1=en:Hodgkin lymphoma | n2=en:neoplasm of unspecified nature of bone, soft tissue, and skin | rel=r_associated | relid=0 | w=24
  1237. en:Hodgkin lymphoma -- r_associated #0: 24 / 0.106 -> en:neoplasm/cancer invasiveness
    n1=en:Hodgkin lymphoma | n2=en:neoplasm/cancer invasiveness | rel=r_associated | relid=0 | w=24
  1238. en:Hodgkin lymphoma -- r_associated #0: 24 / 0.106 -> en:neoplasm/cancer type
    n1=en:Hodgkin lymphoma | n2=en:neoplasm/cancer type | rel=r_associated | relid=0 | w=24
  1239. en:Hodgkin lymphoma -- r_associated #0: 24 / 0.106 -> en:neoplasms of histiocytes and accessory lymphoid cells
    n1=en:Hodgkin lymphoma | n2=en:neoplasms of histiocytes and accessory lymphoid cells | rel=r_associated | relid=0 | w=24
  1240. en:Hodgkin lymphoma -- r_associated #0: 24 / 0.106 -> en:neoplasms, connective tissue
    n1=en:Hodgkin lymphoma | n2=en:neoplasms, connective tissue | rel=r_associated | relid=0 | w=24
  1241. en:Hodgkin lymphoma -- r_associated #0: 24 / 0.106 -> en:neoplastic cell
    n1=en:Hodgkin lymphoma | n2=en:neoplastic cell | rel=r_associated | relid=0 | w=24
  1242. en:Hodgkin lymphoma -- r_associated #0: 24 / 0.106 -> en:neurofibromatosis
    n1=en:Hodgkin lymphoma | n2=en:neurofibromatosis | rel=r_associated | relid=0 | w=24
  1243. en:Hodgkin lymphoma -- r_associated #0: 24 / 0.106 -> en:neuronal or mixed neuronal-glial neoplasm
    n1=en:Hodgkin lymphoma | n2=en:neuronal or mixed neuronal-glial neoplasm | rel=r_associated | relid=0 | w=24
  1244. en:Hodgkin lymphoma -- r_associated #0: 24 / 0.106 -> en:nodular lymphocyte predominant hodgkin lymphoma, unspecified site
    n1=en:Hodgkin lymphoma | n2=en:nodular lymphocyte predominant hodgkin lymphoma, unspecified site | rel=r_associated | relid=0 | w=24
  1245. en:Hodgkin lymphoma -- r_associated #0: 24 / 0.106 -> en:non-follicular lymphoma
    n1=en:Hodgkin lymphoma | n2=en:non-follicular lymphoma | rel=r_associated | relid=0 | w=24
  1246. en:Hodgkin lymphoma -- r_associated #0: 24 / 0.106 -> en:osseous and/or chondromatous neoplasm
    n1=en:Hodgkin lymphoma | n2=en:osseous and/or chondromatous neoplasm | rel=r_associated | relid=0 | w=24
  1247. en:Hodgkin lymphoma -- r_associated #0: 24 / 0.106 -> en:other abdominal hernia
    n1=en:Hodgkin lymphoma | n2=en:other abdominal hernia | rel=r_associated | relid=0 | w=24
  1248. en:Hodgkin lymphoma -- r_associated #0: 24 / 0.106 -> en:other disorders of urinary system
    n1=en:Hodgkin lymphoma | n2=en:other disorders of urinary system | rel=r_associated | relid=0 | w=24
  1249. en:Hodgkin lymphoma -- r_associated #0: 24 / 0.106 -> en:other infection/inflammation of eye (excluding herpes)
    n1=en:Hodgkin lymphoma | n2=en:other infection/inflammation of eye (excluding herpes) | rel=r_associated | relid=0 | w=24
  1250. en:Hodgkin lymphoma -- r_associated #0: 24 / 0.106 -> en:other malignant lymphomas, intrathoracic lymph nodes
    n1=en:Hodgkin lymphoma | n2=en:other malignant lymphomas, intrathoracic lymph nodes | rel=r_associated | relid=0 | w=24
  1251. en:Hodgkin lymphoma -- r_associated #0: 24 / 0.106 -> en:other malignant lymphomas, spleen
    n1=en:Hodgkin lymphoma | n2=en:other malignant lymphomas, spleen | rel=r_associated | relid=0 | w=24
  1252. en:Hodgkin lymphoma -- r_associated #0: 24 / 0.106 -> en:other mental/psychological disorders
    n1=en:Hodgkin lymphoma | n2=en:other mental/psychological disorders | rel=r_associated | relid=0 | w=24
  1253. en:Hodgkin lymphoma -- r_associated #0: 24 / 0.106 -> en:other/unspecified neoplasms
    n1=en:Hodgkin lymphoma | n2=en:other/unspecified neoplasms | rel=r_associated | relid=0 | w=24
  1254. en:Hodgkin lymphoma -- r_associated #0: 24 / 0.106 -> en:ovarian carcinoma
    n1=en:Hodgkin lymphoma | n2=en:ovarian carcinoma | rel=r_associated | relid=0 | w=24
  1255. en:Hodgkin lymphoma -- r_associated #0: 24 / 0.106 -> en:paget's disease and infiltrating duct carcinoma of breast
    n1=en:Hodgkin lymphoma | n2=en:paget's disease and infiltrating duct carcinoma of breast | rel=r_associated | relid=0 | w=24
  1256. en:Hodgkin lymphoma -- r_associated #0: 24 / 0.106 -> en:pancreatic acinar cell cystadenocarcinoma
    n1=en:Hodgkin lymphoma | n2=en:pancreatic acinar cell cystadenocarcinoma | rel=r_associated | relid=0 | w=24
  1257. en:Hodgkin lymphoma -- r_associated #0: 24 / 0.106 -> en:pediatric terminology
    n1=en:Hodgkin lymphoma | n2=en:pediatric terminology | rel=r_associated | relid=0 | w=24
  1258. en:Hodgkin lymphoma -- r_associated #0: 24 / 0.106 -> en:pemphigus
    n1=en:Hodgkin lymphoma | n2=en:pemphigus | rel=r_associated | relid=0 | w=24
  1259. en:Hodgkin lymphoma -- r_associated #0: 24 / 0.106 -> en:pheochromocytoma, extraadrenal (21%)
    n1=en:Hodgkin lymphoma | n2=en:pheochromocytoma, extraadrenal (21%) | rel=r_associated | relid=0 | w=24
  1260. en:Hodgkin lymphoma -- r_associated #0: 24 / 0.106 -> en:plant morphology
    n1=en:Hodgkin lymphoma | n2=en:plant morphology | rel=r_associated | relid=0 | w=24
  1261. en:Hodgkin lymphoma -- r_associated #0: 24 / 0.106 -> en:possible increased risk of germ-cell tumors
    n1=en:Hodgkin lymphoma | n2=en:possible increased risk of germ-cell tumors | rel=r_associated | relid=0 | w=24
  1262. en:Hodgkin lymphoma -- r_associated #0: 24 / 0.106 -> en:presbycusis
    n1=en:Hodgkin lymphoma | n2=en:presbycusis | rel=r_associated | relid=0 | w=24
  1263. en:Hodgkin lymphoma -- r_associated #0: 24 / 0.106 -> en:primary adrenocortical nodular hyperplasia
    n1=en:Hodgkin lymphoma | n2=en:primary adrenocortical nodular hyperplasia | rel=r_associated | relid=0 | w=24
  1264. en:Hodgkin lymphoma -- r_associated #0: 24 / 0.106 -> en:primary malignant adenomatous neoplasm
    n1=en:Hodgkin lymphoma | n2=en:primary malignant adenomatous neoplasm | rel=r_associated | relid=0 | w=24
  1265. en:Hodgkin lymphoma -- r_associated #0: 24 / 0.106 -> en:primary malignant neoplasm of articular cartilage
    n1=en:Hodgkin lymphoma | n2=en:primary malignant neoplasm of articular cartilage | rel=r_associated | relid=0 | w=24
  1266. en:Hodgkin lymphoma -- r_associated #0: 24 / 0.106 -> en:primary malignant neoplasm of soft tissues
    n1=en:Hodgkin lymphoma | n2=en:primary malignant neoplasm of soft tissues | rel=r_associated | relid=0 | w=24
  1267. en:Hodgkin lymphoma -- r_associated #0: 24 / 0.106 -> en:primary malignant neoplasm of unspecified site (clinical)
    n1=en:Hodgkin lymphoma | n2=en:primary malignant neoplasm of unspecified site (clinical) | rel=r_associated | relid=0 | w=24
  1268. en:Hodgkin lymphoma -- r_associated #0: 24 / 0.106 -> en:pulmonary embolism
    n1=en:Hodgkin lymphoma | n2=en:pulmonary embolism | rel=r_associated | relid=0 | w=24
  1269. en:Hodgkin lymphoma -- r_associated #0: 24 / 0.106 -> en:radiotherapeutic
    n1=en:Hodgkin lymphoma | n2=en:radiotherapeutic | rel=r_associated | relid=0 | w=24
  1270. en:Hodgkin lymphoma -- r_associated #0: 24 / 0.106 -> en:red blood cell disorder
    n1=en:Hodgkin lymphoma | n2=en:red blood cell disorder | rel=r_associated | relid=0 | w=24
  1271. en:Hodgkin lymphoma -- r_associated #0: 24 / 0.106 -> en:redundant prepuce and phimosis
    n1=en:Hodgkin lymphoma | n2=en:redundant prepuce and phimosis | rel=r_associated | relid=0 | w=24
  1272. en:Hodgkin lymphoma -- r_associated #0: 24 / 0.106 -> en:refractory cytopenia with multilineage dysplasia
    n1=en:Hodgkin lymphoma | n2=en:refractory cytopenia with multilineage dysplasia | rel=r_associated | relid=0 | w=24
  1273. en:Hodgkin lymphoma -- r_associated #0: 24 / 0.106 -> en:renal cortical adenoma
    n1=en:Hodgkin lymphoma | n2=en:renal cortical adenoma | rel=r_associated | relid=0 | w=24
  1274. en:Hodgkin lymphoma -- r_associated #0: 24 / 0.106 -> en:respiratory and mediastinal neoplasms malignant and unspecified
    n1=en:Hodgkin lymphoma | n2=en:respiratory and mediastinal neoplasms malignant and unspecified | rel=r_associated | relid=0 | w=24
  1275. en:Hodgkin lymphoma -- r_associated #0: 24 / 0.106 -> en:schwannoma
    n1=en:Hodgkin lymphoma | n2=en:schwannoma | rel=r_associated | relid=0 | w=24
  1276. en:Hodgkin lymphoma -- r_associated #0: 24 / 0.106 -> en:sertoli-leydig cell tumor, poorly differentiated, with heterologous elements
    n1=en:Hodgkin lymphoma | n2=en:sertoli-leydig cell tumor, poorly differentiated, with heterologous elements | rel=r_associated | relid=0 | w=24
  1277. en:Hodgkin lymphoma -- r_associated #0: 24 / 0.106 -> en:skin nodular basal cell carcinoma
    n1=en:Hodgkin lymphoma | n2=en:skin nodular basal cell carcinoma | rel=r_associated | relid=0 | w=24
  1278. en:Hodgkin lymphoma -- r_associated #0: 24 / 0.106 -> en:solid neoplasm
    n1=en:Hodgkin lymphoma | n2=en:solid neoplasm | rel=r_associated | relid=0 | w=24
  1279. en:Hodgkin lymphoma -- r_associated #0: 24 / 0.106 -> en:spindle cell rhabdomyosarcoma
    n1=en:Hodgkin lymphoma | n2=en:spindle cell rhabdomyosarcoma | rel=r_associated | relid=0 | w=24
  1280. en:Hodgkin lymphoma -- r_associated #0: 24 / 0.106 -> en:splenic disorder
    n1=en:Hodgkin lymphoma | n2=en:splenic disorder | rel=r_associated | relid=0 | w=24
  1281. en:Hodgkin lymphoma -- r_associated #0: 24 / 0.106 -> en:splenic lymphoma
    n1=en:Hodgkin lymphoma | n2=en:splenic lymphoma | rel=r_associated | relid=0 | w=24
  1282. en:Hodgkin lymphoma -- r_associated #0: 24 / 0.106 -> en:squamous cell carcinoma (1 patient)
    n1=en:Hodgkin lymphoma | n2=en:squamous cell carcinoma (1 patient) | rel=r_associated | relid=0 | w=24
  1283. en:Hodgkin lymphoma -- r_associated #0: 24 / 0.106 -> en:statistical association of extensive metabolism (em, wildtype) and malignancy, especially smoking-induced lung cancer
    n1=en:Hodgkin lymphoma | n2=en:statistical association of extensive metabolism (em, wildtype) and malignancy, especially smoking-induced lung cancer | rel=r_associated | relid=0 | w=24
  1284. en:Hodgkin lymphoma -- r_associated #0: 24 / 0.106 -> en:superficial multifocal basal cell carcinoma
    n1=en:Hodgkin lymphoma | n2=en:superficial multifocal basal cell carcinoma | rel=r_associated | relid=0 | w=24
  1285. en:Hodgkin lymphoma -- r_associated #0: 24 / 0.106 -> en:susceptibility to myelodysplasia
    n1=en:Hodgkin lymphoma | n2=en:susceptibility to myelodysplasia | rel=r_associated | relid=0 | w=24
  1286. en:Hodgkin lymphoma -- r_associated #0: 24 / 0.106 -> en:susceptibility to myeloid leukemia
    n1=en:Hodgkin lymphoma | n2=en:susceptibility to myeloid leukemia | rel=r_associated | relid=0 | w=24
  1287. en:Hodgkin lymphoma -- r_associated #0: 24 / 0.106 -> en:syndromes of cervical spine
    n1=en:Hodgkin lymphoma | n2=en:syndromes of cervical spine | rel=r_associated | relid=0 | w=24
  1288. en:Hodgkin lymphoma -- r_associated #0: 24 / 0.106 -> en:t-cell non-hodgkin lymphoma
    n1=en:Hodgkin lymphoma | n2=en:t-cell non-hodgkin lymphoma | rel=r_associated | relid=0 | w=24
  1289. en:Hodgkin lymphoma -- r_associated #0: 24 / 0.106 -> en:therapeutic aspects
    n1=en:Hodgkin lymphoma | n2=en:therapeutic aspects | rel=r_associated | relid=0 | w=24
  1290. en:Hodgkin lymphoma -- r_associated #0: 24 / 0.106 -> en:thyroid gland carcinoma showing thymus-like differentiation
    n1=en:Hodgkin lymphoma | n2=en:thyroid gland carcinoma showing thymus-like differentiation | rel=r_associated | relid=0 | w=24
  1291. en:Hodgkin lymphoma -- r_associated #0: 24 / 0.106 -> en:thyroid gland diffuse sclerosing papillary carcinoma
    n1=en:Hodgkin lymphoma | n2=en:thyroid gland diffuse sclerosing papillary carcinoma | rel=r_associated | relid=0 | w=24
  1292. en:Hodgkin lymphoma -- r_associated #0: 24 / 0.106 -> en:trauma/injury problem
    n1=en:Hodgkin lymphoma | n2=en:trauma/injury problem | rel=r_associated | relid=0 | w=24
  1293. en:Hodgkin lymphoma -- r_associated #0: 24 / 0.106 -> en:trichoblastoma
    n1=en:Hodgkin lymphoma | n2=en:trichoblastoma | rel=r_associated | relid=0 | w=24
  1294. en:Hodgkin lymphoma -- r_associated #0: 24 / 0.106 -> en:trivalent influenza vaccine
    n1=en:Hodgkin lymphoma | n2=en:trivalent influenza vaccine | rel=r_associated | relid=0 | w=24
  1295. en:Hodgkin lymphoma -- r_associated #0: 24 / 0.106 -> en:tumors and pregnancy
    n1=en:Hodgkin lymphoma | n2=en:tumors and pregnancy | rel=r_associated | relid=0 | w=24
  1296. en:Hodgkin lymphoma -- r_associated #0: 24 / 0.106 -> en:tumors at multiple other sites including cns
    n1=en:Hodgkin lymphoma | n2=en:tumors at multiple other sites including cns | rel=r_associated | relid=0 | w=24
  1297. en:Hodgkin lymphoma -- r_associated #0: 24 / 0.106 -> en:type 1 diabetes mellitus
    n1=en:Hodgkin lymphoma | n2=en:type 1 diabetes mellitus | rel=r_associated | relid=0 | w=24
  1298. en:Hodgkin lymphoma -- r_associated #0: 24 / 0.106 -> en:type 3 autoimmune lymphoproliferative syndrome
    n1=en:Hodgkin lymphoma | n2=en:type 3 autoimmune lymphoproliferative syndrome | rel=r_associated | relid=0 | w=24
  1299. en:Hodgkin lymphoma -- r_associated #0: 24 / 0.106 -> en:type c lymphomatoid papulosis
    n1=en:Hodgkin lymphoma | n2=en:type c lymphomatoid papulosis | rel=r_associated | relid=0 | w=24
  1300. en:Hodgkin lymphoma -- r_associated #0: 24 / 0.106 -> en:urologic injuries
    n1=en:Hodgkin lymphoma | n2=en:urologic injuries | rel=r_associated | relid=0 | w=24
  1301. en:Hodgkin lymphoma -- r_associated #0: 24 / 0.106 -> en:uterine leiomyosarcoma (less common)
    n1=en:Hodgkin lymphoma | n2=en:uterine leiomyosarcoma (less common) | rel=r_associated | relid=0 | w=24
  1302. en:Hodgkin lymphoma -- r_associated #0: 24 / 0.106 -> en:uterine neoplasm
    n1=en:Hodgkin lymphoma | n2=en:uterine neoplasm | rel=r_associated | relid=0 | w=24
  1303. en:Hodgkin lymphoma -- r_associated #0: 23 / 0.102 -> en:abnormal lymphocyte
    n1=en:Hodgkin lymphoma | n2=en:abnormal lymphocyte | rel=r_associated | relid=0 | w=23
  1304. en:Hodgkin lymphoma -- r_associated #0: 23 / 0.102 -> en:acoustic trauma
    n1=en:Hodgkin lymphoma | n2=en:acoustic trauma | rel=r_associated | relid=0 | w=23
  1305. en:Hodgkin lymphoma -- r_associated #0: 23 / 0.102 -> en:acute laryngitis and/or tracheitis
    n1=en:Hodgkin lymphoma | n2=en:acute laryngitis and/or tracheitis | rel=r_associated | relid=0 | w=23
  1306. en:Hodgkin lymphoma -- r_associated #0: 23 / 0.102 -> en:adenomyoepithelioma with carcinoma
    n1=en:Hodgkin lymphoma | n2=en:adenomyoepithelioma with carcinoma | rel=r_associated | relid=0 | w=23
  1307. en:Hodgkin lymphoma -- r_associated #0: 23 / 0.102 -> en:affective psychosis
    n1=en:Hodgkin lymphoma | n2=en:affective psychosis | rel=r_associated | relid=0 | w=23
  1308. en:Hodgkin lymphoma -- r_associated #0: 23 / 0.102 -> en:aids-related malignant neoplasm
    n1=en:Hodgkin lymphoma | n2=en:aids-related malignant neoplasm | rel=r_associated | relid=0 | w=23
  1309. en:Hodgkin lymphoma -- r_associated #0: 23 / 0.102 -> en:antibody-producing cell
    n1=en:Hodgkin lymphoma | n2=en:antibody-producing cell | rel=r_associated | relid=0 | w=23
  1310. en:Hodgkin lymphoma -- r_associated #0: 23 / 0.102 -> en:basocellular neoplasms
    n1=en:Hodgkin lymphoma | n2=en:basocellular neoplasms | rel=r_associated | relid=0 | w=23
  1311. en:Hodgkin lymphoma -- r_associated #0: 23 / 0.102 -> en:benign thyroid gland neoplasm
    n1=en:Hodgkin lymphoma | n2=en:benign thyroid gland neoplasm | rel=r_associated | relid=0 | w=23
  1312. en:Hodgkin lymphoma -- r_associated #0: 23 / 0.102 -> en:blepharitis/stye/chalazion
    n1=en:Hodgkin lymphoma | n2=en:blepharitis/stye/chalazion | rel=r_associated | relid=0 | w=23
  1313. en:Hodgkin lymphoma -- r_associated #0: 23 / 0.102 -> en:blood platelet disorders
    n1=en:Hodgkin lymphoma | n2=en:blood platelet disorders | rel=r_associated | relid=0 | w=23
  1314. en:Hodgkin lymphoma -- r_associated #0: 23 / 0.102 -> en:body constitution
    n1=en:Hodgkin lymphoma | n2=en:body constitution | rel=r_associated | relid=0 | w=23
  1315. en:Hodgkin lymphoma -- r_associated #0: 23 / 0.102 -> en:body mass index 30+ - obesity
    n1=en:Hodgkin lymphoma | n2=en:body mass index 30+ - obesity | rel=r_associated | relid=0 | w=23
  1316. en:Hodgkin lymphoma -- r_associated #0: 23 / 0.102 -> en:breast cancer, early-onset (in some patients)
    n1=en:Hodgkin lymphoma | n2=en:breast cancer, early-onset (in some patients) | rel=r_associated | relid=0 | w=23
  1317. en:Hodgkin lymphoma -- r_associated #0: 23 / 0.102 -> en:breast carcinoma
    n1=en:Hodgkin lymphoma | n2=en:breast carcinoma | rel=r_associated | relid=0 | w=23
  1318. en:Hodgkin lymphoma -- r_associated #0: 23 / 0.102 -> en:burkitt leukemia
    n1=en:Hodgkin lymphoma | n2=en:burkitt leukemia | rel=r_associated | relid=0 | w=23
  1319. en:Hodgkin lymphoma -- r_associated #0: 23 / 0.102 -> en:carcinoma with pleomorphic, sarcomatoid or sarcomatous elements
    n1=en:Hodgkin lymphoma | n2=en:carcinoma with pleomorphic, sarcomatoid or sarcomatous elements | rel=r_associated | relid=0 | w=23
  1320. en:Hodgkin lymphoma -- r_associated #0: 23 / 0.102 -> en:cataract
    n1=en:Hodgkin lymphoma | n2=en:cataract | rel=r_associated | relid=0 | w=23
  1321. en:Hodgkin lymphoma -- r_associated #0: 23 / 0.102 -> en:cervical cancer
    n1=en:Hodgkin lymphoma | n2=en:cervical cancer | rel=r_associated | relid=0 | w=23
  1322. en:Hodgkin lymphoma -- r_associated #0: 23 / 0.102 -> en:chief cell adenocarcinoma
    n1=en:Hodgkin lymphoma | n2=en:chief cell adenocarcinoma | rel=r_associated | relid=0 | w=23
  1323. en:Hodgkin lymphoma -- r_associated #0: 23 / 0.102 -> en:chondrogenic neoplasm
    n1=en:Hodgkin lymphoma | n2=en:chondrogenic neoplasm | rel=r_associated | relid=0 | w=23
  1324. en:Hodgkin lymphoma -- r_associated #0: 23 / 0.102 -> en:choroid plexus carcinoma
    n1=en:Hodgkin lymphoma | n2=en:choroid plexus carcinoma | rel=r_associated | relid=0 | w=23
  1325. en:Hodgkin lymphoma -- r_associated #0: 23 / 0.102 -> en:clear cell renal cell carcinoma
    n1=en:Hodgkin lymphoma | n2=en:clear cell renal cell carcinoma | rel=r_associated | relid=0 | w=23
  1326. en:Hodgkin lymphoma -- r_associated #0: 23 / 0.102 -> en:colorectal cancer, early onset
    n1=en:Hodgkin lymphoma | n2=en:colorectal cancer, early onset | rel=r_associated | relid=0 | w=23
  1327. en:Hodgkin lymphoma -- r_associated #0: 23 / 0.102 -> en:complicated delivery deadborn
    n1=en:Hodgkin lymphoma | n2=en:complicated delivery deadborn | rel=r_associated | relid=0 | w=23
  1328. en:Hodgkin lymphoma -- r_associated #0: 23 / 0.102 -> en:ctrp terminology
    n1=en:Hodgkin lymphoma | n2=en:ctrp terminology | rel=r_associated | relid=0 | w=23
  1329. en:Hodgkin lymphoma -- r_associated #0: 23 / 0.102 -> en:desmoplastic small cell tumor
    n1=en:Hodgkin lymphoma | n2=en:desmoplastic small cell tumor | rel=r_associated | relid=0 | w=23
  1330. en:Hodgkin lymphoma -- r_associated #0: 23 / 0.102 -> en:diagnosis aspect
    n1=en:Hodgkin lymphoma | n2=en:diagnosis aspect | rel=r_associated | relid=0 | w=23
  1331. en:Hodgkin lymphoma -- r_associated #0: 23 / 0.102 -> en:disseminated malignant neoplasm
    n1=en:Hodgkin lymphoma | n2=en:disseminated malignant neoplasm | rel=r_associated | relid=0 | w=23
  1332. en:Hodgkin lymphoma -- r_associated #0: 23 / 0.102 -> en:ectomesenchymoma
    n1=en:Hodgkin lymphoma | n2=en:ectomesenchymoma | rel=r_associated | relid=0 | w=23
  1333. en:Hodgkin lymphoma -- r_associated #0: 23 / 0.102 -> en:endometrial neoplasm
    n1=en:Hodgkin lymphoma | n2=en:endometrial neoplasm | rel=r_associated | relid=0 | w=23
  1334. en:Hodgkin lymphoma -- r_associated #0: 23 / 0.102 -> en:enteropathy-associated t-cell lymphoma
    n1=en:Hodgkin lymphoma | n2=en:enteropathy-associated t-cell lymphoma | rel=r_associated | relid=0 | w=23
  1335. en:Hodgkin lymphoma -- r_associated #0: 23 / 0.102 -> en:entire immune system
    n1=en:Hodgkin lymphoma | n2=en:entire immune system | rel=r_associated | relid=0 | w=23
  1336. en:Hodgkin lymphoma -- r_associated #0: 23 / 0.102 -> en:essential thrombocythemia
    n1=en:Hodgkin lymphoma | n2=en:essential thrombocythemia | rel=r_associated | relid=0 | w=23
  1337. en:Hodgkin lymphoma -- r_associated #0: 23 / 0.102 -> en:esthesioneurocytoma
    n1=en:Hodgkin lymphoma | n2=en:esthesioneurocytoma | rel=r_associated | relid=0 | w=23
  1338. en:Hodgkin lymphoma -- r_associated #0: 23 / 0.102 -> en:exposure as collected domain
    n1=en:Hodgkin lymphoma | n2=en:exposure as collected domain | rel=r_associated | relid=0 | w=23
  1339. en:Hodgkin lymphoma -- r_associated #0: 23 / 0.102 -> en:glomus tympanicum paraganglioma
    n1=en:Hodgkin lymphoma | n2=en:glomus tympanicum paraganglioma | rel=r_associated | relid=0 | w=23
  1340. en:Hodgkin lymphoma -- r_associated #0: 23 / 0.102 -> en:grade 1 nodular sclerosis classical hodgkin lymphoma
    n1=en:Hodgkin lymphoma | n2=en:grade 1 nodular sclerosis classical hodgkin lymphoma | rel=r_associated | relid=0 | w=23
  1341. en:Hodgkin lymphoma -- r_associated #0: 23 / 0.102 -> en:heavy chain disease
    n1=en:Hodgkin lymphoma | n2=en:heavy chain disease | rel=r_associated | relid=0 | w=23
  1342. en:Hodgkin lymphoma -- r_associated #0: 23 / 0.102 -> en:hemorrhoid
    n1=en:Hodgkin lymphoma | n2=en:hemorrhoid | rel=r_associated | relid=0 | w=23
  1343. en:Hodgkin lymphoma -- r_associated #0: 23 / 0.102 -> en:hiv/aids and infections
    n1=en:Hodgkin lymphoma | n2=en:hiv/aids and infections | rel=r_associated | relid=0 | w=23
  1344. en:Hodgkin lymphoma -- r_associated #0: 23 / 0.102 -> en:hodgkin lymphoma, unspecified, extranodal and solid organ sites
    n1=en:Hodgkin lymphoma | n2=en:hodgkin lymphoma, unspecified, extranodal and solid organ sites | rel=r_associated | relid=0 | w=23
  1345. en:Hodgkin lymphoma -- r_associated #0: 23 / 0.102 -> en:hodgkin's disease lymphocyte depletion stage ii site unspecified
    n1=en:Hodgkin lymphoma | n2=en:hodgkin's disease lymphocyte depletion stage ii site unspecified | rel=r_associated | relid=0 | w=23
  1346. en:Hodgkin lymphoma -- r_associated #0: 23 / 0.102 -> en:hodgkin's disease lymphocyte predominance stage ii site unspec
    n1=en:Hodgkin lymphoma | n2=en:hodgkin's disease lymphocyte predominance stage ii site unspec | rel=r_associated | relid=0 | w=23
  1347. en:Hodgkin lymphoma -- r_associated #0: 23 / 0.102 -> en:hodgkin's disease lymphocyte predominance stage ii subdiaphragm
    n1=en:Hodgkin lymphoma | n2=en:hodgkin's disease lymphocyte predominance stage ii subdiaphragm | rel=r_associated | relid=0 | w=23
  1348. en:Hodgkin lymphoma -- r_associated #0: 23 / 0.102 -> en:hodgkin's disease nodular sclerosis type
    n1=en:Hodgkin lymphoma | n2=en:hodgkin's disease nodular sclerosis type | rel=r_associated | relid=0 | w=23
  1349. en:Hodgkin lymphoma -- r_associated #0: 23 / 0.102 -> en:hodgkin's disease, lymphocytic-histiocytic predominance inv axillary lymph ns
    n1=en:Hodgkin lymphoma | n2=en:hodgkin's disease, lymphocytic-histiocytic predominance inv axillary lymph ns | rel=r_associated | relid=0 | w=23
  1350. en:Hodgkin lymphoma -- r_associated #0: 23 / 0.102 -> en:hodgkin's disease, mixed cellularity of lymph nodes of axilla and/or upper limb
    n1=en:Hodgkin lymphoma | n2=en:hodgkin's disease, mixed cellularity of lymph nodes of axilla and/or upper limb | rel=r_associated | relid=0 | w=23
  1351. en:Hodgkin lymphoma -- r_associated #0: 23 / 0.102 -> en:hodgkin's disease, nodular sclerosis of lymph nodes of axilla and/or upper limb
    n1=en:Hodgkin lymphoma | n2=en:hodgkin's disease, nodular sclerosis of lymph nodes of axilla and/or upper limb | rel=r_associated | relid=0 | w=23
  1352. en:Hodgkin lymphoma -- r_associated #0: 23 / 0.102 -> en:hodgkin's disease, nodular sclerosis, lymphocyte predominance
    n1=en:Hodgkin lymphoma | n2=en:hodgkin's disease, nodular sclerosis, lymphocyte predominance | rel=r_associated | relid=0 | w=23
  1353. en:Hodgkin lymphoma -- r_associated #0: 23 / 0.102 -> en:hodgkin's granuloma of intra-abdominal lymph nodes
    n1=en:Hodgkin lymphoma | n2=en:hodgkin's granuloma of intra-abdominal lymph nodes | rel=r_associated | relid=0 | w=23
  1354. en:Hodgkin lymphoma -- r_associated #0: 23 / 0.102 -> en:hodgkin's granuloma of lymph nodes of head, face and neck
    n1=en:Hodgkin lymphoma | n2=en:hodgkin's granuloma of lymph nodes of head, face and neck | rel=r_associated | relid=0 | w=23
  1355. en:Hodgkin lymphoma -- r_associated #0: 23 / 0.102 -> en:hypersensitivity to chemotherapy
    n1=en:Hodgkin lymphoma | n2=en:hypersensitivity to chemotherapy | rel=r_associated | relid=0 | w=23
  1356. en:Hodgkin lymphoma -- r_associated #0: 23 / 0.102 -> en:hypertension with involvement target organs
    n1=en:Hodgkin lymphoma | n2=en:hypertension with involvement target organs | rel=r_associated | relid=0 | w=23
  1357. en:Hodgkin lymphoma -- r_associated #0: 23 / 0.102 -> en:hyperventilation
    n1=en:Hodgkin lymphoma | n2=en:hyperventilation | rel=r_associated | relid=0 | w=23
  1358. en:Hodgkin lymphoma -- r_associated #0: 23 / 0.102 -> en:hypospadias
    n1=en:Hodgkin lymphoma | n2=en:hypospadias | rel=r_associated | relid=0 | w=23
  1359. en:Hodgkin lymphoma -- r_associated #0: 23 / 0.102 -> en:in situ neoplasm (morphology)
    n1=en:Hodgkin lymphoma | n2=en:in situ neoplasm (morphology) | rel=r_associated | relid=0 | w=23
  1360. en:Hodgkin lymphoma -- r_associated #0: 23 / 0.102 -> en:increased risk for monoclonal gammopathy
    n1=en:Hodgkin lymphoma | n2=en:increased risk for monoclonal gammopathy | rel=r_associated | relid=0 | w=23
  1361. en:Hodgkin lymphoma -- r_associated #0: 23 / 0.102 -> en:increased risk of gastrointestinal cancer
    n1=en:Hodgkin lymphoma | n2=en:increased risk of gastrointestinal cancer | rel=r_associated | relid=0 | w=23
  1362. en:Hodgkin lymphoma -- r_associated #0: 23 / 0.102 -> en:increased risk of hematologic malignancy (1 patient)
    n1=en:Hodgkin lymphoma | n2=en:increased risk of hematologic malignancy (1 patient) | rel=r_associated | relid=0 | w=23
  1363. en:Hodgkin lymphoma -- r_associated #0: 23 / 0.102 -> en:increased risk of leukemia
    n1=en:Hodgkin lymphoma | n2=en:increased risk of leukemia | rel=r_associated | relid=0 | w=23
  1364. en:Hodgkin lymphoma -- r_associated #0: 23 / 0.102 -> en:increased risk of malignant lymphoma
    n1=en:Hodgkin lymphoma | n2=en:increased risk of malignant lymphoma | rel=r_associated | relid=0 | w=23
  1365. en:Hodgkin lymphoma -- r_associated #0: 23 / 0.102 -> en:increased risk of tumor formation, especially of the head
    n1=en:Hodgkin lymphoma | n2=en:increased risk of tumor formation, especially of the head | rel=r_associated | relid=0 | w=23
  1366. en:Hodgkin lymphoma -- r_associated #0: 23 / 0.102 -> en:infectious conjunctivitis
    n1=en:Hodgkin lymphoma | n2=en:infectious conjunctivitis | rel=r_associated | relid=0 | w=23
  1367. en:Hodgkin lymphoma -- r_associated #0: 23 / 0.102 -> en:infiltrating duct mixed with other types of carcinoma
    n1=en:Hodgkin lymphoma | n2=en:infiltrating duct mixed with other types of carcinoma | rel=r_associated | relid=0 | w=23
  1368. en:Hodgkin lymphoma -- r_associated #0: 23 / 0.102 -> en:infiltrating lobular mixed with other types of carcinoma
    n1=en:Hodgkin lymphoma | n2=en:infiltrating lobular mixed with other types of carcinoma | rel=r_associated | relid=0 | w=23
  1369. en:Hodgkin lymphoma -- r_associated #0: 23 / 0.102 -> en:lentigo maligna melanoma
    n1=en:Hodgkin lymphoma | n2=en:lentigo maligna melanoma | rel=r_associated | relid=0 | w=23
  1370. en:Hodgkin lymphoma -- r_associated #0: 23 / 0.102 -> en:lip and oral cavity carcinoma
    n1=en:Hodgkin lymphoma | n2=en:lip and oral cavity carcinoma | rel=r_associated | relid=0 | w=23
  1371. en:Hodgkin lymphoma -- r_associated #0: 23 / 0.102 -> en:liver lymphoma
    n1=en:Hodgkin lymphoma | n2=en:liver lymphoma | rel=r_associated | relid=0 | w=23
  1372. en:Hodgkin lymphoma -- r_associated #0: 23 / 0.102 -> en:lumbar disc lesion/radiation
    n1=en:Hodgkin lymphoma | n2=en:lumbar disc lesion/radiation | rel=r_associated | relid=0 | w=23
  1373. en:Hodgkin lymphoma -- r_associated #0: 23 / 0.102 -> en:lymphatic diseases
    n1=en:Hodgkin lymphoma | n2=en:lymphatic diseases | rel=r_associated | relid=0 | w=23
  1374. en:Hodgkin lymphoma -- r_associated #0: 23 / 0.102 -> en:lymphatic system
    n1=en:Hodgkin lymphoma | n2=en:lymphatic system | rel=r_associated | relid=0 | w=23
  1375. en:Hodgkin lymphoma -- r_associated #0: 23 / 0.102 -> en:lymphedema
    n1=en:Hodgkin lymphoma | n2=en:lymphedema | rel=r_associated | relid=0 | w=23
  1376. en:Hodgkin lymphoma -- r_associated #0: 23 / 0.102 -> en:lymphocyte-rich classical hodgkin lymphoma, intrapelvic lymph nodes
    n1=en:Hodgkin lymphoma | n2=en:lymphocyte-rich classical hodgkin lymphoma, intrapelvic lymph nodes | rel=r_associated | relid=0 | w=23
  1377. en:Hodgkin lymphoma -- r_associated #0: 23 / 0.102 -> en:lymphocyte-rich classical hodgkin lymphoma, lymph nodes of multiple sites
    n1=en:Hodgkin lymphoma | n2=en:lymphocyte-rich classical hodgkin lymphoma, lymph nodes of multiple sites | rel=r_associated | relid=0 | w=23
  1378. en:Hodgkin lymphoma -- r_associated #0: 23 / 0.102 -> en:lymphosarcoma
    n1=en:Hodgkin lymphoma | n2=en:lymphosarcoma | rel=r_associated | relid=0 | w=23
  1379. en:Hodgkin lymphoma -- r_associated #0: 23 / 0.102 -> en:lymphosarcoma of lymph nodes of multiple sites
    n1=en:Hodgkin lymphoma | n2=en:lymphosarcoma of lymph nodes of multiple sites | rel=r_associated | relid=0 | w=23
  1380. en:Hodgkin lymphoma -- r_associated #0: 23 / 0.102 -> en:malignancy (34%)
    n1=en:Hodgkin lymphoma | n2=en:malignancy (34%) | rel=r_associated | relid=0 | w=23
  1381. en:Hodgkin lymphoma -- r_associated #0: 23 / 0.102 -> en:malignancy in giant cell tumor of bone
    n1=en:Hodgkin lymphoma | n2=en:malignancy in giant cell tumor of bone | rel=r_associated | relid=0 | w=23
  1382. en:Hodgkin lymphoma -- r_associated #0: 23 / 0.102 -> en:malignant adrenal gland pheochromocytoma
    n1=en:Hodgkin lymphoma | n2=en:malignant adrenal gland pheochromocytoma | rel=r_associated | relid=0 | w=23
  1383. en:Hodgkin lymphoma -- r_associated #0: 23 / 0.102 -> en:malignant bladder neoplasm
    n1=en:Hodgkin lymphoma | n2=en:malignant bladder neoplasm | rel=r_associated | relid=0 | w=23
  1384. en:Hodgkin lymphoma -- r_associated #0: 23 / 0.102 -> en:malignant cell
    n1=en:Hodgkin lymphoma | n2=en:malignant cell | rel=r_associated | relid=0 | w=23
  1385. en:Hodgkin lymphoma -- r_associated #0: 23 / 0.102 -> en:malignant digestive system neoplasm
    n1=en:Hodgkin lymphoma | n2=en:malignant digestive system neoplasm | rel=r_associated | relid=0 | w=23
  1386. en:Hodgkin lymphoma -- r_associated #0: 23 / 0.102 -> en:malignant lymphoma of extranodal and/or solid organ site
    n1=en:Hodgkin lymphoma | n2=en:malignant lymphoma of extranodal and/or solid organ site | rel=r_associated | relid=0 | w=23
  1387. en:Hodgkin lymphoma -- r_associated #0: 23 / 0.102 -> en:malignant lymphoma of the eye region
    n1=en:Hodgkin lymphoma | n2=en:malignant lymphoma of the eye region | rel=r_associated | relid=0 | w=23
  1388. en:Hodgkin lymphoma -- r_associated #0: 23 / 0.102 -> en:malignant mixed tumor, osteosarcomatous type
    n1=en:Hodgkin lymphoma | n2=en:malignant mixed tumor, osteosarcomatous type | rel=r_associated | relid=0 | w=23
  1389. en:Hodgkin lymphoma -- r_associated #0: 23 / 0.102 -> en:malignant neoplasm growth accelerated
    n1=en:Hodgkin lymphoma | n2=en:malignant neoplasm growth accelerated | rel=r_associated | relid=0 | w=23
  1390. en:Hodgkin lymphoma -- r_associated #0: 23 / 0.102 -> en:malignant neoplasm of bone, connective tissue, skin and breast
    n1=en:Hodgkin lymphoma | n2=en:malignant neoplasm of bone, connective tissue, skin and breast | rel=r_associated | relid=0 | w=23
  1391. en:Hodgkin lymphoma -- r_associated #0: 23 / 0.102 -> en:malignant neoplasm of female breast
    n1=en:Hodgkin lymphoma | n2=en:malignant neoplasm of female breast | rel=r_associated | relid=0 | w=23
  1392. en:Hodgkin lymphoma -- r_associated #0: 23 / 0.102 -> en:malignant neoplasm, uncertain whether primary or metastatic
    n1=en:Hodgkin lymphoma | n2=en:malignant neoplasm, uncertain whether primary or metastatic | rel=r_associated | relid=0 | w=23
  1393. en:Hodgkin lymphoma -- r_associated #0: 23 / 0.102 -> en:malignant neoplastic disease co-occurrent with human immunodeficiency virus infection
    n1=en:Hodgkin lymphoma | n2=en:malignant neoplastic disease co-occurrent with human immunodeficiency virus infection | rel=r_associated | relid=0 | w=23
  1394. en:Hodgkin lymphoma -- r_associated #0: 23 / 0.102 -> en:malignant neoplastic disease in mother complicating childbirth
    n1=en:Hodgkin lymphoma | n2=en:malignant neoplastic disease in mother complicating childbirth | rel=r_associated | relid=0 | w=23
  1395. en:Hodgkin lymphoma -- r_associated #0: 23 / 0.102 -> en:malignant nervous system neoplasm
    n1=en:Hodgkin lymphoma | n2=en:malignant nervous system neoplasm | rel=r_associated | relid=0 | w=23
  1396. en:Hodgkin lymphoma -- r_associated #0: 23 / 0.102 -> en:malignant testicular neoplasm
    n1=en:Hodgkin lymphoma | n2=en:malignant testicular neoplasm | rel=r_associated | relid=0 | w=23
  1397. en:Hodgkin lymphoma -- r_associated #0: 23 / 0.102 -> en:malignant tumor involving an organ by direct extension from fallopian tube
    n1=en:Hodgkin lymphoma | n2=en:malignant tumor involving an organ by direct extension from fallopian tube | rel=r_associated | relid=0 | w=23
  1398. en:Hodgkin lymphoma -- r_associated #0: 23 / 0.102 -> en:malignant tumor involving vasa deferentia by direct extension from prostate
    n1=en:Hodgkin lymphoma | n2=en:malignant tumor involving vasa deferentia by direct extension from prostate | rel=r_associated | relid=0 | w=23
  1399. en:Hodgkin lymphoma -- r_associated #0: 23 / 0.102 -> en:malignant tumor of lymphoid hemopoietic and related tissue
    n1=en:Hodgkin lymphoma | n2=en:malignant tumor of lymphoid hemopoietic and related tissue | rel=r_associated | relid=0 | w=23
  1400. en:Hodgkin lymphoma -- r_associated #0: 23 / 0.102 -> en:malignant type b1 thymoma
    n1=en:Hodgkin lymphoma | n2=en:malignant type b1 thymoma | rel=r_associated | relid=0 | w=23
  1401. en:Hodgkin lymphoma -- r_associated #0: 23 / 0.102 -> en:malignant uterine neoplasm
    n1=en:Hodgkin lymphoma | n2=en:malignant uterine neoplasm | rel=r_associated | relid=0 | w=23
  1402. en:Hodgkin lymphoma -- r_associated #0: 23 / 0.102 -> en:mast cell neoplasm
    n1=en:Hodgkin lymphoma | n2=en:mast cell neoplasm | rel=r_associated | relid=0 | w=23
  1403. en:Hodgkin lymphoma -- r_associated #0: 23 / 0.102 -> en:mastitis, postpartum
    n1=en:Hodgkin lymphoma | n2=en:mastitis, postpartum | rel=r_associated | relid=0 | w=23
  1404. en:Hodgkin lymphoma -- r_associated #0: 23 / 0.102 -> en:mature b-cell neoplasms (all subtypes)
    n1=en:Hodgkin lymphoma | n2=en:mature b-cell neoplasms (all subtypes) | rel=r_associated | relid=0 | w=23
  1405. en:Hodgkin lymphoma -- r_associated #0: 23 / 0.102 -> en:metastasizing ameloblastoma
    n1=en:Hodgkin lymphoma | n2=en:metastasizing ameloblastoma | rel=r_associated | relid=0 | w=23
  1406. en:Hodgkin lymphoma -- r_associated #0: 23 / 0.102 -> en:methotrexate-associated lymphoproliferative disorder
    n1=en:Hodgkin lymphoma | n2=en:methotrexate-associated lymphoproliferative disorder | rel=r_associated | relid=0 | w=23
  1407. en:Hodgkin lymphoma -- r_associated #0: 23 / 0.102 -> en:miscellaneous mesenchymal tumors (all subtypes)
    n1=en:Hodgkin lymphoma | n2=en:miscellaneous mesenchymal tumors (all subtypes) | rel=r_associated | relid=0 | w=23
  1408. en:Hodgkin lymphoma -- r_associated #0: 23 / 0.102 -> en:mixed cellularity classical hodgkin lymphoma
    n1=en:Hodgkin lymphoma | n2=en:mixed cellularity classical hodgkin lymphoma | rel=r_associated | relid=0 | w=23
  1409. en:Hodgkin lymphoma -- r_associated #0: 23 / 0.102 -> en:mixed cellularity classical hodgkin lymphoma, intra-abdominal lymph nodes
    n1=en:Hodgkin lymphoma | n2=en:mixed cellularity classical hodgkin lymphoma, intra-abdominal lymph nodes | rel=r_associated | relid=0 | w=23
  1410. en:Hodgkin lymphoma -- r_associated #0: 23 / 0.102 -> en:mixed cellularity classical hodgkin lymphoma, lymph nodes of inguinal region and lower limb
    n1=en:Hodgkin lymphoma | n2=en:mixed cellularity classical hodgkin lymphoma, lymph nodes of inguinal region and lower limb | rel=r_associated | relid=0 | w=23
  1411. en:Hodgkin lymphoma -- r_associated #0: 23 / 0.102 -> en:multiple myeloma and immunoproliferative neoplasms
    n1=en:Hodgkin lymphoma | n2=en:multiple myeloma and immunoproliferative neoplasms | rel=r_associated | relid=0 | w=23
  1412. en:Hodgkin lymphoma -- r_associated #0: 23 / 0.102 -> en:multiple schwannomas
    n1=en:Hodgkin lymphoma | n2=en:multiple schwannomas | rel=r_associated | relid=0 | w=23
  1413. en:Hodgkin lymphoma -- r_associated #0: 23 / 0.102 -> en:neoplasm of perivascular myoid type - category
    n1=en:Hodgkin lymphoma | n2=en:neoplasm of perivascular myoid type - category | rel=r_associated | relid=0 | w=23
  1414. en:Hodgkin lymphoma -- r_associated #0: 23 / 0.102 -> en:neoplasm of unspecified nature of other specified sites
    n1=en:Hodgkin lymphoma | n2=en:neoplasm of unspecified nature of other specified sites | rel=r_associated | relid=0 | w=23
  1415. en:Hodgkin lymphoma -- r_associated #0: 23 / 0.102 -> en:neoplasm of unspecified nature of respiratory system
    n1=en:Hodgkin lymphoma | n2=en:neoplasm of unspecified nature of respiratory system | rel=r_associated | relid=0 | w=23
  1416. en:Hodgkin lymphoma -- r_associated #0: 23 / 0.102 -> en:neoplasms by histologic type
    n1=en:Hodgkin lymphoma | n2=en:neoplasms by histologic type | rel=r_associated | relid=0 | w=23
  1417. en:Hodgkin lymphoma -- r_associated #0: 23 / 0.102 -> en:neuroblastoma (less common)
    n1=en:Hodgkin lymphoma | n2=en:neuroblastoma (less common) | rel=r_associated | relid=0 | w=23
  1418. en:Hodgkin lymphoma -- r_associated #0: 23 / 0.102 -> en:neuroepitheliomatous neoplasm
    n1=en:Hodgkin lymphoma | n2=en:neuroepitheliomatous neoplasm | rel=r_associated | relid=0 | w=23
  1419. en:Hodgkin lymphoma -- r_associated #0: 23 / 0.102 -> en:no progression to cancer
    n1=en:Hodgkin lymphoma | n2=en:no progression to cancer | rel=r_associated | relid=0 | w=23
  1420. en:Hodgkin lymphoma -- r_associated #0: 23 / 0.102 -> en:nodular lymphocyte predominant hodgkin lymphoma, intrapelvic lymph nodes
    n1=en:Hodgkin lymphoma | n2=en:nodular lymphocyte predominant hodgkin lymphoma, intrapelvic lymph nodes | rel=r_associated | relid=0 | w=23
  1421. en:Hodgkin lymphoma -- r_associated #0: 23 / 0.102 -> en:nodular lymphocyte predominant hodgkin lymphoma, lymph nodes of head, face, and neck
    n1=en:Hodgkin lymphoma | n2=en:nodular lymphocyte predominant hodgkin lymphoma, lymph nodes of head, face, and neck | rel=r_associated | relid=0 | w=23
  1422. en:Hodgkin lymphoma -- r_associated #0: 23 / 0.102 -> en:nodular sclerosis classical hodgkin lymphoma, spleen
    n1=en:Hodgkin lymphoma | n2=en:nodular sclerosis classical hodgkin lymphoma, spleen | rel=r_associated | relid=0 | w=23
  1423. en:Hodgkin lymphoma -- r_associated #0: 23 / 0.102 -> en:oral cavity neoplasm
    n1=en:Hodgkin lymphoma | n2=en:oral cavity neoplasm | rel=r_associated | relid=0 | w=23
  1424. en:Hodgkin lymphoma -- r_associated #0: 23 / 0.102 -> en:orthostatic proteinuria
    n1=en:Hodgkin lymphoma | n2=en:orthostatic proteinuria | rel=r_associated | relid=0 | w=23
  1425. en:Hodgkin lymphoma -- r_associated #0: 23 / 0.102 -> en:osteoarthritis, spine
    n1=en:Hodgkin lymphoma | n2=en:osteoarthritis, spine | rel=r_associated | relid=0 | w=23
  1426. en:Hodgkin lymphoma -- r_associated #0: 23 / 0.102 -> en:osteogenic/miscellaneous bone tumors (all subtypes)
    n1=en:Hodgkin lymphoma | n2=en:osteogenic/miscellaneous bone tumors (all subtypes) | rel=r_associated | relid=0 | w=23
  1427. en:Hodgkin lymphoma -- r_associated #0: 23 / 0.102 -> en:osteosarcoma
    n1=en:Hodgkin lymphoma | n2=en:osteosarcoma | rel=r_associated | relid=0 | w=23
  1428. en:Hodgkin lymphoma -- r_associated #0: 23 / 0.102 -> en:other classical hodgkin lymphoma
    n1=en:Hodgkin lymphoma | n2=en:other classical hodgkin lymphoma | rel=r_associated | relid=0 | w=23
  1429. en:Hodgkin lymphoma -- r_associated #0: 23 / 0.102 -> en:other classical hodgkin lymphoma, extranodal and solid organ sites
    n1=en:Hodgkin lymphoma | n2=en:other classical hodgkin lymphoma, extranodal and solid organ sites | rel=r_associated | relid=0 | w=23
  1430. en:Hodgkin lymphoma -- r_associated #0: 23 / 0.102 -> en:other disorders of eye
    n1=en:Hodgkin lymphoma | n2=en:other disorders of eye | rel=r_associated | relid=0 | w=23
  1431. en:Hodgkin lymphoma -- r_associated #0: 23 / 0.102 -> en:other peptic ulcers
    n1=en:Hodgkin lymphoma | n2=en:other peptic ulcers | rel=r_associated | relid=0 | w=23
  1432. en:Hodgkin lymphoma -- r_associated #0: 23 / 0.102 -> en:other/unspecified neoplasm female genital
    n1=en:Hodgkin lymphoma | n2=en:other/unspecified neoplasm female genital | rel=r_associated | relid=0 | w=23
  1433. en:Hodgkin lymphoma -- r_associated #0: 23 / 0.102 -> en:overlapping malignant melanoma of skin
    n1=en:Hodgkin lymphoma | n2=en:overlapping malignant melanoma of skin | rel=r_associated | relid=0 | w=23
  1434. en:Hodgkin lymphoma -- r_associated #0: 23 / 0.102 -> en:oxyphilic adenocarcinoma
    n1=en:Hodgkin lymphoma | n2=en:oxyphilic adenocarcinoma | rel=r_associated | relid=0 | w=23
  1435. en:Hodgkin lymphoma -- r_associated #0: 23 / 0.102 -> en:pancreatic carcinoma
    n1=en:Hodgkin lymphoma | n2=en:pancreatic carcinoma | rel=r_associated | relid=0 | w=23
  1436. en:Hodgkin lymphoma -- r_associated #0: 23 / 0.102 -> en:pancreatic squamous cell carcinoma
    n1=en:Hodgkin lymphoma | n2=en:pancreatic squamous cell carcinoma | rel=r_associated | relid=0 | w=23
  1437. en:Hodgkin lymphoma -- r_associated #0: 23 / 0.102 -> en:pathological aspects
    n1=en:Hodgkin lymphoma | n2=en:pathological aspects | rel=r_associated | relid=0 | w=23
  1438. en:Hodgkin lymphoma -- r_associated #0: 23 / 0.102 -> en:pilomatrical carcinoma
    n1=en:Hodgkin lymphoma | n2=en:pilomatrical carcinoma | rel=r_associated | relid=0 | w=23
  1439. en:Hodgkin lymphoma -- r_associated #0: 23 / 0.102 -> en:plasma cell myeloma
    n1=en:Hodgkin lymphoma | n2=en:plasma cell myeloma | rel=r_associated | relid=0 | w=23
  1440. en:Hodgkin lymphoma -- r_associated #0: 23 / 0.102 -> en:plasma cell myeloma/plasmacytoma
    n1=en:Hodgkin lymphoma | n2=en:plasma cell myeloma/plasmacytoma | rel=r_associated | relid=0 | w=23
  1441. en:Hodgkin lymphoma -- r_associated #0: 23 / 0.102 -> en:polygonal cell carcinoma
    n1=en:Hodgkin lymphoma | n2=en:polygonal cell carcinoma | rel=r_associated | relid=0 | w=23
  1442. en:Hodgkin lymphoma -- r_associated #0: 23 / 0.102 -> en:poorly differentiated malignant neoplasm
    n1=en:Hodgkin lymphoma | n2=en:poorly differentiated malignant neoplasm | rel=r_associated | relid=0 | w=23
  1443. en:Hodgkin lymphoma -- r_associated #0: 23 / 0.102 -> en:precancerous condition
    n1=en:Hodgkin lymphoma | n2=en:precancerous condition | rel=r_associated | relid=0 | w=23
  1444. en:Hodgkin lymphoma -- r_associated #0: 23 / 0.102 -> en:primary central nervous system hodgkin lymphoma
    n1=en:Hodgkin lymphoma | n2=en:primary central nervous system hodgkin lymphoma | rel=r_associated | relid=0 | w=23
  1445. en:Hodgkin lymphoma -- r_associated #0: 23 / 0.102 -> en:primary malignant liver neoplasm
    n1=en:Hodgkin lymphoma | n2=en:primary malignant liver neoplasm | rel=r_associated | relid=0 | w=23
  1446. en:Hodgkin lymphoma -- r_associated #0: 23 / 0.102 -> en:primary malignant neoplasm of endocrine gland
    n1=en:Hodgkin lymphoma | n2=en:primary malignant neoplasm of endocrine gland | rel=r_associated | relid=0 | w=23
  1447. en:Hodgkin lymphoma -- r_associated #0: 23 / 0.102 -> en:primary malignant neoplasm of neck
    n1=en:Hodgkin lymphoma | n2=en:primary malignant neoplasm of neck | rel=r_associated | relid=0 | w=23
  1448. en:Hodgkin lymphoma -- r_associated #0: 23 / 0.102 -> en:primary malignant neoplasm of trunk
    n1=en:Hodgkin lymphoma | n2=en:primary malignant neoplasm of trunk | rel=r_associated | relid=0 | w=23
  1449. en:Hodgkin lymphoma -- r_associated #0: 23 / 0.102 -> en:prolactin-producing pituitary gland adenoma
    n1=en:Hodgkin lymphoma | n2=en:prolactin-producing pituitary gland adenoma | rel=r_associated | relid=0 | w=23
  1450. en:Hodgkin lymphoma -- r_associated #0: 23 / 0.102 -> en:prostate carcinoma
    n1=en:Hodgkin lymphoma | n2=en:prostate carcinoma | rel=r_associated | relid=0 | w=23
  1451. en:Hodgkin lymphoma -- r_associated #0: 23 / 0.102 -> en:pseudolymphoma
    n1=en:Hodgkin lymphoma | n2=en:pseudolymphoma | rel=r_associated | relid=0 | w=23
  1452. en:Hodgkin lymphoma -- r_associated #0: 23 / 0.102 -> en:refractory anemia with excess blasts
    n1=en:Hodgkin lymphoma | n2=en:refractory anemia with excess blasts | rel=r_associated | relid=0 | w=23
  1453. en:Hodgkin lymphoma -- r_associated #0: 23 / 0.102 -> en:refractory anemia with excess blasts in transformation
    n1=en:Hodgkin lymphoma | n2=en:refractory anemia with excess blasts in transformation | rel=r_associated | relid=0 | w=23
  1454. en:Hodgkin lymphoma -- r_associated #0: 23 / 0.102 -> en:renal and urinary tract neoplasms benign
    n1=en:Hodgkin lymphoma | n2=en:renal and urinary tract neoplasms benign | rel=r_associated | relid=0 | w=23
  1455. en:Hodgkin lymphoma -- r_associated #0: 23 / 0.102 -> en:renal cell carcinoma (less common)
    n1=en:Hodgkin lymphoma | n2=en:renal cell carcinoma (less common) | rel=r_associated | relid=0 | w=23
  1456. en:Hodgkin lymphoma -- r_associated #0: 23 / 0.102 -> en:rheumatoid arthritis
    n1=en:Hodgkin lymphoma | n2=en:rheumatoid arthritis | rel=r_associated | relid=0 | w=23
  1457. en:Hodgkin lymphoma -- r_associated #0: 23 / 0.102 -> en:sacrococcygeal teratoma
    n1=en:Hodgkin lymphoma | n2=en:sacrococcygeal teratoma | rel=r_associated | relid=0 | w=23
  1458. en:Hodgkin lymphoma -- r_associated #0: 23 / 0.102 -> en:secondary neoplasm
    n1=en:Hodgkin lymphoma | n2=en:secondary neoplasm | rel=r_associated | relid=0 | w=23
  1459. en:Hodgkin lymphoma -- r_associated #0: 23 / 0.102 -> en:seropositive rheumatoid arthritis
    n1=en:Hodgkin lymphoma | n2=en:seropositive rheumatoid arthritis | rel=r_associated | relid=0 | w=23
  1460. en:Hodgkin lymphoma -- r_associated #0: 23 / 0.102 -> en:sinonasal undifferentiated carcinoma
    n1=en:Hodgkin lymphoma | n2=en:sinonasal undifferentiated carcinoma | rel=r_associated | relid=0 | w=23
  1461. en:Hodgkin lymphoma -- r_associated #0: 23 / 0.102 -> en:skeletal neoplasms benign
    n1=en:Hodgkin lymphoma | n2=en:skeletal neoplasms benign | rel=r_associated | relid=0 | w=23
  1462. en:Hodgkin lymphoma -- r_associated #0: 23 / 0.102 -> en:skin basal cell carcinoma
    n1=en:Hodgkin lymphoma | n2=en:skin basal cell carcinoma | rel=r_associated | relid=0 | w=23
  1463. en:Hodgkin lymphoma -- r_associated #0: 23 / 0.102 -> en:small lymphocytic lymphoma
    n1=en:Hodgkin lymphoma | n2=en:small lymphocytic lymphoma | rel=r_associated | relid=0 | w=23
  1464. en:Hodgkin lymphoma -- r_associated #0: 23 / 0.102 -> en:somatostatin-producing neuroendocrine tumor
    n1=en:Hodgkin lymphoma | n2=en:somatostatin-producing neuroendocrine tumor | rel=r_associated | relid=0 | w=23
  1465. en:Hodgkin lymphoma -- r_associated #0: 23 / 0.102 -> en:squamous cell carcinoma (skin or mucosa)
    n1=en:Hodgkin lymphoma | n2=en:squamous cell carcinoma (skin or mucosa) | rel=r_associated | relid=0 | w=23
  1466. en:Hodgkin lymphoma -- r_associated #0: 23 / 0.102 -> en:subependymoma
    n1=en:Hodgkin lymphoma | n2=en:subependymoma | rel=r_associated | relid=0 | w=23
  1467. en:Hodgkin lymphoma -- r_associated #0: 23 / 0.102 -> en:syringocystadenoma papilliferum
    n1=en:Hodgkin lymphoma | n2=en:syringocystadenoma papilliferum | rel=r_associated | relid=0 | w=23
  1468. en:Hodgkin lymphoma -- r_associated #0: 23 / 0.102 -> en:temporal arteritis
    n1=en:Hodgkin lymphoma | n2=en:temporal arteritis | rel=r_associated | relid=0 | w=23
  1469. en:Hodgkin lymphoma -- r_associated #0: 23 / 0.102 -> en:testicular hydrocele
    n1=en:Hodgkin lymphoma | n2=en:testicular hydrocele | rel=r_associated | relid=0 | w=23
  1470. en:Hodgkin lymphoma -- r_associated #0: 23 / 0.102 -> en:testicular spermatocytic seminoma
    n1=en:Hodgkin lymphoma | n2=en:testicular spermatocytic seminoma | rel=r_associated | relid=0 | w=23
  1471. en:Hodgkin lymphoma -- r_associated #0: 23 / 0.102 -> en:tetanus
    n1=en:Hodgkin lymphoma | n2=en:tetanus | rel=r_associated | relid=0 | w=23
  1472. en:Hodgkin lymphoma -- r_associated #0: 23 / 0.102 -> en:tonsil and adenoid structure
    n1=en:Hodgkin lymphoma | n2=en:tonsil and adenoid structure | rel=r_associated | relid=0 | w=23
  1473. en:Hodgkin lymphoma -- r_associated #0: 23 / 0.102 -> en:transitional cell papilloma and/or carcinoma
    n1=en:Hodgkin lymphoma | n2=en:transitional cell papilloma and/or carcinoma | rel=r_associated | relid=0 | w=23
  1474. en:Hodgkin lymphoma -- r_associated #0: 23 / 0.102 -> en:tumor in vein
    n1=en:Hodgkin lymphoma | n2=en:tumor in vein | rel=r_associated | relid=0 | w=23
  1475. en:Hodgkin lymphoma -- r_associated #0: 23 / 0.102 -> en:type a lymphomatoid papulosis
    n1=en:Hodgkin lymphoma | n2=en:type a lymphomatoid papulosis | rel=r_associated | relid=0 | w=23
  1476. en:Hodgkin lymphoma -- r_associated #0: 23 / 0.102 -> en:type a spindle cell melanoma
    n1=en:Hodgkin lymphoma | n2=en:type a spindle cell melanoma | rel=r_associated | relid=0 | w=23
  1477. en:Hodgkin lymphoma -- r_associated #0: 23 / 0.102 -> en:tyrosine-protein kinase jak2
    n1=en:Hodgkin lymphoma | n2=en:tyrosine-protein kinase jak2 | rel=r_associated | relid=0 | w=23
  1478. en:Hodgkin lymphoma -- r_associated #0: 23 / 0.102 -> en:undescended testes
    n1=en:Hodgkin lymphoma | n2=en:undescended testes | rel=r_associated | relid=0 | w=23
  1479. en:Hodgkin lymphoma -- r_associated #0: 23 / 0.102 -> en:unspecified neoplasms
    n1=en:Hodgkin lymphoma | n2=en:unspecified neoplasms | rel=r_associated | relid=0 | w=23
  1480. en:Hodgkin lymphoma -- r_associated #0: 23 / 0.102 -> en:unwanted pregnancy confirmed
    n1=en:Hodgkin lymphoma | n2=en:unwanted pregnancy confirmed | rel=r_associated | relid=0 | w=23
  1481. en:Hodgkin lymphoma -- r_associated #0: 23 / 0.102 -> en:vestibular schwannoma (over 90% of patients)
    n1=en:Hodgkin lymphoma | n2=en:vestibular schwannoma (over 90% of patients) | rel=r_associated | relid=0 | w=23
  1482. en:Hodgkin lymphoma -- r_associated #0: 23 / 0.102 -> en:vitamin deficiency/other nutritional/disease
    n1=en:Hodgkin lymphoma | n2=en:vitamin deficiency/other nutritional/disease | rel=r_associated | relid=0 | w=23
  1483. en:Hodgkin lymphoma -- r_associated #0: 22 / 0.097 -> en:accelerated neoplasm growth
    n1=en:Hodgkin lymphoma | n2=en:accelerated neoplasm growth | rel=r_associated | relid=0 | w=22
  1484. en:Hodgkin lymphoma -- r_associated #0: 22 / 0.097 -> en:adenosarcoma
    n1=en:Hodgkin lymphoma | n2=en:adenosarcoma | rel=r_associated | relid=0 | w=22
  1485. en:Hodgkin lymphoma -- r_associated #0: 22 / 0.097 -> en:adipocytic tumors (all subtypes)
    n1=en:Hodgkin lymphoma | n2=en:adipocytic tumors (all subtypes) | rel=r_associated | relid=0 | w=22
  1486. en:Hodgkin lymphoma -- r_associated #0: 22 / 0.097 -> en:adult t-cell leukemia/lymphoma
    n1=en:Hodgkin lymphoma | n2=en:adult t-cell leukemia/lymphoma | rel=r_associated | relid=0 | w=22
  1487. en:Hodgkin lymphoma -- r_associated #0: 22 / 0.097 -> en:adverse effect of physical agent
    n1=en:Hodgkin lymphoma | n2=en:adverse effect of physical agent | rel=r_associated | relid=0 | w=22
  1488. en:Hodgkin lymphoma -- r_associated #0: 22 / 0.097 -> en:anaplastic ganglioglioma
    n1=en:Hodgkin lymphoma | n2=en:anaplastic ganglioglioma | rel=r_associated | relid=0 | w=22
  1489. en:Hodgkin lymphoma -- r_associated #0: 22 / 0.097 -> en:angina
    n1=en:Hodgkin lymphoma | n2=en:angina | rel=r_associated | relid=0 | w=22
  1490. en:Hodgkin lymphoma -- r_associated #0: 22 / 0.097 -> en:ankylosing spondylitis
    n1=en:Hodgkin lymphoma | n2=en:ankylosing spondylitis | rel=r_associated | relid=0 | w=22
  1491. en:Hodgkin lymphoma -- r_associated #0: 22 / 0.097 -> en:anxiety disorder/anxiety state
    n1=en:Hodgkin lymphoma | n2=en:anxiety disorder/anxiety state | rel=r_associated | relid=0 | w=22
  1492. en:Hodgkin lymphoma -- r_associated #0: 22 / 0.097 -> en:atopic dermatitis/eczema
    n1=en:Hodgkin lymphoma | n2=en:atopic dermatitis/eczema | rel=r_associated | relid=0 | w=22
  1493. en:Hodgkin lymphoma -- r_associated #0: 22 / 0.097 -> en:benign endocrine neoplasm
    n1=en:Hodgkin lymphoma | n2=en:benign endocrine neoplasm | rel=r_associated | relid=0 | w=22
  1494. en:Hodgkin lymphoma -- r_associated #0: 22 / 0.097 -> en:benign obstetric neoplasm
    n1=en:Hodgkin lymphoma | n2=en:benign obstetric neoplasm | rel=r_associated | relid=0 | w=22
  1495. en:Hodgkin lymphoma -- r_associated #0: 22 / 0.097 -> en:bile duct carcinoma
    n1=en:Hodgkin lymphoma | n2=en:bile duct carcinoma | rel=r_associated | relid=0 | w=22
  1496. en:Hodgkin lymphoma -- r_associated #0: 22 / 0.097 -> en:bladder neoplasm
    n1=en:Hodgkin lymphoma | n2=en:bladder neoplasm | rel=r_associated | relid=0 | w=22
  1497. en:Hodgkin lymphoma -- r_associated #0: 22 / 0.097 -> en:blocked lacrimal duct of infant
    n1=en:Hodgkin lymphoma | n2=en:blocked lacrimal duct of infant | rel=r_associated | relid=0 | w=22
  1498. en:Hodgkin lymphoma -- r_associated #0: 22 / 0.097 -> en:blood or lymphatic cancer
    n1=en:Hodgkin lymphoma | n2=en:blood or lymphatic cancer | rel=r_associated | relid=0 | w=22
  1499. en:Hodgkin lymphoma -- r_associated #0: 22 / 0.097 -> en:bone neoplasm
    n1=en:Hodgkin lymphoma | n2=en:bone neoplasm | rel=r_associated | relid=0 | w=22
  1500. en:Hodgkin lymphoma -- r_associated #0: 22 / 0.097 -> en:bone-forming neoplasm
    n1=en:Hodgkin lymphoma | n2=en:bone-forming neoplasm | rel=r_associated | relid=0 | w=22
  1501. en:Hodgkin lymphoma -- r_associated #0: 22 / 0.097 -> en:breast cancer (rare)
    n1=en:Hodgkin lymphoma | n2=en:breast cancer (rare) | rel=r_associated | relid=0 | w=22
  1502. en:Hodgkin lymphoma -- r_associated #0: 22 / 0.097 -> en:cancer--living with cancer
    n1=en:Hodgkin lymphoma | n2=en:cancer--living with cancer | rel=r_associated | relid=0 | w=22
  1503. en:Hodgkin lymphoma -- r_associated #0: 22 / 0.097 -> en:cartilage-forming neoplasm
    n1=en:Hodgkin lymphoma | n2=en:cartilage-forming neoplasm | rel=r_associated | relid=0 | w=22
  1504. en:Hodgkin lymphoma -- r_associated #0: 22 / 0.097 -> en:cervical cancer screening
    n1=en:Hodgkin lymphoma | n2=en:cervical cancer screening | rel=r_associated | relid=0 | w=22
  1505. en:Hodgkin lymphoma -- r_associated #0: 22 / 0.097 -> en:cervical disorder
    n1=en:Hodgkin lymphoma | n2=en:cervical disorder | rel=r_associated | relid=0 | w=22
  1506. en:Hodgkin lymphoma -- r_associated #0: 22 / 0.097 -> en:childhood lymphocyte-depleted classical hodgkin lymphoma
    n1=en:Hodgkin lymphoma | n2=en:childhood lymphocyte-depleted classical hodgkin lymphoma | rel=r_associated | relid=0 | w=22
  1507. en:Hodgkin lymphoma -- r_associated #0: 22 / 0.097 -> en:chondroid chordoma
    n1=en:Hodgkin lymphoma | n2=en:chondroid chordoma | rel=r_associated | relid=0 | w=22
  1508. en:Hodgkin lymphoma -- r_associated #0: 22 / 0.097 -> en:chronic cystic disease breast
    n1=en:Hodgkin lymphoma | n2=en:chronic cystic disease breast | rel=r_associated | relid=0 | w=22
  1509. en:Hodgkin lymphoma -- r_associated #0: 22 / 0.097 -> en:chronic/non specific lymphadenitis
    n1=en:Hodgkin lymphoma | n2=en:chronic/non specific lymphadenitis | rel=r_associated | relid=0 | w=22
  1510. en:Hodgkin lymphoma -- r_associated #0: 22 / 0.097 -> en:cirrhosis/other liver disease
    n1=en:Hodgkin lymphoma | n2=en:cirrhosis/other liver disease | rel=r_associated | relid=0 | w=22
  1511. en:Hodgkin lymphoma -- r_associated #0: 22 / 0.097 -> en:clear cell acanthoma
    n1=en:Hodgkin lymphoma | n2=en:clear cell acanthoma | rel=r_associated | relid=0 | w=22
  1512. en:Hodgkin lymphoma -- r_associated #0: 22 / 0.097 -> en:complex mixed and/or stromal neoplasm
    n1=en:Hodgkin lymphoma | n2=en:complex mixed and/or stromal neoplasm | rel=r_associated | relid=0 | w=22
  1513. en:Hodgkin lymphoma -- r_associated #0: 22 / 0.097 -> en:complicated delivery liveborn
    n1=en:Hodgkin lymphoma | n2=en:complicated delivery liveborn | rel=r_associated | relid=0 | w=22
  1514. en:Hodgkin lymphoma -- r_associated #0: 22 / 0.097 -> en:congenital musculoskeletal defect
    n1=en:Hodgkin lymphoma | n2=en:congenital musculoskeletal defect | rel=r_associated | relid=0 | w=22
  1515. en:Hodgkin lymphoma -- r_associated #0: 22 / 0.097 -> en:congenital respiratory system disorder
    n1=en:Hodgkin lymphoma | n2=en:congenital respiratory system disorder | rel=r_associated | relid=0 | w=22
  1516. en:Hodgkin lymphoma -- r_associated #0: 22 / 0.097 -> en:cor pulmonale
    n1=en:Hodgkin lymphoma | n2=en:cor pulmonale | rel=r_associated | relid=0 | w=22
  1517. en:Hodgkin lymphoma -- r_associated #0: 22 / 0.097 -> en:craniopharyngioma
    n1=en:Hodgkin lymphoma | n2=en:craniopharyngioma | rel=r_associated | relid=0 | w=22
  1518. en:Hodgkin lymphoma -- r_associated #0: 22 / 0.097 -> en:cylindromas may show malignant transformation
    n1=en:Hodgkin lymphoma | n2=en:cylindromas may show malignant transformation | rel=r_associated | relid=0 | w=22
  1519. en:Hodgkin lymphoma -- r_associated #0: 22 / 0.097 -> en:cystitis/other urinary infection nos
    n1=en:Hodgkin lymphoma | n2=en:cystitis/other urinary infection nos | rel=r_associated | relid=0 | w=22
  1520. en:Hodgkin lymphoma -- r_associated #0: 22 / 0.097 -> en:deafness
    n1=en:Hodgkin lymphoma | n2=en:deafness | rel=r_associated | relid=0 | w=22
  1521. en:Hodgkin lymphoma -- r_associated #0: 22 / 0.097 -> en:dedifferentiated chordoma
    n1=en:Hodgkin lymphoma | n2=en:dedifferentiated chordoma | rel=r_associated | relid=0 | w=22
  1522. en:Hodgkin lymphoma -- r_associated #0: 22 / 0.097 -> en:ductal carcinoma
    n1=en:Hodgkin lymphoma | n2=en:ductal carcinoma | rel=r_associated | relid=0 | w=22
  1523. en:Hodgkin lymphoma -- r_associated #0: 22 / 0.097 -> en:endocrine infection
    n1=en:Hodgkin lymphoma | n2=en:endocrine infection | rel=r_associated | relid=0 | w=22
  1524. en:Hodgkin lymphoma -- r_associated #0: 22 / 0.097 -> en:epithelioid cell melanoma
    n1=en:Hodgkin lymphoma | n2=en:epithelioid cell melanoma | rel=r_associated | relid=0 | w=22
  1525. en:Hodgkin lymphoma -- r_associated #0: 22 / 0.097 -> en:ethnologic
    n1=en:Hodgkin lymphoma | n2=en:ethnologic | rel=r_associated | relid=0 | w=22
  1526. en:Hodgkin lymphoma -- r_associated #0: 22 / 0.097 -> en:eustachian tube salpingitis
    n1=en:Hodgkin lymphoma | n2=en:eustachian tube salpingitis | rel=r_associated | relid=0 | w=22
  1527. en:Hodgkin lymphoma -- r_associated #0: 22 / 0.097 -> en:excessive cerumen
    n1=en:Hodgkin lymphoma | n2=en:excessive cerumen | rel=r_associated | relid=0 | w=22
  1528. en:Hodgkin lymphoma -- r_associated #0: 22 / 0.097 -> en:extra-adrenal sympathetic paraganglioma
    n1=en:Hodgkin lymphoma | n2=en:extra-adrenal sympathetic paraganglioma | rel=r_associated | relid=0 | w=22
  1529. en:Hodgkin lymphoma -- r_associated #0: 22 / 0.097 -> en:extramammary paget disease
    n1=en:Hodgkin lymphoma | n2=en:extramammary paget disease | rel=r_associated | relid=0 | w=22
  1530. en:Hodgkin lymphoma -- r_associated #0: 22 / 0.097 -> en:fracture of tibia and fibula
    n1=en:Hodgkin lymphoma | n2=en:fracture of tibia and fibula | rel=r_associated | relid=0 | w=22
  1531. en:Hodgkin lymphoma -- r_associated #0: 22 / 0.097 -> en:gallbladder carcinoma
    n1=en:Hodgkin lymphoma | n2=en:gallbladder carcinoma | rel=r_associated | relid=0 | w=22
  1532. en:Hodgkin lymphoma -- r_associated #0: 22 / 0.097 -> en:gastric lymphoma
    n1=en:Hodgkin lymphoma | n2=en:gastric lymphoma | rel=r_associated | relid=0 | w=22
  1533. en:Hodgkin lymphoma -- r_associated #0: 22 / 0.097 -> en:gastrointestinal stromal tumors (less common)
    n1=en:Hodgkin lymphoma | n2=en:gastrointestinal stromal tumors (less common) | rel=r_associated | relid=0 | w=22
  1534. en:Hodgkin lymphoma -- r_associated #0: 22 / 0.097 -> en:genital herpes in women
    n1=en:Hodgkin lymphoma | n2=en:genital herpes in women | rel=r_associated | relid=0 | w=22
  1535. en:Hodgkin lymphoma -- r_associated #0: 22 / 0.097 -> en:giant cell tumor
    n1=en:Hodgkin lymphoma | n2=en:giant cell tumor | rel=r_associated | relid=0 | w=22
  1536. en:Hodgkin lymphoma -- r_associated #0: 22 / 0.097 -> en:glassy cell carcinoma
    n1=en:Hodgkin lymphoma | n2=en:glassy cell carcinoma | rel=r_associated | relid=0 | w=22
  1537. en:Hodgkin lymphoma -- r_associated #0: 22 / 0.097 -> en:haemolyses and related conditions
    n1=en:Hodgkin lymphoma | n2=en:haemolyses and related conditions | rel=r_associated | relid=0 | w=22
  1538. en:Hodgkin lymphoma -- r_associated #0: 22 / 0.097 -> en:heart failure
    n1=en:Hodgkin lymphoma | n2=en:heart failure | rel=r_associated | relid=0 | w=22
  1539. en:Hodgkin lymphoma -- r_associated #0: 22 / 0.097 -> en:hematologic and lymphocytic disorder
    n1=en:Hodgkin lymphoma | n2=en:hematologic and lymphocytic disorder | rel=r_associated | relid=0 | w=22
  1540. en:Hodgkin lymphoma -- r_associated #0: 22 / 0.097 -> en:hepatobiliary neoplasms malignant and unspecified
    n1=en:Hodgkin lymphoma | n2=en:hepatobiliary neoplasms malignant and unspecified | rel=r_associated | relid=0 | w=22
  1541. en:Hodgkin lymphoma -- r_associated #0: 22 / 0.097 -> en:hepatoid adenocarcinoma
    n1=en:Hodgkin lymphoma | n2=en:hepatoid adenocarcinoma | rel=r_associated | relid=0 | w=22
  1542. en:Hodgkin lymphoma -- r_associated #0: 22 / 0.097 -> en:hodgkin lymphoma, lymphocyte depletion, reticular
    n1=en:Hodgkin lymphoma | n2=en:hodgkin lymphoma, lymphocyte depletion, reticular | rel=r_associated | relid=0 | w=22
  1543. en:Hodgkin lymphoma -- r_associated #0: 22 / 0.097 -> en:hodgkin lymphoma, unspecified, intrapelvic lymph nodes
    n1=en:Hodgkin lymphoma | n2=en:hodgkin lymphoma, unspecified, intrapelvic lymph nodes | rel=r_associated | relid=0 | w=22
  1544. en:Hodgkin lymphoma -- r_associated #0: 22 / 0.097 -> en:hodgkin lymphoma, unspecified, unspecified site
    n1=en:Hodgkin lymphoma | n2=en:hodgkin lymphoma, unspecified, unspecified site | rel=r_associated | relid=0 | w=22
  1545. en:Hodgkin lymphoma -- r_associated #0: 22 / 0.097 -> en:hodgkin's disease mixed cellularity type
    n1=en:Hodgkin lymphoma | n2=en:hodgkin's disease mixed cellularity type | rel=r_associated | relid=0 | w=22
  1546. en:Hodgkin lymphoma -- r_associated #0: 22 / 0.097 -> en:hodgkin's disease, lymphocytic-histiocytic predominance inv inguinal lymph ns
    n1=en:Hodgkin lymphoma | n2=en:hodgkin's disease, lymphocytic-histiocytic predominance inv inguinal lymph ns | rel=r_associated | relid=0 | w=22
  1547. en:Hodgkin lymphoma -- r_associated #0: 22 / 0.097 -> en:hodgkin's disease, nodular sclerosis of lymph nodes of inguinal region and lower limb
    n1=en:Hodgkin lymphoma | n2=en:hodgkin's disease, nodular sclerosis of lymph nodes of inguinal region and lower limb | rel=r_associated | relid=0 | w=22
  1548. en:Hodgkin lymphoma -- r_associated #0: 22 / 0.097 -> en:hodgkin's granuloma
    n1=en:Hodgkin lymphoma | n2=en:hodgkin's granuloma | rel=r_associated | relid=0 | w=22
  1549. en:Hodgkin lymphoma -- r_associated #0: 22 / 0.097 -> en:hodgkin's granuloma of lymph nodes of multiple sites
    n1=en:Hodgkin lymphoma | n2=en:hodgkin's granuloma of lymph nodes of multiple sites | rel=r_associated | relid=0 | w=22
  1550. en:Hodgkin lymphoma -- r_associated #0: 22 / 0.097 -> en:hodgkin's paragranuloma of extranodal and/or solid organ site
    n1=en:Hodgkin lymphoma | n2=en:hodgkin's paragranuloma of extranodal and/or solid organ site | rel=r_associated | relid=0 | w=22
  1551. en:Hodgkin lymphoma -- r_associated #0: 22 / 0.097 -> en:host-tumor interaction
    n1=en:Hodgkin lymphoma | n2=en:host-tumor interaction | rel=r_associated | relid=0 | w=22
  1552. en:Hodgkin lymphoma -- r_associated #0: 22 / 0.097 -> en:hysterical/hypochondriacal disease
    n1=en:Hodgkin lymphoma | n2=en:hysterical/hypochondriacal disease | rel=r_associated | relid=0 | w=22
  1553. en:Hodgkin lymphoma -- r_associated #0: 22 / 0.097 -> en:increased hepatocellular carcinoma risk
    n1=en:Hodgkin lymphoma | n2=en:increased hepatocellular carcinoma risk | rel=r_associated | relid=0 | w=22
  1554. en:Hodgkin lymphoma -- r_associated #0: 22 / 0.097 -> en:increased incidence of hepatocellular carcinoma
    n1=en:Hodgkin lymphoma | n2=en:increased incidence of hepatocellular carcinoma | rel=r_associated | relid=0 | w=22
  1555. en:Hodgkin lymphoma -- r_associated #0: 22 / 0.097 -> en:indolent systemic mastocytosis
    n1=en:Hodgkin lymphoma | n2=en:indolent systemic mastocytosis | rel=r_associated | relid=0 | w=22
  1556. en:Hodgkin lymphoma -- r_associated #0: 22 / 0.097 -> en:intra-abdominal cancer advanced
    n1=en:Hodgkin lymphoma | n2=en:intra-abdominal cancer advanced | rel=r_associated | relid=0 | w=22
  1557. en:Hodgkin lymphoma -- r_associated #0: 22 / 0.097 -> en:iron-deficiency anemia
    n1=en:Hodgkin lymphoma | n2=en:iron-deficiency anemia | rel=r_associated | relid=0 | w=22
  1558. en:Hodgkin lymphoma -- r_associated #0: 22 / 0.097 -> en:jak2 gene
    n1=en:Hodgkin lymphoma | n2=en:jak2 gene | rel=r_associated | relid=0 | w=22
  1559. en:Hodgkin lymphoma -- r_associated #0: 22 / 0.097 -> en:juvenile rheumatoid arthritis
    n1=en:Hodgkin lymphoma | n2=en:juvenile rheumatoid arthritis | rel=r_associated | relid=0 | w=22
  1560. en:Hodgkin lymphoma -- r_associated #0: 22 / 0.097 -> en:kidney lymphoma
    n1=en:Hodgkin lymphoma | n2=en:kidney lymphoma | rel=r_associated | relid=0 | w=22
  1561. en:Hodgkin lymphoma -- r_associated #0: 22 / 0.097 -> en:lipomatous neoplasm
    n1=en:Hodgkin lymphoma | n2=en:lipomatous neoplasm | rel=r_associated | relid=0 | w=22
  1562. en:Hodgkin lymphoma -- r_associated #0: 22 / 0.097 -> en:living with hiv/aids
    n1=en:Hodgkin lymphoma | n2=en:living with hiv/aids | rel=r_associated | relid=0 | w=22
  1563. en:Hodgkin lymphoma -- r_associated #0: 22 / 0.097 -> en:localized lymphoma
    n1=en:Hodgkin lymphoma | n2=en:localized lymphoma | rel=r_associated | relid=0 | w=22
  1564. en:Hodgkin lymphoma -- r_associated #0: 22 / 0.097 -> en:lung adenocarcinoma
    n1=en:Hodgkin lymphoma | n2=en:lung adenocarcinoma | rel=r_associated | relid=0 | w=22
  1565. en:Hodgkin lymphoma -- r_associated #0: 22 / 0.097 -> en:lung carcinoma
    n1=en:Hodgkin lymphoma | n2=en:lung carcinoma | rel=r_associated | relid=0 | w=22
  1566. en:Hodgkin lymphoma -- r_associated #0: 22 / 0.097 -> en:lymphocyte depleted classical hodgkin lymphoma, unspecified site
    n1=en:Hodgkin lymphoma | n2=en:lymphocyte depleted classical hodgkin lymphoma, unspecified site | rel=r_associated | relid=0 | w=22
  1567. en:Hodgkin lymphoma -- r_associated #0: 22 / 0.097 -> en:lymphocyte-rich classical hodgkin lymphoma, extranodal and solid organ sites
    n1=en:Hodgkin lymphoma | n2=en:lymphocyte-rich classical hodgkin lymphoma, extranodal and solid organ sites | rel=r_associated | relid=0 | w=22
  1568. en:Hodgkin lymphoma -- r_associated #0: 22 / 0.097 -> en:lymphoid leukemia
    n1=en:Hodgkin lymphoma | n2=en:lymphoid leukemia | rel=r_associated | relid=0 | w=22
  1569. en:Hodgkin lymphoma -- r_associated #0: 22 / 0.097 -> en:lymphoproliferative disorder
    n1=en:Hodgkin lymphoma | n2=en:lymphoproliferative disorder | rel=r_associated | relid=0 | w=22
  1570. en:Hodgkin lymphoma -- r_associated #0: 22 / 0.097 -> en:lymphoproliferative disorder (in some patients)
    n1=en:Hodgkin lymphoma | n2=en:lymphoproliferative disorder (in some patients) | rel=r_associated | relid=0 | w=22
  1571. en:Hodgkin lymphoma -- r_associated #0: 22 / 0.097 -> en:lymphosarcoma of lymph nodes of head, face and neck
    n1=en:Hodgkin lymphoma | n2=en:lymphosarcoma of lymph nodes of head, face and neck | rel=r_associated | relid=0 | w=22
  1572. en:Hodgkin lymphoma -- r_associated #0: 22 / 0.097 -> en:malignant bone marrow neoplasm
    n1=en:Hodgkin lymphoma | n2=en:malignant bone marrow neoplasm | rel=r_associated | relid=0 | w=22
  1573. en:Hodgkin lymphoma -- r_associated #0: 22 / 0.097 -> en:malignant immunoproliferative disease (clinical)
    n1=en:Hodgkin lymphoma | n2=en:malignant immunoproliferative disease (clinical) | rel=r_associated | relid=0 | w=22
  1574. en:Hodgkin lymphoma -- r_associated #0: 22 / 0.097 -> en:malignant lymphoma in remission
    n1=en:Hodgkin lymphoma | n2=en:malignant lymphoma in remission | rel=r_associated | relid=0 | w=22
  1575. en:Hodgkin lymphoma -- r_associated #0: 22 / 0.097 -> en:malignant lymphoma of bone
    n1=en:Hodgkin lymphoma | n2=en:malignant lymphoma of bone | rel=r_associated | relid=0 | w=22
  1576. en:Hodgkin lymphoma -- r_associated #0: 22 / 0.097 -> en:malignant lymphoma of lymph nodes
    n1=en:Hodgkin lymphoma | n2=en:malignant lymphoma of lymph nodes | rel=r_associated | relid=0 | w=22
  1577. en:Hodgkin lymphoma -- r_associated #0: 22 / 0.097 -> en:malignant mesothelioma
    n1=en:Hodgkin lymphoma | n2=en:malignant mesothelioma | rel=r_associated | relid=0 | w=22
  1578. en:Hodgkin lymphoma -- r_associated #0: 22 / 0.097 -> en:malignant mixed neoplasm
    n1=en:Hodgkin lymphoma | n2=en:malignant mixed neoplasm | rel=r_associated | relid=0 | w=22
  1579. en:Hodgkin lymphoma -- r_associated #0: 22 / 0.097 -> en:malignant neoplasm of abdomen
    n1=en:Hodgkin lymphoma | n2=en:malignant neoplasm of abdomen | rel=r_associated | relid=0 | w=22
  1580. en:Hodgkin lymphoma -- r_associated #0: 22 / 0.097 -> en:malignant neoplasm of liver
    n1=en:Hodgkin lymphoma | n2=en:malignant neoplasm of liver | rel=r_associated | relid=0 | w=22
  1581. en:Hodgkin lymphoma -- r_associated #0: 22 / 0.097 -> en:malignant peripheral nerve sheath tumors (21%)
    n1=en:Hodgkin lymphoma | n2=en:malignant peripheral nerve sheath tumors (21%) | rel=r_associated | relid=0 | w=22
  1582. en:Hodgkin lymphoma -- r_associated #0: 22 / 0.097 -> en:malignant pharyngeal neoplasm
    n1=en:Hodgkin lymphoma | n2=en:malignant pharyngeal neoplasm | rel=r_associated | relid=0 | w=22
  1583. en:Hodgkin lymphoma -- r_associated #0: 22 / 0.097 -> en:malignant sertoli cell tumor
    n1=en:Hodgkin lymphoma | n2=en:malignant sertoli cell tumor | rel=r_associated | relid=0 | w=22
  1584. en:Hodgkin lymphoma -- r_associated #0: 22 / 0.097 -> en:malignant skin appendage neoplasm
    n1=en:Hodgkin lymphoma | n2=en:malignant skin appendage neoplasm | rel=r_associated | relid=0 | w=22
  1585. en:Hodgkin lymphoma -- r_associated #0: 22 / 0.097 -> en:malignant squamous cell neoplasm
    n1=en:Hodgkin lymphoma | n2=en:malignant squamous cell neoplasm | rel=r_associated | relid=0 | w=22
  1586. en:Hodgkin lymphoma -- r_associated #0: 22 / 0.097 -> en:malignant tumor involving an organ by direct extension from prostate
    n1=en:Hodgkin lymphoma | n2=en:malignant tumor involving an organ by direct extension from prostate | rel=r_associated | relid=0 | w=22
  1587. en:Hodgkin lymphoma -- r_associated #0: 22 / 0.097 -> en:malignant tumor involving an organ by direct extension from uterus
    n1=en:Hodgkin lymphoma | n2=en:malignant tumor involving an organ by direct extension from uterus | rel=r_associated | relid=0 | w=22
  1588. en:Hodgkin lymphoma -- r_associated #0: 22 / 0.097 -> en:mature t- and nk-cell neoplasms (all subtypes)
    n1=en:Hodgkin lymphoma | n2=en:mature t- and nk-cell neoplasms (all subtypes) | rel=r_associated | relid=0 | w=22
  1589. en:Hodgkin lymphoma -- r_associated #0: 22 / 0.097 -> en:mature t-cell and nk-cell non-hodgkin lymphoma
    n1=en:Hodgkin lymphoma | n2=en:mature t-cell and nk-cell non-hodgkin lymphoma | rel=r_associated | relid=0 | w=22
  1590. en:Hodgkin lymphoma -- r_associated #0: 22 / 0.097 -> en:melanoma in junctional nevus
    n1=en:Hodgkin lymphoma | n2=en:melanoma in junctional nevus | rel=r_associated | relid=0 | w=22
  1591. en:Hodgkin lymphoma -- r_associated #0: 22 / 0.097 -> en:mental retardation
    n1=en:Hodgkin lymphoma | n2=en:mental retardation | rel=r_associated | relid=0 | w=22
  1592. en:Hodgkin lymphoma -- r_associated #0: 22 / 0.097 -> en:mesothelial neoplasm
    n1=en:Hodgkin lymphoma | n2=en:mesothelial neoplasm | rel=r_associated | relid=0 | w=22
  1593. en:Hodgkin lymphoma -- r_associated #0: 22 / 0.097 -> en:mesothelioma
    n1=en:Hodgkin lymphoma | n2=en:mesothelioma | rel=r_associated | relid=0 | w=22
  1594. en:Hodgkin lymphoma -- r_associated #0: 22 / 0.097 -> en:microcystic adnexal carcinoma
    n1=en:Hodgkin lymphoma | n2=en:microcystic adnexal carcinoma | rel=r_associated | relid=0 | w=22
  1595. en:Hodgkin lymphoma -- r_associated #0: 22 / 0.097 -> en:miscellaneous and site unspecified neoplasms benign
    n1=en:Hodgkin lymphoma | n2=en:miscellaneous and site unspecified neoplasms benign | rel=r_associated | relid=0 | w=22
  1596. en:Hodgkin lymphoma -- r_associated #0: 22 / 0.097 -> en:mixed epithelioid and spindle cell melanoma
    n1=en:Hodgkin lymphoma | n2=en:mixed epithelioid and spindle cell melanoma | rel=r_associated | relid=0 | w=22
  1597. en:Hodgkin lymphoma -- r_associated #0: 22 / 0.097 -> en:mixed mesodermal (mullerian) tumor
    n1=en:Hodgkin lymphoma | n2=en:mixed mesodermal (mullerian) tumor | rel=r_associated | relid=0 | w=22
  1598. en:Hodgkin lymphoma -- r_associated #0: 22 / 0.097 -> en:moderately differentiated malignant neoplasm
    n1=en:Hodgkin lymphoma | n2=en:moderately differentiated malignant neoplasm | rel=r_associated | relid=0 | w=22
  1599. en:Hodgkin lymphoma -- r_associated #0: 22 / 0.097 -> en:moniliasis/candida (excluding x72 y75)
    n1=en:Hodgkin lymphoma | n2=en:moniliasis/candida (excluding x72 y75) | rel=r_associated | relid=0 | w=22
  1600. en:Hodgkin lymphoma -- r_associated #0: 22 / 0.097 -> en:mucosal neuromas
    n1=en:Hodgkin lymphoma | n2=en:mucosal neuromas | rel=r_associated | relid=0 | w=22
  1601. en:Hodgkin lymphoma -- r_associated #0: 22 / 0.097 -> en:multiple giant cell granulomas (bones, joints, soft tissues)
    n1=en:Hodgkin lymphoma | n2=en:multiple giant cell granulomas (bones, joints, soft tissues) | rel=r_associated | relid=0 | w=22
  1602. en:Hodgkin lymphoma -- r_associated #0: 22 / 0.097 -> en:multiple myeloma and malignant plasma cell neoplasms
    n1=en:Hodgkin lymphoma | n2=en:multiple myeloma and malignant plasma cell neoplasms | rel=r_associated | relid=0 | w=22
  1603. en:Hodgkin lymphoma -- r_associated #0: 22 / 0.097 -> en:nci ctep sdc hodgkin lymphoma sub-category terminology
    n1=en:Hodgkin lymphoma | n2=en:nci ctep sdc hodgkin lymphoma sub-category terminology | rel=r_associated | relid=0 | w=22
  1604. en:Hodgkin lymphoma -- r_associated #0: 22 / 0.097 -> en:ncit neoplasm core terminology
    n1=en:Hodgkin lymphoma | n2=en:ncit neoplasm core terminology | rel=r_associated | relid=0 | w=22
  1605. en:Hodgkin lymphoma -- r_associated #0: 22 / 0.097 -> en:neoplasm related morbidities
    n1=en:Hodgkin lymphoma | n2=en:neoplasm related morbidities | rel=r_associated | relid=0 | w=22
  1606. en:Hodgkin lymphoma -- r_associated #0: 22 / 0.097 -> en:neoplasm/cancer site
    n1=en:Hodgkin lymphoma | n2=en:neoplasm/cancer site | rel=r_associated | relid=0 | w=22
  1607. en:Hodgkin lymphoma -- r_associated #0: 22 / 0.097 -> en:nervous system neoplasm
    n1=en:Hodgkin lymphoma | n2=en:nervous system neoplasm | rel=r_associated | relid=0 | w=22
  1608. en:Hodgkin lymphoma -- r_associated #0: 22 / 0.097 -> en:nervous system tumor morphology
    n1=en:Hodgkin lymphoma | n2=en:nervous system tumor morphology | rel=r_associated | relid=0 | w=22
  1609. en:Hodgkin lymphoma -- r_associated #0: 22 / 0.097 -> en:neuroimmune system
    n1=en:Hodgkin lymphoma | n2=en:neuroimmune system | rel=r_associated | relid=0 | w=22
  1610. en:Hodgkin lymphoma -- r_associated #0: 22 / 0.097 -> en:nodular sclerosis classical hodgkin lymphoma, extranodal and solid organ sites
    n1=en:Hodgkin lymphoma | n2=en:nodular sclerosis classical hodgkin lymphoma, extranodal and solid organ sites | rel=r_associated | relid=0 | w=22
  1611. en:Hodgkin lymphoma -- r_associated #0: 22 / 0.097 -> en:nonseminoma (embryonal carcinoma, teratoma, choriocarcinoma, endodermal sinus tumor)
    n1=en:Hodgkin lymphoma | n2=en:nonseminoma (embryonal carcinoma, teratoma, choriocarcinoma, endodermal sinus tumor) | rel=r_associated | relid=0 | w=22
  1612. en:Hodgkin lymphoma -- r_associated #0: 22 / 0.097 -> en:ocular foreign body
    n1=en:Hodgkin lymphoma | n2=en:ocular foreign body | rel=r_associated | relid=0 | w=22
  1613. en:Hodgkin lymphoma -- r_associated #0: 22 / 0.097 -> en:other classical hodgkin lymphoma, lymph nodes of head, face, and neck
    n1=en:Hodgkin lymphoma | n2=en:other classical hodgkin lymphoma, lymph nodes of head, face, and neck | rel=r_associated | relid=0 | w=22
  1614. en:Hodgkin lymphoma -- r_associated #0: 22 / 0.097 -> en:other classical hodgkin lymphoma, lymph nodes of inguinal region and lower limb
    n1=en:Hodgkin lymphoma | n2=en:other classical hodgkin lymphoma, lymph nodes of inguinal region and lower limb | rel=r_associated | relid=0 | w=22
  1615. en:Hodgkin lymphoma -- r_associated #0: 22 / 0.097 -> en:other classical hodgkin lymphoma, unspecified site
    n1=en:Hodgkin lymphoma | n2=en:other classical hodgkin lymphoma, unspecified site | rel=r_associated | relid=0 | w=22
  1616. en:Hodgkin lymphoma -- r_associated #0: 22 / 0.097 -> en:other diseases of digestive system
    n1=en:Hodgkin lymphoma | n2=en:other diseases of digestive system | rel=r_associated | relid=0 | w=22
  1617. en:Hodgkin lymphoma -- r_associated #0: 22 / 0.097 -> en:other general/unspecified diseases
    n1=en:Hodgkin lymphoma | n2=en:other general/unspecified diseases | rel=r_associated | relid=0 | w=22
  1618. en:Hodgkin lymphoma -- r_associated #0: 22 / 0.097 -> en:other hematologic malignant neoplasms
    n1=en:Hodgkin lymphoma | n2=en:other hematologic malignant neoplasms | rel=r_associated | relid=0 | w=22
  1619. en:Hodgkin lymphoma -- r_associated #0: 22 / 0.097 -> en:other infection neurological system
    n1=en:Hodgkin lymphoma | n2=en:other infection neurological system | rel=r_associated | relid=0 | w=22
  1620. en:Hodgkin lymphoma -- r_associated #0: 22 / 0.097 -> en:other infectious skin disease
    n1=en:Hodgkin lymphoma | n2=en:other infectious skin disease | rel=r_associated | relid=0 | w=22
  1621. en:Hodgkin lymphoma -- r_associated #0: 22 / 0.097 -> en:other malignant lymphomas, intrapelvic lymph nodes
    n1=en:Hodgkin lymphoma | n2=en:other malignant lymphomas, intrapelvic lymph nodes | rel=r_associated | relid=0 | w=22
  1622. en:Hodgkin lymphoma -- r_associated #0: 22 / 0.097 -> en:other respiratory injuries
    n1=en:Hodgkin lymphoma | n2=en:other respiratory injuries | rel=r_associated | relid=0 | w=22
  1623. en:Hodgkin lymphoma -- r_associated #0: 22 / 0.097 -> en:other respiratory system diseases
    n1=en:Hodgkin lymphoma | n2=en:other respiratory system diseases | rel=r_associated | relid=0 | w=22
  1624. en:Hodgkin lymphoma -- r_associated #0: 22 / 0.097 -> en:other specified leukemia (disorder)
    n1=en:Hodgkin lymphoma | n2=en:other specified leukemia (disorder) | rel=r_associated | relid=0 | w=22
  1625. en:Hodgkin lymphoma -- r_associated #0: 22 / 0.097 -> en:other symptom blood/spleen nos
    n1=en:Hodgkin lymphoma | n2=en:other symptom blood/spleen nos | rel=r_associated | relid=0 | w=22
  1626. en:Hodgkin lymphoma -- r_associated #0: 22 / 0.097 -> en:otosclerosis
    n1=en:Hodgkin lymphoma | n2=en:otosclerosis | rel=r_associated | relid=0 | w=22
  1627. en:Hodgkin lymphoma -- r_associated #0: 22 / 0.097 -> en:paragangliomas, head and neck (79%)
    n1=en:Hodgkin lymphoma | n2=en:paragangliomas, head and neck (79%) | rel=r_associated | relid=0 | w=22
  1628. en:Hodgkin lymphoma -- r_associated #0: 22 / 0.097 -> en:parotid gland adenoma and adenocarcinoma
    n1=en:Hodgkin lymphoma | n2=en:parotid gland adenoma and adenocarcinoma | rel=r_associated | relid=0 | w=22
  1629. en:Hodgkin lymphoma -- r_associated #0: 22 / 0.097 -> en:personal history of hodgkin lymphoma
    n1=en:Hodgkin lymphoma | n2=en:personal history of hodgkin lymphoma | rel=r_associated | relid=0 | w=22
  1630. en:Hodgkin lymphoma -- r_associated #0: 22 / 0.097 -> en:pharmacotherapeutic
    n1=en:Hodgkin lymphoma | n2=en:pharmacotherapeutic | rel=r_associated | relid=0 | w=22
  1631. en:Hodgkin lymphoma -- r_associated #0: 22 / 0.097 -> en:pinealoma (trilateral retinoblastoma)
    n1=en:Hodgkin lymphoma | n2=en:pinealoma (trilateral retinoblastoma) | rel=r_associated | relid=0 | w=22
  1632. en:Hodgkin lymphoma -- r_associated #0: 22 / 0.097 -> en:pityriasis rosea
    n1=en:Hodgkin lymphoma | n2=en:pityriasis rosea | rel=r_associated | relid=0 | w=22
  1633. en:Hodgkin lymphoma -- r_associated #0: 22 / 0.097 -> en:pleomorphic rhabdomyosarcoma
    n1=en:Hodgkin lymphoma | n2=en:pleomorphic rhabdomyosarcoma | rel=r_associated | relid=0 | w=22
  1634. en:Hodgkin lymphoma -- r_associated #0: 22 / 0.097 -> en:pleural effusion
    n1=en:Hodgkin lymphoma | n2=en:pleural effusion | rel=r_associated | relid=0 | w=22
  1635. en:Hodgkin lymphoma -- r_associated #0: 22 / 0.097 -> en:pneumococcal polyvalent vaccine
    n1=en:Hodgkin lymphoma | n2=en:pneumococcal polyvalent vaccine | rel=r_associated | relid=0 | w=22
  1636. en:Hodgkin lymphoma -- r_associated #0: 22 / 0.097 -> en:poliomyelitis/other enterovirus
    n1=en:Hodgkin lymphoma | n2=en:poliomyelitis/other enterovirus | rel=r_associated | relid=0 | w=22
  1637. en:Hodgkin lymphoma -- r_associated #0: 22 / 0.097 -> en:polycythemia vera
    n1=en:Hodgkin lymphoma | n2=en:polycythemia vera | rel=r_associated | relid=0 | w=22
  1638. en:Hodgkin lymphoma -- r_associated #0: 22 / 0.097 -> en:primary malignant neoplasm of nervous system
    n1=en:Hodgkin lymphoma | n2=en:primary malignant neoplasm of nervous system | rel=r_associated | relid=0 | w=22
  1639. en:Hodgkin lymphoma -- r_associated #0: 22 / 0.097 -> en:prolymphocytic lymphosarcoma
    n1=en:Hodgkin lymphoma | n2=en:prolymphocytic lymphosarcoma | rel=r_associated | relid=0 | w=22
  1640. en:Hodgkin lymphoma -- r_associated #0: 22 / 0.097 -> en:pyelonephritis/pyelitis acute
    n1=en:Hodgkin lymphoma | n2=en:pyelonephritis/pyelitis acute | rel=r_associated | relid=0 | w=22
  1641. en:Hodgkin lymphoma -- r_associated #0: 22 / 0.097 -> en:radiation-related malignant neoplasm
    n1=en:Hodgkin lymphoma | n2=en:radiation-related malignant neoplasm | rel=r_associated | relid=0 | w=22
  1642. en:Hodgkin lymphoma -- r_associated #0: 22 / 0.097 -> en:reactive immunoproliferative disease
    n1=en:Hodgkin lymphoma | n2=en:reactive immunoproliferative disease | rel=r_associated | relid=0 | w=22
  1643. en:Hodgkin lymphoma -- r_associated #0: 22 / 0.097 -> en:refractory hodgkin lymphoma
    n1=en:Hodgkin lymphoma | n2=en:refractory hodgkin lymphoma | rel=r_associated | relid=0 | w=22
  1644. en:Hodgkin lymphoma -- r_associated #0: 22 / 0.097 -> en:refractory lymphocyte-depleted classical hodgkin lymphoma
    n1=en:Hodgkin lymphoma | n2=en:refractory lymphocyte-depleted classical hodgkin lymphoma | rel=r_associated | relid=0 | w=22
  1645. en:Hodgkin lymphoma -- r_associated #0: 22 / 0.097 -> en:regressed germ cell tumor
    n1=en:Hodgkin lymphoma | n2=en:regressed germ cell tumor | rel=r_associated | relid=0 | w=22
  1646. en:Hodgkin lymphoma -- r_associated #0: 22 / 0.097 -> en:reproductive neoplasms male malignant and unspecified
    n1=en:Hodgkin lymphoma | n2=en:reproductive neoplasms male malignant and unspecified | rel=r_associated | relid=0 | w=22
  1647. en:Hodgkin lymphoma -- r_associated #0: 22 / 0.097 -> en:retinal detachment
    n1=en:Hodgkin lymphoma | n2=en:retinal detachment | rel=r_associated | relid=0 | w=22
  1648. en:Hodgkin lymphoma -- r_associated #0: 22 / 0.097 -> en:sarcomatoid carcinoma
    n1=en:Hodgkin lymphoma | n2=en:sarcomatoid carcinoma | rel=r_associated | relid=0 | w=22
  1649. en:Hodgkin lymphoma -- r_associated #0: 22 / 0.097 -> en:sarcomatoid mesothelioma
    n1=en:Hodgkin lymphoma | n2=en:sarcomatoid mesothelioma | rel=r_associated | relid=0 | w=22
  1650. en:Hodgkin lymphoma -- r_associated #0: 22 / 0.097 -> en:scleroderma
    n1=en:Hodgkin lymphoma | n2=en:scleroderma | rel=r_associated | relid=0 | w=22
  1651. en:Hodgkin lymphoma -- r_associated #0: 22 / 0.097 -> en:seasonal allergic rhinitis
    n1=en:Hodgkin lymphoma | n2=en:seasonal allergic rhinitis | rel=r_associated | relid=0 | w=22
  1652. en:Hodgkin lymphoma -- r_associated #0: 22 / 0.097 -> en:sebaceous adenoma
    n1=en:Hodgkin lymphoma | n2=en:sebaceous adenoma | rel=r_associated | relid=0 | w=22
  1653. en:Hodgkin lymphoma -- r_associated #0: 22 / 0.097 -> en:sebaceous carcinoma
    n1=en:Hodgkin lymphoma | n2=en:sebaceous carcinoma | rel=r_associated | relid=0 | w=22
  1654. en:Hodgkin lymphoma -- r_associated #0: 22 / 0.097 -> en:secondary osteosarcoma
    n1=en:Hodgkin lymphoma | n2=en:secondary osteosarcoma | rel=r_associated | relid=0 | w=22
  1655. en:Hodgkin lymphoma -- r_associated #0: 22 / 0.097 -> en:secretory breast carcinoma
    n1=en:Hodgkin lymphoma | n2=en:secretory breast carcinoma | rel=r_associated | relid=0 | w=22
  1656. en:Hodgkin lymphoma -- r_associated #0: 22 / 0.097 -> en:sensitivity to genotoxic agents
    n1=en:Hodgkin lymphoma | n2=en:sensitivity to genotoxic agents | rel=r_associated | relid=0 | w=22
  1657. en:Hodgkin lymphoma -- r_associated #0: 22 / 0.097 -> en:shoulder syndrome
    n1=en:Hodgkin lymphoma | n2=en:shoulder syndrome | rel=r_associated | relid=0 | w=22
  1658. en:Hodgkin lymphoma -- r_associated #0: 22 / 0.097 -> en:sinusitis acute/chronic
    n1=en:Hodgkin lymphoma | n2=en:sinusitis acute/chronic | rel=r_associated | relid=0 | w=22
  1659. en:Hodgkin lymphoma -- r_associated #0: 22 / 0.097 -> en:sjogren syndrome
    n1=en:Hodgkin lymphoma | n2=en:sjogren syndrome | rel=r_associated | relid=0 | w=22
  1660. en:Hodgkin lymphoma -- r_associated #0: 22 / 0.097 -> en:skin infiltrating basal cell carcinoma
    n1=en:Hodgkin lymphoma | n2=en:skin infiltrating basal cell carcinoma | rel=r_associated | relid=0 | w=22
  1661. en:Hodgkin lymphoma -- r_associated #0: 22 / 0.097 -> en:soft tissue tumor and/or sarcoma
    n1=en:Hodgkin lymphoma | n2=en:soft tissue tumor and/or sarcoma | rel=r_associated | relid=0 | w=22
  1662. en:Hodgkin lymphoma -- r_associated #0: 22 / 0.097 -> en:solid pseudopapillary carcinoma
    n1=en:Hodgkin lymphoma | n2=en:solid pseudopapillary carcinoma | rel=r_associated | relid=0 | w=22
  1663. en:Hodgkin lymphoma -- r_associated #0: 22 / 0.097 -> en:stage ii hodgkin lymphoma
    n1=en:Hodgkin lymphoma | n2=en:stage ii hodgkin lymphoma | rel=r_associated | relid=0 | w=22
  1664. en:Hodgkin lymphoma -- r_associated #0: 22 / 0.097 -> en:stomach function disorder
    n1=en:Hodgkin lymphoma | n2=en:stomach function disorder | rel=r_associated | relid=0 | w=22
  1665. en:Hodgkin lymphoma -- r_associated #0: 22 / 0.097 -> en:swollen lymph node
    n1=en:Hodgkin lymphoma | n2=en:swollen lymph node | rel=r_associated | relid=0 | w=22
  1666. en:Hodgkin lymphoma -- r_associated #0: 22 / 0.097 -> en:synovial sarcoma - category
    n1=en:Hodgkin lymphoma | n2=en:synovial sarcoma - category | rel=r_associated | relid=0 | w=22
  1667. en:Hodgkin lymphoma -- r_associated #0: 22 / 0.097 -> en:syphilis female
    n1=en:Hodgkin lymphoma | n2=en:syphilis female | rel=r_associated | relid=0 | w=22
  1668. en:Hodgkin lymphoma -- r_associated #0: 22 / 0.097 -> en:testicular lymphoma
    n1=en:Hodgkin lymphoma | n2=en:testicular lymphoma | rel=r_associated | relid=0 | w=22
  1669. en:Hodgkin lymphoma -- r_associated #0: 22 / 0.097 -> en:thymic carcinoma
    n1=en:Hodgkin lymphoma | n2=en:thymic carcinoma | rel=r_associated | relid=0 | w=22
  1670. en:Hodgkin lymphoma -- r_associated #0: 22 / 0.097 -> en:thymoma
    n1=en:Hodgkin lymphoma | n2=en:thymoma | rel=r_associated | relid=0 | w=22
  1671. en:Hodgkin lymphoma -- r_associated #0: 22 / 0.097 -> en:thymus epithelial neoplasm
    n1=en:Hodgkin lymphoma | n2=en:thymus epithelial neoplasm | rel=r_associated | relid=0 | w=22
  1672. en:Hodgkin lymphoma -- r_associated #0: 22 / 0.097 -> en:thyroid gland papillary carcinoma
    n1=en:Hodgkin lymphoma | n2=en:thyroid gland papillary carcinoma | rel=r_associated | relid=0 | w=22
  1673. en:Hodgkin lymphoma -- r_associated #0: 22 / 0.097 -> en:toxic effect of other and unspecified substances
    n1=en:Hodgkin lymphoma | n2=en:toxic effect of other and unspecified substances | rel=r_associated | relid=0 | w=22
  1674. en:Hodgkin lymphoma -- r_associated #0: 22 / 0.097 -> en:trigeminal neuralgia
    n1=en:Hodgkin lymphoma | n2=en:trigeminal neuralgia | rel=r_associated | relid=0 | w=22
  1675. en:Hodgkin lymphoma -- r_associated #0: 22 / 0.097 -> en:tumor lysis syndrome adverse event
    n1=en:Hodgkin lymphoma | n2=en:tumor lysis syndrome adverse event | rel=r_associated | relid=0 | w=22
  1676. en:Hodgkin lymphoma -- r_associated #0: 22 / 0.097 -> en:tympanic membrane perforation
    n1=en:Hodgkin lymphoma | n2=en:tympanic membrane perforation | rel=r_associated | relid=0 | w=22
  1677. en:Hodgkin lymphoma -- r_associated #0: 22 / 0.097 -> en:urinary stone
    n1=en:Hodgkin lymphoma | n2=en:urinary stone | rel=r_associated | relid=0 | w=22
  1678. en:Hodgkin lymphoma -- r_associated #0: 22 / 0.097 -> en:urogenital trichomoniasis proven
    n1=en:Hodgkin lymphoma | n2=en:urogenital trichomoniasis proven | rel=r_associated | relid=0 | w=22
  1679. en:Hodgkin lymphoma -- r_associated #0: 22 / 0.097 -> en:urticaria
    n1=en:Hodgkin lymphoma | n2=en:urticaria | rel=r_associated | relid=0 | w=22
  1680. en:Hodgkin lymphoma -- r_associated #0: 22 / 0.097 -> en:vascular and perivascular tumors (all subtypes)
    n1=en:Hodgkin lymphoma | n2=en:vascular and perivascular tumors (all subtypes) | rel=r_associated | relid=0 | w=22
  1681. en:Hodgkin lymphoma -- r_associated #0: 22 / 0.097 -> lymphome de Hodgkin (classification)
    n1=en:Hodgkin lymphoma | n2=lymphome de Hodgkin (classification) | rel=r_associated | relid=0 | w=22
  1682. en:Hodgkin lymphoma -- r_associated #0: 21 / 0.093 -> en:acute damage meniscus knee
    n1=en:Hodgkin lymphoma | n2=en:acute damage meniscus knee | rel=r_associated | relid=0 | w=21
  1683. en:Hodgkin lymphoma -- r_associated #0: 21 / 0.093 -> en:adamantinoma
    n1=en:Hodgkin lymphoma | n2=en:adamantinoma | rel=r_associated | relid=0 | w=21
  1684. en:Hodgkin lymphoma -- r_associated #0: 21 / 0.093 -> en:adult lymphocyte-depleted classical hodgkin lymphoma
    n1=en:Hodgkin lymphoma | n2=en:adult lymphocyte-depleted classical hodgkin lymphoma | rel=r_associated | relid=0 | w=21
  1685. en:Hodgkin lymphoma -- r_associated #0: 21 / 0.093 -> en:aggravated malignant neoplasm
    n1=en:Hodgkin lymphoma | n2=en:aggravated malignant neoplasm | rel=r_associated | relid=0 | w=21
  1686. en:Hodgkin lymphoma -- r_associated #0: 21 / 0.093 -> en:aids related neoplasm/cancer
    n1=en:Hodgkin lymphoma | n2=en:aids related neoplasm/cancer | rel=r_associated | relid=0 | w=21
  1687. en:Hodgkin lymphoma -- r_associated #0: 21 / 0.093 -> en:anal canal cloacogenic carcinoma
    n1=en:Hodgkin lymphoma | n2=en:anal canal cloacogenic carcinoma | rel=r_associated | relid=0 | w=21
  1688. en:Hodgkin lymphoma -- r_associated #0: 21 / 0.093 -> en:appendicitis
    n1=en:Hodgkin lymphoma | n2=en:appendicitis | rel=r_associated | relid=0 | w=21
  1689. en:Hodgkin lymphoma -- r_associated #0: 21 / 0.093 -> en:approximately 10% of cases are paraneoplastic
    n1=en:Hodgkin lymphoma | n2=en:approximately 10% of cases are paraneoplastic | rel=r_associated | relid=0 | w=21
  1690. en:Hodgkin lymphoma -- r_associated #0: 21 / 0.093 -> en:aspects of mortality statistics
    n1=en:Hodgkin lymphoma | n2=en:aspects of mortality statistics | rel=r_associated | relid=0 | w=21
  1691. en:Hodgkin lymphoma -- r_associated #0: 21 / 0.093 -> en:ataxia telangiectasia syndrome
    n1=en:Hodgkin lymphoma | n2=en:ataxia telangiectasia syndrome | rel=r_associated | relid=0 | w=21
  1692. en:Hodgkin lymphoma -- r_associated #0: 21 / 0.093 -> en:benign epithelial neoplasm
    n1=en:Hodgkin lymphoma | n2=en:benign epithelial neoplasm | rel=r_associated | relid=0 | w=21
  1693. en:Hodgkin lymphoma -- r_associated #0: 21 / 0.093 -> en:benign nervous system neoplasm
    n1=en:Hodgkin lymphoma | n2=en:benign nervous system neoplasm | rel=r_associated | relid=0 | w=21
  1694. en:Hodgkin lymphoma -- r_associated #0: 21 / 0.093 -> en:benign respiratory neoplasm
    n1=en:Hodgkin lymphoma | n2=en:benign respiratory neoplasm | rel=r_associated | relid=0 | w=21
  1695. en:Hodgkin lymphoma -- r_associated #0: 21 / 0.093 -> en:benign/unspecified neoplasms
    n1=en:Hodgkin lymphoma | n2=en:benign/unspecified neoplasms | rel=r_associated | relid=0 | w=21
  1696. en:Hodgkin lymphoma -- r_associated #0: 21 / 0.093 -> en:biological polymorphism
    n1=en:Hodgkin lymphoma | n2=en:biological polymorphism | rel=r_associated | relid=0 | w=21
  1697. en:Hodgkin lymphoma -- r_associated #0: 21 / 0.093 -> en:breast cancer, lobular
    n1=en:Hodgkin lymphoma | n2=en:breast cancer, lobular | rel=r_associated | relid=0 | w=21
  1698. en:Hodgkin lymphoma -- r_associated #0: 21 / 0.093 -> en:burkitt lymphoma
    n1=en:Hodgkin lymphoma | n2=en:burkitt lymphoma | rel=r_associated | relid=0 | w=21
  1699. en:Hodgkin lymphoma -- r_associated #0: 21 / 0.093 -> en:carcinomatosis (unknown primary site)
    n1=en:Hodgkin lymphoma | n2=en:carcinomatosis (unknown primary site) | rel=r_associated | relid=0 | w=21
  1700. en:Hodgkin lymphoma -- r_associated #0: 21 / 0.093 -> en:cerebrovascular accident
    n1=en:Hodgkin lymphoma | n2=en:cerebrovascular accident | rel=r_associated | relid=0 | w=21
  1701. en:Hodgkin lymphoma -- r_associated #0: 21 / 0.093 -> en:cervical cancer (rare)
    n1=en:Hodgkin lymphoma | n2=en:cervical cancer (rare) | rel=r_associated | relid=0 | w=21
  1702. en:Hodgkin lymphoma -- r_associated #0: 21 / 0.093 -> en:chicken pox
    n1=en:Hodgkin lymphoma | n2=en:chicken pox | rel=r_associated | relid=0 | w=21
  1703. en:Hodgkin lymphoma -- r_associated #0: 21 / 0.093 -> en:childhood asthma
    n1=en:Hodgkin lymphoma | n2=en:childhood asthma | rel=r_associated | relid=0 | w=21
  1704. en:Hodgkin lymphoma -- r_associated #0: 21 / 0.093 -> en:clear cell neoplasm
    n1=en:Hodgkin lymphoma | n2=en:clear cell neoplasm | rel=r_associated | relid=0 | w=21
  1705. en:Hodgkin lymphoma -- r_associated #0: 21 / 0.093 -> en:colon lymphoma
    n1=en:Hodgkin lymphoma | n2=en:colon lymphoma | rel=r_associated | relid=0 | w=21
  1706. en:Hodgkin lymphoma -- r_associated #0: 21 / 0.093 -> en:composite hodgkin and non-hodgkin lymphoma
    n1=en:Hodgkin lymphoma | n2=en:composite hodgkin and non-hodgkin lymphoma | rel=r_associated | relid=0 | w=21
  1707. en:Hodgkin lymphoma -- r_associated #0: 21 / 0.093 -> en:condylomata acuminata in men
    n1=en:Hodgkin lymphoma | n2=en:condylomata acuminata in men | rel=r_associated | relid=0 | w=21
  1708. en:Hodgkin lymphoma -- r_associated #0: 21 / 0.093 -> en:congenital cardiovascular abnormality
    n1=en:Hodgkin lymphoma | n2=en:congenital cardiovascular abnormality | rel=r_associated | relid=0 | w=21
  1709. en:Hodgkin lymphoma -- r_associated #0: 21 / 0.093 -> en:contact dermatitis and other eczema
    n1=en:Hodgkin lymphoma | n2=en:contact dermatitis and other eczema | rel=r_associated | relid=0 | w=21
  1710. en:Hodgkin lymphoma -- r_associated #0: 21 / 0.093 -> en:cystadenoma
    n1=en:Hodgkin lymphoma | n2=en:cystadenoma | rel=r_associated | relid=0 | w=21
  1711. en:Hodgkin lymphoma -- r_associated #0: 21 / 0.093 -> en:desmoid-type fibromatosis
    n1=en:Hodgkin lymphoma | n2=en:desmoid-type fibromatosis | rel=r_associated | relid=0 | w=21
  1712. en:Hodgkin lymphoma -- r_associated #0: 21 / 0.093 -> en:desmoplastic melanoma
    n1=en:Hodgkin lymphoma | n2=en:desmoplastic melanoma | rel=r_associated | relid=0 | w=21
  1713. en:Hodgkin lymphoma -- r_associated #0: 21 / 0.093 -> en:development of tumors in adulthood
    n1=en:Hodgkin lymphoma | n2=en:development of tumors in adulthood | rel=r_associated | relid=0 | w=21
  1714. en:Hodgkin lymphoma -- r_associated #0: 21 / 0.093 -> en:diabetes mellitus
    n1=en:Hodgkin lymphoma | n2=en:diabetes mellitus | rel=r_associated | relid=0 | w=21
  1715. en:Hodgkin lymphoma -- r_associated #0: 21 / 0.093 -> en:disease of teeth/gums
    n1=en:Hodgkin lymphoma | n2=en:disease of teeth/gums | rel=r_associated | relid=0 | w=21
  1716. en:Hodgkin lymphoma -- r_associated #0: 21 / 0.093 -> en:diverticulosis
    n1=en:Hodgkin lymphoma | n2=en:diverticulosis | rel=r_associated | relid=0 | w=21
  1717. en:Hodgkin lymphoma -- r_associated #0: 21 / 0.093 -> en:duodenal ulcer
    n1=en:Hodgkin lymphoma | n2=en:duodenal ulcer | rel=r_associated | relid=0 | w=21
  1718. en:Hodgkin lymphoma -- r_associated #0: 21 / 0.093 -> en:effect prosthetic device
    n1=en:Hodgkin lymphoma | n2=en:effect prosthetic device | rel=r_associated | relid=0 | w=21
  1719. en:Hodgkin lymphoma -- r_associated #0: 21 / 0.093 -> en:egg shell
    n1=en:Hodgkin lymphoma | n2=en:egg shell | rel=r_associated | relid=0 | w=21
  1720. en:Hodgkin lymphoma -- r_associated #0: 21 / 0.093 -> en:electric organ
    n1=en:Hodgkin lymphoma | n2=en:electric organ | rel=r_associated | relid=0 | w=21
  1721. en:Hodgkin lymphoma -- r_associated #0: 21 / 0.093 -> en:end stage cancer
    n1=en:Hodgkin lymphoma | n2=en:end stage cancer | rel=r_associated | relid=0 | w=21
  1722. en:Hodgkin lymphoma -- r_associated #0: 21 / 0.093 -> en:endolymphatic sac tumor
    n1=en:Hodgkin lymphoma | n2=en:endolymphatic sac tumor | rel=r_associated | relid=0 | w=21
  1723. en:Hodgkin lymphoma -- r_associated #0: 21 / 0.093 -> en:environment-related malignant neoplasm
    n1=en:Hodgkin lymphoma | n2=en:environment-related malignant neoplasm | rel=r_associated | relid=0 | w=21
  1724. en:Hodgkin lymphoma -- r_associated #0: 21 / 0.093 -> en:eosinophilic disorder
    n1=en:Hodgkin lymphoma | n2=en:eosinophilic disorder | rel=r_associated | relid=0 | w=21
  1725. en:Hodgkin lymphoma -- r_associated #0: 21 / 0.093 -> en:epithelioid malignant peripheral nerve sheath tumor
    n1=en:Hodgkin lymphoma | n2=en:epithelioid malignant peripheral nerve sheath tumor | rel=r_associated | relid=0 | w=21
  1726. en:Hodgkin lymphoma -- r_associated #0: 21 / 0.093 -> en:etiology aspects
    n1=en:Hodgkin lymphoma | n2=en:etiology aspects | rel=r_associated | relid=0 | w=21
  1727. en:Hodgkin lymphoma -- r_associated #0: 21 / 0.093 -> en:extra-adrenal paraganglioma
    n1=en:Hodgkin lymphoma | n2=en:extra-adrenal paraganglioma | rel=r_associated | relid=0 | w=21
  1728. en:Hodgkin lymphoma -- r_associated #0: 21 / 0.093 -> en:familial letterer-siwe disease
    n1=en:Hodgkin lymphoma | n2=en:familial letterer-siwe disease | rel=r_associated | relid=0 | w=21
  1729. en:Hodgkin lymphoma -- r_associated #0: 21 / 0.093 -> en:fear of contracting hiv infection
    n1=en:Hodgkin lymphoma | n2=en:fear of contracting hiv infection | rel=r_associated | relid=0 | w=21
  1730. en:Hodgkin lymphoma -- r_associated #0: 21 / 0.093 -> en:fear other blood/lymph disease
    n1=en:Hodgkin lymphoma | n2=en:fear other blood/lymph disease | rel=r_associated | relid=0 | w=21
  1731. en:Hodgkin lymphoma -- r_associated #0: 21 / 0.093 -> en:fibrosarcoma
    n1=en:Hodgkin lymphoma | n2=en:fibrosarcoma | rel=r_associated | relid=0 | w=21
  1732. en:Hodgkin lymphoma -- r_associated #0: 21 / 0.093 -> en:food allergy
    n1=en:Hodgkin lymphoma | n2=en:food allergy | rel=r_associated | relid=0 | w=21
  1733. en:Hodgkin lymphoma -- r_associated #0: 21 / 0.093 -> en:fracture other
    n1=en:Hodgkin lymphoma | n2=en:fracture other | rel=r_associated | relid=0 | w=21
  1734. en:Hodgkin lymphoma -- r_associated #0: 21 / 0.093 -> en:ganglioneuroblastoma
    n1=en:Hodgkin lymphoma | n2=en:ganglioneuroblastoma | rel=r_associated | relid=0 | w=21
  1735. en:Hodgkin lymphoma -- r_associated #0: 21 / 0.093 -> en:genitourinary neoplasms
    n1=en:Hodgkin lymphoma | n2=en:genitourinary neoplasms | rel=r_associated | relid=0 | w=21
  1736. en:Hodgkin lymphoma -- r_associated #0: 21 / 0.093 -> en:giant cell lesion of small bones
    n1=en:Hodgkin lymphoma | n2=en:giant cell lesion of small bones | rel=r_associated | relid=0 | w=21
  1737. en:Hodgkin lymphoma -- r_associated #0: 21 / 0.093 -> en:glioma
    n1=en:Hodgkin lymphoma | n2=en:glioma | rel=r_associated | relid=0 | w=21
  1738. en:Hodgkin lymphoma -- r_associated #0: 21 / 0.093 -> en:gout
    n1=en:Hodgkin lymphoma | n2=en:gout | rel=r_associated | relid=0 | w=21
  1739. en:Hodgkin lymphoma -- r_associated #0: 21 / 0.093 -> en:granular cell tumor and/or alveolar soft part sarcoma
    n1=en:Hodgkin lymphoma | n2=en:granular cell tumor and/or alveolar soft part sarcoma | rel=r_associated | relid=0 | w=21
  1740. en:Hodgkin lymphoma -- r_associated #0: 21 / 0.093 -> en:hematopoietic neoplasm/lymphoma
    n1=en:Hodgkin lymphoma | n2=en:hematopoietic neoplasm/lymphoma | rel=r_associated | relid=0 | w=21
  1741. en:Hodgkin lymphoma -- r_associated #0: 21 / 0.093 -> en:hemophagocytic lymphohistiocytosis
    n1=en:Hodgkin lymphoma | n2=en:hemophagocytic lymphohistiocytosis | rel=r_associated | relid=0 | w=21
  1742. en:Hodgkin lymphoma -- r_associated #0: 21 / 0.093 -> en:hepatic and biliary neoplasms benign
    n1=en:Hodgkin lymphoma | n2=en:hepatic and biliary neoplasms benign | rel=r_associated | relid=0 | w=21
  1743. en:Hodgkin lymphoma -- r_associated #0: 21 / 0.093 -> en:hodgkin lymphoma, unspecified, intra-abdominal lymph nodes
    n1=en:Hodgkin lymphoma | n2=en:hodgkin lymphoma, unspecified, intra-abdominal lymph nodes | rel=r_associated | relid=0 | w=21
  1744. en:Hodgkin lymphoma -- r_associated #0: 21 / 0.093 -> en:hodgkin lymphoma, unspecified, lymph nodes of inguinal region and lower limb
    n1=en:Hodgkin lymphoma | n2=en:hodgkin lymphoma, unspecified, lymph nodes of inguinal region and lower limb | rel=r_associated | relid=0 | w=21
  1745. en:Hodgkin lymphoma -- r_associated #0: 21 / 0.093 -> en:hodgkin's disease of intrathoracic lymph nodes
    n1=en:Hodgkin lymphoma | n2=en:hodgkin's disease of intrathoracic lymph nodes | rel=r_associated | relid=0 | w=21
  1746. en:Hodgkin lymphoma -- r_associated #0: 21 / 0.093 -> en:hodgkin's disease, lymphocytic depletion of lymph nodes of inguinal region and lower limb
    n1=en:Hodgkin lymphoma | n2=en:hodgkin's disease, lymphocytic depletion of lymph nodes of inguinal region and lower limb | rel=r_associated | relid=0 | w=21
  1747. en:Hodgkin lymphoma -- r_associated #0: 21 / 0.093 -> en:hodgkin's disease, lymphocytic-histiocytic predominance of intrathoracic lymph nodes
    n1=en:Hodgkin lymphoma | n2=en:hodgkin's disease, lymphocytic-histiocytic predominance of intrathoracic lymph nodes | rel=r_associated | relid=0 | w=21
  1748. en:Hodgkin lymphoma -- r_associated #0: 21 / 0.093 -> en:hodgkin's disease, mixed cellularity of intrapelvic lymph nodes
    n1=en:Hodgkin lymphoma | n2=en:hodgkin's disease, mixed cellularity of intrapelvic lymph nodes | rel=r_associated | relid=0 | w=21
  1749. en:Hodgkin lymphoma -- r_associated #0: 21 / 0.093 -> en:hodgkin's disease, unspecified type, unspecified site, extranodal and solid organ sites
    n1=en:Hodgkin lymphoma | n2=en:hodgkin's disease, unspecified type, unspecified site, extranodal and solid organ sites | rel=r_associated | relid=0 | w=21
  1750. en:Hodgkin lymphoma -- r_associated #0: 21 / 0.093 -> en:hodgkin's paragranuloma of intrapelvic lymph nodes
    n1=en:Hodgkin lymphoma | n2=en:hodgkin's paragranuloma of intrapelvic lymph nodes | rel=r_associated | relid=0 | w=21
  1751. en:Hodgkin lymphoma -- r_associated #0: 21 / 0.093 -> en:idiopathic hypereosinophilic syndrome
    n1=en:Hodgkin lymphoma | n2=en:idiopathic hypereosinophilic syndrome | rel=r_associated | relid=0 | w=21
  1752. en:Hodgkin lymphoma -- r_associated #0: 21 / 0.093 -> en:increased risk of chondrosarcoma
    n1=en:Hodgkin lymphoma | n2=en:increased risk of chondrosarcoma | rel=r_associated | relid=0 | w=21
  1753. en:Hodgkin lymphoma -- r_associated #0: 21 / 0.093 -> en:increased risk of myelodysplastic syndrome or leukemia (in some patients)
    n1=en:Hodgkin lymphoma | n2=en:increased risk of myelodysplastic syndrome or leukemia (in some patients) | rel=r_associated | relid=0 | w=21
  1754. en:Hodgkin lymphoma -- r_associated #0: 21 / 0.093 -> en:increased susceptibility to hematologic malignancies
    n1=en:Hodgkin lymphoma | n2=en:increased susceptibility to hematologic malignancies | rel=r_associated | relid=0 | w=21
  1755. en:Hodgkin lymphoma -- r_associated #0: 21 / 0.093 -> en:induced abortion finding
    n1=en:Hodgkin lymphoma | n2=en:induced abortion finding | rel=r_associated | relid=0 | w=21
  1756. en:Hodgkin lymphoma -- r_associated #0: 21 / 0.093 -> en:infectious disease circulatory system
    n1=en:Hodgkin lymphoma | n2=en:infectious disease circulatory system | rel=r_associated | relid=0 | w=21
  1757. en:Hodgkin lymphoma -- r_associated #0: 21 / 0.093 -> en:infectious disorder
    n1=en:Hodgkin lymphoma | n2=en:infectious disorder | rel=r_associated | relid=0 | w=21
  1758. en:Hodgkin lymphoma -- r_associated #0: 21 / 0.093 -> en:invasive ductal carcinoma, not otherwise specified
    n1=en:Hodgkin lymphoma | n2=en:invasive ductal carcinoma, not otherwise specified | rel=r_associated | relid=0 | w=21
  1759. en:Hodgkin lymphoma -- r_associated #0: 21 / 0.093 -> en:invasive malignant neoplasm
    n1=en:Hodgkin lymphoma | n2=en:invasive malignant neoplasm | rel=r_associated | relid=0 | w=21
  1760. en:Hodgkin lymphoma -- r_associated #0: 21 / 0.093 -> en:jaw and kidney tumor (endemic form)
    n1=en:Hodgkin lymphoma | n2=en:jaw and kidney tumor (endemic form) | rel=r_associated | relid=0 | w=21
  1761. en:Hodgkin lymphoma -- r_associated #0: 21 / 0.093 -> en:juvenile ovarian granulosa cell tumor
    n1=en:Hodgkin lymphoma | n2=en:juvenile ovarian granulosa cell tumor | rel=r_associated | relid=0 | w=21
  1762. en:Hodgkin lymphoma -- r_associated #0: 21 / 0.093 -> en:kidney wilms tumor
    n1=en:Hodgkin lymphoma | n2=en:kidney wilms tumor | rel=r_associated | relid=0 | w=21
  1763. en:Hodgkin lymphoma -- r_associated #0: 21 / 0.093 -> en:limited hematological function
    n1=en:Hodgkin lymphoma | n2=en:limited hematological function | rel=r_associated | relid=0 | w=21
  1764. en:Hodgkin lymphoma -- r_associated #0: 21 / 0.093 -> en:liposarcoma
    n1=en:Hodgkin lymphoma | n2=en:liposarcoma | rel=r_associated | relid=0 | w=21
  1765. en:Hodgkin lymphoma -- r_associated #0: 21 / 0.093 -> en:localized malignant neoplasm
    n1=en:Hodgkin lymphoma | n2=en:localized malignant neoplasm | rel=r_associated | relid=0 | w=21
  1766. en:Hodgkin lymphoma -- r_associated #0: 21 / 0.093 -> en:lung lymphoma
    n1=en:Hodgkin lymphoma | n2=en:lung lymphoma | rel=r_associated | relid=0 | w=21
  1767. en:Hodgkin lymphoma -- r_associated #0: 21 / 0.093 -> en:lymphocyte-rich classical hodgkin lymphoma, intrathoracic lymph nodes
    n1=en:Hodgkin lymphoma | n2=en:lymphocyte-rich classical hodgkin lymphoma, intrathoracic lymph nodes | rel=r_associated | relid=0 | w=21
  1768. en:Hodgkin lymphoma -- r_associated #0: 21 / 0.093 -> en:lymphoid tissue
    n1=en:Hodgkin lymphoma | n2=en:lymphoid tissue | rel=r_associated | relid=0 | w=21
  1769. en:Hodgkin lymphoma -- r_associated #0: 21 / 0.093 -> en:lymphoma of retroperitoneal space
    n1=en:Hodgkin lymphoma | n2=en:lymphoma of retroperitoneal space | rel=r_associated | relid=0 | w=21
  1770. en:Hodgkin lymphoma -- r_associated #0: 21 / 0.093 -> en:male genital injuries
    n1=en:Hodgkin lymphoma | n2=en:male genital injuries | rel=r_associated | relid=0 | w=21
  1771. en:Hodgkin lymphoma -- r_associated #0: 21 / 0.093 -> en:malignant blood vessel neoplasm
    n1=en:Hodgkin lymphoma | n2=en:malignant blood vessel neoplasm | rel=r_associated | relid=0 | w=21
  1772. en:Hodgkin lymphoma -- r_associated #0: 21 / 0.093 -> en:malignant endocrine neoplasm
    n1=en:Hodgkin lymphoma | n2=en:malignant endocrine neoplasm | rel=r_associated | relid=0 | w=21
  1773. en:Hodgkin lymphoma -- r_associated #0: 21 / 0.093 -> en:malignant epithelioma
    n1=en:Hodgkin lymphoma | n2=en:malignant epithelioma | rel=r_associated | relid=0 | w=21
  1774. en:Hodgkin lymphoma -- r_associated #0: 21 / 0.093 -> en:malignant lipomatous neoplasm
    n1=en:Hodgkin lymphoma | n2=en:malignant lipomatous neoplasm | rel=r_associated | relid=0 | w=21
  1775. en:Hodgkin lymphoma -- r_associated #0: 21 / 0.093 -> en:malignant neoplasm
    n1=en:Hodgkin lymphoma | n2=en:malignant neoplasm | rel=r_associated | relid=0 | w=21
  1776. en:Hodgkin lymphoma -- r_associated #0: 21 / 0.093 -> en:malignant neoplasm of nail apparatus
    n1=en:Hodgkin lymphoma | n2=en:malignant neoplasm of nail apparatus | rel=r_associated | relid=0 | w=21
  1777. en:Hodgkin lymphoma -- r_associated #0: 21 / 0.093 -> en:malignant neoplasm of other and unspecified sites
    n1=en:Hodgkin lymphoma | n2=en:malignant neoplasm of other and unspecified sites | rel=r_associated | relid=0 | w=21
  1778. en:Hodgkin lymphoma -- r_associated #0: 21 / 0.093 -> en:malignant neuroendocrine neoplasm, neural
    n1=en:Hodgkin lymphoma | n2=en:malignant neuroendocrine neoplasm, neural | rel=r_associated | relid=0 | w=21
  1779. en:Hodgkin lymphoma -- r_associated #0: 21 / 0.093 -> en:malignant obstetric neoplasm
    n1=en:Hodgkin lymphoma | n2=en:malignant obstetric neoplasm | rel=r_associated | relid=0 | w=21
  1780. en:Hodgkin lymphoma -- r_associated #0: 21 / 0.093 -> en:malignant ovarian brenner tumor
    n1=en:Hodgkin lymphoma | n2=en:malignant ovarian brenner tumor | rel=r_associated | relid=0 | w=21
  1781. en:Hodgkin lymphoma -- r_associated #0: 21 / 0.093 -> en:malignant struma ovarii
    n1=en:Hodgkin lymphoma | n2=en:malignant struma ovarii | rel=r_associated | relid=0 | w=21
  1782. en:Hodgkin lymphoma -- r_associated #0: 21 / 0.093 -> en:malignant tenosynovial giant cell tumor
    n1=en:Hodgkin lymphoma | n2=en:malignant tenosynovial giant cell tumor | rel=r_associated | relid=0 | w=21
  1783. en:Hodgkin lymphoma -- r_associated #0: 21 / 0.093 -> en:marek disease
    n1=en:Hodgkin lymphoma | n2=en:marek disease | rel=r_associated | relid=0 | w=21
  1784. en:Hodgkin lymphoma -- r_associated #0: 21 / 0.093 -> en:measles
    n1=en:Hodgkin lymphoma | n2=en:measles | rel=r_associated | relid=0 | w=21
  1785. en:Hodgkin lymphoma -- r_associated #0: 21 / 0.093 -> en:mesothelioma, malignant, after asbestos exposure
    n1=en:Hodgkin lymphoma | n2=en:mesothelioma, malignant, after asbestos exposure | rel=r_associated | relid=0 | w=21
  1786. en:Hodgkin lymphoma -- r_associated #0: 21 / 0.093 -> en:microbiological
    n1=en:Hodgkin lymphoma | n2=en:microbiological | rel=r_associated | relid=0 | w=21
  1787. en:Hodgkin lymphoma -- r_associated #0: 21 / 0.093 -> en:miscellaneous and site unspecified neoplasms malignant and unspecified
    n1=en:Hodgkin lymphoma | n2=en:miscellaneous and site unspecified neoplasms malignant and unspecified | rel=r_associated | relid=0 | w=21
  1788. en:Hodgkin lymphoma -- r_associated #0: 21 / 0.093 -> en:mixed cellularity classical hodgkin lymphoma, lymph nodes of axilla and upper limb
    n1=en:Hodgkin lymphoma | n2=en:mixed cellularity classical hodgkin lymphoma, lymph nodes of axilla and upper limb | rel=r_associated | relid=0 | w=21
  1789. en:Hodgkin lymphoma -- r_associated #0: 21 / 0.093 -> en:mixed cellularity classical hodgkin lymphoma, unspecified site
    n1=en:Hodgkin lymphoma | n2=en:mixed cellularity classical hodgkin lymphoma, unspecified site | rel=r_associated | relid=0 | w=21
  1790. en:Hodgkin lymphoma -- r_associated #0: 21 / 0.093 -> en:mixed tumor, mesodermal
    n1=en:Hodgkin lymphoma | n2=en:mixed tumor, mesodermal | rel=r_associated | relid=0 | w=21
  1791. en:Hodgkin lymphoma -- r_associated #0: 21 / 0.093 -> en:mononuclear phagocyte system
    n1=en:Hodgkin lymphoma | n2=en:mononuclear phagocyte system | rel=r_associated | relid=0 | w=21
  1792. en:Hodgkin lymphoma -- r_associated #0: 21 / 0.093 -> en:mucoepidermoid carcinoma
    n1=en:Hodgkin lymphoma | n2=en:mucoepidermoid carcinoma | rel=r_associated | relid=0 | w=21
  1793. en:Hodgkin lymphoma -- r_associated #0: 21 / 0.093 -> en:mumps
    n1=en:Hodgkin lymphoma | n2=en:mumps | rel=r_associated | relid=0 | w=21
  1794. en:Hodgkin lymphoma -- r_associated #0: 21 / 0.093 -> en:myxoid subcutaneous tumors
    n1=en:Hodgkin lymphoma | n2=en:myxoid subcutaneous tumors | rel=r_associated | relid=0 | w=21
  1795. en:Hodgkin lymphoma -- r_associated #0: 21 / 0.093 -> en:neoplasm of uncertain behavior of other specified sites
    n1=en:Hodgkin lymphoma | n2=en:neoplasm of uncertain behavior of other specified sites | rel=r_associated | relid=0 | w=21
  1796. en:Hodgkin lymphoma -- r_associated #0: 21 / 0.093 -> en:neoplasms, experimental
    n1=en:Hodgkin lymphoma | n2=en:neoplasms, experimental | rel=r_associated | relid=0 | w=21
  1797. en:Hodgkin lymphoma -- r_associated #0: 21 / 0.093 -> en:neoplasms, post-traumatic
    n1=en:Hodgkin lymphoma | n2=en:neoplasms, post-traumatic | rel=r_associated | relid=0 | w=21
  1798. en:Hodgkin lymphoma -- r_associated #0: 21 / 0.093 -> en:neoplastic processes
    n1=en:Hodgkin lymphoma | n2=en:neoplastic processes | rel=r_associated | relid=0 | w=21
  1799. en:Hodgkin lymphoma -- r_associated #0: 21 / 0.093 -> en:neuroblastoma
    n1=en:Hodgkin lymphoma | n2=en:neuroblastoma | rel=r_associated | relid=0 | w=21
  1800. en:Hodgkin lymphoma -- r_associated #0: 21 / 0.093 -> en:neuroendocrine neoplasm
    n1=en:Hodgkin lymphoma | n2=en:neuroendocrine neoplasm | rel=r_associated | relid=0 | w=21
  1801. en:Hodgkin lymphoma -- r_associated #0: 21 / 0.093 -> en:nevus/mole
    n1=en:Hodgkin lymphoma | n2=en:nevus/mole | rel=r_associated | relid=0 | w=21
  1802. en:Hodgkin lymphoma -- r_associated #0: 21 / 0.093 -> en:nodular lymphocyte predominant hodgkin lymphoma, lymph nodes of axilla and upper limb
    n1=en:Hodgkin lymphoma | n2=en:nodular lymphocyte predominant hodgkin lymphoma, lymph nodes of axilla and upper limb | rel=r_associated | relid=0 | w=21
  1803. en:Hodgkin lymphoma -- r_associated #0: 21 / 0.093 -> en:nonneoplastic disorders/lesions (all subtypes)
    n1=en:Hodgkin lymphoma | n2=en:nonneoplastic disorders/lesions (all subtypes) | rel=r_associated | relid=0 | w=21
  1804. en:Hodgkin lymphoma -- r_associated #0: 21 / 0.093 -> en:oncocytic adenoma
    n1=en:Hodgkin lymphoma | n2=en:oncocytic adenoma | rel=r_associated | relid=0 | w=21
  1805. en:Hodgkin lymphoma -- r_associated #0: 21 / 0.093 -> en:osgood-schlatter's disease
    n1=en:Hodgkin lymphoma | n2=en:osgood-schlatter's disease | rel=r_associated | relid=0 | w=21
  1806. en:Hodgkin lymphoma -- r_associated #0: 21 / 0.093 -> en:other and unspecified malignant neoplasms of lymphoid, haematopoietic and related tissue
    n1=en:Hodgkin lymphoma | n2=en:other and unspecified malignant neoplasms of lymphoid, haematopoietic and related tissue | rel=r_associated | relid=0 | w=21
  1807. en:Hodgkin lymphoma -- r_associated #0: 21 / 0.093 -> en:other classical hodgkin lymphoma, lymph nodes of axilla and upper limb
    n1=en:Hodgkin lymphoma | n2=en:other classical hodgkin lymphoma, lymph nodes of axilla and upper limb | rel=r_associated | relid=0 | w=21
  1808. en:Hodgkin lymphoma -- r_associated #0: 21 / 0.093 -> en:other disease blood/lymph/spleen
    n1=en:Hodgkin lymphoma | n2=en:other disease blood/lymph/spleen | rel=r_associated | relid=0 | w=21
  1809. en:Hodgkin lymphoma -- r_associated #0: 21 / 0.093 -> en:other disease of neurological system
    n1=en:Hodgkin lymphoma | n2=en:other disease of neurological system | rel=r_associated | relid=0 | w=21
  1810. en:Hodgkin lymphoma -- r_associated #0: 21 / 0.093 -> en:other endocrine/metabolic nutritional disease
    n1=en:Hodgkin lymphoma | n2=en:other endocrine/metabolic nutritional disease | rel=r_associated | relid=0 | w=21
  1811. en:Hodgkin lymphoma -- r_associated #0: 21 / 0.093 -> en:other infections of respiratory system
    n1=en:Hodgkin lymphoma | n2=en:other infections of respiratory system | rel=r_associated | relid=0 | w=21
  1812. en:Hodgkin lymphoma -- r_associated #0: 21 / 0.093 -> en:other malignant lymphomas
    n1=en:Hodgkin lymphoma | n2=en:other malignant lymphomas | rel=r_associated | relid=0 | w=21
  1813. en:Hodgkin lymphoma -- r_associated #0: 21 / 0.093 -> en:other malignant neoplasm urinary tract
    n1=en:Hodgkin lymphoma | n2=en:other malignant neoplasm urinary tract | rel=r_associated | relid=0 | w=21
  1814. en:Hodgkin lymphoma -- r_associated #0: 21 / 0.093 -> en:other malignant respiratory neoplasm
    n1=en:Hodgkin lymphoma | n2=en:other malignant respiratory neoplasm | rel=r_associated | relid=0 | w=21
  1815. en:Hodgkin lymphoma -- r_associated #0: 21 / 0.093 -> en:other specified types of t/nk-cell lymphoma
    n1=en:Hodgkin lymphoma | n2=en:other specified types of t/nk-cell lymphoma | rel=r_associated | relid=0 | w=21
  1816. en:Hodgkin lymphoma -- r_associated #0: 21 / 0.093 -> en:papillary meningioma
    n1=en:Hodgkin lymphoma | n2=en:papillary meningioma | rel=r_associated | relid=0 | w=21
  1817. en:Hodgkin lymphoma -- r_associated #0: 21 / 0.093 -> en:papillary renal cell carcinoma
    n1=en:Hodgkin lymphoma | n2=en:papillary renal cell carcinoma | rel=r_associated | relid=0 | w=21
  1818. en:Hodgkin lymphoma -- r_associated #0: 21 / 0.093 -> en:personality disorder
    n1=en:Hodgkin lymphoma | n2=en:personality disorder | rel=r_associated | relid=0 | w=21
  1819. en:Hodgkin lymphoma -- r_associated #0: 21 / 0.093 -> en:pheochromocytomas, extraadrenal (48%)
    n1=en:Hodgkin lymphoma | n2=en:pheochromocytomas, extraadrenal (48%) | rel=r_associated | relid=0 | w=21
  1820. en:Hodgkin lymphoma -- r_associated #0: 21 / 0.093 -> en:phlebitis and thrombophlebitis
    n1=en:Hodgkin lymphoma | n2=en:phlebitis and thrombophlebitis | rel=r_associated | relid=0 | w=21
  1821. en:Hodgkin lymphoma -- r_associated #0: 21 / 0.093 -> en:pilocytic astrocytoma
    n1=en:Hodgkin lymphoma | n2=en:pilocytic astrocytoma | rel=r_associated | relid=0 | w=21
  1822. en:Hodgkin lymphoma -- r_associated #0: 21 / 0.093 -> en:pleuropulmonary blastoma
    n1=en:Hodgkin lymphoma | n2=en:pleuropulmonary blastoma | rel=r_associated | relid=0 | w=21
  1823. en:Hodgkin lymphoma -- r_associated #0: 21 / 0.093 -> en:pneumocystis infections
    n1=en:Hodgkin lymphoma | n2=en:pneumocystis infections | rel=r_associated | relid=0 | w=21
  1824. en:Hodgkin lymphoma -- r_associated #0: 21 / 0.093 -> en:precursor b-lymphoblastic leukemia/lymphoblastic lymphoma
    n1=en:Hodgkin lymphoma | n2=en:precursor b-lymphoblastic leukemia/lymphoblastic lymphoma | rel=r_associated | relid=0 | w=21
  1825. en:Hodgkin lymphoma -- r_associated #0: 21 / 0.093 -> en:pregnancy complications, infectious
    n1=en:Hodgkin lymphoma | n2=en:pregnancy complications, infectious | rel=r_associated | relid=0 | w=21
  1826. en:Hodgkin lymphoma -- r_associated #0: 21 / 0.093 -> en:preneoplastic state
    n1=en:Hodgkin lymphoma | n2=en:preneoplastic state | rel=r_associated | relid=0 | w=21
  1827. en:Hodgkin lymphoma -- r_associated #0: 21 / 0.093 -> en:primary malignant neoplasm of muscle
    n1=en:Hodgkin lymphoma | n2=en:primary malignant neoplasm of muscle | rel=r_associated | relid=0 | w=21
  1828. en:Hodgkin lymphoma -- r_associated #0: 21 / 0.093 -> en:primary myelofibrosis
    n1=en:Hodgkin lymphoma | n2=en:primary myelofibrosis | rel=r_associated | relid=0 | w=21
  1829. en:Hodgkin lymphoma -- r_associated #0: 21 / 0.093 -> en:primary pulmonary lymphoma
    n1=en:Hodgkin lymphoma | n2=en:primary pulmonary lymphoma | rel=r_associated | relid=0 | w=21
  1830. en:Hodgkin lymphoma -- r_associated #0: 21 / 0.093 -> en:primitive neuroectodermal tumor
    n1=en:Hodgkin lymphoma | n2=en:primitive neuroectodermal tumor | rel=r_associated | relid=0 | w=21
  1831. en:Hodgkin lymphoma -- r_associated #0: 21 / 0.093 -> en:protozoal cyst
    n1=en:Hodgkin lymphoma | n2=en:protozoal cyst | rel=r_associated | relid=0 | w=21
  1832. en:Hodgkin lymphoma -- r_associated #0: 21 / 0.093 -> en:psychology qualifier
    n1=en:Hodgkin lymphoma | n2=en:psychology qualifier | rel=r_associated | relid=0 | w=21
  1833. en:Hodgkin lymphoma -- r_associated #0: 21 / 0.093 -> en:radiation therapy
    n1=en:Hodgkin lymphoma | n2=en:radiation therapy | rel=r_associated | relid=0 | w=21
  1834. en:Hodgkin lymphoma -- r_associated #0: 21 / 0.093 -> en:recurrent lymphocyte-depleted classical hodgkin lymphoma
    n1=en:Hodgkin lymphoma | n2=en:recurrent lymphocyte-depleted classical hodgkin lymphoma | rel=r_associated | relid=0 | w=21
  1835. en:Hodgkin lymphoma -- r_associated #0: 21 / 0.093 -> en:refractive error
    n1=en:Hodgkin lymphoma | n2=en:refractive error | rel=r_associated | relid=0 | w=21
  1836. en:Hodgkin lymphoma -- r_associated #0: 21 / 0.093 -> en:rehabilitation aspects
    n1=en:Hodgkin lymphoma | n2=en:rehabilitation aspects | rel=r_associated | relid=0 | w=21
  1837. en:Hodgkin lymphoma -- r_associated #0: 21 / 0.093 -> en:reticulosarcoma
    n1=en:Hodgkin lymphoma | n2=en:reticulosarcoma | rel=r_associated | relid=0 | w=21
  1838. en:Hodgkin lymphoma -- r_associated #0: 21 / 0.093 -> en:rhabdoid tumors, malignant (renal or extrarenal)
    n1=en:Hodgkin lymphoma | n2=en:rhabdoid tumors, malignant (renal or extrarenal) | rel=r_associated | relid=0 | w=21
  1839. en:Hodgkin lymphoma -- r_associated #0: 21 / 0.093 -> en:sarcoma
    n1=en:Hodgkin lymphoma | n2=en:sarcoma | rel=r_associated | relid=0 | w=21
  1840. en:Hodgkin lymphoma -- r_associated #0: 21 / 0.093 -> en:skin adenoid basal cell carcinoma
    n1=en:Hodgkin lymphoma | n2=en:skin adenoid basal cell carcinoma | rel=r_associated | relid=0 | w=21
  1841. en:Hodgkin lymphoma -- r_associated #0: 21 / 0.093 -> en:skin squamous cell carcinoma
    n1=en:Hodgkin lymphoma | n2=en:skin squamous cell carcinoma | rel=r_associated | relid=0 | w=21
  1842. en:Hodgkin lymphoma -- r_associated #0: 21 / 0.093 -> en:spleen, lymphatic and reticuloendothelial system disorders
    n1=en:Hodgkin lymphoma | n2=en:spleen, lymphatic and reticuloendothelial system disorders | rel=r_associated | relid=0 | w=21
  1843. en:Hodgkin lymphoma -- r_associated #0: 21 / 0.093 -> en:squamous cell carcinoma (skin and tongue)
    n1=en:Hodgkin lymphoma | n2=en:squamous cell carcinoma (skin and tongue) | rel=r_associated | relid=0 | w=21
  1844. en:Hodgkin lymphoma -- r_associated #0: 21 / 0.093 -> en:stage 0 cervical cancer ajcc v6
    n1=en:Hodgkin lymphoma | n2=en:stage 0 cervical cancer ajcc v6 | rel=r_associated | relid=0 | w=21
  1845. en:Hodgkin lymphoma -- r_associated #0: 21 / 0.093 -> en:stage ii lymphocyte-depleted classical hodgkin lymphoma
    n1=en:Hodgkin lymphoma | n2=en:stage ii lymphocyte-depleted classical hodgkin lymphoma | rel=r_associated | relid=0 | w=21
  1846. en:Hodgkin lymphoma -- r_associated #0: 21 / 0.093 -> en:stage iii hodgkin lymphoma
    n1=en:Hodgkin lymphoma | n2=en:stage iii hodgkin lymphoma | rel=r_associated | relid=0 | w=21
  1847. en:Hodgkin lymphoma -- r_associated #0: 21 / 0.093 -> en:stage iii lymphocyte-depleted classical hodgkin lymphoma
    n1=en:Hodgkin lymphoma | n2=en:stage iii lymphocyte-depleted classical hodgkin lymphoma | rel=r_associated | relid=0 | w=21
  1848. en:Hodgkin lymphoma -- r_associated #0: 21 / 0.093 -> en:stage iv hodgkin's disease lymphocyte predominance type
    n1=en:Hodgkin lymphoma | n2=en:stage iv hodgkin's disease lymphocyte predominance type | rel=r_associated | relid=0 | w=21
  1849. en:Hodgkin lymphoma -- r_associated #0: 21 / 0.093 -> en:susceptibility to malignant melanoma
    n1=en:Hodgkin lymphoma | n2=en:susceptibility to malignant melanoma | rel=r_associated | relid=0 | w=21
  1850. en:Hodgkin lymphoma -- r_associated #0: 21 / 0.093 -> en:thyroid follicular cell tumor
    n1=en:Hodgkin lymphoma | n2=en:thyroid follicular cell tumor | rel=r_associated | relid=0 | w=21
  1851. en:Hodgkin lymphoma -- r_associated #0: 21 / 0.093 -> en:trachoma
    n1=en:Hodgkin lymphoma | n2=en:trachoma | rel=r_associated | relid=0 | w=21
  1852. en:Hodgkin lymphoma -- r_associated #0: 21 / 0.093 -> en:type 1b autoimmune lymphoproliferative syndrome
    n1=en:Hodgkin lymphoma | n2=en:type 1b autoimmune lymphoproliferative syndrome | rel=r_associated | relid=0 | w=21
  1853. en:Hodgkin lymphoma -- r_associated #0: 21 / 0.093 -> en:undifferentiated and biphenotypic leukemia (all subtypes)
    n1=en:Hodgkin lymphoma | n2=en:undifferentiated and biphenotypic leukemia (all subtypes) | rel=r_associated | relid=0 | w=21
  1854. en:Hodgkin lymphoma -- r_associated #0: 21 / 0.093 -> en:undifferentiated carcinoma
    n1=en:Hodgkin lymphoma | n2=en:undifferentiated carcinoma | rel=r_associated | relid=0 | w=21
  1855. en:Hodgkin lymphoma -- r_associated #0: 21 / 0.093 -> en:use of ultrasonography
    n1=en:Hodgkin lymphoma | n2=en:use of ultrasonography | rel=r_associated | relid=0 | w=21
  1856. en:Hodgkin lymphoma -- r_associated #0: 20 / 0.088 -> en:hodgkin's disease
    n1=en:Hodgkin lymphoma | n2=en:hodgkin's disease | rel=r_associated | relid=0 | w=20
  1857. en:Hodgkin lymphoma -- r_associated #0: 20 / 0.088 -> maladie de hodgkin
    n1=en:Hodgkin lymphoma | n2=maladie de hodgkin | rel=r_associated | relid=0 | w=20
  1858. en:Hodgkin lymphoma -- r_associated #0: 20 / 0.088 -> Maladie de Hodgkin
    n1=en:Hodgkin lymphoma | n2=Maladie de Hodgkin | rel=r_associated | relid=0 | w=20
  1859. en:Hodgkin lymphoma -- r_associated #0: 15 / 0.066 -> en:hematology
    n1=en:Hodgkin lymphoma | n2=en:hematology | rel=r_associated | relid=0 | w=15
  1860. en:Hodgkin lymphoma -- r_associated #0: 15 / 0.066 -> en:medicine
    n1=en:Hodgkin lymphoma | n2=en:medicine | rel=r_associated | relid=0 | w=15
  1861. en:Hodgkin lymphoma -- r_associated #0: 15 / 0.066 -> en:specialized branches of medicine
    n1=en:Hodgkin lymphoma | n2=en:specialized branches of medicine | rel=r_associated | relid=0 | w=15
  1862. en:Hodgkin lymphoma -- r_associated #0: 15 / 0.066 -> pathologie
    n1=en:Hodgkin lymphoma | n2=pathologie | rel=r_associated | relid=0 | w=15
  1863. en:Hodgkin lymphoma -- r_associated #0: 5 / 0.022 -> Médecine
    n1=en:Hodgkin lymphoma | n2=Médecine | rel=r_associated | relid=0 | w=5
  1864. en:Hodgkin lymphoma -- r_associated #0: 2 / 0.009 -> lymphome à cellules b
    n1=en:Hodgkin lymphoma | n2=lymphome à cellules b | rel=r_associated | relid=0 | w=2
  1865. en:Hodgkin lymphoma -- r_associated #0: 2 / 0.009 -> lymphome malin diffus
    n1=en:Hodgkin lymphoma | n2=lymphome malin diffus | rel=r_associated | relid=0 | w=2
  1866. en:Hodgkin lymphoma -- r_associated #0: 2 / 0.009 -> processus néoplasique
    n1=en:Hodgkin lymphoma | n2=processus néoplasique | rel=r_associated | relid=0 | w=2
≈ 1138 relations entrantes

  1. médecine --- r_associated #0: 176 --> en:Hodgkin lymphoma
    n1=médecine | n2=en:Hodgkin lymphoma | rel=r_associated | relid=0 | w=176
  2. en:Hodgkin's disease --- r_associated #0: 35 --> en:Hodgkin lymphoma
    n1=en:Hodgkin's disease | n2=en:Hodgkin lymphoma | rel=r_associated | relid=0 | w=35
  3. lymphogranulomatose maligne --- r_associated #0: 35 --> en:Hodgkin lymphoma
    n1=lymphogranulomatose maligne | n2=en:Hodgkin lymphoma | rel=r_associated | relid=0 | w=35
  4. maladie de hodgkin --- r_associated #0: 33 --> en:Hodgkin lymphoma
    n1=maladie de hodgkin | n2=en:Hodgkin lymphoma | rel=r_associated | relid=0 | w=33
  5. en:malignant lymphogranulomatosis --- r_associated #0: 32 --> en:Hodgkin lymphoma
    n1=en:malignant lymphogranulomatosis | n2=en:Hodgkin lymphoma | rel=r_associated | relid=0 | w=32
  6. Hodgkin (maladie de) --- r_associated #0: 29 --> en:Hodgkin lymphoma
    n1=Hodgkin (maladie de) | n2=en:Hodgkin lymphoma | rel=r_associated | relid=0 | w=29
  7. maladie de Hodgkin --- r_associated #0: 29 --> en:Hodgkin lymphoma
    n1=maladie de Hodgkin | n2=en:Hodgkin lymphoma | rel=r_associated | relid=0 | w=29
  8. en:hodgkin's disease --- r_associated #0: 28 --> en:Hodgkin lymphoma
    n1=en:hodgkin's disease | n2=en:Hodgkin lymphoma | rel=r_associated | relid=0 | w=28
  9. Maladie de Hodgkin --- r_associated #0: 27 --> en:Hodgkin lymphoma
    n1=Maladie de Hodgkin | n2=en:Hodgkin lymphoma | rel=r_associated | relid=0 | w=27
  10. en:Hodgkin's lymphoma --- r_associated #0: 27 --> en:Hodgkin lymphoma
    n1=en:Hodgkin's lymphoma | n2=en:Hodgkin lymphoma | rel=r_associated | relid=0 | w=27
  11. hodgkin --- r_associated #0: 21 --> en:Hodgkin lymphoma
    n1=hodgkin | n2=en:Hodgkin lymphoma | rel=r_associated | relid=0 | w=21
  12. lymphogranulomatose --- r_associated #0: 21 --> en:Hodgkin lymphoma
    n1=lymphogranulomatose | n2=en:Hodgkin lymphoma | rel=r_associated | relid=0 | w=21
  13. 965-966 lymphome de hodgkin --- r_associated #0: 20 --> en:Hodgkin lymphoma
    n1=965-966 lymphome de hodgkin | n2=en:Hodgkin lymphoma | rel=r_associated | relid=0 | w=20
  14. Hodgkin --- r_associated #0: 20 --> en:Hodgkin lymphoma
    n1=Hodgkin | n2=en:Hodgkin lymphoma | rel=r_associated | relid=0 | w=20
  15. Hodgkin (localisations cutanées de la maladie de) --- r_associated #0: 20 --> en:Hodgkin lymphoma
    n1=Hodgkin (localisations cutanées de la maladie de) | n2=en:Hodgkin lymphoma | rel=r_associated | relid=0 | w=20
  16. Hodgkin à prédominance lymphocytaire nodulaire (maladie de) --- r_associated #0: 20 --> en:Hodgkin lymphoma
    n1=Hodgkin à prédominance lymphocytaire nodulaire (maladie de) | n2=en:Hodgkin lymphoma | rel=r_associated | relid=0 | w=20
  17. MDH --- r_associated #0: 20 --> en:Hodgkin lymphoma
    n1=MDH | n2=en:Hodgkin lymphoma | rel=r_associated | relid=0 | w=20
  18. Sternberg (cellule de) --- r_associated #0: 20 --> en:Hodgkin lymphoma
    n1=Sternberg (cellule de) | n2=en:Hodgkin lymphoma | rel=r_associated | relid=0 | w=20
  19. adénopathie --- r_associated #0: 20 --> en:Hodgkin lymphoma
    n1=adénopathie | n2=en:Hodgkin lymphoma | rel=r_associated | relid=0 | w=20
  20. angéite associée à des cancers --- r_associated #0: 20 --> en:Hodgkin lymphoma
    n1=angéite associée à des cancers | n2=en:Hodgkin lymphoma | rel=r_associated | relid=0 | w=20
  21. cancer --- r_associated #0: 20 --> en:Hodgkin lymphoma
    n1=cancer | n2=en:Hodgkin lymphoma | rel=r_associated | relid=0 | w=20
  22. cancer de la rate --- r_associated #0: 20 --> en:Hodgkin lymphoma
    n1=cancer de la rate | n2=en:Hodgkin lymphoma | rel=r_associated | relid=0 | w=20
  23. cancer du système lymphatique --- r_associated #0: 20 --> en:Hodgkin lymphoma
    n1=cancer du système lymphatique | n2=en:Hodgkin lymphoma | rel=r_associated | relid=0 | w=20
  24. cancer splénique --- r_associated #0: 20 --> en:Hodgkin lymphoma
    n1=cancer splénique | n2=en:Hodgkin lymphoma | rel=r_associated | relid=0 | w=20
  25. cellule de Reed-Sternberg --- r_associated #0: 20 --> en:Hodgkin lymphoma
    n1=cellule de Reed-Sternberg | n2=en:Hodgkin lymphoma | rel=r_associated | relid=0 | w=20
  26. en:abdominal tumors (immunodeficiency-associated form) --- r_associated #0: 20 --> en:Hodgkin lymphoma
    n1=en:abdominal tumors (immunodeficiency-associated form) | n2=en:Hodgkin lymphoma | rel=r_associated | relid=0 | w=20
  27. en:abnormal pap smear --- r_associated #0: 20 --> en:Hodgkin lymphoma
    n1=en:abnormal pap smear | n2=en:Hodgkin lymphoma | rel=r_associated | relid=0 | w=20
  28. en:abnormal results investigation nos --- r_associated #0: 20 --> en:Hodgkin lymphoma
    n1=en:abnormal results investigation nos | n2=en:Hodgkin lymphoma | rel=r_associated | relid=0 | w=20
  29. en:acinar cell carcinoma --- r_associated #0: 20 --> en:Hodgkin lymphoma
    n1=en:acinar cell carcinoma | n2=en:Hodgkin lymphoma | rel=r_associated | relid=0 | w=20
  30. en:acne --- r_associated #0: 20 --> en:Hodgkin lymphoma
    n1=en:acne | n2=en:Hodgkin lymphoma | rel=r_associated | relid=0 | w=20
  31. en:acquired deformity of limb --- r_associated #0: 20 --> en:Hodgkin lymphoma
    n1=en:acquired deformity of limb | n2=en:Hodgkin lymphoma | rel=r_associated | relid=0 | w=20
  32. en:acquired deformity of spine --- r_associated #0: 20 --> en:Hodgkin lymphoma
    n1=en:acquired deformity of spine | n2=en:Hodgkin lymphoma | rel=r_associated | relid=0 | w=20
  33. en:acute bronchitis and bronchiolitis --- r_associated #0: 20 --> en:Hodgkin lymphoma
    n1=en:acute bronchitis and bronchiolitis | n2=en:Hodgkin lymphoma | rel=r_associated | relid=0 | w=20
  34. en:acute lymphadenitis --- r_associated #0: 20 --> en:Hodgkin lymphoma
    n1=en:acute lymphadenitis | n2=en:Hodgkin lymphoma | rel=r_associated | relid=0 | w=20
  35. en:acute lymphoblastic leukemia (in 1 patient) --- r_associated #0: 20 --> en:Hodgkin lymphoma
    n1=en:acute lymphoblastic leukemia (in 1 patient) | n2=en:Hodgkin lymphoma | rel=r_associated | relid=0 | w=20
  36. en:acute miliary tuberculosis --- r_associated #0: 20 --> en:Hodgkin lymphoma
    n1=en:acute miliary tuberculosis | n2=en:Hodgkin lymphoma | rel=r_associated | relid=0 | w=20
  37. en:acute monoblastic leukemia --- r_associated #0: 20 --> en:Hodgkin lymphoma
    n1=en:acute monoblastic leukemia | n2=en:Hodgkin lymphoma | rel=r_associated | relid=0 | w=20
  38. en:acute myeloid leukemia --- r_associated #0: 20 --> en:Hodgkin lymphoma
    n1=en:acute myeloid leukemia | n2=en:Hodgkin lymphoma | rel=r_associated | relid=0 | w=20
  39. en:acute myocardial infarction --- r_associated #0: 20 --> en:Hodgkin lymphoma
    n1=en:acute myocardial infarction | n2=en:Hodgkin lymphoma | rel=r_associated | relid=0 | w=20
  40. en:acute tonsillitis --- r_associated #0: 20 --> en:Hodgkin lymphoma
    n1=en:acute tonsillitis | n2=en:Hodgkin lymphoma | rel=r_associated | relid=0 | w=20
  41. en:addison's disease --- r_associated #0: 20 --> en:Hodgkin lymphoma
    n1=en:addison's disease | n2=en:Hodgkin lymphoma | rel=r_associated | relid=0 | w=20
  42. en:adenocarcinoma --- r_associated #0: 20 --> en:Hodgkin lymphoma
    n1=en:adenocarcinoma | n2=en:Hodgkin lymphoma | rel=r_associated | relid=0 | w=20
  43. en:adenocarcinoma (some) --- r_associated #0: 20 --> en:Hodgkin lymphoma
    n1=en:adenocarcinoma (some) | n2=en:Hodgkin lymphoma | rel=r_associated | relid=0 | w=20
  44. en:adenocarcinoma in adenomatous polyp --- r_associated #0: 20 --> en:Hodgkin lymphoma
    n1=en:adenocarcinoma in adenomatous polyp | n2=en:Hodgkin lymphoma | rel=r_associated | relid=0 | w=20
  45. en:adenosquamous carcinoma --- r_associated #0: 20 --> en:Hodgkin lymphoma
    n1=en:adenosquamous carcinoma | n2=en:Hodgkin lymphoma | rel=r_associated | relid=0 | w=20
  46. en:adnexal and/or skin appendage neoplasm --- r_associated #0: 20 --> en:Hodgkin lymphoma
    n1=en:adnexal and/or skin appendage neoplasm | n2=en:Hodgkin lymphoma | rel=r_associated | relid=0 | w=20
  47. en:adnexal carcinoma --- r_associated #0: 20 --> en:Hodgkin lymphoma
    n1=en:adnexal carcinoma | n2=en:Hodgkin lymphoma | rel=r_associated | relid=0 | w=20
  48. en:adrenal cortex carcinoma --- r_associated #0: 20 --> en:Hodgkin lymphoma
    n1=en:adrenal cortex carcinoma | n2=en:Hodgkin lymphoma | rel=r_associated | relid=0 | w=20
  49. en:adrenal gland pheochromocytoma --- r_associated #0: 20 --> en:Hodgkin lymphoma
    n1=en:adrenal gland pheochromocytoma | n2=en:Hodgkin lymphoma | rel=r_associated | relid=0 | w=20
  50. en:adrenal glands are most common site --- r_associated #0: 20 --> en:Hodgkin lymphoma
    n1=en:adrenal glands are most common site | n2=en:Hodgkin lymphoma | rel=r_associated | relid=0 | w=20
  51. en:adult lymphoma --- r_associated #0: 20 --> en:Hodgkin lymphoma
    n1=en:adult lymphoma | n2=en:Hodgkin lymphoma | rel=r_associated | relid=0 | w=20
  52. en:advanced malignant neoplasm --- r_associated #0: 20 --> en:Hodgkin lymphoma
    n1=en:advanced malignant neoplasm | n2=en:Hodgkin lymphoma | rel=r_associated | relid=0 | w=20
  53. en:aids-related lymphoma --- r_associated #0: 20 --> en:Hodgkin lymphoma
    n1=en:aids-related lymphoma | n2=en:Hodgkin lymphoma | rel=r_associated | relid=0 | w=20
  54. en:alpha heavy chain disease --- r_associated #0: 20 --> en:Hodgkin lymphoma
    n1=en:alpha heavy chain disease | n2=en:Hodgkin lymphoma | rel=r_associated | relid=0 | w=20
  55. en:alveolar cell carcinoma (some) --- r_associated #0: 20 --> en:Hodgkin lymphoma
    n1=en:alveolar cell carcinoma (some) | n2=en:Hodgkin lymphoma | rel=r_associated | relid=0 | w=20
  56. en:alveolar rhabdomyosarcoma --- r_associated #0: 20 --> en:Hodgkin lymphoma
    n1=en:alveolar rhabdomyosarcoma | n2=en:Hodgkin lymphoma | rel=r_associated | relid=0 | w=20
  57. en:amelanotic melanoma --- r_associated #0: 20 --> en:Hodgkin lymphoma
    n1=en:amelanotic melanoma | n2=en:Hodgkin lymphoma | rel=r_associated | relid=0 | w=20
  58. en:ameloblastic fibrosarcoma --- r_associated #0: 20 --> en:Hodgkin lymphoma
    n1=en:ameloblastic fibrosarcoma | n2=en:Hodgkin lymphoma | rel=r_associated | relid=0 | w=20
  59. en:ameloblastic odontosarcoma --- r_associated #0: 20 --> en:Hodgkin lymphoma
    n1=en:ameloblastic odontosarcoma | n2=en:Hodgkin lymphoma | rel=r_associated | relid=0 | w=20
  60. en:ampulla of vater adenocarcinoma --- r_associated #0: 20 --> en:Hodgkin lymphoma
    n1=en:ampulla of vater adenocarcinoma | n2=en:Hodgkin lymphoma | rel=r_associated | relid=0 | w=20
  61. en:anaemias nonhaemolytic and marrow depression --- r_associated #0: 20 --> en:Hodgkin lymphoma
    n1=en:anaemias nonhaemolytic and marrow depression | n2=en:Hodgkin lymphoma | rel=r_associated | relid=0 | w=20
  62. en:anal carcinoma --- r_associated #0: 20 --> en:Hodgkin lymphoma
    n1=en:anal carcinoma | n2=en:Hodgkin lymphoma | rel=r_associated | relid=0 | w=20
  63. en:anaphylaxis (non medication) --- r_associated #0: 20 --> en:Hodgkin lymphoma
    n1=en:anaphylaxis (non medication) | n2=en:Hodgkin lymphoma | rel=r_associated | relid=0 | w=20
  64. en:anaplastic (malignant) meningioma --- r_associated #0: 20 --> en:Hodgkin lymphoma
    n1=en:anaplastic (malignant) meningioma | n2=en:Hodgkin lymphoma | rel=r_associated | relid=0 | w=20
  65. en:anaplastic large cell lymphoma --- r_associated #0: 20 --> en:Hodgkin lymphoma
    n1=en:anaplastic large cell lymphoma | n2=en:Hodgkin lymphoma | rel=r_associated | relid=0 | w=20
  66. en:anaplastic malignant neoplasm --- r_associated #0: 20 --> en:Hodgkin lymphoma
    n1=en:anaplastic malignant neoplasm | n2=en:Hodgkin lymphoma | rel=r_associated | relid=0 | w=20
  67. en:anatomic structures --- r_associated #0: 20 --> en:Hodgkin lymphoma
    n1=en:anatomic structures | n2=en:Hodgkin lymphoma | rel=r_associated | relid=0 | w=20
  68. en:angioimmunoblastic t-cell lymphoma --- r_associated #0: 20 --> en:Hodgkin lymphoma
    n1=en:angioimmunoblastic t-cell lymphoma | n2=en:Hodgkin lymphoma | rel=r_associated | relid=0 | w=20
  69. en:angiolipoma --- r_associated #0: 20 --> en:Hodgkin lymphoma
    n1=en:angiolipoma | n2=en:Hodgkin lymphoma | rel=r_associated | relid=0 | w=20
  70. en:angiomyoliposarcoma --- r_associated #0: 20 --> en:Hodgkin lymphoma
    n1=en:angiomyoliposarcoma | n2=en:Hodgkin lymphoma | rel=r_associated | relid=0 | w=20
  71. en:angiomyosarcoma --- r_associated #0: 20 --> en:Hodgkin lymphoma
    n1=en:angiomyosarcoma | n2=en:Hodgkin lymphoma | rel=r_associated | relid=0 | w=20
  72. en:animal bite --- r_associated #0: 20 --> en:Hodgkin lymphoma
    n1=en:animal bite | n2=en:Hodgkin lymphoma | rel=r_associated | relid=0 | w=20
  73. en:aplastic anemia --- r_associated #0: 20 --> en:Hodgkin lymphoma
    n1=en:aplastic anemia | n2=en:Hodgkin lymphoma | rel=r_associated | relid=0 | w=20
  74. en:arrhythmia --- r_associated #0: 20 --> en:Hodgkin lymphoma
    n1=en:arrhythmia | n2=en:Hodgkin lymphoma | rel=r_associated | relid=0 | w=20
  75. en:associated with other malignancies --- r_associated #0: 20 --> en:Hodgkin lymphoma
    n1=en:associated with other malignancies | n2=en:Hodgkin lymphoma | rel=r_associated | relid=0 | w=20
  76. en:asthma --- r_associated #0: 20 --> en:Hodgkin lymphoma
    n1=en:asthma | n2=en:Hodgkin lymphoma | rel=r_associated | relid=0 | w=20
  77. en:astrocytoma --- r_associated #0: 20 --> en:Hodgkin lymphoma
    n1=en:astrocytoma | n2=en:Hodgkin lymphoma | rel=r_associated | relid=0 | w=20
  78. en:atherosclerosis excluding heart/brain --- r_associated #0: 20 --> en:Hodgkin lymphoma
    n1=en:atherosclerosis excluding heart/brain | n2=en:Hodgkin lymphoma | rel=r_associated | relid=0 | w=20
  79. en:atopic conjunctivitis --- r_associated #0: 20 --> en:Hodgkin lymphoma
    n1=en:atopic conjunctivitis | n2=en:Hodgkin lymphoma | rel=r_associated | relid=0 | w=20
  80. en:atrial fibrillation and flutter --- r_associated #0: 20 --> en:Hodgkin lymphoma
    n1=en:atrial fibrillation and flutter | n2=en:Hodgkin lymphoma | rel=r_associated | relid=0 | w=20
  81. en:atypical medullary carcinoma --- r_associated #0: 20 --> en:Hodgkin lymphoma
    n1=en:atypical medullary carcinoma | n2=en:Hodgkin lymphoma | rel=r_associated | relid=0 | w=20
  82. en:atypical teratoid/rhabdoid tumor --- r_associated #0: 20 --> en:Hodgkin lymphoma
    n1=en:atypical teratoid/rhabdoid tumor | n2=en:Hodgkin lymphoma | rel=r_associated | relid=0 | w=20
  83. en:autoimmune disease --- r_associated #0: 20 --> en:Hodgkin lymphoma
    n1=en:autoimmune disease | n2=en:Hodgkin lymphoma | rel=r_associated | relid=0 | w=20
  84. en:autoimmune lymphoproliferative syndrome --- r_associated #0: 20 --> en:Hodgkin lymphoma
    n1=en:autoimmune lymphoproliferative syndrome | n2=en:Hodgkin lymphoma | rel=r_associated | relid=0 | w=20
  85. en:autoimmune lymphoproliferative syndrome-associated lymphoma --- r_associated #0: 20 --> en:Hodgkin lymphoma
    n1=en:autoimmune lymphoproliferative syndrome-associated lymphoma | n2=en:Hodgkin lymphoma | rel=r_associated | relid=0 | w=20
  86. en:b-cell lymphoma, unclassifiable, with features intermediate between diffuse large b-cell lymphoma and classical hodgkin lymphoma --- r_associated #0: 20 --> en:Hodgkin lymphoma
    n1=en:b-cell lymphoma, unclassifiable, with features intermediate between diffuse large b-cell lymphoma and classical hodgkin lymphoma | n2=en:Hodgkin lymphoma | rel=r_associated | relid=0 | w=20
  87. en:b-cell lymphomas --- r_associated #0: 20 --> en:Hodgkin lymphoma
    n1=en:b-cell lymphomas | n2=en:Hodgkin lymphoma | rel=r_associated | relid=0 | w=20
  88. en:b-cell non-hodgkin lymphoma --- r_associated #0: 20 --> en:Hodgkin lymphoma
    n1=en:b-cell non-hodgkin lymphoma | n2=en:Hodgkin lymphoma | rel=r_associated | relid=0 | w=20
  89. en:balanitis --- r_associated #0: 20 --> en:Hodgkin lymphoma
    n1=en:balanitis | n2=en:Hodgkin lymphoma | rel=r_associated | relid=0 | w=20
  90. en:balloon cell melanoma --- r_associated #0: 20 --> en:Hodgkin lymphoma
    n1=en:balloon cell melanoma | n2=en:Hodgkin lymphoma | rel=r_associated | relid=0 | w=20
  91. en:basal cell neoplasm --- r_associated #0: 20 --> en:Hodgkin lymphoma
    n1=en:basal cell neoplasm | n2=en:Hodgkin lymphoma | rel=r_associated | relid=0 | w=20
  92. en:basal cell nevus --- r_associated #0: 20 --> en:Hodgkin lymphoma
    n1=en:basal cell nevus | n2=en:Hodgkin lymphoma | rel=r_associated | relid=0 | w=20
  93. en:basaloid carcinoma --- r_associated #0: 20 --> en:Hodgkin lymphoma
    n1=en:basaloid carcinoma | n2=en:Hodgkin lymphoma | rel=r_associated | relid=0 | w=20
  94. en:basocellular neoplasms develop after second decade --- r_associated #0: 20 --> en:Hodgkin lymphoma
    n1=en:basocellular neoplasms develop after second decade | n2=en:Hodgkin lymphoma | rel=r_associated | relid=0 | w=20
  95. en:bence jones proteins increased --- r_associated #0: 20 --> en:Hodgkin lymphoma
    n1=en:bence jones proteins increased | n2=en:Hodgkin lymphoma | rel=r_associated | relid=0 | w=20
  96. en:benign digestive system neoplasm --- r_associated #0: 20 --> en:Hodgkin lymphoma
    n1=en:benign digestive system neoplasm | n2=en:Hodgkin lymphoma | rel=r_associated | relid=0 | w=20
  97. en:benign female breast neoplasm --- r_associated #0: 20 --> en:Hodgkin lymphoma
    n1=en:benign female breast neoplasm | n2=en:Hodgkin lymphoma | rel=r_associated | relid=0 | w=20
  98. en:benign female reproductive system neoplasm --- r_associated #0: 20 --> en:Hodgkin lymphoma
    n1=en:benign female reproductive system neoplasm | n2=en:Hodgkin lymphoma | rel=r_associated | relid=0 | w=20
  99. en:benign genitourinary tract neoplasm --- r_associated #0: 20 --> en:Hodgkin lymphoma
    n1=en:benign genitourinary tract neoplasm | n2=en:Hodgkin lymphoma | rel=r_associated | relid=0 | w=20
  100. en:benign male reproductive system neoplasm --- r_associated #0: 20 --> en:Hodgkin lymphoma
    n1=en:benign male reproductive system neoplasm | n2=en:Hodgkin lymphoma | rel=r_associated | relid=0 | w=20
  101. en:benign neoplasm --- r_associated #0: 20 --> en:Hodgkin lymphoma
    n1=en:benign neoplasm | n2=en:Hodgkin lymphoma | rel=r_associated | relid=0 | w=20
  102. en:benign skin neoplasm --- r_associated #0: 20 --> en:Hodgkin lymphoma
    n1=en:benign skin neoplasm | n2=en:Hodgkin lymphoma | rel=r_associated | relid=0 | w=20
  103. en:benign soft tissue neoplasm --- r_associated #0: 20 --> en:Hodgkin lymphoma
    n1=en:benign soft tissue neoplasm | n2=en:Hodgkin lymphoma | rel=r_associated | relid=0 | w=20
  104. en:benign teratoma --- r_associated #0: 20 --> en:Hodgkin lymphoma
    n1=en:benign teratoma | n2=en:Hodgkin lymphoma | rel=r_associated | relid=0 | w=20
  105. en:benign tumors of the eye, heart, and lungs --- r_associated #0: 20 --> en:Hodgkin lymphoma
    n1=en:benign tumors of the eye, heart, and lungs | n2=en:Hodgkin lymphoma | rel=r_associated | relid=0 | w=20
  106. en:benign urinary system neoplasm --- r_associated #0: 20 --> en:Hodgkin lymphoma
    n1=en:benign urinary system neoplasm | n2=en:Hodgkin lymphoma | rel=r_associated | relid=0 | w=20
  107. en:biliary tract neoplasm --- r_associated #0: 20 --> en:Hodgkin lymphoma
    n1=en:biliary tract neoplasm | n2=en:Hodgkin lymphoma | rel=r_associated | relid=0 | w=20
  108. en:biopsy --- r_associated #0: 20 --> en:Hodgkin lymphoma
    n1=en:biopsy | n2=en:Hodgkin lymphoma | rel=r_associated | relid=0 | w=20
  109. en:biphasic mesothelioma --- r_associated #0: 20 --> en:Hodgkin lymphoma
    n1=en:biphasic mesothelioma | n2=en:Hodgkin lymphoma | rel=r_associated | relid=0 | w=20
  110. en:bladder carcinoma --- r_associated #0: 20 --> en:Hodgkin lymphoma
    n1=en:bladder carcinoma | n2=en:Hodgkin lymphoma | rel=r_associated | relid=0 | w=20
  111. en:bladder urothelial carcinoma --- r_associated #0: 20 --> en:Hodgkin lymphoma
    n1=en:bladder urothelial carcinoma | n2=en:Hodgkin lymphoma | rel=r_associated | relid=0 | w=20
  112. en:blood vessel neoplasm --- r_associated #0: 20 --> en:Hodgkin lymphoma
    n1=en:blood vessel neoplasm | n2=en:Hodgkin lymphoma | rel=r_associated | relid=0 | w=20
  113. en:blood, blood forming organs, lymphatics, spleen --- r_associated #0: 20 --> en:Hodgkin lymphoma
    n1=en:blood, blood forming organs, lymphatics, spleen | n2=en:Hodgkin lymphoma | rel=r_associated | relid=0 | w=20
  114. en:bone marrow --- r_associated #0: 20 --> en:Hodgkin lymphoma
    n1=en:bone marrow | n2=en:Hodgkin lymphoma | rel=r_associated | relid=0 | w=20
  115. en:bone marrow disorder --- r_associated #0: 20 --> en:Hodgkin lymphoma
    n1=en:bone marrow disorder | n2=en:Hodgkin lymphoma | rel=r_associated | relid=0 | w=20
  116. en:bone marrow transplantation --- r_associated #0: 20 --> en:Hodgkin lymphoma
    n1=en:bone marrow transplantation | n2=en:Hodgkin lymphoma | rel=r_associated | relid=0 | w=20
  117. en:bone sarcoma --- r_associated #0: 20 --> en:Hodgkin lymphoma
    n1=en:bone sarcoma | n2=en:Hodgkin lymphoma | rel=r_associated | relid=0 | w=20
  118. en:brain morphology --- r_associated #0: 20 --> en:Hodgkin lymphoma
    n1=en:brain morphology | n2=en:Hodgkin lymphoma | rel=r_associated | relid=0 | w=20
  119. en:brain neoplasm --- r_associated #0: 20 --> en:Hodgkin lymphoma
    n1=en:brain neoplasm | n2=en:Hodgkin lymphoma | rel=r_associated | relid=0 | w=20
  120. en:breast disorder in pregnancy/puerperium other --- r_associated #0: 20 --> en:Hodgkin lymphoma
    n1=en:breast disorder in pregnancy/puerperium other | n2=en:Hodgkin lymphoma | rel=r_associated | relid=0 | w=20
  121. en:breast lymphoma --- r_associated #0: 20 --> en:Hodgkin lymphoma
    n1=en:breast lymphoma | n2=en:Hodgkin lymphoma | rel=r_associated | relid=0 | w=20
  122. en:breast neoplasm --- r_associated #0: 20 --> en:Hodgkin lymphoma
    n1=en:breast neoplasm | n2=en:Hodgkin lymphoma | rel=r_associated | relid=0 | w=20
  123. en:breast neoplasms malignant and unspecified (incl nipple) --- r_associated #0: 20 --> en:Hodgkin lymphoma
    n1=en:breast neoplasms malignant and unspecified (incl nipple) | n2=en:Hodgkin lymphoma | rel=r_associated | relid=0 | w=20
  124. en:bronchogenic carcinoma (some) --- r_associated #0: 20 --> en:Hodgkin lymphoma
    n1=en:bronchogenic carcinoma (some) | n2=en:Hodgkin lymphoma | rel=r_associated | relid=0 | w=20
  125. en:cancer alternative therapies --- r_associated #0: 20 --> en:Hodgkin lymphoma
    n1=en:cancer alternative therapies | n2=en:Hodgkin lymphoma | rel=r_associated | relid=0 | w=20
  126. en:cancer of nose --- r_associated #0: 20 --> en:Hodgkin lymphoma
    n1=en:cancer of nose | n2=en:Hodgkin lymphoma | rel=r_associated | relid=0 | w=20
  127. en:carcinofibroma --- r_associated #0: 20 --> en:Hodgkin lymphoma
    n1=en:carcinofibroma | n2=en:Hodgkin lymphoma | rel=r_associated | relid=0 | w=20
  128. en:carcinogenesis --- r_associated #0: 20 --> en:Hodgkin lymphoma
    n1=en:carcinogenesis | n2=en:Hodgkin lymphoma | rel=r_associated | relid=0 | w=20
  129. en:carcinoid tumor --- r_associated #0: 20 --> en:Hodgkin lymphoma
    n1=en:carcinoid tumor | n2=en:Hodgkin lymphoma | rel=r_associated | relid=0 | w=20
  130. en:carcinoma --- r_associated #0: 20 --> en:Hodgkin lymphoma
    n1=en:carcinoma | n2=en:Hodgkin lymphoma | rel=r_associated | relid=0 | w=20
  131. en:carcinoma in situ --- r_associated #0: 20 --> en:Hodgkin lymphoma
    n1=en:carcinoma in situ | n2=en:Hodgkin lymphoma | rel=r_associated | relid=0 | w=20
  132. en:carcinoma of bone, connective tissue, skin and breast --- r_associated #0: 20 --> en:Hodgkin lymphoma
    n1=en:carcinoma of bone, connective tissue, skin and breast | n2=en:Hodgkin lymphoma | rel=r_associated | relid=0 | w=20
  133. en:carcinoma of lip, oral cavity and pharynx --- r_associated #0: 20 --> en:Hodgkin lymphoma
    n1=en:carcinoma of lip, oral cavity and pharynx | n2=en:Hodgkin lymphoma | rel=r_associated | relid=0 | w=20
  134. en:carcinoma with osteoclast-like giant cells --- r_associated #0: 20 --> en:Hodgkin lymphoma
    n1=en:carcinoma with osteoclast-like giant cells | n2=en:Hodgkin lymphoma | rel=r_associated | relid=0 | w=20
  135. en:carcinosarcoma of skin --- r_associated #0: 20 --> en:Hodgkin lymphoma
    n1=en:carcinosarcoma of skin | n2=en:Hodgkin lymphoma | rel=r_associated | relid=0 | w=20
  136. en:carcinosarcoma, embryonal --- r_associated #0: 20 --> en:Hodgkin lymphoma
    n1=en:carcinosarcoma, embryonal | n2=en:Hodgkin lymphoma | rel=r_associated | relid=0 | w=20
  137. en:carotid body paraganglioma --- r_associated #0: 20 --> en:Hodgkin lymphoma
    n1=en:carotid body paraganglioma | n2=en:Hodgkin lymphoma | rel=r_associated | relid=0 | w=20
  138. en:carotid body tumors (most common location) --- r_associated #0: 20 --> en:Hodgkin lymphoma
    n1=en:carotid body tumors (most common location) | n2=en:Hodgkin lymphoma | rel=r_associated | relid=0 | w=20
  139. en:carotid body tumors (most common) --- r_associated #0: 20 --> en:Hodgkin lymphoma
    n1=en:carotid body tumors (most common) | n2=en:Hodgkin lymphoma | rel=r_associated | relid=0 | w=20
  140. en:carpal tunnel syndrome --- r_associated #0: 20 --> en:Hodgkin lymphoma
    n1=en:carpal tunnel syndrome | n2=en:Hodgkin lymphoma | rel=r_associated | relid=0 | w=20
  141. en:cellular morphology --- r_associated #0: 20 --> en:Hodgkin lymphoma
    n1=en:cellular morphology | n2=en:Hodgkin lymphoma | rel=r_associated | relid=0 | w=20
  142. en:central nervous system embryonal neoplasm --- r_associated #0: 20 --> en:Hodgkin lymphoma
    n1=en:central nervous system embryonal neoplasm | n2=en:Hodgkin lymphoma | rel=r_associated | relid=0 | w=20
  143. en:central nervous system lymphoma --- r_associated #0: 20 --> en:Hodgkin lymphoma
    n1=en:central nervous system lymphoma | n2=en:Hodgkin lymphoma | rel=r_associated | relid=0 | w=20
  144. en:central nervous system neoplasm --- r_associated #0: 20 --> en:Hodgkin lymphoma
    n1=en:central nervous system neoplasm | n2=en:Hodgkin lymphoma | rel=r_associated | relid=0 | w=20
  145. en:centroblastic lymphoma --- r_associated #0: 20 --> en:Hodgkin lymphoma
    n1=en:centroblastic lymphoma | n2=en:Hodgkin lymphoma | rel=r_associated | relid=0 | w=20
  146. en:cerebral lymphoma --- r_associated #0: 20 --> en:Hodgkin lymphoma
    n1=en:cerebral lymphoma | n2=en:Hodgkin lymphoma | rel=r_associated | relid=0 | w=20
  147. en:cervical carcinoma --- r_associated #0: 20 --> en:Hodgkin lymphoma
    n1=en:cervical carcinoma | n2=en:Hodgkin lymphoma | rel=r_associated | relid=0 | w=20
  148. en:cervical neoplasm --- r_associated #0: 20 --> en:Hodgkin lymphoma
    n1=en:cervical neoplasm | n2=en:Hodgkin lymphoma | rel=r_associated | relid=0 | w=20
  149. en:chemically induced --- r_associated #0: 20 --> en:Hodgkin lymphoma
    n1=en:chemically induced | n2=en:Hodgkin lymphoma | rel=r_associated | relid=0 | w=20
  150. en:chemotherapy --- r_associated #0: 20 --> en:Hodgkin lymphoma
    n1=en:chemotherapy | n2=en:Hodgkin lymphoma | rel=r_associated | relid=0 | w=20
  151. en:childhood brain neoplasm --- r_associated #0: 20 --> en:Hodgkin lymphoma
    n1=en:childhood brain neoplasm | n2=en:Hodgkin lymphoma | rel=r_associated | relid=0 | w=20
  152. en:childhood hodgkin lymphoma --- r_associated #0: 20 --> en:Hodgkin lymphoma
    n1=en:childhood hodgkin lymphoma | n2=en:Hodgkin lymphoma | rel=r_associated | relid=0 | w=20
  153. en:childhood immunization --- r_associated #0: 20 --> en:Hodgkin lymphoma
    n1=en:childhood immunization | n2=en:Hodgkin lymphoma | rel=r_associated | relid=0 | w=20
  154. en:childhood leukemia --- r_associated #0: 20 --> en:Hodgkin lymphoma
    n1=en:childhood leukemia | n2=en:Hodgkin lymphoma | rel=r_associated | relid=0 | w=20
  155. en:childhood lymphoma --- r_associated #0: 20 --> en:Hodgkin lymphoma
    n1=en:childhood lymphoma | n2=en:Hodgkin lymphoma | rel=r_associated | relid=0 | w=20
  156. en:childhood malignant neoplasm --- r_associated #0: 20 --> en:Hodgkin lymphoma
    n1=en:childhood malignant neoplasm | n2=en:Hodgkin lymphoma | rel=r_associated | relid=0 | w=20
  157. en:chondroblastoma, malignant --- r_associated #0: 20 --> en:Hodgkin lymphoma
    n1=en:chondroblastoma, malignant | n2=en:Hodgkin lymphoma | rel=r_associated | relid=0 | w=20
  158. en:chondrosarcoma --- r_associated #0: 20 --> en:Hodgkin lymphoma
    n1=en:chondrosarcoma | n2=en:Hodgkin lymphoma | rel=r_associated | relid=0 | w=20
  159. en:chordoma --- r_associated #0: 20 --> en:Hodgkin lymphoma
    n1=en:chordoma | n2=en:Hodgkin lymphoma | rel=r_associated | relid=0 | w=20
  160. en:choriocarcinoma --- r_associated #0: 20 --> en:Hodgkin lymphoma
    n1=en:choriocarcinoma | n2=en:Hodgkin lymphoma | rel=r_associated | relid=0 | w=20
  161. en:choriocarcinoma combined with other germ cell elements --- r_associated #0: 20 --> en:Hodgkin lymphoma
    n1=en:choriocarcinoma combined with other germ cell elements | n2=en:Hodgkin lymphoma | rel=r_associated | relid=0 | w=20
  162. en:chromaffin cell neoplasm --- r_associated #0: 20 --> en:Hodgkin lymphoma
    n1=en:chromaffin cell neoplasm | n2=en:Hodgkin lymphoma | rel=r_associated | relid=0 | w=20
  163. en:chronic internal knee derangement --- r_associated #0: 20 --> en:Hodgkin lymphoma
    n1=en:chronic internal knee derangement | n2=en:Hodgkin lymphoma | rel=r_associated | relid=0 | w=20
  164. en:chronic lymphocytic leukemia --- r_associated #0: 20 --> en:Hodgkin lymphoma
    n1=en:chronic lymphocytic leukemia | n2=en:Hodgkin lymphoma | rel=r_associated | relid=0 | w=20
  165. en:chronic lymphocytic leukemia, b-cell, susceptibility to --- r_associated #0: 20 --> en:Hodgkin lymphoma
    n1=en:chronic lymphocytic leukemia, b-cell, susceptibility to | n2=en:Hodgkin lymphoma | rel=r_associated | relid=0 | w=20
  166. en:chronic myelomonocytic leukemia --- r_associated #0: 20 --> en:Hodgkin lymphoma
    n1=en:chronic myelomonocytic leukemia | n2=en:Hodgkin lymphoma | rel=r_associated | relid=0 | w=20
  167. en:chronic otitis other infection ear --- r_associated #0: 20 --> en:Hodgkin lymphoma
    n1=en:chronic otitis other infection ear | n2=en:Hodgkin lymphoma | rel=r_associated | relid=0 | w=20
  168. en:chronic skin ulcer --- r_associated #0: 20 --> en:Hodgkin lymphoma
    n1=en:chronic skin ulcer | n2=en:Hodgkin lymphoma | rel=r_associated | relid=0 | w=20
  169. en:classical hodgkin lymphoma --- r_associated #0: 20 --> en:Hodgkin lymphoma
    n1=en:classical hodgkin lymphoma | n2=en:Hodgkin lymphoma | rel=r_associated | relid=0 | w=20
  170. en:clear cell chondrosarcoma --- r_associated #0: 20 --> en:Hodgkin lymphoma
    n1=en:clear cell chondrosarcoma | n2=en:Hodgkin lymphoma | rel=r_associated | relid=0 | w=20
  171. en:clear cell sarcoma of the kidney --- r_associated #0: 20 --> en:Hodgkin lymphoma
    n1=en:clear cell sarcoma of the kidney | n2=en:Hodgkin lymphoma | rel=r_associated | relid=0 | w=20
  172. en:clip1 wt allele --- r_associated #0: 20 --> en:Hodgkin lymphoma
    n1=en:clip1 wt allele | n2=en:Hodgkin lymphoma | rel=r_associated | relid=0 | w=20
  173. en:cluster headache --- r_associated #0: 20 --> en:Hodgkin lymphoma
    n1=en:cluster headache | n2=en:Hodgkin lymphoma | rel=r_associated | relid=0 | w=20
  174. en:coagulopathies and bleeding diatheses (excl thrombocytopenic) --- r_associated #0: 20 --> en:Hodgkin lymphoma
    n1=en:coagulopathies and bleeding diatheses (excl thrombocytopenic) | n2=en:Hodgkin lymphoma | rel=r_associated | relid=0 | w=20
  175. en:colon carcinoma --- r_associated #0: 20 --> en:Hodgkin lymphoma
    n1=en:colon carcinoma | n2=en:Hodgkin lymphoma | rel=r_associated | relid=0 | w=20
  176. en:colorectal cancer (in some patients) --- r_associated #0: 20 --> en:Hodgkin lymphoma
    n1=en:colorectal cancer (in some patients) | n2=en:Hodgkin lymphoma | rel=r_associated | relid=0 | w=20
  177. en:combined small cell lung carcinoma --- r_associated #0: 20 --> en:Hodgkin lymphoma
    n1=en:combined small cell lung carcinoma | n2=en:Hodgkin lymphoma | rel=r_associated | relid=0 | w=20
  178. en:complex epithelial neoplasm --- r_associated #0: 20 --> en:Hodgkin lymphoma
    n1=en:complex epithelial neoplasm | n2=en:Hodgkin lymphoma | rel=r_associated | relid=0 | w=20
  179. en:complex mixed and stromal neoplasms --- r_associated #0: 20 --> en:Hodgkin lymphoma
    n1=en:complex mixed and stromal neoplasms | n2=en:Hodgkin lymphoma | rel=r_associated | relid=0 | w=20
  180. en:complication aspects --- r_associated #0: 20 --> en:Hodgkin lymphoma
    n1=en:complication aspects | n2=en:Hodgkin lymphoma | rel=r_associated | relid=0 | w=20
  181. en:compound eye --- r_associated #0: 20 --> en:Hodgkin lymphoma
    n1=en:compound eye | n2=en:Hodgkin lymphoma | rel=r_associated | relid=0 | w=20
  182. en:concussion --- r_associated #0: 20 --> en:Hodgkin lymphoma
    n1=en:concussion | n2=en:Hodgkin lymphoma | rel=r_associated | relid=0 | w=20
  183. en:condylomata acuminata in women --- r_associated #0: 20 --> en:Hodgkin lymphoma
    n1=en:condylomata acuminata in women | n2=en:Hodgkin lymphoma | rel=r_associated | relid=0 | w=20
  184. en:confirmation of pregnancy --- r_associated #0: 20 --> en:Hodgkin lymphoma
    n1=en:confirmation of pregnancy | n2=en:Hodgkin lymphoma | rel=r_associated | relid=0 | w=20
  185. en:congenital abnormality --- r_associated #0: 20 --> en:Hodgkin lymphoma
    n1=en:congenital abnormality | n2=en:Hodgkin lymphoma | rel=r_associated | relid=0 | w=20
  186. en:congenital anomaly of female genital system --- r_associated #0: 20 --> en:Hodgkin lymphoma
    n1=en:congenital anomaly of female genital system | n2=en:Hodgkin lymphoma | rel=r_associated | relid=0 | w=20
  187. en:congenital anomaly of male genital system --- r_associated #0: 20 --> en:Hodgkin lymphoma
    n1=en:congenital anomaly of male genital system | n2=en:Hodgkin lymphoma | rel=r_associated | relid=0 | w=20
  188. en:congenital mesh qualifier --- r_associated #0: 20 --> en:Hodgkin lymphoma
    n1=en:congenital mesh qualifier | n2=en:Hodgkin lymphoma | rel=r_associated | relid=0 | w=20
  189. en:congenital urinary system abnormality --- r_associated #0: 20 --> en:Hodgkin lymphoma
    n1=en:congenital urinary system abnormality | n2=en:Hodgkin lymphoma | rel=r_associated | relid=0 | w=20
  190. en:contusion/hemorrhage eye --- r_associated #0: 20 --> en:Hodgkin lymphoma
    n1=en:contusion/hemorrhage eye | n2=en:Hodgkin lymphoma | rel=r_associated | relid=0 | w=20
  191. en:conventional osteosarcoma --- r_associated #0: 20 --> en:Hodgkin lymphoma
    n1=en:conventional osteosarcoma | n2=en:Hodgkin lymphoma | rel=r_associated | relid=0 | w=20
  192. en:corneal ulcer --- r_associated #0: 20 --> en:Hodgkin lymphoma
    n1=en:corneal ulcer | n2=en:Hodgkin lymphoma | rel=r_associated | relid=0 | w=20
  193. en:cryptosporidiosis --- r_associated #0: 20 --> en:Hodgkin lymphoma
    n1=en:cryptosporidiosis | n2=en:Hodgkin lymphoma | rel=r_associated | relid=0 | w=20
  194. en:cutaneous leiomyosarcoma (less common) --- r_associated #0: 20 --> en:Hodgkin lymphoma
    n1=en:cutaneous leiomyosarcoma (less common) | n2=en:Hodgkin lymphoma | rel=r_associated | relid=0 | w=20
  195. en:cutaneous melanoma --- r_associated #0: 20 --> en:Hodgkin lymphoma
    n1=en:cutaneous melanoma | n2=en:Hodgkin lymphoma | rel=r_associated | relid=0 | w=20
  196. en:cyst --- r_associated #0: 20 --> en:Hodgkin lymphoma
    n1=en:cyst | n2=en:Hodgkin lymphoma | rel=r_associated | relid=0 | w=20
  197. en:cystic partially differentiated nephroblastoma --- r_associated #0: 20 --> en:Hodgkin lymphoma
    n1=en:cystic partially differentiated nephroblastoma | n2=en:Hodgkin lymphoma | rel=r_associated | relid=0 | w=20
  198. en:death --- r_associated #0: 20 --> en:Hodgkin lymphoma
    n1=en:death | n2=en:Hodgkin lymphoma | rel=r_associated | relid=0 | w=20
  199. en:dedifferentiated liposarcoma --- r_associated #0: 20 --> en:Hodgkin lymphoma
    n1=en:dedifferentiated liposarcoma | n2=en:Hodgkin lymphoma | rel=r_associated | relid=0 | w=20
  200. en:depressive disorder --- r_associated #0: 20 --> en:Hodgkin lymphoma
    n1=en:depressive disorder | n2=en:Hodgkin lymphoma | rel=r_associated | relid=0 | w=20
  201. en:desmoplastic small round cell tumor --- r_associated #0: 20 --> en:Hodgkin lymphoma
    n1=en:desmoplastic small round cell tumor | n2=en:Hodgkin lymphoma | rel=r_associated | relid=0 | w=20
  202. en:diaper dermatitis --- r_associated #0: 20 --> en:Hodgkin lymphoma
    n1=en:diaper dermatitis | n2=en:Hodgkin lymphoma | rel=r_associated | relid=0 | w=20
  203. en:diffuse embryoma --- r_associated #0: 20 --> en:Hodgkin lymphoma
    n1=en:diffuse embryoma | n2=en:Hodgkin lymphoma | rel=r_associated | relid=0 | w=20
  204. en:digestive system carcinoma --- r_associated #0: 20 --> en:Hodgkin lymphoma
    n1=en:digestive system carcinoma | n2=en:Hodgkin lymphoma | rel=r_associated | relid=0 | w=20
  205. en:digestive system lymphoma --- r_associated #0: 20 --> en:Hodgkin lymphoma
    n1=en:digestive system lymphoma | n2=en:Hodgkin lymphoma | rel=r_associated | relid=0 | w=20
  206. en:digestive system neoplasms --- r_associated #0: 20 --> en:Hodgkin lymphoma
    n1=en:digestive system neoplasms | n2=en:Hodgkin lymphoma | rel=r_associated | relid=0 | w=20
  207. en:disease of mouth/tongue/lips --- r_associated #0: 20 --> en:Hodgkin lymphoma
    n1=en:disease of mouth/tongue/lips | n2=en:Hodgkin lymphoma | rel=r_associated | relid=0 | w=20
  208. en:dislocation --- r_associated #0: 20 --> en:Hodgkin lymphoma
    n1=en:dislocation | n2=en:Hodgkin lymphoma | rel=r_associated | relid=0 | w=20
  209. en:duct carcinoma, desmoplastic type --- r_associated #0: 20 --> en:Hodgkin lymphoma
    n1=en:duct carcinoma, desmoplastic type | n2=en:Hodgkin lymphoma | rel=r_associated | relid=0 | w=20
  210. en:ductal and lobular neoplasms --- r_associated #0: 20 --> en:Hodgkin lymphoma
    n1=en:ductal and lobular neoplasms | n2=en:Hodgkin lymphoma | rel=r_associated | relid=0 | w=20
  211. en:ductal breast carcinoma --- r_associated #0: 20 --> en:Hodgkin lymphoma
    n1=en:ductal breast carcinoma | n2=en:Hodgkin lymphoma | rel=r_associated | relid=0 | w=20
  212. en:duodenal carcinoid --- r_associated #0: 20 --> en:Hodgkin lymphoma
    n1=en:duodenal carcinoid | n2=en:Hodgkin lymphoma | rel=r_associated | relid=0 | w=20
  213. en:duodenal carcinoma --- r_associated #0: 20 --> en:Hodgkin lymphoma
    n1=en:duodenal carcinoma | n2=en:Hodgkin lymphoma | rel=r_associated | relid=0 | w=20
  214. en:dyshidrosis [pompholyx] --- r_associated #0: 20 --> en:Hodgkin lymphoma
    n1=en:dyshidrosis [pompholyx] | n2=en:Hodgkin lymphoma | rel=r_associated | relid=0 | w=20
  215. en:dysplasia with neoplasia --- r_associated #0: 20 --> en:Hodgkin lymphoma
    n1=en:dysplasia with neoplasia | n2=en:Hodgkin lymphoma | rel=r_associated | relid=0 | w=20
  216. en:ear neoplasm --- r_associated #0: 20 --> en:Hodgkin lymphoma
    n1=en:ear neoplasm | n2=en:Hodgkin lymphoma | rel=r_associated | relid=0 | w=20
  217. en:ebv-induced b-cell lymphoma --- r_associated #0: 20 --> en:Hodgkin lymphoma
    n1=en:ebv-induced b-cell lymphoma | n2=en:Hodgkin lymphoma | rel=r_associated | relid=0 | w=20
  218. en:eccrine porocarcinoma --- r_associated #0: 20 --> en:Hodgkin lymphoma
    n1=en:eccrine porocarcinoma | n2=en:Hodgkin lymphoma | rel=r_associated | relid=0 | w=20
  219. en:ectopic pregnancy --- r_associated #0: 20 --> en:Hodgkin lymphoma
    n1=en:ectopic pregnancy | n2=en:Hodgkin lymphoma | rel=r_associated | relid=0 | w=20
  220. en:embryologic --- r_associated #0: 20 --> en:Hodgkin lymphoma
    n1=en:embryologic | n2=en:Hodgkin lymphoma | rel=r_associated | relid=0 | w=20
  221. en:embryonal carcinoma --- r_associated #0: 20 --> en:Hodgkin lymphoma
    n1=en:embryonal carcinoma | n2=en:Hodgkin lymphoma | rel=r_associated | relid=0 | w=20
  222. en:embryonal neoplasm --- r_associated #0: 20 --> en:Hodgkin lymphoma
    n1=en:embryonal neoplasm | n2=en:Hodgkin lymphoma | rel=r_associated | relid=0 | w=20
  223. en:embryonal rhabdomyosarcoma --- r_associated #0: 20 --> en:Hodgkin lymphoma
    n1=en:embryonal rhabdomyosarcoma | n2=en:Hodgkin lymphoma | rel=r_associated | relid=0 | w=20
  224. en:embryonal tumor with multilayered rosettes, c19mc-altered --- r_associated #0: 20 --> en:Hodgkin lymphoma
    n1=en:embryonal tumor with multilayered rosettes, c19mc-altered | n2=en:Hodgkin lymphoma | rel=r_associated | relid=0 | w=20
  225. en:endocrine neoplasms malignant and unspecified --- r_associated #0: 20 --> en:Hodgkin lymphoma
    n1=en:endocrine neoplasms malignant and unspecified | n2=en:Hodgkin lymphoma | rel=r_associated | relid=0 | w=20
  226. en:endocrine system cancer --- r_associated #0: 20 --> en:Hodgkin lymphoma
    n1=en:endocrine system cancer | n2=en:Hodgkin lymphoma | rel=r_associated | relid=0 | w=20
  227. en:endometrial adenocarcinoma --- r_associated #0: 20 --> en:Hodgkin lymphoma
    n1=en:endometrial adenocarcinoma | n2=en:Hodgkin lymphoma | rel=r_associated | relid=0 | w=20
  228. en:environment related neoplasm/cancer --- r_associated #0: 20 --> en:Hodgkin lymphoma
    n1=en:environment related neoplasm/cancer | n2=en:Hodgkin lymphoma | rel=r_associated | relid=0 | w=20
  229. en:enzymology --- r_associated #0: 20 --> en:Hodgkin lymphoma
    n1=en:enzymology | n2=en:Hodgkin lymphoma | rel=r_associated | relid=0 | w=20
  230. en:ependymoma --- r_associated #0: 20 --> en:Hodgkin lymphoma
    n1=en:ependymoma | n2=en:Hodgkin lymphoma | rel=r_associated | relid=0 | w=20
  231. en:epididymo-orchitis --- r_associated #0: 20 --> en:Hodgkin lymphoma
    n1=en:epididymo-orchitis | n2=en:Hodgkin lymphoma | rel=r_associated | relid=0 | w=20
  232. en:epithelial-myoepithelial carcinoma --- r_associated #0: 20 --> en:Hodgkin lymphoma
    n1=en:epithelial-myoepithelial carcinoma | n2=en:Hodgkin lymphoma | rel=r_associated | relid=0 | w=20
  233. en:epithelioid leiomyosarcoma --- r_associated #0: 20 --> en:Hodgkin lymphoma
    n1=en:epithelioid leiomyosarcoma | n2=en:Hodgkin lymphoma | rel=r_associated | relid=0 | w=20
  234. en:epithelioid mesothelioma --- r_associated #0: 20 --> en:Hodgkin lymphoma
    n1=en:epithelioid mesothelioma | n2=en:Hodgkin lymphoma | rel=r_associated | relid=0 | w=20
  235. en:epithelioid sarcoma --- r_associated #0: 20 --> en:Hodgkin lymphoma
    n1=en:epithelioid sarcoma | n2=en:Hodgkin lymphoma | rel=r_associated | relid=0 | w=20
  236. en:epithelioid trophoblastic tumor --- r_associated #0: 20 --> en:Hodgkin lymphoma
    n1=en:epithelioid trophoblastic tumor | n2=en:Hodgkin lymphoma | rel=r_associated | relid=0 | w=20
  237. en:esophageal carcinoma --- r_associated #0: 20 --> en:Hodgkin lymphoma
    n1=en:esophageal carcinoma | n2=en:Hodgkin lymphoma | rel=r_associated | relid=0 | w=20
  238. en:esophageal disorder --- r_associated #0: 20 --> en:Hodgkin lymphoma
    n1=en:esophageal disorder | n2=en:Hodgkin lymphoma | rel=r_associated | relid=0 | w=20
  239. en:ewing sarcoma/peripheral primitive neuroectodermal tumor --- r_associated #0: 20 --> en:Hodgkin lymphoma
    n1=en:ewing sarcoma/peripheral primitive neuroectodermal tumor | n2=en:Hodgkin lymphoma | rel=r_associated | relid=0 | w=20
  240. en:extrarenal rhabdoid tumor --- r_associated #0: 20 --> en:Hodgkin lymphoma
    n1=en:extrarenal rhabdoid tumor | n2=en:Hodgkin lymphoma | rel=r_associated | relid=0 | w=20
  241. en:extraskeletal osteosarcoma --- r_associated #0: 20 --> en:Hodgkin lymphoma
    n1=en:extraskeletal osteosarcoma | n2=en:Hodgkin lymphoma | rel=r_associated | relid=0 | w=20
  242. en:eye neoplasm --- r_associated #0: 20 --> en:Hodgkin lymphoma
    n1=en:eye neoplasm | n2=en:Hodgkin lymphoma | rel=r_associated | relid=0 | w=20
  243. en:facial nerve palsy --- r_associated #0: 20 --> en:Hodgkin lymphoma
    n1=en:facial nerve palsy | n2=en:Hodgkin lymphoma | rel=r_associated | relid=0 | w=20
  244. en:family history of hodgkin's disease --- r_associated #0: 20 --> en:Hodgkin lymphoma
    n1=en:family history of hodgkin's disease | n2=en:Hodgkin lymphoma | rel=r_associated | relid=0 | w=20
  245. en:fascial fibrosarcoma --- r_associated #0: 20 --> en:Hodgkin lymphoma
    n1=en:fascial fibrosarcoma | n2=en:Hodgkin lymphoma | rel=r_associated | relid=0 | w=20
  246. en:fear cancer of blood/lymph organs --- r_associated #0: 20 --> en:Hodgkin lymphoma
    n1=en:fear cancer of blood/lymph organs | n2=en:Hodgkin lymphoma | rel=r_associated | relid=0 | w=20
  247. en:fibroblastic liposarcoma --- r_associated #0: 20 --> en:Hodgkin lymphoma
    n1=en:fibroblastic liposarcoma | n2=en:Hodgkin lymphoma | rel=r_associated | relid=0 | w=20
  248. en:fibroblastic osteosarcoma --- r_associated #0: 20 --> en:Hodgkin lymphoma
    n1=en:fibroblastic osteosarcoma | n2=en:Hodgkin lymphoma | rel=r_associated | relid=0 | w=20
  249. en:fibroblastic/myofibroblastic tumors (all subtypes) --- r_associated #0: 20 --> en:Hodgkin lymphoma
    n1=en:fibroblastic/myofibroblastic tumors (all subtypes) | n2=en:Hodgkin lymphoma | rel=r_associated | relid=0 | w=20
  250. en:fibroelastoma --- r_associated #0: 20 --> en:Hodgkin lymphoma
    n1=en:fibroelastoma | n2=en:Hodgkin lymphoma | rel=r_associated | relid=0 | w=20
  251. en:fibrohistiocytic neoplasm --- r_associated #0: 20 --> en:Hodgkin lymphoma
    n1=en:fibrohistiocytic neoplasm | n2=en:Hodgkin lymphoma | rel=r_associated | relid=0 | w=20
  252. en:fibroid/myoma (uterus/cervix) --- r_associated #0: 20 --> en:Hodgkin lymphoma
    n1=en:fibroid/myoma (uterus/cervix) | n2=en:Hodgkin lymphoma | rel=r_associated | relid=0 | w=20
  253. en:fibromatous neoplasm --- r_associated #0: 20 --> en:Hodgkin lymphoma
    n1=en:fibromatous neoplasm | n2=en:Hodgkin lymphoma | rel=r_associated | relid=0 | w=20
  254. en:fibrosarcoma of connective tissue --- r_associated #0: 20 --> en:Hodgkin lymphoma
    n1=en:fibrosarcoma of connective tissue | n2=en:Hodgkin lymphoma | rel=r_associated | relid=0 | w=20
  255. en:fibrous connective tissue neoplasm --- r_associated #0: 20 --> en:Hodgkin lymphoma
    n1=en:fibrous connective tissue neoplasm | n2=en:Hodgkin lymphoma | rel=r_associated | relid=0 | w=20
  256. en:follicular dendritic sarcoma of lymph nodes of multiple sites --- r_associated #0: 20 --> en:Hodgkin lymphoma
    n1=en:follicular dendritic sarcoma of lymph nodes of multiple sites | n2=en:Hodgkin lymphoma | rel=r_associated | relid=0 | w=20
  257. en:follicular lymphoma --- r_associated #0: 20 --> en:Hodgkin lymphoma
    n1=en:follicular lymphoma | n2=en:Hodgkin lymphoma | rel=r_associated | relid=0 | w=20
  258. en:follicular neoplasm --- r_associated #0: 20 --> en:Hodgkin lymphoma
    n1=en:follicular neoplasm | n2=en:Hodgkin lymphoma | rel=r_associated | relid=0 | w=20
  259. en:foreign body in auditory canal --- r_associated #0: 20 --> en:Hodgkin lymphoma
    n1=en:foreign body in auditory canal | n2=en:Hodgkin lymphoma | rel=r_associated | relid=0 | w=20
  260. en:fracture hand/foot bones --- r_associated #0: 20 --> en:Hodgkin lymphoma
    n1=en:fracture hand/foot bones | n2=en:Hodgkin lymphoma | rel=r_associated | relid=0 | w=20
  261. en:frequent skin cancer --- r_associated #0: 20 --> en:Hodgkin lymphoma
    n1=en:frequent skin cancer | n2=en:Hodgkin lymphoma | rel=r_associated | relid=0 | w=20
  262. en:ganglion joint/tendon --- r_associated #0: 20 --> en:Hodgkin lymphoma
    n1=en:ganglion joint/tendon | n2=en:Hodgkin lymphoma | rel=r_associated | relid=0 | w=20
  263. en:ganglioneuroma --- r_associated #0: 20 --> en:Hodgkin lymphoma
    n1=en:ganglioneuroma | n2=en:Hodgkin lymphoma | rel=r_associated | relid=0 | w=20
  264. en:gastric adenocarcinoma --- r_associated #0: 20 --> en:Hodgkin lymphoma
    n1=en:gastric adenocarcinoma | n2=en:Hodgkin lymphoma | rel=r_associated | relid=0 | w=20
  265. en:gastric cancer, diffuse type, poorly differentiated, high-grade submucosal lesions --- r_associated #0: 20 --> en:Hodgkin lymphoma
    n1=en:gastric cancer, diffuse type, poorly differentiated, high-grade submucosal lesions | n2=en:Hodgkin lymphoma | rel=r_associated | relid=0 | w=20
  266. en:gastric carcinoma --- r_associated #0: 20 --> en:Hodgkin lymphoma
    n1=en:gastric carcinoma | n2=en:Hodgkin lymphoma | rel=r_associated | relid=0 | w=20
  267. en:gastroenteritis presumed infectious --- r_associated #0: 20 --> en:Hodgkin lymphoma
    n1=en:gastroenteritis presumed infectious | n2=en:Hodgkin lymphoma | rel=r_associated | relid=0 | w=20
  268. en:gastrointestinal neoplasms malignant and unspecified --- r_associated #0: 20 --> en:Hodgkin lymphoma
    n1=en:gastrointestinal neoplasms malignant and unspecified | n2=en:Hodgkin lymphoma | rel=r_associated | relid=0 | w=20
  269. en:genetic aspects --- r_associated #0: 20 --> en:Hodgkin lymphoma
    n1=en:genetic aspects | n2=en:Hodgkin lymphoma | rel=r_associated | relid=0 | w=20
  270. en:genital cancer --- r_associated #0: 20 --> en:Hodgkin lymphoma
    n1=en:genital cancer | n2=en:Hodgkin lymphoma | rel=r_associated | relid=0 | w=20
  271. en:genital herpes in men --- r_associated #0: 20 --> en:Hodgkin lymphoma
    n1=en:genital herpes in men | n2=en:Hodgkin lymphoma | rel=r_associated | relid=0 | w=20
  272. en:genital tract lymphoma --- r_associated #0: 20 --> en:Hodgkin lymphoma
    n1=en:genital tract lymphoma | n2=en:Hodgkin lymphoma | rel=r_associated | relid=0 | w=20
  273. en:germ cell and gonadal stromal cell neoplasms (all subtypes) --- r_associated #0: 20 --> en:Hodgkin lymphoma
    n1=en:germ cell and gonadal stromal cell neoplasms (all subtypes) | n2=en:Hodgkin lymphoma | rel=r_associated | relid=0 | w=20
  274. en:germ cell tumor --- r_associated #0: 20 --> en:Hodgkin lymphoma
    n1=en:germ cell tumor | n2=en:Hodgkin lymphoma | rel=r_associated | relid=0 | w=20
  275. en:germinoma --- r_associated #0: 20 --> en:Hodgkin lymphoma
    n1=en:germinoma | n2=en:Hodgkin lymphoma | rel=r_associated | relid=0 | w=20
  276. en:giant cell astrocytoma --- r_associated #0: 20 --> en:Hodgkin lymphoma
    n1=en:giant cell astrocytoma | n2=en:Hodgkin lymphoma | rel=r_associated | relid=0 | w=20
  277. en:giant cell sarcoma (except of bone, m-92503) --- r_associated #0: 20 --> en:Hodgkin lymphoma
    n1=en:giant cell sarcoma (except of bone, m-92503) | n2=en:Hodgkin lymphoma | rel=r_associated | relid=0 | w=20
  278. en:glaucoma --- r_associated #0: 20 --> en:Hodgkin lymphoma
    n1=en:glaucoma | n2=en:Hodgkin lymphoma | rel=r_associated | relid=0 | w=20
  279. en:glioblastoma --- r_associated #0: 20 --> en:Hodgkin lymphoma
    n1=en:glioblastoma | n2=en:Hodgkin lymphoma | rel=r_associated | relid=0 | w=20
  280. en:glomerulonephritis/nephrosis --- r_associated #0: 20 --> en:Hodgkin lymphoma
    n1=en:glomerulonephritis/nephrosis | n2=en:Hodgkin lymphoma | rel=r_associated | relid=0 | w=20
  281. en:glycosuria, renal --- r_associated #0: 20 --> en:Hodgkin lymphoma
    n1=en:glycosuria, renal | n2=en:Hodgkin lymphoma | rel=r_associated | relid=0 | w=20
  282. en:goiter --- r_associated #0: 20 --> en:Hodgkin lymphoma
    n1=en:goiter | n2=en:Hodgkin lymphoma | rel=r_associated | relid=0 | w=20
  283. en:gonadoblastoma --- r_associated #0: 20 --> en:Hodgkin lymphoma
    n1=en:gonadoblastoma | n2=en:Hodgkin lymphoma | rel=r_associated | relid=0 | w=20
  284. en:gonorrhea female --- r_associated #0: 20 --> en:Hodgkin lymphoma
    n1=en:gonorrhea female | n2=en:Hodgkin lymphoma | rel=r_associated | relid=0 | w=20
  285. en:granular cell tumors and alveolar soft part sarcomas --- r_associated #0: 20 --> en:Hodgkin lymphoma
    n1=en:granular cell tumors and alveolar soft part sarcomas | n2=en:Hodgkin lymphoma | rel=r_associated | relid=0 | w=20
  286. en:granulocytic sarcoma --- r_associated #0: 20 --> en:Hodgkin lymphoma
    n1=en:granulocytic sarcoma | n2=en:Hodgkin lymphoma | rel=r_associated | relid=0 | w=20
  287. en:granulomatous slack skin disease --- r_associated #0: 20 --> en:Hodgkin lymphoma
    n1=en:granulomatous slack skin disease | n2=en:Hodgkin lymphoma | rel=r_associated | relid=0 | w=20
  288. en:growth hormone-producing pituitary gland neoplasm --- r_associated #0: 20 --> en:Hodgkin lymphoma
    n1=en:growth hormone-producing pituitary gland neoplasm | n2=en:Hodgkin lymphoma | rel=r_associated | relid=0 | w=20
  289. en:haematological disorders nec --- r_associated #0: 20 --> en:Hodgkin lymphoma
    n1=en:haematological disorders nec | n2=en:Hodgkin lymphoma | rel=r_associated | relid=0 | w=20
  290. en:haematopoietic neoplasms (excl leukaemias and lymphomas) --- r_associated #0: 20 --> en:Hodgkin lymphoma
    n1=en:haematopoietic neoplasms (excl leukaemias and lymphomas) | n2=en:Hodgkin lymphoma | rel=r_associated | relid=0 | w=20
  291. en:hamartoma --- r_associated #0: 20 --> en:Hodgkin lymphoma
    n1=en:hamartoma | n2=en:Hodgkin lymphoma | rel=r_associated | relid=0 | w=20
  292. en:head and neck paraganglioma --- r_associated #0: 20 --> en:Hodgkin lymphoma
    n1=en:head and neck paraganglioma | n2=en:Hodgkin lymphoma | rel=r_associated | relid=0 | w=20
  293. en:heart dimension/size --- r_associated #0: 20 --> en:Hodgkin lymphoma
    n1=en:heart dimension/size | n2=en:Hodgkin lymphoma | rel=r_associated | relid=0 | w=20
  294. en:heart murmur --- r_associated #0: 20 --> en:Hodgkin lymphoma
    n1=en:heart murmur | n2=en:Hodgkin lymphoma | rel=r_associated | relid=0 | w=20
  295. en:hemangioblastoma, sporadic cerebellar (e.g., 193300.0007) --- r_associated #0: 20 --> en:Hodgkin lymphoma
    n1=en:hemangioblastoma, sporadic cerebellar (e.g., 193300.0007) | n2=en:Hodgkin lymphoma | rel=r_associated | relid=0 | w=20
  296. en:hemangiomas and lymphangiomas of any site --- r_associated #0: 20 --> en:Hodgkin lymphoma
    n1=en:hemangiomas and lymphangiomas of any site | n2=en:Hodgkin lymphoma | rel=r_associated | relid=0 | w=20
  297. en:hematopoietic and lymphatic system --- r_associated #0: 20 --> en:Hodgkin lymphoma
    n1=en:hematopoietic and lymphatic system | n2=en:Hodgkin lymphoma | rel=r_associated | relid=0 | w=20
  298. en:hematopoietic and lymphoid cell --- r_associated #0: 20 --> en:Hodgkin lymphoma
    n1=en:hematopoietic and lymphoid cell | n2=en:Hodgkin lymphoma | rel=r_associated | relid=0 | w=20
  299. en:hematopoietic and lymphoid system disorder --- r_associated #0: 20 --> en:Hodgkin lymphoma
    n1=en:hematopoietic and lymphoid system disorder | n2=en:Hodgkin lymphoma | rel=r_associated | relid=0 | w=20
  300. en:hematopoietic and lymphoid system neoplasm --- r_associated #0: 20 --> en:Hodgkin lymphoma
    n1=en:hematopoietic and lymphoid system neoplasm | n2=en:Hodgkin lymphoma | rel=r_associated | relid=0 | w=20
  301. en:hematopoietic and lymphoid tissue --- r_associated #0: 20 --> en:Hodgkin lymphoma
    n1=en:hematopoietic and lymphoid tissue | n2=en:Hodgkin lymphoma | rel=r_associated | relid=0 | w=20
  302. en:hemoglobinopathy --- r_associated #0: 20 --> en:Hodgkin lymphoma
    n1=en:hemoglobinopathy | n2=en:Hodgkin lymphoma | rel=r_associated | relid=0 | w=20
  303. en:hemophagocytic lymphohistiocytosis (in some patients) --- r_associated #0: 20 --> en:Hodgkin lymphoma
    n1=en:hemophagocytic lymphohistiocytosis (in some patients) | n2=en:Hodgkin lymphoma | rel=r_associated | relid=0 | w=20
  304. en:hepatoblastoma --- r_associated #0: 20 --> en:Hodgkin lymphoma
    n1=en:hepatoblastoma | n2=en:Hodgkin lymphoma | rel=r_associated | relid=0 | w=20
  305. en:hepatocellular carcinoma --- r_associated #0: 20 --> en:Hodgkin lymphoma
    n1=en:hepatocellular carcinoma | n2=en:Hodgkin lymphoma | rel=r_associated | relid=0 | w=20
  306. en:hepatomegaly --- r_associated #0: 20 --> en:Hodgkin lymphoma
    n1=en:hepatomegaly | n2=en:Hodgkin lymphoma | rel=r_associated | relid=0 | w=20
  307. en:hereditary malignant neoplasm --- r_associated #0: 20 --> en:Hodgkin lymphoma
    n1=en:hereditary malignant neoplasm | n2=en:Hodgkin lymphoma | rel=r_associated | relid=0 | w=20
  308. en:hereditary neoplastic syndrome --- r_associated #0: 20 --> en:Hodgkin lymphoma
    n1=en:hereditary neoplastic syndrome | n2=en:Hodgkin lymphoma | rel=r_associated | relid=0 | w=20
  309. en:herpes zoster --- r_associated #0: 20 --> en:Hodgkin lymphoma
    n1=en:herpes zoster | n2=en:Hodgkin lymphoma | rel=r_associated | relid=0 | w=20
  310. en:hiatal hernia --- r_associated #0: 20 --> en:Hodgkin lymphoma
    n1=en:hiatal hernia | n2=en:Hodgkin lymphoma | rel=r_associated | relid=0 | w=20
  311. en:high grade serous carcinoma --- r_associated #0: 20 --> en:Hodgkin lymphoma
    n1=en:high grade serous carcinoma | n2=en:Hodgkin lymphoma | rel=r_associated | relid=0 | w=20
  312. en:high grade surface osteosarcoma --- r_associated #0: 20 --> en:Hodgkin lymphoma
    n1=en:high grade surface osteosarcoma | n2=en:Hodgkin lymphoma | rel=r_associated | relid=0 | w=20
  313. en:high risk gastrointestinal stromal tumor --- r_associated #0: 20 --> en:Hodgkin lymphoma
    n1=en:high risk gastrointestinal stromal tumor | n2=en:Hodgkin lymphoma | rel=r_associated | relid=0 | w=20
  314. en:hip osteoarthritis --- r_associated #0: 20 --> en:Hodgkin lymphoma
    n1=en:hip osteoarthritis | n2=en:Hodgkin lymphoma | rel=r_associated | relid=0 | w=20
  315. en:histiocytic sarcoma --- r_associated #0: 20 --> en:Hodgkin lymphoma
    n1=en:histiocytic sarcoma | n2=en:Hodgkin lymphoma | rel=r_associated | relid=0 | w=20
  316. en:historical aspects qualifier --- r_associated #0: 20 --> en:Hodgkin lymphoma
    n1=en:historical aspects qualifier | n2=en:Hodgkin lymphoma | rel=r_associated | relid=0 | w=20
  317. en:hiv/aids --- r_associated #0: 20 --> en:Hodgkin lymphoma
    n1=en:hiv/aids | n2=en:Hodgkin lymphoma | rel=r_associated | relid=0 | w=20
  318. en:hiv/aids in women --- r_associated #0: 20 --> en:Hodgkin lymphoma
    n1=en:hiv/aids in women | n2=en:Hodgkin lymphoma | rel=r_associated | relid=0 | w=20
  319. en:hodgkin disease --- r_associated #0: 20 --> en:Hodgkin lymphoma
    n1=en:hodgkin disease | n2=en:Hodgkin lymphoma | rel=r_associated | relid=0 | w=20
  320. en:hodgkin disease, x-linked pseudoautosomal --- r_associated #0: 20 --> en:Hodgkin lymphoma
    n1=en:hodgkin disease, x-linked pseudoautosomal | n2=en:Hodgkin lymphoma | rel=r_associated | relid=0 | w=20
  321. en:hodgkin lymphoma --- r_associated #0: 20 --> en:Hodgkin lymphoma
    n1=en:hodgkin lymphoma | n2=en:Hodgkin lymphoma | rel=r_associated | relid=0 | w=20
  322. en:hodgkin lymphoma (category) --- r_associated #0: 20 --> en:Hodgkin lymphoma
    n1=en:hodgkin lymphoma (category) | n2=en:Hodgkin lymphoma | rel=r_associated | relid=0 | w=20
  323. en:hodgkin lymphoma, unspecified, lymph nodes of axilla and upper limb --- r_associated #0: 20 --> en:Hodgkin lymphoma
    n1=en:hodgkin lymphoma, unspecified, lymph nodes of axilla and upper limb | n2=en:Hodgkin lymphoma | rel=r_associated | relid=0 | w=20
  324. en:hodgkin lymphoma, unspecified, lymph nodes of head, face, and neck --- r_associated #0: 20 --> en:Hodgkin lymphoma
    n1=en:hodgkin lymphoma, unspecified, lymph nodes of head, face, and neck | n2=en:Hodgkin lymphoma | rel=r_associated | relid=0 | w=20
  325. en:hodgkin's disease lymphocyte depletion stage i supradiaphragm --- r_associated #0: 20 --> en:Hodgkin lymphoma
    n1=en:hodgkin's disease lymphocyte depletion stage i supradiaphragm | n2=en:Hodgkin lymphoma | rel=r_associated | relid=0 | w=20
  326. en:hodgkin's disease lymphocyte depletion stage ii subdiaphragm --- r_associated #0: 20 --> en:Hodgkin lymphoma
    n1=en:hodgkin's disease lymphocyte depletion stage ii subdiaphragm | n2=en:Hodgkin lymphoma | rel=r_associated | relid=0 | w=20
  327. en:hodgkin's disease lymphocyte depletion stage ii supradiaphragm --- r_associated #0: 20 --> en:Hodgkin lymphoma
    n1=en:hodgkin's disease lymphocyte depletion stage ii supradiaphragm | n2=en:Hodgkin lymphoma | rel=r_associated | relid=0 | w=20
  328. en:hodgkin's disease lymphocyte predominance stage i site unspec --- r_associated #0: 20 --> en:Hodgkin lymphoma
    n1=en:hodgkin's disease lymphocyte predominance stage i site unspec | n2=en:Hodgkin lymphoma | rel=r_associated | relid=0 | w=20
  329. en:hodgkin's disease lymphocyte predominance stage i subdiaphragm --- r_associated #0: 20 --> en:Hodgkin lymphoma
    n1=en:hodgkin's disease lymphocyte predominance stage i subdiaphragm | n2=en:Hodgkin lymphoma | rel=r_associated | relid=0 | w=20
  330. en:hodgkin's disease lymphocyte predominance stage ii supradiaphragm --- r_associated #0: 20 --> en:Hodgkin lymphoma
    n1=en:hodgkin's disease lymphocyte predominance stage ii supradiaphragm | n2=en:Hodgkin lymphoma | rel=r_associated | relid=0 | w=20
  331. en:hodgkin's disease of intra-abdominal lymph nodes --- r_associated #0: 20 --> en:Hodgkin lymphoma
    n1=en:hodgkin's disease of intra-abdominal lymph nodes | n2=en:Hodgkin lymphoma | rel=r_associated | relid=0 | w=20
  332. en:hodgkin's disease of lymph nodes of axilla and/or upper limb --- r_associated #0: 20 --> en:Hodgkin lymphoma
    n1=en:hodgkin's disease of lymph nodes of axilla and/or upper limb | n2=en:Hodgkin lymphoma | rel=r_associated | relid=0 | w=20
  333. en:hodgkin's disease unclassifiable --- r_associated #0: 20 --> en:Hodgkin lymphoma
    n1=en:hodgkin's disease unclassifiable | n2=en:Hodgkin lymphoma | rel=r_associated | relid=0 | w=20
  334. en:hodgkin's disease, lymphocytic depletion of extranodal and/or solid organ site --- r_associated #0: 20 --> en:Hodgkin lymphoma
    n1=en:hodgkin's disease, lymphocytic depletion of extranodal and/or solid organ site | n2=en:Hodgkin lymphoma | rel=r_associated | relid=0 | w=20
  335. en:hodgkin's disease, lymphocytic depletion of intra-abdominal lymph nodes --- r_associated #0: 20 --> en:Hodgkin lymphoma
    n1=en:hodgkin's disease, lymphocytic depletion of intra-abdominal lymph nodes | n2=en:Hodgkin lymphoma | rel=r_associated | relid=0 | w=20
  336. en:hodgkin's disease, lymphocytic depletion of intrapelvic lymph nodes --- r_associated #0: 20 --> en:Hodgkin lymphoma
    n1=en:hodgkin's disease, lymphocytic depletion of intrapelvic lymph nodes | n2=en:Hodgkin lymphoma | rel=r_associated | relid=0 | w=20
  337. en:hodgkin's disease, lymphocytic depletion of lymph nodes of axilla and/or upper limb --- r_associated #0: 20 --> en:Hodgkin lymphoma
    n1=en:hodgkin's disease, lymphocytic depletion of lymph nodes of axilla and/or upper limb | n2=en:Hodgkin lymphoma | rel=r_associated | relid=0 | w=20
  338. en:hodgkin's disease, lymphocytic depletion of spleen --- r_associated #0: 20 --> en:Hodgkin lymphoma
    n1=en:hodgkin's disease, lymphocytic depletion of spleen | n2=en:Hodgkin lymphoma | rel=r_associated | relid=0 | w=20
  339. en:hodgkin's disease, lymphocytic-histiocytic predominance of intra-abdominal lymph nodes --- r_associated #0: 20 --> en:Hodgkin lymphoma
    n1=en:hodgkin's disease, lymphocytic-histiocytic predominance of intra-abdominal lymph nodes | n2=en:Hodgkin lymphoma | rel=r_associated | relid=0 | w=20
  340. en:hodgkin's disease, lymphocytic-histiocytic predominance of intrapelvic lymph nodes --- r_associated #0: 20 --> en:Hodgkin lymphoma
    n1=en:hodgkin's disease, lymphocytic-histiocytic predominance of intrapelvic lymph nodes | n2=en:Hodgkin lymphoma | rel=r_associated | relid=0 | w=20
  341. en:hodgkin's disease, lymphocytic-histiocytic predominance of lymph nodes of head, face and neck --- r_associated #0: 20 --> en:Hodgkin lymphoma
    n1=en:hodgkin's disease, lymphocytic-histiocytic predominance of lymph nodes of head, face and neck | n2=en:Hodgkin lymphoma | rel=r_associated | relid=0 | w=20
  342. en:hodgkin's disease, mixed cellularity of lymph nodes of head, face and neck --- r_associated #0: 20 --> en:Hodgkin lymphoma
    n1=en:hodgkin's disease, mixed cellularity of lymph nodes of head, face and neck | n2=en:Hodgkin lymphoma | rel=r_associated | relid=0 | w=20
  343. en:hodgkin's disease, mixed cellularity of lymph nodes of inguinal region and lower limb --- r_associated #0: 20 --> en:Hodgkin lymphoma
    n1=en:hodgkin's disease, mixed cellularity of lymph nodes of inguinal region and lower limb | n2=en:Hodgkin lymphoma | rel=r_associated | relid=0 | w=20
  344. en:hodgkin's disease, nodular sclerosis of intrapelvic lymph nodes --- r_associated #0: 20 --> en:Hodgkin lymphoma
    n1=en:hodgkin's disease, nodular sclerosis of intrapelvic lymph nodes | n2=en:Hodgkin lymphoma | rel=r_associated | relid=0 | w=20
  345. en:hodgkin's disease, nodular sclerosis of lymph nodes of head, face and neck --- r_associated #0: 20 --> en:Hodgkin lymphoma
    n1=en:hodgkin's disease, nodular sclerosis of lymph nodes of head, face and neck | n2=en:Hodgkin lymphoma | rel=r_associated | relid=0 | w=20
  346. en:hodgkin's granuloma of intrathoracic lymph nodes --- r_associated #0: 20 --> en:Hodgkin lymphoma
    n1=en:hodgkin's granuloma of intrathoracic lymph nodes | n2=en:Hodgkin lymphoma | rel=r_associated | relid=0 | w=20
  347. en:hodgkin's granuloma of lymph nodes of inguinal region and lower limb --- r_associated #0: 20 --> en:Hodgkin lymphoma
    n1=en:hodgkin's granuloma of lymph nodes of inguinal region and lower limb | n2=en:Hodgkin lymphoma | rel=r_associated | relid=0 | w=20
  348. en:hodgkin's granuloma of spleen --- r_associated #0: 20 --> en:Hodgkin lymphoma
    n1=en:hodgkin's granuloma of spleen | n2=en:Hodgkin lymphoma | rel=r_associated | relid=0 | w=20
  349. en:hodgkin's granuloma, unspecified site, extranodal and solid organ sites --- r_associated #0: 20 --> en:Hodgkin lymphoma
    n1=en:hodgkin's granuloma, unspecified site, extranodal and solid organ sites | n2=en:Hodgkin lymphoma | rel=r_associated | relid=0 | w=20
  350. en:hodgkin's paragranuloma involving spleen --- r_associated #0: 20 --> en:Hodgkin lymphoma
    n1=en:hodgkin's paragranuloma involving spleen | n2=en:Hodgkin lymphoma | rel=r_associated | relid=0 | w=20
  351. en:hodgkin's paragranuloma of intra-abdominal lymph nodes --- r_associated #0: 20 --> en:Hodgkin lymphoma
    n1=en:hodgkin's paragranuloma of intra-abdominal lymph nodes | n2=en:Hodgkin lymphoma | rel=r_associated | relid=0 | w=20
  352. en:hodgkin's paragranuloma of intrathoracic lymph nodes --- r_associated #0: 20 --> en:Hodgkin lymphoma
    n1=en:hodgkin's paragranuloma of intrathoracic lymph nodes | n2=en:Hodgkin lymphoma | rel=r_associated | relid=0 | w=20
  353. en:hodgkin's paragranuloma of lymph nodes of axilla and/or upper limb --- r_associated #0: 20 --> en:Hodgkin lymphoma
    n1=en:hodgkin's paragranuloma of lymph nodes of axilla and/or upper limb | n2=en:Hodgkin lymphoma | rel=r_associated | relid=0 | w=20
  354. en:hodgkin's paragranuloma of lymph nodes of head, face and/or neck --- r_associated #0: 20 --> en:Hodgkin lymphoma
    n1=en:hodgkin's paragranuloma of lymph nodes of head, face and/or neck | n2=en:Hodgkin lymphoma | rel=r_associated | relid=0 | w=20
  355. en:hodgkin's paragranuloma of lymph nodes of inguinal region and/or lower limb --- r_associated #0: 20 --> en:Hodgkin lymphoma
    n1=en:hodgkin's paragranuloma of lymph nodes of inguinal region and/or lower limb | n2=en:Hodgkin lymphoma | rel=r_associated | relid=0 | w=20
  356. en:hodgkin's paragranuloma of lymph nodes of multiple sites --- r_associated #0: 20 --> en:Hodgkin lymphoma
    n1=en:hodgkin's paragranuloma of lymph nodes of multiple sites | n2=en:Hodgkin lymphoma | rel=r_associated | relid=0 | w=20
  357. en:hodgkin's sarcoma of extranodal and/or solid organ site --- r_associated #0: 20 --> en:Hodgkin lymphoma
    n1=en:hodgkin's sarcoma of extranodal and/or solid organ site | n2=en:Hodgkin lymphoma | rel=r_associated | relid=0 | w=20
  358. en:hodgkin's sarcoma of intrathoracic lymph nodes --- r_associated #0: 20 --> en:Hodgkin lymphoma
    n1=en:hodgkin's sarcoma of intrathoracic lymph nodes | n2=en:Hodgkin lymphoma | rel=r_associated | relid=0 | w=20
  359. en:hodgkin's sarcoma of lymph nodes of axilla and/or upper limb --- r_associated #0: 20 --> en:Hodgkin lymphoma
    n1=en:hodgkin's sarcoma of lymph nodes of axilla and/or upper limb | n2=en:Hodgkin lymphoma | rel=r_associated | relid=0 | w=20
  360. en:hodgkin's sarcoma of lymph nodes of head, face and neck --- r_associated #0: 20 --> en:Hodgkin lymphoma
    n1=en:hodgkin's sarcoma of lymph nodes of head, face and neck | n2=en:Hodgkin lymphoma | rel=r_associated | relid=0 | w=20
  361. en:hodgkin's sarcoma of lymph nodes of inguinal region and lower limb --- r_associated #0: 20 --> en:Hodgkin lymphoma
    n1=en:hodgkin's sarcoma of lymph nodes of inguinal region and lower limb | n2=en:Hodgkin lymphoma | rel=r_associated | relid=0 | w=20
  362. en:hodgkin's sarcoma of spleen --- r_associated #0: 20 --> en:Hodgkin lymphoma
    n1=en:hodgkin's sarcoma of spleen | n2=en:Hodgkin lymphoma | rel=r_associated | relid=0 | w=20
  363. en:hodgkin's sarcoma, unspecified site, extranodal and solid organ sites --- r_associated #0: 20 --> en:Hodgkin lymphoma
    n1=en:hodgkin's sarcoma, unspecified site, extranodal and solid organ sites | n2=en:Hodgkin lymphoma | rel=r_associated | relid=0 | w=20
  364. en:hodgkin-like post-transplant lymphoproliferative disorder --- r_associated #0: 20 --> en:Hodgkin lymphoma
    n1=en:hodgkin-like post-transplant lymphoproliferative disorder | n2=en:Hodgkin lymphoma | rel=r_associated | relid=0 | w=20
  365. en:hormone related neoplasm/cancer --- r_associated #0: 20 --> en:Hodgkin lymphoma
    n1=en:hormone related neoplasm/cancer | n2=en:Hodgkin lymphoma | rel=r_associated | relid=0 | w=20
  366. en:hypereosinophilic syndrome --- r_associated #0: 20 --> en:Hodgkin lymphoma
    n1=en:hypereosinophilic syndrome | n2=en:Hodgkin lymphoma | rel=r_associated | relid=0 | w=20
  367. en:hypersensitivity --- r_associated #0: 20 --> en:Hodgkin lymphoma
    n1=en:hypersensitivity | n2=en:Hodgkin lymphoma | rel=r_associated | relid=0 | w=20
  368. en:hypertrophy of tonsils and adenoids --- r_associated #0: 20 --> en:Hodgkin lymphoma
    n1=en:hypertrophy of tonsils and adenoids | n2=en:Hodgkin lymphoma | rel=r_associated | relid=0 | w=20
  369. en:hypoglycemia --- r_associated #0: 20 --> en:Hodgkin lymphoma
    n1=en:hypoglycemia | n2=en:Hodgkin lymphoma | rel=r_associated | relid=0 | w=20
  370. en:hypothalamic neoplasm --- r_associated #0: 20 --> en:Hodgkin lymphoma
    n1=en:hypothalamic neoplasm | n2=en:Hodgkin lymphoma | rel=r_associated | relid=0 | w=20
  371. en:imaginal discs --- r_associated #0: 20 --> en:Hodgkin lymphoma
    n1=en:imaginal discs | n2=en:Hodgkin lymphoma | rel=r_associated | relid=0 | w=20
  372. en:immune system --- r_associated #0: 20 --> en:Hodgkin lymphoma
    n1=en:immune system | n2=en:Hodgkin lymphoma | rel=r_associated | relid=0 | w=20
  373. en:immune system disorder --- r_associated #0: 20 --> en:Hodgkin lymphoma
    n1=en:immune system disorder | n2=en:Hodgkin lymphoma | rel=r_associated | relid=0 | w=20
  374. en:immunization --- r_associated #0: 20 --> en:Hodgkin lymphoma
    n1=en:immunization | n2=en:Hodgkin lymphoma | rel=r_associated | relid=0 | w=20
  375. en:immunodeficiency-related malignant neoplasm --- r_associated #0: 20 --> en:Hodgkin lymphoma
    n1=en:immunodeficiency-related malignant neoplasm | n2=en:Hodgkin lymphoma | rel=r_associated | relid=0 | w=20
  376. en:immunology aspects --- r_associated #0: 20 --> en:Hodgkin lymphoma
    n1=en:immunology aspects | n2=en:Hodgkin lymphoma | rel=r_associated | relid=0 | w=20
  377. en:immunoproliferative disorders --- r_associated #0: 20 --> en:Hodgkin lymphoma
    n1=en:immunoproliferative disorders | n2=en:Hodgkin lymphoma | rel=r_associated | relid=0 | w=20
  378. en:impetigo --- r_associated #0: 20 --> en:Hodgkin lymphoma
    n1=en:impetigo | n2=en:Hodgkin lymphoma | rel=r_associated | relid=0 | w=20
  379. en:in blood --- r_associated #0: 20 --> en:Hodgkin lymphoma
    n1=en:in blood | n2=en:Hodgkin lymphoma | rel=r_associated | relid=0 | w=20
  380. en:in cerebrospinal fluid --- r_associated #0: 20 --> en:Hodgkin lymphoma
    n1=en:in cerebrospinal fluid | n2=en:Hodgkin lymphoma | rel=r_associated | relid=0 | w=20
  381. en:in urine --- r_associated #0: 20 --> en:Hodgkin lymphoma
    n1=en:in urine | n2=en:Hodgkin lymphoma | rel=r_associated | relid=0 | w=20
  382. en:increase in blood pressure --- r_associated #0: 20 --> en:Hodgkin lymphoma
    n1=en:increase in blood pressure | n2=en:Hodgkin lymphoma | rel=r_associated | relid=0 | w=20
  383. en:increased incidence of rectosigmoid cancer --- r_associated #0: 20 --> en:Hodgkin lymphoma
    n1=en:increased incidence of rectosigmoid cancer | n2=en:Hodgkin lymphoma | rel=r_associated | relid=0 | w=20
  384. en:increased risk for cancer --- r_associated #0: 20 --> en:Hodgkin lymphoma
    n1=en:increased risk for cancer | n2=en:Hodgkin lymphoma | rel=r_associated | relid=0 | w=20
  385. en:increased risk for embryonal tumors --- r_associated #0: 20 --> en:Hodgkin lymphoma
    n1=en:increased risk for embryonal tumors | n2=en:Hodgkin lymphoma | rel=r_associated | relid=0 | w=20
  386. en:increased risk for hematologic cancer, particularly acute myeloid leukemia --- r_associated #0: 20 --> en:Hodgkin lymphoma
    n1=en:increased risk for hematologic cancer, particularly acute myeloid leukemia | n2=en:Hodgkin lymphoma | rel=r_associated | relid=0 | w=20
  387. en:increased risk for lymphoma hodgkin disease --- r_associated #0: 20 --> en:Hodgkin lymphoma
    n1=en:increased risk for lymphoma hodgkin disease | n2=en:Hodgkin lymphoma | rel=r_associated | relid=0 | w=20
  388. en:increased risk for multiple myeloma --- r_associated #0: 20 --> en:Hodgkin lymphoma
    n1=en:increased risk for multiple myeloma | n2=en:Hodgkin lymphoma | rel=r_associated | relid=0 | w=20
  389. en:increased risk for wilms tumor --- r_associated #0: 20 --> en:Hodgkin lymphoma
    n1=en:increased risk for wilms tumor | n2=en:Hodgkin lymphoma | rel=r_associated | relid=0 | w=20
  390. en:increased risk in heterozygotes --- r_associated #0: 20 --> en:Hodgkin lymphoma
    n1=en:increased risk in heterozygotes | n2=en:Hodgkin lymphoma | rel=r_associated | relid=0 | w=20
  391. en:increased risk of breast cancer in women --- r_associated #0: 20 --> en:Hodgkin lymphoma
    n1=en:increased risk of breast cancer in women | n2=en:Hodgkin lymphoma | rel=r_associated | relid=0 | w=20
  392. en:increased risk of chondrosarcoma (mean age of onset 31 years) --- r_associated #0: 20 --> en:Hodgkin lymphoma
    n1=en:increased risk of chondrosarcoma (mean age of onset 31 years) | n2=en:Hodgkin lymphoma | rel=r_associated | relid=0 | w=20
  393. en:increased risk of malignancy --- r_associated #0: 20 --> en:Hodgkin lymphoma
    n1=en:increased risk of malignancy | n2=en:Hodgkin lymphoma | rel=r_associated | relid=0 | w=20
  394. en:increased risk of malignancy (classic feature) --- r_associated #0: 20 --> en:Hodgkin lymphoma
    n1=en:increased risk of malignancy (classic feature) | n2=en:Hodgkin lymphoma | rel=r_associated | relid=0 | w=20
  395. en:increased risk of medulloblastoma (rare) --- r_associated #0: 20 --> en:Hodgkin lymphoma
    n1=en:increased risk of medulloblastoma (rare) | n2=en:Hodgkin lymphoma | rel=r_associated | relid=0 | w=20
  396. en:increased risk of meningioma --- r_associated #0: 20 --> en:Hodgkin lymphoma
    n1=en:increased risk of meningioma | n2=en:Hodgkin lymphoma | rel=r_associated | relid=0 | w=20
  397. en:increased risk of myelodysplastic syndromes --- r_associated #0: 20 --> en:Hodgkin lymphoma
    n1=en:increased risk of myelodysplastic syndromes | n2=en:Hodgkin lymphoma | rel=r_associated | relid=0 | w=20
  398. en:increased risk of pancreatic cancer --- r_associated #0: 20 --> en:Hodgkin lymphoma
    n1=en:increased risk of pancreatic cancer | n2=en:Hodgkin lymphoma | rel=r_associated | relid=0 | w=20
  399. en:increased risk of testicular cancer --- r_associated #0: 20 --> en:Hodgkin lymphoma
    n1=en:increased risk of testicular cancer | n2=en:Hodgkin lymphoma | rel=r_associated | relid=0 | w=20
  400. en:increased susceptibility to cancer --- r_associated #0: 20 --> en:Hodgkin lymphoma
    n1=en:increased susceptibility to cancer | n2=en:Hodgkin lymphoma | rel=r_associated | relid=0 | w=20
  401. en:increased susceptibility to carcinomas, especially cancers related to cutaneous viral infections --- r_associated #0: 20 --> en:Hodgkin lymphoma
    n1=en:increased susceptibility to carcinomas, especially cancers related to cutaneous viral infections | n2=en:Hodgkin lymphoma | rel=r_associated | relid=0 | w=20
  402. en:increased susceptibility to large granular lymphocytic t-cell leukemia --- r_associated #0: 20 --> en:Hodgkin lymphoma
    n1=en:increased susceptibility to large granular lymphocytic t-cell leukemia | n2=en:Hodgkin lymphoma | rel=r_associated | relid=0 | w=20
  403. en:index tumor --- r_associated #0: 20 --> en:Hodgkin lymphoma
    n1=en:index tumor | n2=en:Hodgkin lymphoma | rel=r_associated | relid=0 | w=20
  404. en:infantile fibrosarcoma --- r_associated #0: 20 --> en:Hodgkin lymphoma
    n1=en:infantile fibrosarcoma | n2=en:Hodgkin lymphoma | rel=r_associated | relid=0 | w=20
  405. en:infectious diarrhea/dysentery --- r_associated #0: 20 --> en:Hodgkin lymphoma
    n1=en:infectious diarrhea/dysentery | n2=en:Hodgkin lymphoma | rel=r_associated | relid=0 | w=20
  406. en:infiltrating carcinoma with ductal and lobular features --- r_associated #0: 20 --> en:Hodgkin lymphoma
    n1=en:infiltrating carcinoma with ductal and lobular features | n2=en:Hodgkin lymphoma | rel=r_associated | relid=0 | w=20
  407. en:influenza (proven) without pneumonia --- r_associated #0: 20 --> en:Hodgkin lymphoma
    n1=en:influenza (proven) without pneumonia | n2=en:Hodgkin lymphoma | rel=r_associated | relid=0 | w=20
  408. en:ingrown toenail/other disease of nail --- r_associated #0: 20 --> en:Hodgkin lymphoma
    n1=en:ingrown toenail/other disease of nail | n2=en:Hodgkin lymphoma | rel=r_associated | relid=0 | w=20
  409. en:inguinal hernia --- r_associated #0: 20 --> en:Hodgkin lymphoma
    n1=en:inguinal hernia | n2=en:Hodgkin lymphoma | rel=r_associated | relid=0 | w=20
  410. en:interdigitating dendritic cell sarcoma --- r_associated #0: 20 --> en:Hodgkin lymphoma
    n1=en:interdigitating dendritic cell sarcoma | n2=en:Hodgkin lymphoma | rel=r_associated | relid=0 | w=20
  411. en:intraductal papillary adenocarcinoma with invasion --- r_associated #0: 20 --> en:Hodgkin lymphoma
    n1=en:intraductal papillary adenocarcinoma with invasion | n2=en:Hodgkin lymphoma | rel=r_associated | relid=0 | w=20
  412. en:intraocular lymphoma --- r_associated #0: 20 --> en:Hodgkin lymphoma
    n1=en:intraocular lymphoma | n2=en:Hodgkin lymphoma | rel=r_associated | relid=0 | w=20
  413. en:invasive ductal and lobular carcinoma in situ --- r_associated #0: 20 --> en:Hodgkin lymphoma
    n1=en:invasive ductal and lobular carcinoma in situ | n2=en:Hodgkin lymphoma | rel=r_associated | relid=0 | w=20
  414. en:invasive micropapillary breast carcinoma --- r_associated #0: 20 --> en:Hodgkin lymphoma
    n1=en:invasive micropapillary breast carcinoma | n2=en:Hodgkin lymphoma | rel=r_associated | relid=0 | w=20
  415. en:invertebrate cuticle --- r_associated #0: 20 --> en:Hodgkin lymphoma
    n1=en:invertebrate cuticle | n2=en:Hodgkin lymphoma | rel=r_associated | relid=0 | w=20
  416. en:irritable bowel syndrome --- r_associated #0: 20 --> en:Hodgkin lymphoma
    n1=en:irritable bowel syndrome | n2=en:Hodgkin lymphoma | rel=r_associated | relid=0 | w=20
  417. en:jak2 wt allele --- r_associated #0: 20 --> en:Hodgkin lymphoma
    n1=en:jak2 wt allele | n2=en:Hodgkin lymphoma | rel=r_associated | relid=0 | w=20
  418. en:jugulotympanic paraganglioma --- r_associated #0: 20 --> en:Hodgkin lymphoma
    n1=en:jugulotympanic paraganglioma | n2=en:Hodgkin lymphoma | rel=r_associated | relid=0 | w=20
  419. en:kaposi sarcoma --- r_associated #0: 20 --> en:Hodgkin lymphoma
    n1=en:kaposi sarcoma | n2=en:Hodgkin lymphoma | rel=r_associated | relid=0 | w=20
  420. en:kaposi sarcoma (1 patient) --- r_associated #0: 20 --> en:Hodgkin lymphoma
    n1=en:kaposi sarcoma (1 patient) | n2=en:Hodgkin lymphoma | rel=r_associated | relid=0 | w=20
  421. en:kawasaki disease --- r_associated #0: 20 --> en:Hodgkin lymphoma
    n1=en:kawasaki disease | n2=en:Hodgkin lymphoma | rel=r_associated | relid=0 | w=20
  422. en:klhdc8b, 5-prime utr, +28c-t --- r_associated #0: 20 --> en:Hodgkin lymphoma
    n1=en:klhdc8b, 5-prime utr, +28c-t | n2=en:Hodgkin lymphoma | rel=r_associated | relid=0 | w=20
  423. en:large cell neuroendocrine carcinoma --- r_associated #0: 20 --> en:Hodgkin lymphoma
    n1=en:large cell neuroendocrine carcinoma | n2=en:Hodgkin lymphoma | rel=r_associated | relid=0 | w=20
  424. en:laryngeal neoplasm --- r_associated #0: 20 --> en:Hodgkin lymphoma
    n1=en:laryngeal neoplasm | n2=en:Hodgkin lymphoma | rel=r_associated | relid=0 | w=20
  425. en:lateral epicondylitis --- r_associated #0: 20 --> en:Hodgkin lymphoma
    n1=en:lateral epicondylitis | n2=en:Hodgkin lymphoma | rel=r_associated | relid=0 | w=20
  426. en:latex allergy --- r_associated #0: 20 --> en:Hodgkin lymphoma
    n1=en:latex allergy | n2=en:Hodgkin lymphoma | rel=r_associated | relid=0 | w=20
  427. en:leiomyosarcoma --- r_associated #0: 20 --> en:Hodgkin lymphoma
    n1=en:leiomyosarcoma | n2=en:Hodgkin lymphoma | rel=r_associated | relid=0 | w=20
  428. en:leukemia --- r_associated #0: 20 --> en:Hodgkin lymphoma
    n1=en:leukemia | n2=en:Hodgkin lymphoma | rel=r_associated | relid=0 | w=20
  429. en:leukemia (both all and aml) --- r_associated #0: 20 --> en:Hodgkin lymphoma
    n1=en:leukemia (both all and aml) | n2=en:Hodgkin lymphoma | rel=r_associated | relid=0 | w=20
  430. en:leukemic infiltrate of kidney --- r_associated #0: 20 --> en:Hodgkin lymphoma
    n1=en:leukemic infiltrate of kidney | n2=en:Hodgkin lymphoma | rel=r_associated | relid=0 | w=20
  431. en:leukocyte --- r_associated #0: 20 --> en:Hodgkin lymphoma
    n1=en:leukocyte | n2=en:Hodgkin lymphoma | rel=r_associated | relid=0 | w=20
  432. en:leukocyte disorders --- r_associated #0: 20 --> en:Hodgkin lymphoma
    n1=en:leukocyte disorders | n2=en:Hodgkin lymphoma | rel=r_associated | relid=0 | w=20
  433. en:lipid metabolism disorder --- r_associated #0: 20 --> en:Hodgkin lymphoma
    n1=en:lipid metabolism disorder | n2=en:Hodgkin lymphoma | rel=r_associated | relid=0 | w=20
  434. en:lipoma --- r_associated #0: 20 --> en:Hodgkin lymphoma
    n1=en:lipoma | n2=en:Hodgkin lymphoma | rel=r_associated | relid=0 | w=20
  435. en:liver carcinoma --- r_associated #0: 20 --> en:Hodgkin lymphoma
    n1=en:liver carcinoma | n2=en:Hodgkin lymphoma | rel=r_associated | relid=0 | w=20
  436. en:low grade fibromyxoid sarcoma --- r_associated #0: 20 --> en:Hodgkin lymphoma
    n1=en:low grade fibromyxoid sarcoma | n2=en:Hodgkin lymphoma | rel=r_associated | relid=0 | w=20
  437. en:low grade myofibroblastic sarcoma --- r_associated #0: 20 --> en:Hodgkin lymphoma
    n1=en:low grade myofibroblastic sarcoma | n2=en:Hodgkin lymphoma | rel=r_associated | relid=0 | w=20
  438. en:low incidence of plexiform neurofibromas --- r_associated #0: 20 --> en:Hodgkin lymphoma
    n1=en:low incidence of plexiform neurofibromas | n2=en:Hodgkin lymphoma | rel=r_associated | relid=0 | w=20
  439. en:low-grade neuroendocrine carcinoma (submandibular glands, salivary glands, maxillary sinus, nasal cavity) --- r_associated #0: 20 --> en:Hodgkin lymphoma
    n1=en:low-grade neuroendocrine carcinoma (submandibular glands, salivary glands, maxillary sinus, nasal cavity) | n2=en:Hodgkin lymphoma | rel=r_associated | relid=0 | w=20
  440. en:lund --- r_associated #0: 20 --> en:Hodgkin lymphoma
    n1=en:lund | n2=en:Hodgkin lymphoma | rel=r_associated | relid=0 | w=20
  441. en:lung --- r_associated #0: 20 --> en:Hodgkin lymphoma
    n1=en:lung | n2=en:Hodgkin lymphoma | rel=r_associated | relid=0 | w=20
  442. en:lupus erythematosus --- r_associated #0: 20 --> en:Hodgkin lymphoma
    n1=en:lupus erythematosus | n2=en:Hodgkin lymphoma | rel=r_associated | relid=0 | w=20
  443. en:lymph node disorder --- r_associated #0: 20 --> en:Hodgkin lymphoma
    n1=en:lymph node disorder | n2=en:Hodgkin lymphoma | rel=r_associated | relid=0 | w=20
  444. en:lymph node neoplasm --- r_associated #0: 20 --> en:Hodgkin lymphoma
    n1=en:lymph node neoplasm | n2=en:Hodgkin lymphoma | rel=r_associated | relid=0 | w=20
  445. en:lymphatic vessel neoplasm --- r_associated #0: 20 --> en:Hodgkin lymphoma
    n1=en:lymphatic vessel neoplasm | n2=en:Hodgkin lymphoma | rel=r_associated | relid=0 | w=20
  446. en:lymphocyte depleted classical hodgkin lymphoma, extranodal and solid organ sites --- r_associated #0: 20 --> en:Hodgkin lymphoma
    n1=en:lymphocyte depleted classical hodgkin lymphoma, extranodal and solid organ sites | n2=en:Hodgkin lymphoma | rel=r_associated | relid=0 | w=20
  447. en:lymphocyte depleted classical hodgkin lymphoma, intrathoracic lymph nodes --- r_associated #0: 20 --> en:Hodgkin lymphoma
    n1=en:lymphocyte depleted classical hodgkin lymphoma, intrathoracic lymph nodes | n2=en:Hodgkin lymphoma | rel=r_associated | relid=0 | w=20
  448. en:lymphocyte depleted classical hodgkin lymphoma, lymph nodes of head, face, and neck --- r_associated #0: 20 --> en:Hodgkin lymphoma
    n1=en:lymphocyte depleted classical hodgkin lymphoma, lymph nodes of head, face, and neck | n2=en:Hodgkin lymphoma | rel=r_associated | relid=0 | w=20
  449. en:lymphocyte depleted classical hodgkin lymphoma, lymph nodes of inguinal region and lower limb --- r_associated #0: 20 --> en:Hodgkin lymphoma
    n1=en:lymphocyte depleted classical hodgkin lymphoma, lymph nodes of inguinal region and lower limb | n2=en:Hodgkin lymphoma | rel=r_associated | relid=0 | w=20
  450. en:lymphocyte depleted classical hodgkin lymphoma, lymph nodes of multiple sites --- r_associated #0: 20 --> en:Hodgkin lymphoma
    n1=en:lymphocyte depleted classical hodgkin lymphoma, lymph nodes of multiple sites | n2=en:Hodgkin lymphoma | rel=r_associated | relid=0 | w=20
  451. en:lymphocyte depleted classical hodgkin lymphoma, spleen --- r_associated #0: 20 --> en:Hodgkin lymphoma
    n1=en:lymphocyte depleted classical hodgkin lymphoma, spleen | n2=en:Hodgkin lymphoma | rel=r_associated | relid=0 | w=20
  452. en:lymphocyte predominant type hodgkin's disease --- r_associated #0: 20 --> en:Hodgkin lymphoma
    n1=en:lymphocyte predominant type hodgkin's disease | n2=en:Hodgkin lymphoma | rel=r_associated | relid=0 | w=20
  453. en:lymphocyte-depleted classical hodgkin lymphoma --- r_associated #0: 20 --> en:Hodgkin lymphoma
    n1=en:lymphocyte-depleted classical hodgkin lymphoma | n2=en:Hodgkin lymphoma | rel=r_associated | relid=0 | w=20
  454. en:lymphocyte-rich classical hodgkin lymphoma --- r_associated #0: 20 --> en:Hodgkin lymphoma
    n1=en:lymphocyte-rich classical hodgkin lymphoma | n2=en:Hodgkin lymphoma | rel=r_associated | relid=0 | w=20
  455. en:lymphocyte-rich classical hodgkin lymphoma, lymph nodes of axilla and upper limb --- r_associated #0: 20 --> en:Hodgkin lymphoma
    n1=en:lymphocyte-rich classical hodgkin lymphoma, lymph nodes of axilla and upper limb | n2=en:Hodgkin lymphoma | rel=r_associated | relid=0 | w=20
  456. en:lymphocyte-rich classical hodgkin lymphoma, lymph nodes of head, face, and neck --- r_associated #0: 20 --> en:Hodgkin lymphoma
    n1=en:lymphocyte-rich classical hodgkin lymphoma, lymph nodes of head, face, and neck | n2=en:Hodgkin lymphoma | rel=r_associated | relid=0 | w=20
  457. en:lymphocyte-rich classical hodgkin lymphoma, lymph nodes of inguinal region and lower limb --- r_associated #0: 20 --> en:Hodgkin lymphoma
    n1=en:lymphocyte-rich classical hodgkin lymphoma, lymph nodes of inguinal region and lower limb | n2=en:Hodgkin lymphoma | rel=r_associated | relid=0 | w=20
  458. en:lymphocyte-rich classical hodgkin lymphoma, unspecified site --- r_associated #0: 20 --> en:Hodgkin lymphoma
    n1=en:lymphocyte-rich classical hodgkin lymphoma, unspecified site | n2=en:Hodgkin lymphoma | rel=r_associated | relid=0 | w=20
  459. en:lymphoma --- r_associated #0: 20 --> en:Hodgkin lymphoma
    n1=en:lymphoma | n2=en:Hodgkin lymphoma | rel=r_associated | relid=0 | w=20
  460. en:lymphoma by site --- r_associated #0: 20 --> en:Hodgkin lymphoma
    n1=en:lymphoma by site | n2=en:Hodgkin lymphoma | rel=r_associated | relid=0 | w=20
  461. en:lymphomatoid papulosis --- r_associated #0: 20 --> en:Hodgkin lymphoma
    n1=en:lymphomatoid papulosis | n2=en:Hodgkin lymphoma | rel=r_associated | relid=0 | w=20
  462. en:lymphosarcoma and reticulosarcoma and other specified malignant tumors of lymphatic tissue --- r_associated #0: 20 --> en:Hodgkin lymphoma
    n1=en:lymphosarcoma and reticulosarcoma and other specified malignant tumors of lymphatic tissue | n2=en:Hodgkin lymphoma | rel=r_associated | relid=0 | w=20
  463. en:macular degeneration --- r_associated #0: 20 --> en:Hodgkin lymphoma
    n1=en:macular degeneration | n2=en:Hodgkin lymphoma | rel=r_associated | relid=0 | w=20
  464. en:malaria --- r_associated #0: 20 --> en:Hodgkin lymphoma
    n1=en:malaria | n2=en:Hodgkin lymphoma | rel=r_associated | relid=0 | w=20
  465. en:male germ cell tumors (gct), 2 subtypes - --- r_associated #0: 20 --> en:Hodgkin lymphoma
    n1=en:male germ cell tumors (gct), 2 subtypes - | n2=en:Hodgkin lymphoma | rel=r_associated | relid=0 | w=20
  466. en:malignancy in approximately 10% --- r_associated #0: 20 --> en:Hodgkin lymphoma
    n1=en:malignancy in approximately 10% | n2=en:Hodgkin lymphoma | rel=r_associated | relid=0 | w=20
  467. en:malignant (primary) neoplasm, unspecified --- r_associated #0: 20 --> en:Hodgkin lymphoma
    n1=en:malignant (primary) neoplasm, unspecified | n2=en:Hodgkin lymphoma | rel=r_associated | relid=0 | w=20
  468. en:malignant adrenal gland neoplasm --- r_associated #0: 20 --> en:Hodgkin lymphoma
    n1=en:malignant adrenal gland neoplasm | n2=en:Hodgkin lymphoma | rel=r_associated | relid=0 | w=20
  469. en:malignant aortic body tumor --- r_associated #0: 20 --> en:Hodgkin lymphoma
    n1=en:malignant aortic body tumor | n2=en:Hodgkin lymphoma | rel=r_associated | relid=0 | w=20
  470. en:malignant bone neoplasm --- r_associated #0: 20 --> en:Hodgkin lymphoma
    n1=en:malignant bone neoplasm | n2=en:Hodgkin lymphoma | rel=r_associated | relid=0 | w=20
  471. en:malignant breast neoplasm --- r_associated #0: 20 --> en:Hodgkin lymphoma
    n1=en:malignant breast neoplasm | n2=en:Hodgkin lymphoma | rel=r_associated | relid=0 | w=20
  472. en:malignant cervical neoplasm --- r_associated #0: 20 --> en:Hodgkin lymphoma
    n1=en:malignant cervical neoplasm | n2=en:Hodgkin lymphoma | rel=r_associated | relid=0 | w=20
  473. en:malignant esophageal neoplasm --- r_associated #0: 20 --> en:Hodgkin lymphoma
    n1=en:malignant esophageal neoplasm | n2=en:Hodgkin lymphoma | rel=r_associated | relid=0 | w=20
  474. en:malignant eye neoplasm --- r_associated #0: 20 --> en:Hodgkin lymphoma
    n1=en:malignant eye neoplasm | n2=en:Hodgkin lymphoma | rel=r_associated | relid=0 | w=20
  475. en:malignant fibromatous neoplasm --- r_associated #0: 20 --> en:Hodgkin lymphoma
    n1=en:malignant fibromatous neoplasm | n2=en:Hodgkin lymphoma | rel=r_associated | relid=0 | w=20
  476. en:malignant fibrous histiocytoma (in about 35% of patients) --- r_associated #0: 20 --> en:Hodgkin lymphoma
    n1=en:malignant fibrous histiocytoma (in about 35% of patients) | n2=en:Hodgkin lymphoma | rel=r_associated | relid=0 | w=20
  477. en:malignant gastric neoplasm --- r_associated #0: 20 --> en:Hodgkin lymphoma
    n1=en:malignant gastric neoplasm | n2=en:Hodgkin lymphoma | rel=r_associated | relid=0 | w=20
  478. en:malignant genitourinary tract tumor --- r_associated #0: 20 --> en:Hodgkin lymphoma
    n1=en:malignant genitourinary tract tumor | n2=en:Hodgkin lymphoma | rel=r_associated | relid=0 | w=20
  479. en:malignant glioma --- r_associated #0: 20 --> en:Hodgkin lymphoma
    n1=en:malignant glioma | n2=en:Hodgkin lymphoma | rel=r_associated | relid=0 | w=20
  480. en:malignant glomus tumor --- r_associated #0: 20 --> en:Hodgkin lymphoma
    n1=en:malignant glomus tumor | n2=en:Hodgkin lymphoma | rel=r_associated | relid=0 | w=20
  481. en:malignant granular cell tumor --- r_associated #0: 20 --> en:Hodgkin lymphoma
    n1=en:malignant granular cell tumor | n2=en:Hodgkin lymphoma | rel=r_associated | relid=0 | w=20
  482. en:malignant granulosa cell tumor --- r_associated #0: 20 --> en:Hodgkin lymphoma
    n1=en:malignant granulosa cell tumor | n2=en:Hodgkin lymphoma | rel=r_associated | relid=0 | w=20
  483. en:malignant histiocytosis --- r_associated #0: 20 --> en:Hodgkin lymphoma
    n1=en:malignant histiocytosis | n2=en:Hodgkin lymphoma | rel=r_associated | relid=0 | w=20
  484. en:malignant immunoproliferative diseases and certain other b-cell lymphomas --- r_associated #0: 20 --> en:Hodgkin lymphoma
    n1=en:malignant immunoproliferative diseases and certain other b-cell lymphomas | n2=en:Hodgkin lymphoma | rel=r_associated | relid=0 | w=20
  485. en:malignant immunoproliferative neoplasm --- r_associated #0: 20 --> en:Hodgkin lymphoma
    n1=en:malignant immunoproliferative neoplasm | n2=en:Hodgkin lymphoma | rel=r_associated | relid=0 | w=20
  486. en:malignant intestinal neoplasm --- r_associated #0: 20 --> en:Hodgkin lymphoma
    n1=en:malignant intestinal neoplasm | n2=en:Hodgkin lymphoma | rel=r_associated | relid=0 | w=20
  487. en:malignant leydig cell tumor --- r_associated #0: 20 --> en:Hodgkin lymphoma
    n1=en:malignant leydig cell tumor | n2=en:Hodgkin lymphoma | rel=r_associated | relid=0 | w=20
  488. en:malignant lung neoplasm --- r_associated #0: 20 --> en:Hodgkin lymphoma
    n1=en:malignant lung neoplasm | n2=en:Hodgkin lymphoma | rel=r_associated | relid=0 | w=20
  489. en:malignant lymph node neoplasm --- r_associated #0: 20 --> en:Hodgkin lymphoma
    n1=en:malignant lymph node neoplasm | n2=en:Hodgkin lymphoma | rel=r_associated | relid=0 | w=20
  490. en:malignant lymphadenopathy --- r_associated #0: 20 --> en:Hodgkin lymphoma
    n1=en:malignant lymphadenopathy | n2=en:Hodgkin lymphoma | rel=r_associated | relid=0 | w=20
  491. en:malignant melanoma in giant pigmented nevus --- r_associated #0: 20 --> en:Hodgkin lymphoma
    n1=en:malignant melanoma in giant pigmented nevus | n2=en:Hodgkin lymphoma | rel=r_associated | relid=0 | w=20
  492. en:malignant melanoma in precancerous melanosis --- r_associated #0: 20 --> en:Hodgkin lymphoma
    n1=en:malignant melanoma in precancerous melanosis | n2=en:Hodgkin lymphoma | rel=r_associated | relid=0 | w=20
  493. en:malignant mesenchymoma --- r_associated #0: 20 --> en:Hodgkin lymphoma
    n1=en:malignant mesenchymoma | n2=en:Hodgkin lymphoma | rel=r_associated | relid=0 | w=20
  494. en:malignant mixed tumor, carcinomatous type --- r_associated #0: 20 --> en:Hodgkin lymphoma
    n1=en:malignant mixed tumor, carcinomatous type | n2=en:Hodgkin lymphoma | rel=r_associated | relid=0 | w=20
  495. en:malignant mixed tumor, chondrosarcomatous type --- r_associated #0: 20 --> en:Hodgkin lymphoma
    n1=en:malignant mixed tumor, chondrosarcomatous type | n2=en:Hodgkin lymphoma | rel=r_associated | relid=0 | w=20
  496. en:malignant muscle neoplasm --- r_associated #0: 20 --> en:Hodgkin lymphoma
    n1=en:malignant muscle neoplasm | n2=en:Hodgkin lymphoma | rel=r_associated | relid=0 | w=20
  497. en:malignant neoplasm (morphology) --- r_associated #0: 20 --> en:Hodgkin lymphoma
    n1=en:malignant neoplasm (morphology) | n2=en:Hodgkin lymphoma | rel=r_associated | relid=0 | w=20
  498. en:malignant neoplasm after immunosuppressive therapy --- r_associated #0: 20 --> en:Hodgkin lymphoma
    n1=en:malignant neoplasm after immunosuppressive therapy | n2=en:Hodgkin lymphoma | rel=r_associated | relid=0 | w=20
  499. en:malignant neoplasm associated with aids --- r_associated #0: 20 --> en:Hodgkin lymphoma
    n1=en:malignant neoplasm associated with aids | n2=en:Hodgkin lymphoma | rel=r_associated | relid=0 | w=20
  500. en:malignant neoplasm associated with transplant organ --- r_associated #0: 20 --> en:Hodgkin lymphoma
    n1=en:malignant neoplasm associated with transplant organ | n2=en:Hodgkin lymphoma | rel=r_associated | relid=0 | w=20
  501. en:malignant neoplasm by grade --- r_associated #0: 20 --> en:Hodgkin lymphoma
    n1=en:malignant neoplasm by grade | n2=en:Hodgkin lymphoma | rel=r_associated | relid=0 | w=20
  502. en:malignant neoplasm of colon with rectum --- r_associated #0: 20 --> en:Hodgkin lymphoma
    n1=en:malignant neoplasm of colon with rectum | n2=en:Hodgkin lymphoma | rel=r_associated | relid=0 | w=20
  503. en:malignant neoplasm of gartner's duct --- r_associated #0: 20 --> en:Hodgkin lymphoma
    n1=en:malignant neoplasm of gartner's duct | n2=en:Hodgkin lymphoma | rel=r_associated | relid=0 | w=20
  504. en:malignant neoplasm of lip, oral cavity and pharynx --- r_associated #0: 20 --> en:Hodgkin lymphoma
    n1=en:malignant neoplasm of lip, oral cavity and pharynx | n2=en:Hodgkin lymphoma | rel=r_associated | relid=0 | w=20
  505. en:malignant neoplasm of lower limb --- r_associated #0: 20 --> en:Hodgkin lymphoma
    n1=en:malignant neoplasm of lower limb | n2=en:Hodgkin lymphoma | rel=r_associated | relid=0 | w=20
  506. en:malignant neoplasm of other and ill-defined sites: other ill-defined sites --- r_associated #0: 20 --> en:Hodgkin lymphoma
    n1=en:malignant neoplasm of other and ill-defined sites: other ill-defined sites | n2=en:Hodgkin lymphoma | rel=r_associated | relid=0 | w=20
  507. en:malignant neoplasm of other specified sites --- r_associated #0: 20 --> en:Hodgkin lymphoma
    n1=en:malignant neoplasm of other specified sites | n2=en:Hodgkin lymphoma | rel=r_associated | relid=0 | w=20
  508. en:malignant neoplasm of pelvis --- r_associated #0: 20 --> en:Hodgkin lymphoma
    n1=en:malignant neoplasm of pelvis | n2=en:Hodgkin lymphoma | rel=r_associated | relid=0 | w=20
  509. en:malignant neoplasm of respiratory system --- r_associated #0: 20 --> en:Hodgkin lymphoma
    n1=en:malignant neoplasm of respiratory system | n2=en:Hodgkin lymphoma | rel=r_associated | relid=0 | w=20
  510. en:malignant neoplasm of skeletal system --- r_associated #0: 20 --> en:Hodgkin lymphoma
    n1=en:malignant neoplasm of skeletal system | n2=en:Hodgkin lymphoma | rel=r_associated | relid=0 | w=20
  511. en:malignant neoplasm of upper limb nos --- r_associated #0: 20 --> en:Hodgkin lymphoma
    n1=en:malignant neoplasm of upper limb nos | n2=en:Hodgkin lymphoma | rel=r_associated | relid=0 | w=20
  512. en:malignant neoplasm, overlapping lesion of digestive system --- r_associated #0: 20 --> en:Hodgkin lymphoma
    n1=en:malignant neoplasm, overlapping lesion of digestive system | n2=en:Hodgkin lymphoma | rel=r_associated | relid=0 | w=20
  513. en:malignant neoplasm, primary site unknown, so stated --- r_associated #0: 20 --> en:Hodgkin lymphoma
    n1=en:malignant neoplasm, primary site unknown, so stated | n2=en:Hodgkin lymphoma | rel=r_associated | relid=0 | w=20
  514. en:malignant neoplasm: bronchus or lung, unspecified --- r_associated #0: 20 --> en:Hodgkin lymphoma
    n1=en:malignant neoplasm: bronchus or lung, unspecified | n2=en:Hodgkin lymphoma | rel=r_associated | relid=0 | w=20
  515. en:malignant neoplasms of ill-defined, secondary and unspecified sites --- r_associated #0: 20 --> en:Hodgkin lymphoma
    n1=en:malignant neoplasms of ill-defined, secondary and unspecified sites | n2=en:Hodgkin lymphoma | rel=r_associated | relid=0 | w=20
  516. en:malignant neoplasms, stated or presumed to be primary, of lymphoid, haematopoietic and related tissue --- r_associated #0: 20 --> en:Hodgkin lymphoma
    n1=en:malignant neoplasms, stated or presumed to be primary, of lymphoid, haematopoietic and related tissue | n2=en:Hodgkin lymphoma | rel=r_associated | relid=0 | w=20
  517. en:malignant neoplastic disease in pregnancy --- r_associated #0: 20 --> en:Hodgkin lymphoma
    n1=en:malignant neoplastic disease in pregnancy | n2=en:Hodgkin lymphoma | rel=r_associated | relid=0 | w=20
  518. en:malignant neuroendocrine neoplasm, epithelial --- r_associated #0: 20 --> en:Hodgkin lymphoma
    n1=en:malignant neuroendocrine neoplasm, epithelial | n2=en:Hodgkin lymphoma | rel=r_associated | relid=0 | w=20
  519. en:malignant neuroendocrine tumor --- r_associated #0: 20 --> en:Hodgkin lymphoma
    n1=en:malignant neuroendocrine tumor | n2=en:Hodgkin lymphoma | rel=r_associated | relid=0 | w=20
  520. en:malignant odontogenic ghost cell tumor --- r_associated #0: 20 --> en:Hodgkin lymphoma
    n1=en:malignant odontogenic ghost cell tumor | n2=en:Hodgkin lymphoma | rel=r_associated | relid=0 | w=20
  521. en:malignant ossifying fibromyxoid tumor --- r_associated #0: 20 --> en:Hodgkin lymphoma
    n1=en:malignant ossifying fibromyxoid tumor | n2=en:Hodgkin lymphoma | rel=r_associated | relid=0 | w=20
  522. en:malignant ovarian neoplasm --- r_associated #0: 20 --> en:Hodgkin lymphoma
    n1=en:malignant ovarian neoplasm | n2=en:Hodgkin lymphoma | rel=r_associated | relid=0 | w=20
  523. en:malignant ovarian thecoma --- r_associated #0: 20 --> en:Hodgkin lymphoma
    n1=en:malignant ovarian thecoma | n2=en:Hodgkin lymphoma | rel=r_associated | relid=0 | w=20
  524. en:malignant pancreatic neoplasm --- r_associated #0: 20 --> en:Hodgkin lymphoma
    n1=en:malignant pancreatic neoplasm | n2=en:Hodgkin lymphoma | rel=r_associated | relid=0 | w=20
  525. en:malignant pecoma --- r_associated #0: 20 --> en:Hodgkin lymphoma
    n1=en:malignant pecoma | n2=en:Hodgkin lymphoma | rel=r_associated | relid=0 | w=20
  526. en:malignant peripheral nerve sheath tumor --- r_associated #0: 20 --> en:Hodgkin lymphoma
    n1=en:malignant peripheral nerve sheath tumor | n2=en:Hodgkin lymphoma | rel=r_associated | relid=0 | w=20
  527. en:malignant peripheral nerve sheath tumor with perineurial differentiation --- r_associated #0: 20 --> en:Hodgkin lymphoma
    n1=en:malignant peripheral nerve sheath tumor with perineurial differentiation | n2=en:Hodgkin lymphoma | rel=r_associated | relid=0 | w=20
  528. en:malignant phyllodes tumor --- r_associated #0: 20 --> en:Hodgkin lymphoma
    n1=en:malignant phyllodes tumor | n2=en:Hodgkin lymphoma | rel=r_associated | relid=0 | w=20
  529. en:malignant prostate neoplasm --- r_associated #0: 20 --> en:Hodgkin lymphoma
    n1=en:malignant prostate neoplasm | n2=en:Hodgkin lymphoma | rel=r_associated | relid=0 | w=20
  530. en:malignant salivary gland neoplasm --- r_associated #0: 20 --> en:Hodgkin lymphoma
    n1=en:malignant salivary gland neoplasm | n2=en:Hodgkin lymphoma | rel=r_associated | relid=0 | w=20
  531. en:malignant sebaceous neoplasm --- r_associated #0: 20 --> en:Hodgkin lymphoma
    n1=en:malignant sebaceous neoplasm | n2=en:Hodgkin lymphoma | rel=r_associated | relid=0 | w=20
  532. en:malignant sex cord-stromal tumor --- r_associated #0: 20 --> en:Hodgkin lymphoma
    n1=en:malignant sex cord-stromal tumor | n2=en:Hodgkin lymphoma | rel=r_associated | relid=0 | w=20
  533. en:malignant skin neoplasm --- r_associated #0: 20 --> en:Hodgkin lymphoma
    n1=en:malignant skin neoplasm | n2=en:Hodgkin lymphoma | rel=r_associated | relid=0 | w=20
  534. en:malignant soft tissue neoplasm --- r_associated #0: 20 --> en:Hodgkin lymphoma
    n1=en:malignant soft tissue neoplasm | n2=en:Hodgkin lymphoma | rel=r_associated | relid=0 | w=20
  535. en:malignant solid tumor --- r_associated #0: 20 --> en:Hodgkin lymphoma
    n1=en:malignant solid tumor | n2=en:Hodgkin lymphoma | rel=r_associated | relid=0 | w=20
  536. en:malignant solitary fibrous tumor --- r_associated #0: 20 --> en:Hodgkin lymphoma
    n1=en:malignant solitary fibrous tumor | n2=en:Hodgkin lymphoma | rel=r_associated | relid=0 | w=20
  537. en:malignant splenic neoplasm --- r_associated #0: 20 --> en:Hodgkin lymphoma
    n1=en:malignant splenic neoplasm | n2=en:Hodgkin lymphoma | rel=r_associated | relid=0 | w=20
  538. en:malignant thoracic neoplasm --- r_associated #0: 20 --> en:Hodgkin lymphoma
    n1=en:malignant thoracic neoplasm | n2=en:Hodgkin lymphoma | rel=r_associated | relid=0 | w=20
  539. en:malignant thymus neoplasm --- r_associated #0: 20 --> en:Hodgkin lymphoma
    n1=en:malignant thymus neoplasm | n2=en:Hodgkin lymphoma | rel=r_associated | relid=0 | w=20
  540. en:malignant thyroid gland neoplasm --- r_associated #0: 20 --> en:Hodgkin lymphoma
    n1=en:malignant thyroid gland neoplasm | n2=en:Hodgkin lymphoma | rel=r_associated | relid=0 | w=20
  541. en:malignant triton tumor --- r_associated #0: 20 --> en:Hodgkin lymphoma
    n1=en:malignant triton tumor | n2=en:Hodgkin lymphoma | rel=r_associated | relid=0 | w=20
  542. en:malignant trophoblastic teratoma --- r_associated #0: 20 --> en:Hodgkin lymphoma
    n1=en:malignant trophoblastic teratoma | n2=en:Hodgkin lymphoma | rel=r_associated | relid=0 | w=20
  543. en:malignant tumor involving an organ by direct extension from endometrium --- r_associated #0: 20 --> en:Hodgkin lymphoma
    n1=en:malignant tumor involving an organ by direct extension from endometrium | n2=en:Hodgkin lymphoma | rel=r_associated | relid=0 | w=20
  544. en:malignant tumor involving an organ by direct extension from ovary --- r_associated #0: 20 --> en:Hodgkin lymphoma
    n1=en:malignant tumor involving an organ by direct extension from ovary | n2=en:Hodgkin lymphoma | rel=r_associated | relid=0 | w=20
  545. en:malignant tumor of nerve sheath origin --- r_associated #0: 20 --> en:Hodgkin lymphoma
    n1=en:malignant tumor of nerve sheath origin | n2=en:Hodgkin lymphoma | rel=r_associated | relid=0 | w=20
  546. en:malignant tumor of unknown origin or ill-defined site --- r_associated #0: 20 --> en:Hodgkin lymphoma
    n1=en:malignant tumor of unknown origin or ill-defined site | n2=en:Hodgkin lymphoma | rel=r_associated | relid=0 | w=20
  547. en:malignant type ab thymoma --- r_associated #0: 20 --> en:Hodgkin lymphoma
    n1=en:malignant type ab thymoma | n2=en:Hodgkin lymphoma | rel=r_associated | relid=0 | w=20
  548. en:malignant type b2 thymoma --- r_associated #0: 20 --> en:Hodgkin lymphoma
    n1=en:malignant type b2 thymoma | n2=en:Hodgkin lymphoma | rel=r_associated | relid=0 | w=20
  549. en:malignant urinary system neoplasm --- r_associated #0: 20 --> en:Hodgkin lymphoma
    n1=en:malignant urinary system neoplasm | n2=en:Hodgkin lymphoma | rel=r_associated | relid=0 | w=20
  550. en:malignant vaginal neoplasm --- r_associated #0: 20 --> en:Hodgkin lymphoma
    n1=en:malignant vaginal neoplasm | n2=en:Hodgkin lymphoma | rel=r_associated | relid=0 | w=20
  551. en:malignant vulvar neoplasm --- r_associated #0: 20 --> en:Hodgkin lymphoma
    n1=en:malignant vulvar neoplasm | n2=en:Hodgkin lymphoma | rel=r_associated | relid=0 | w=20
  552. en:malignant white blood cell disorder --- r_associated #0: 20 --> en:Hodgkin lymphoma
    n1=en:malignant white blood cell disorder | n2=en:Hodgkin lymphoma | rel=r_associated | relid=0 | w=20
  553. en:mast cell --- r_associated #0: 20 --> en:Hodgkin lymphoma
    n1=en:mast cell | n2=en:Hodgkin lymphoma | rel=r_associated | relid=0 | w=20
  554. en:mature b-cell non-hodgkin lymphoma --- r_associated #0: 20 --> en:Hodgkin lymphoma
    n1=en:mature b-cell non-hodgkin lymphoma | n2=en:Hodgkin lymphoma | rel=r_associated | relid=0 | w=20
  555. en:mature lymphocyte --- r_associated #0: 20 --> en:Hodgkin lymphoma
    n1=en:mature lymphocyte | n2=en:Hodgkin lymphoma | rel=r_associated | relid=0 | w=20
  556. en:medullary carcinoma with lymphoid stroma --- r_associated #0: 20 --> en:Hodgkin lymphoma
    n1=en:medullary carcinoma with lymphoid stroma | n2=en:Hodgkin lymphoma | rel=r_associated | relid=0 | w=20
  557. en:medulloblastoma --- r_associated #0: 20 --> en:Hodgkin lymphoma
    n1=en:medulloblastoma | n2=en:Hodgkin lymphoma | rel=r_associated | relid=0 | w=20
  558. en:melanoma --- r_associated #0: 20 --> en:Hodgkin lymphoma
    n1=en:melanoma | n2=en:Hodgkin lymphoma | rel=r_associated | relid=0 | w=20
  559. en:melanoma arising from blue nevus --- r_associated #0: 20 --> en:Hodgkin lymphoma
    n1=en:melanoma arising from blue nevus | n2=en:Hodgkin lymphoma | rel=r_associated | relid=0 | w=20
  560. en:meningeal melanomatosis --- r_associated #0: 20 --> en:Hodgkin lymphoma
    n1=en:meningeal melanomatosis | n2=en:Hodgkin lymphoma | rel=r_associated | relid=0 | w=20
  561. en:meningeal sarcomatosis --- r_associated #0: 20 --> en:Hodgkin lymphoma
    n1=en:meningeal sarcomatosis | n2=en:Hodgkin lymphoma | rel=r_associated | relid=0 | w=20
  562. en:meningioma --- r_associated #0: 20 --> en:Hodgkin lymphoma
    n1=en:meningioma | n2=en:Hodgkin lymphoma | rel=r_associated | relid=0 | w=20
  563. en:meningitis/encephalitis --- r_associated #0: 20 --> en:Hodgkin lymphoma
    n1=en:meningitis/encephalitis | n2=en:Hodgkin lymphoma | rel=r_associated | relid=0 | w=20
  564. en:mesenchymal chondrosarcoma --- r_associated #0: 20 --> en:Hodgkin lymphoma
    n1=en:mesenchymal chondrosarcoma | n2=en:Hodgkin lymphoma | rel=r_associated | relid=0 | w=20
  565. en:mesonephric adenocarcinoma --- r_associated #0: 20 --> en:Hodgkin lymphoma
    n1=en:mesonephric adenocarcinoma | n2=en:Hodgkin lymphoma | rel=r_associated | relid=0 | w=20
  566. en:mesonephric neoplasm --- r_associated #0: 20 --> en:Hodgkin lymphoma
    n1=en:mesonephric neoplasm | n2=en:Hodgkin lymphoma | rel=r_associated | relid=0 | w=20
  567. en:mesothelioma (malignant, clinical disorder) (disorder) --- r_associated #0: 20 --> en:Hodgkin lymphoma
    n1=en:mesothelioma (malignant, clinical disorder) (disorder) | n2=en:Hodgkin lymphoma | rel=r_associated | relid=0 | w=20
  568. en:metaplastic carcinoma --- r_associated #0: 20 --> en:Hodgkin lymphoma
    n1=en:metaplastic carcinoma | n2=en:Hodgkin lymphoma | rel=r_associated | relid=0 | w=20
  569. en:metastasis to lymph node from squamous cell carcinoma --- r_associated #0: 20 --> en:Hodgkin lymphoma
    n1=en:metastasis to lymph node from squamous cell carcinoma | n2=en:Hodgkin lymphoma | rel=r_associated | relid=0 | w=20
  570. en:metastatic angiosarcoma --- r_associated #0: 20 --> en:Hodgkin lymphoma
    n1=en:metastatic angiosarcoma | n2=en:Hodgkin lymphoma | rel=r_associated | relid=0 | w=20
  571. en:metastatic neoplasm --- r_associated #0: 20 --> en:Hodgkin lymphoma
    n1=en:metastatic neoplasm | n2=en:Hodgkin lymphoma | rel=r_associated | relid=0 | w=20
  572. en:micropapillary transitional cell carcinoma --- r_associated #0: 20 --> en:Hodgkin lymphoma
    n1=en:micropapillary transitional cell carcinoma | n2=en:Hodgkin lymphoma | rel=r_associated | relid=0 | w=20
  573. en:migraine --- r_associated #0: 20 --> en:Hodgkin lymphoma
    n1=en:migraine | n2=en:Hodgkin lymphoma | rel=r_associated | relid=0 | w=20
  574. en:minimal deviation malignant melanoma --- r_associated #0: 20 --> en:Hodgkin lymphoma
    n1=en:minimal deviation malignant melanoma | n2=en:Hodgkin lymphoma | rel=r_associated | relid=0 | w=20
  575. en:minimal residual disease --- r_associated #0: 20 --> en:Hodgkin lymphoma
    n1=en:minimal residual disease | n2=en:Hodgkin lymphoma | rel=r_associated | relid=0 | w=20
  576. en:miscellaneous bone tumors --- r_associated #0: 20 --> en:Hodgkin lymphoma
    n1=en:miscellaneous bone tumors | n2=en:Hodgkin lymphoma | rel=r_associated | relid=0 | w=20
  577. en:miscellaneous soft tissue tumors (all subtypes) --- r_associated #0: 20 --> en:Hodgkin lymphoma
    n1=en:miscellaneous soft tissue tumors (all subtypes) | n2=en:Hodgkin lymphoma | rel=r_associated | relid=0 | w=20
  578. en:miscellaneous tumors --- r_associated #0: 20 --> en:Hodgkin lymphoma
    n1=en:miscellaneous tumors | n2=en:Hodgkin lymphoma | rel=r_associated | relid=0 | w=20
  579. en:mixed cellularity classical hodgkin lymphoma, intrapelvic lymph nodes --- r_associated #0: 20 --> en:Hodgkin lymphoma
    n1=en:mixed cellularity classical hodgkin lymphoma, intrapelvic lymph nodes | n2=en:Hodgkin lymphoma | rel=r_associated | relid=0 | w=20
  580. en:mixed cellularity classical hodgkin lymphoma, intrathoracic lymph nodes --- r_associated #0: 20 --> en:Hodgkin lymphoma
    n1=en:mixed cellularity classical hodgkin lymphoma, intrathoracic lymph nodes | n2=en:Hodgkin lymphoma | rel=r_associated | relid=0 | w=20
  581. en:mixed cellularity classical hodgkin lymphoma, lymph nodes of head, face, and neck --- r_associated #0: 20 --> en:Hodgkin lymphoma
    n1=en:mixed cellularity classical hodgkin lymphoma, lymph nodes of head, face, and neck | n2=en:Hodgkin lymphoma | rel=r_associated | relid=0 | w=20
  582. en:mixed cellularity classical hodgkin lymphoma, lymph nodes of multiple sites --- r_associated #0: 20 --> en:Hodgkin lymphoma
    n1=en:mixed cellularity classical hodgkin lymphoma, lymph nodes of multiple sites | n2=en:Hodgkin lymphoma | rel=r_associated | relid=0 | w=20
  583. en:mixed cellularity classical hodgkin lymphoma, spleen --- r_associated #0: 20 --> en:Hodgkin lymphoma
    n1=en:mixed cellularity classical hodgkin lymphoma, spleen | n2=en:Hodgkin lymphoma | rel=r_associated | relid=0 | w=20
  584. en:mixed glioma --- r_associated #0: 20 --> en:Hodgkin lymphoma
    n1=en:mixed glioma | n2=en:Hodgkin lymphoma | rel=r_associated | relid=0 | w=20
  585. en:mixed liposarcoma --- r_associated #0: 20 --> en:Hodgkin lymphoma
    n1=en:mixed liposarcoma | n2=en:Hodgkin lymphoma | rel=r_associated | relid=0 | w=20
  586. en:moniliasis genital female --- r_associated #0: 20 --> en:Hodgkin lymphoma
    n1=en:moniliasis genital female | n2=en:Hodgkin lymphoma | rel=r_associated | relid=0 | w=20
  587. en:morphology --- r_associated #0: 20 --> en:Hodgkin lymphoma
    n1=en:morphology | n2=en:Hodgkin lymphoma | rel=r_associated | relid=0 | w=20
  588. en:mucoepidermoid tumor --- r_associated #0: 20 --> en:Hodgkin lymphoma
    n1=en:mucoepidermoid tumor | n2=en:Hodgkin lymphoma | rel=r_associated | relid=0 | w=20
  589. en:mucosal lentiginous melanoma --- r_associated #0: 20 --> en:Hodgkin lymphoma
    n1=en:mucosal lentiginous melanoma | n2=en:Hodgkin lymphoma | rel=r_associated | relid=0 | w=20
  590. en:multiple congenital anomalies --- r_associated #0: 20 --> en:Hodgkin lymphoma
    n1=en:multiple congenital anomalies | n2=en:Hodgkin lymphoma | rel=r_associated | relid=0 | w=20
  591. en:multiple malignancy --- r_associated #0: 20 --> en:Hodgkin lymphoma
    n1=en:multiple malignancy | n2=en:Hodgkin lymphoma | rel=r_associated | relid=0 | w=20
  592. en:multiple trauma/internal injury --- r_associated #0: 20 --> en:Hodgkin lymphoma
    n1=en:multiple trauma/internal injury | n2=en:Hodgkin lymphoma | rel=r_associated | relid=0 | w=20
  593. en:multiple tumors in 28% of patients --- r_associated #0: 20 --> en:Hodgkin lymphoma
    n1=en:multiple tumors in 28% of patients | n2=en:Hodgkin lymphoma | rel=r_associated | relid=0 | w=20
  594. en:multiple tumors in 74% of patients --- r_associated #0: 20 --> en:Hodgkin lymphoma
    n1=en:multiple tumors in 74% of patients | n2=en:Hodgkin lymphoma | rel=r_associated | relid=0 | w=20
  595. en:muscle tumors (all subtypes) --- r_associated #0: 20 --> en:Hodgkin lymphoma
    n1=en:muscle tumors (all subtypes) | n2=en:Hodgkin lymphoma | rel=r_associated | relid=0 | w=20
  596. en:mycosis fungoides --- r_associated #0: 20 --> en:Hodgkin lymphoma
    n1=en:mycosis fungoides | n2=en:Hodgkin lymphoma | rel=r_associated | relid=0 | w=20
  597. en:myelodysplastic syndrome, no icd-o subtype --- r_associated #0: 20 --> en:Hodgkin lymphoma
    n1=en:myelodysplastic syndrome, no icd-o subtype | n2=en:Hodgkin lymphoma | rel=r_associated | relid=0 | w=20
  598. en:myeloid cell --- r_associated #0: 20 --> en:Hodgkin lymphoma
    n1=en:myeloid cell | n2=en:Hodgkin lymphoma | rel=r_associated | relid=0 | w=20
  599. en:myeloliposarcoma --- r_associated #0: 20 --> en:Hodgkin lymphoma
    n1=en:myeloliposarcoma | n2=en:Hodgkin lymphoma | rel=r_associated | relid=0 | w=20
  600. en:myeloproliferative neoplasm --- r_associated #0: 20 --> en:Hodgkin lymphoma
    n1=en:myeloproliferative neoplasm | n2=en:Hodgkin lymphoma | rel=r_associated | relid=0 | w=20
  601. en:myxoid chondrosarcoma --- r_associated #0: 20 --> en:Hodgkin lymphoma
    n1=en:myxoid chondrosarcoma | n2=en:Hodgkin lymphoma | rel=r_associated | relid=0 | w=20
  602. en:myxoid liposarcoma --- r_associated #0: 20 --> en:Hodgkin lymphoma
    n1=en:myxoid liposarcoma | n2=en:Hodgkin lymphoma | rel=r_associated | relid=0 | w=20
  603. en:myxoma --- r_associated #0: 20 --> en:Hodgkin lymphoma
    n1=en:myxoma | n2=en:Hodgkin lymphoma | rel=r_associated | relid=0 | w=20
  604. en:myxomatous neoplasm --- r_associated #0: 20 --> en:Hodgkin lymphoma
    n1=en:myxomatous neoplasm | n2=en:Hodgkin lymphoma | rel=r_associated | relid=0 | w=20
  605. en:nci ctep simplified disease classification terminology --- r_associated #0: 20 --> en:Hodgkin lymphoma
    n1=en:nci ctep simplified disease classification terminology | n2=en:Hodgkin lymphoma | rel=r_associated | relid=0 | w=20
  606. en:neoplasm by site --- r_associated #0: 20 --> en:Hodgkin lymphoma
    n1=en:neoplasm by site | n2=en:Hodgkin lymphoma | rel=r_associated | relid=0 | w=20
  607. en:neoplasm of ocular adnexa --- r_associated #0: 20 --> en:Hodgkin lymphoma
    n1=en:neoplasm of ocular adnexa | n2=en:Hodgkin lymphoma | rel=r_associated | relid=0 | w=20
  608. en:neoplasm of uncertain behavior of endocrine glands and nervous system --- r_associated #0: 20 --> en:Hodgkin lymphoma
    n1=en:neoplasm of uncertain behavior of endocrine glands and nervous system | n2=en:Hodgkin lymphoma | rel=r_associated | relid=0 | w=20
  609. en:neoplasm of uncertain malignant potential --- r_associated #0: 20 --> en:Hodgkin lymphoma
    n1=en:neoplasm of uncertain malignant potential | n2=en:Hodgkin lymphoma | rel=r_associated | relid=0 | w=20
  610. en:neoplasm of unspecified nature of endocrine glands and other parts of nervous system --- r_associated #0: 20 --> en:Hodgkin lymphoma
    n1=en:neoplasm of unspecified nature of endocrine glands and other parts of nervous system | n2=en:Hodgkin lymphoma | rel=r_associated | relid=0 | w=20
  611. en:neoplasm, uncertain whether benign or malignant --- r_associated #0: 20 --> en:Hodgkin lymphoma
    n1=en:neoplasm, uncertain whether benign or malignant | n2=en:Hodgkin lymphoma | rel=r_associated | relid=0 | w=20
  612. en:neoplasms of uncertain or unknown behaviour --- r_associated #0: 20 --> en:Hodgkin lymphoma
    n1=en:neoplasms of uncertain or unknown behaviour | n2=en:Hodgkin lymphoma | rel=r_associated | relid=0 | w=20
  613. en:neoplasms, adnexal and skin appendage --- r_associated #0: 20 --> en:Hodgkin lymphoma
    n1=en:neoplasms, adnexal and skin appendage | n2=en:Hodgkin lymphoma | rel=r_associated | relid=0 | w=20
  614. en:neoplasms, cystic, mucinous, and serous --- r_associated #0: 20 --> en:Hodgkin lymphoma
    n1=en:neoplasms, cystic, mucinous, and serous | n2=en:Hodgkin lymphoma | rel=r_associated | relid=0 | w=20
  615. en:neoplasms, hormone-dependent --- r_associated #0: 20 --> en:Hodgkin lymphoma
    n1=en:neoplasms, hormone-dependent | n2=en:Hodgkin lymphoma | rel=r_associated | relid=0 | w=20
  616. en:neoplasms, multiple primary --- r_associated #0: 20 --> en:Hodgkin lymphoma
    n1=en:neoplasms, multiple primary | n2=en:Hodgkin lymphoma | rel=r_associated | relid=0 | w=20
  617. en:neoplasms, second primary --- r_associated #0: 20 --> en:Hodgkin lymphoma
    n1=en:neoplasms, second primary | n2=en:Hodgkin lymphoma | rel=r_associated | relid=0 | w=20
  618. en:neoplastic lymphocyte --- r_associated #0: 20 --> en:Hodgkin lymphoma
    n1=en:neoplastic lymphocyte | n2=en:Hodgkin lymphoma | rel=r_associated | relid=0 | w=20
  619. en:nerve sheath neoplasm --- r_associated #0: 20 --> en:Hodgkin lymphoma
    n1=en:nerve sheath neoplasm | n2=en:Hodgkin lymphoma | rel=r_associated | relid=0 | w=20
  620. en:nervous system neoplasms malignant and unspecified nec --- r_associated #0: 20 --> en:Hodgkin lymphoma
    n1=en:nervous system neoplasms malignant and unspecified nec | n2=en:Hodgkin lymphoma | rel=r_associated | relid=0 | w=20
  621. en:neural tissue tumors --- r_associated #0: 20 --> en:Hodgkin lymphoma
    n1=en:neural tissue tumors | n2=en:Hodgkin lymphoma | rel=r_associated | relid=0 | w=20
  622. en:neurasthenia/surmenage --- r_associated #0: 20 --> en:Hodgkin lymphoma
    n1=en:neurasthenia/surmenage | n2=en:Hodgkin lymphoma | rel=r_associated | relid=0 | w=20
  623. en:neuroblastoma, arises anywhere along the sympathetic chain (including intracranially) --- r_associated #0: 20 --> en:Hodgkin lymphoma
    n1=en:neuroblastoma, arises anywhere along the sympathetic chain (including intracranially) | n2=en:Hodgkin lymphoma | rel=r_associated | relid=0 | w=20
  624. en:neuroepithelioma --- r_associated #0: 20 --> en:Hodgkin lymphoma
    n1=en:neuroepithelioma | n2=en:Hodgkin lymphoma | rel=r_associated | relid=0 | w=20
  625. en:nevi and melanomas --- r_associated #0: 20 --> en:Hodgkin lymphoma
    n1=en:nevi and melanomas | n2=en:Hodgkin lymphoma | rel=r_associated | relid=0 | w=20
  626. en:nevus and/or melanoma --- r_associated #0: 20 --> en:Hodgkin lymphoma
    n1=en:nevus and/or melanoma | n2=en:Hodgkin lymphoma | rel=r_associated | relid=0 | w=20
  627. en:no cancer despite harboring complete deletions of the tp53 gene --- r_associated #0: 20 --> en:Hodgkin lymphoma
    n1=en:no cancer despite harboring complete deletions of the tp53 gene | n2=en:Hodgkin lymphoma | rel=r_associated | relid=0 | w=20
  628. en:no disease --- r_associated #0: 20 --> en:Hodgkin lymphoma
    n1=en:no disease | n2=en:Hodgkin lymphoma | rel=r_associated | relid=0 | w=20
  629. en:nodular lymphocyte predominant hodgkin lymphoma --- r_associated #0: 20 --> en:Hodgkin lymphoma
    n1=en:nodular lymphocyte predominant hodgkin lymphoma | n2=en:Hodgkin lymphoma | rel=r_associated | relid=0 | w=20
  630. en:nodular lymphocyte predominant hodgkin lymphoma, extranodal and solid organ sites --- r_associated #0: 20 --> en:Hodgkin lymphoma
    n1=en:nodular lymphocyte predominant hodgkin lymphoma, extranodal and solid organ sites | n2=en:Hodgkin lymphoma | rel=r_associated | relid=0 | w=20
  631. en:nodular lymphocyte predominant hodgkin lymphoma, intra-abdominal lymph nodes --- r_associated #0: 20 --> en:Hodgkin lymphoma
    n1=en:nodular lymphocyte predominant hodgkin lymphoma, intra-abdominal lymph nodes | n2=en:Hodgkin lymphoma | rel=r_associated | relid=0 | w=20
  632. en:nodular lymphocyte predominant hodgkin lymphoma, intrathoracic lymph nodes --- r_associated #0: 20 --> en:Hodgkin lymphoma
    n1=en:nodular lymphocyte predominant hodgkin lymphoma, intrathoracic lymph nodes | n2=en:Hodgkin lymphoma | rel=r_associated | relid=0 | w=20
  633. en:nodular lymphocyte predominant hodgkin lymphoma, lymph nodes of inguinal region and lower limb --- r_associated #0: 20 --> en:Hodgkin lymphoma
    n1=en:nodular lymphocyte predominant hodgkin lymphoma, lymph nodes of inguinal region and lower limb | n2=en:Hodgkin lymphoma | rel=r_associated | relid=0 | w=20
  634. en:nodular lymphocyte predominant hodgkin lymphoma, lymph nodes of multiple sites --- r_associated #0: 20 --> en:Hodgkin lymphoma
    n1=en:nodular lymphocyte predominant hodgkin lymphoma, lymph nodes of multiple sites | n2=en:Hodgkin lymphoma | rel=r_associated | relid=0 | w=20
  635. en:nodular lymphocyte predominant hodgkin lymphoma, spleen --- r_associated #0: 20 --> en:Hodgkin lymphoma
    n1=en:nodular lymphocyte predominant hodgkin lymphoma, spleen | n2=en:Hodgkin lymphoma | rel=r_associated | relid=0 | w=20
  636. en:nodular melanoma --- r_associated #0: 20 --> en:Hodgkin lymphoma
    n1=en:nodular melanoma | n2=en:Hodgkin lymphoma | rel=r_associated | relid=0 | w=20
  637. en:nodular sclerosis classical hodgkin lymphoma, cellular phase --- r_associated #0: 20 --> en:Hodgkin lymphoma
    n1=en:nodular sclerosis classical hodgkin lymphoma, cellular phase | n2=en:Hodgkin lymphoma | rel=r_associated | relid=0 | w=20
  638. en:nodular sclerosis classical hodgkin lymphoma, intra-abdominal lymph nodes --- r_associated #0: 20 --> en:Hodgkin lymphoma
    n1=en:nodular sclerosis classical hodgkin lymphoma, intra-abdominal lymph nodes | n2=en:Hodgkin lymphoma | rel=r_associated | relid=0 | w=20
  639. en:nodular sclerosis classical hodgkin lymphoma, intrapelvic lymph nodes --- r_associated #0: 20 --> en:Hodgkin lymphoma
    n1=en:nodular sclerosis classical hodgkin lymphoma, intrapelvic lymph nodes | n2=en:Hodgkin lymphoma | rel=r_associated | relid=0 | w=20
  640. en:nodular sclerosis classical hodgkin lymphoma, intrathoracic lymph nodes --- r_associated #0: 20 --> en:Hodgkin lymphoma
    n1=en:nodular sclerosis classical hodgkin lymphoma, intrathoracic lymph nodes | n2=en:Hodgkin lymphoma | rel=r_associated | relid=0 | w=20
  641. en:nodular sclerosis classical hodgkin lymphoma, lymph nodes of axilla and upper limb --- r_associated #0: 20 --> en:Hodgkin lymphoma
    n1=en:nodular sclerosis classical hodgkin lymphoma, lymph nodes of axilla and upper limb | n2=en:Hodgkin lymphoma | rel=r_associated | relid=0 | w=20
  642. en:nodular sclerosis classical hodgkin lymphoma, lymph nodes of inguinal region and lower limb --- r_associated #0: 20 --> en:Hodgkin lymphoma
    n1=en:nodular sclerosis classical hodgkin lymphoma, lymph nodes of inguinal region and lower limb | n2=en:Hodgkin lymphoma | rel=r_associated | relid=0 | w=20
  643. en:nodular sclerosis classical hodgkin lymphoma, unspecified site --- r_associated #0: 20 --> en:Hodgkin lymphoma
    n1=en:nodular sclerosis classical hodgkin lymphoma, unspecified site | n2=en:Hodgkin lymphoma | rel=r_associated | relid=0 | w=20
  644. en:non-hematologic malignancy --- r_associated #0: 20 --> en:Hodgkin lymphoma
    n1=en:non-hematologic malignancy | n2=en:Hodgkin lymphoma | rel=r_associated | relid=0 | w=20
  645. en:non-hodgkin lymphoma --- r_associated #0: 20 --> en:Hodgkin lymphoma
    n1=en:non-hodgkin lymphoma | n2=en:Hodgkin lymphoma | rel=r_associated | relid=0 | w=20
  646. en:non-rheum heart valve disease --- r_associated #0: 20 --> en:Hodgkin lymphoma
    n1=en:non-rheum heart valve disease | n2=en:Hodgkin lymphoma | rel=r_associated | relid=0 | w=20
  647. en:nonestrogen-dependent cancer --- r_associated #0: 20 --> en:Hodgkin lymphoma
    n1=en:nonestrogen-dependent cancer | n2=en:Hodgkin lymphoma | rel=r_associated | relid=0 | w=20
  648. en:nonmelanoma skin cancer (in some patients) --- r_associated #0: 20 --> en:Hodgkin lymphoma
    n1=en:nonmelanoma skin cancer (in some patients) | n2=en:Hodgkin lymphoma | rel=r_associated | relid=0 | w=20
  649. en:nonseminomatous germ cell tumor --- r_associated #0: 20 --> en:Hodgkin lymphoma
    n1=en:nonseminomatous germ cell tumor | n2=en:Hodgkin lymphoma | rel=r_associated | relid=0 | w=20
  650. en:normal delivery deadborn --- r_associated #0: 20 --> en:Hodgkin lymphoma
    n1=en:normal delivery deadborn | n2=en:Hodgkin lymphoma | rel=r_associated | relid=0 | w=20
  651. en:nursing therapy --- r_associated #0: 20 --> en:Hodgkin lymphoma
    n1=en:nursing therapy | n2=en:Hodgkin lymphoma | rel=r_associated | relid=0 | w=20
  652. en:nutritional management --- r_associated #0: 20 --> en:Hodgkin lymphoma
    n1=en:nutritional management | n2=en:Hodgkin lymphoma | rel=r_associated | relid=0 | w=20
  653. en:odontogenic neoplasm --- r_associated #0: 20 --> en:Hodgkin lymphoma
    n1=en:odontogenic neoplasm | n2=en:Hodgkin lymphoma | rel=r_associated | relid=0 | w=20
  654. en:olfactory neurogenic tumor --- r_associated #0: 20 --> en:Hodgkin lymphoma
    n1=en:olfactory neurogenic tumor | n2=en:Hodgkin lymphoma | rel=r_associated | relid=0 | w=20
  655. en:oligodendroglioma --- r_associated #0: 20 --> en:Hodgkin lymphoma
    n1=en:oligodendroglioma | n2=en:Hodgkin lymphoma | rel=r_associated | relid=0 | w=20
  656. en:optic glioma (19%) --- r_associated #0: 20 --> en:Hodgkin lymphoma
    n1=en:optic glioma (19%) | n2=en:Hodgkin lymphoma | rel=r_associated | relid=0 | w=20
  657. en:optic nerve glioma --- r_associated #0: 20 --> en:Hodgkin lymphoma
    n1=en:optic nerve glioma | n2=en:Hodgkin lymphoma | rel=r_associated | relid=0 | w=20
  658. en:oral cavity carcinoma --- r_associated #0: 20 --> en:Hodgkin lymphoma
    n1=en:oral cavity carcinoma | n2=en:Hodgkin lymphoma | rel=r_associated | relid=0 | w=20
  659. en:oropharyngeal carcinoma --- r_associated #0: 20 --> en:Hodgkin lymphoma
    n1=en:oropharyngeal carcinoma | n2=en:Hodgkin lymphoma | rel=r_associated | relid=0 | w=20
  660. en:oropharyngeal squamous cell carcinoma --- r_associated #0: 20 --> en:Hodgkin lymphoma
    n1=en:oropharyngeal squamous cell carcinoma | n2=en:Hodgkin lymphoma | rel=r_associated | relid=0 | w=20
  661. en:orthostatic hypotension --- r_associated #0: 20 --> en:Hodgkin lymphoma
    n1=en:orthostatic hypotension | n2=en:Hodgkin lymphoma | rel=r_associated | relid=0 | w=20
  662. en:osseous and chondromatous neoplasms --- r_associated #0: 20 --> en:Hodgkin lymphoma
    n1=en:osseous and chondromatous neoplasms | n2=en:Hodgkin lymphoma | rel=r_associated | relid=0 | w=20
  663. en:osteoporosis --- r_associated #0: 20 --> en:Hodgkin lymphoma
    n1=en:osteoporosis | n2=en:Hodgkin lymphoma | rel=r_associated | relid=0 | w=20
  664. en:osteosarcoma and meningioma especially --- r_associated #0: 20 --> en:Hodgkin lymphoma
    n1=en:osteosarcoma and meningioma especially | n2=en:Hodgkin lymphoma | rel=r_associated | relid=0 | w=20
  665. en:other anaemias --- r_associated #0: 20 --> en:Hodgkin lymphoma
    n1=en:other anaemias | n2=en:Hodgkin lymphoma | rel=r_associated | relid=0 | w=20
  666. en:other and unspecified disorders of the circulatory system --- r_associated #0: 20 --> en:Hodgkin lymphoma
    n1=en:other and unspecified disorders of the circulatory system | n2=en:Hodgkin lymphoma | rel=r_associated | relid=0 | w=20
  667. en:other and unspecified types of non-hodgkin lymphoma --- r_associated #0: 20 --> en:Hodgkin lymphoma
    n1=en:other and unspecified types of non-hodgkin lymphoma | n2=en:Hodgkin lymphoma | rel=r_associated | relid=0 | w=20
  668. en:other arterial obstructive/peripheral vascular disease --- r_associated #0: 20 --> en:Hodgkin lymphoma
    n1=en:other arterial obstructive/peripheral vascular disease | n2=en:Hodgkin lymphoma | rel=r_associated | relid=0 | w=20
  669. en:other auditory injuries --- r_associated #0: 20 --> en:Hodgkin lymphoma
    n1=en:other auditory injuries | n2=en:Hodgkin lymphoma | rel=r_associated | relid=0 | w=20
  670. en:other benign neoplasm of skin, unspecified --- r_associated #0: 20 --> en:Hodgkin lymphoma
    n1=en:other benign neoplasm of skin, unspecified | n2=en:Hodgkin lymphoma | rel=r_associated | relid=0 | w=20
  671. en:other classical hodgkin lymphoma, intrapelvic lymph nodes --- r_associated #0: 20 --> en:Hodgkin lymphoma
    n1=en:other classical hodgkin lymphoma, intrapelvic lymph nodes | n2=en:Hodgkin lymphoma | rel=r_associated | relid=0 | w=20
  672. en:other classical hodgkin lymphoma, intrathoracic lymph nodes --- r_associated #0: 20 --> en:Hodgkin lymphoma
    n1=en:other classical hodgkin lymphoma, intrathoracic lymph nodes | n2=en:Hodgkin lymphoma | rel=r_associated | relid=0 | w=20
  673. en:other classical hodgkin lymphoma, lymph nodes of multiple sites --- r_associated #0: 20 --> en:Hodgkin lymphoma
    n1=en:other classical hodgkin lymphoma, lymph nodes of multiple sites | n2=en:Hodgkin lymphoma | rel=r_associated | relid=0 | w=20
  674. en:other classical hodgkin lymphoma, spleen --- r_associated #0: 20 --> en:Hodgkin lymphoma
    n1=en:other classical hodgkin lymphoma, spleen | n2=en:Hodgkin lymphoma | rel=r_associated | relid=0 | w=20
  675. en:other complications of the puerperium --- r_associated #0: 20 --> en:Hodgkin lymphoma
    n1=en:other complications of the puerperium | n2=en:Hodgkin lymphoma | rel=r_associated | relid=0 | w=20
  676. en:other congenital malformations of eye --- r_associated #0: 20 --> en:Hodgkin lymphoma
    n1=en:other congenital malformations of eye | n2=en:Hodgkin lymphoma | rel=r_associated | relid=0 | w=20
  677. en:other dermatologic congenital anomalies --- r_associated #0: 20 --> en:Hodgkin lymphoma
    n1=en:other dermatologic congenital anomalies | n2=en:Hodgkin lymphoma | rel=r_associated | relid=0 | w=20
  678. en:other disease male genital including breast --- r_associated #0: 20 --> en:Hodgkin lymphoma
    n1=en:other disease male genital including breast | n2=en:Hodgkin lymphoma | rel=r_associated | relid=0 | w=20
  679. en:other disease of pregnancy/delivery/puerperium --- r_associated #0: 20 --> en:Hodgkin lymphoma
    n1=en:other disease of pregnancy/delivery/puerperium | n2=en:Hodgkin lymphoma | rel=r_associated | relid=0 | w=20
  680. en:other diseases female genital system --- r_associated #0: 20 --> en:Hodgkin lymphoma
    n1=en:other diseases female genital system | n2=en:Hodgkin lymphoma | rel=r_associated | relid=0 | w=20
  681. en:other diseases of ear/mastoid --- r_associated #0: 20 --> en:Hodgkin lymphoma
    n1=en:other diseases of ear/mastoid | n2=en:Hodgkin lymphoma | rel=r_associated | relid=0 | w=20
  682. en:other endocrine or metabolic congenital anomalies --- r_associated #0: 20 --> en:Hodgkin lymphoma
    n1=en:other endocrine or metabolic congenital anomalies | n2=en:Hodgkin lymphoma | rel=r_associated | relid=0 | w=20
  683. en:other female genital malignant neoplasms --- r_associated #0: 20 --> en:Hodgkin lymphoma
    n1=en:other female genital malignant neoplasms | n2=en:Hodgkin lymphoma | rel=r_associated | relid=0 | w=20
  684. en:other forms of chronic ischaemic heart disease --- r_associated #0: 20 --> en:Hodgkin lymphoma
    n1=en:other forms of chronic ischaemic heart disease | n2=en:Hodgkin lymphoma | rel=r_associated | relid=0 | w=20
  685. en:other forms of heart disease --- r_associated #0: 20 --> en:Hodgkin lymphoma
    n1=en:other forms of heart disease | n2=en:Hodgkin lymphoma | rel=r_associated | relid=0 | w=20
  686. en:other head injury without skull fracture --- r_associated #0: 20 --> en:Hodgkin lymphoma
    n1=en:other head injury without skull fracture | n2=en:Hodgkin lymphoma | rel=r_associated | relid=0 | w=20
  687. en:other hematologic congenital anomalies --- r_associated #0: 20 --> en:Hodgkin lymphoma
    n1=en:other hematologic congenital anomalies | n2=en:Hodgkin lymphoma | rel=r_associated | relid=0 | w=20
  688. en:other hematological abnormality --- r_associated #0: 20 --> en:Hodgkin lymphoma
    n1=en:other hematological abnormality | n2=en:Hodgkin lymphoma | rel=r_associated | relid=0 | w=20
  689. en:other infectious diseases --- r_associated #0: 20 --> en:Hodgkin lymphoma
    n1=en:other infectious diseases | n2=en:Hodgkin lymphoma | rel=r_associated | relid=0 | w=20
  690. en:other lymphomas, unspecified site, extranodal and solid organ sites --- r_associated #0: 20 --> en:Hodgkin lymphoma
    n1=en:other lymphomas, unspecified site, extranodal and solid organ sites | n2=en:Hodgkin lymphoma | rel=r_associated | relid=0 | w=20
  691. en:other malignant lymphomas, intra-abdominal lymph nodes --- r_associated #0: 20 --> en:Hodgkin lymphoma
    n1=en:other malignant lymphomas, intra-abdominal lymph nodes | n2=en:Hodgkin lymphoma | rel=r_associated | relid=0 | w=20
  692. en:other malignant lymphomas, lymph nodes of axilla and upper limb --- r_associated #0: 20 --> en:Hodgkin lymphoma
    n1=en:other malignant lymphomas, lymph nodes of axilla and upper limb | n2=en:Hodgkin lymphoma | rel=r_associated | relid=0 | w=20
  693. en:other malignant lymphomas, lymph nodes of head, face, and neck --- r_associated #0: 20 --> en:Hodgkin lymphoma
    n1=en:other malignant lymphomas, lymph nodes of head, face, and neck | n2=en:Hodgkin lymphoma | rel=r_associated | relid=0 | w=20
  694. en:other malignant lymphomas, lymph nodes of inguinal region and lower limb --- r_associated #0: 20 --> en:Hodgkin lymphoma
    n1=en:other malignant lymphomas, lymph nodes of inguinal region and lower limb | n2=en:Hodgkin lymphoma | rel=r_associated | relid=0 | w=20
  695. en:other malignant neoplasms of lymphoid and histiocytic tissue --- r_associated #0: 20 --> en:Hodgkin lymphoma
    n1=en:other malignant neoplasms of lymphoid and histiocytic tissue | n2=en:Hodgkin lymphoma | rel=r_associated | relid=0 | w=20
  696. en:other musculoskeletal disorder --- r_associated #0: 20 --> en:Hodgkin lymphoma
    n1=en:other musculoskeletal disorder | n2=en:Hodgkin lymphoma | rel=r_associated | relid=0 | w=20
  697. en:other neurologic injuries --- r_associated #0: 20 --> en:Hodgkin lymphoma
    n1=en:other neurologic injuries | n2=en:Hodgkin lymphoma | rel=r_associated | relid=0 | w=20
  698. en:other non-obstetrical conditions --- r_associated #0: 20 --> en:Hodgkin lymphoma
    n1=en:other non-obstetrical conditions | n2=en:Hodgkin lymphoma | rel=r_associated | relid=0 | w=20
  699. en:other osteoarthritis --- r_associated #0: 20 --> en:Hodgkin lymphoma
    n1=en:other osteoarthritis | n2=en:Hodgkin lymphoma | rel=r_associated | relid=0 | w=20
  700. en:other peripheral neuritis --- r_associated #0: 20 --> en:Hodgkin lymphoma
    n1=en:other peripheral neuritis | n2=en:Hodgkin lymphoma | rel=r_associated | relid=0 | w=20
  701. en:other psychoses --- r_associated #0: 20 --> en:Hodgkin lymphoma
    n1=en:other psychoses | n2=en:Hodgkin lymphoma | rel=r_associated | relid=0 | w=20
  702. en:other symptom lymph gland(s) --- r_associated #0: 20 --> en:Hodgkin lymphoma
    n1=en:other symptom lymph gland(s) | n2=en:Hodgkin lymphoma | rel=r_associated | relid=0 | w=20
  703. en:other viral disease with exanthems --- r_associated #0: 20 --> en:Hodgkin lymphoma
    n1=en:other viral disease with exanthems | n2=en:Hodgkin lymphoma | rel=r_associated | relid=0 | w=20
  704. en:other viral diseases --- r_associated #0: 20 --> en:Hodgkin lymphoma
    n1=en:other viral diseases | n2=en:Hodgkin lymphoma | rel=r_associated | relid=0 | w=20
  705. en:other/unspecified neoplasm skin --- r_associated #0: 20 --> en:Hodgkin lymphoma
    n1=en:other/unspecified neoplasm skin | n2=en:Hodgkin lymphoma | rel=r_associated | relid=0 | w=20
  706. en:otitis externa --- r_associated #0: 20 --> en:Hodgkin lymphoma
    n1=en:otitis externa | n2=en:Hodgkin lymphoma | rel=r_associated | relid=0 | w=20
  707. en:ovarian cystadenoma --- r_associated #0: 20 --> en:Hodgkin lymphoma
    n1=en:ovarian cystadenoma | n2=en:Hodgkin lymphoma | rel=r_associated | relid=0 | w=20
  708. en:ovarian sex cord-stromal tumor --- r_associated #0: 20 --> en:Hodgkin lymphoma
    n1=en:ovarian sex cord-stromal tumor | n2=en:Hodgkin lymphoma | rel=r_associated | relid=0 | w=20
  709. en:overlapping malignant neoplasm of gastrointestinal tract --- r_associated #0: 20 --> en:Hodgkin lymphoma
    n1=en:overlapping malignant neoplasm of gastrointestinal tract | n2=en:Hodgkin lymphoma | rel=r_associated | relid=0 | w=20
  710. en:overlapping malignant neoplasm of ill-defined site --- r_associated #0: 20 --> en:Hodgkin lymphoma
    n1=en:overlapping malignant neoplasm of ill-defined site | n2=en:Hodgkin lymphoma | rel=r_associated | relid=0 | w=20
  711. en:overlapping malignant neoplasm of lip, oral cavity and pharynx --- r_associated #0: 20 --> en:Hodgkin lymphoma
    n1=en:overlapping malignant neoplasm of lip, oral cavity and pharynx | n2=en:Hodgkin lymphoma | rel=r_associated | relid=0 | w=20
  712. en:overweight --- r_associated #0: 20 --> en:Hodgkin lymphoma
    n1=en:overweight | n2=en:Hodgkin lymphoma | rel=r_associated | relid=0 | w=20
  713. en:pancreatic adenocarcinoma --- r_associated #0: 20 --> en:Hodgkin lymphoma
    n1=en:pancreatic adenocarcinoma | n2=en:Hodgkin lymphoma | rel=r_associated | relid=0 | w=20
  714. en:pancreatoblastoma --- r_associated #0: 20 --> en:Hodgkin lymphoma
    n1=en:pancreatoblastoma | n2=en:Hodgkin lymphoma | rel=r_associated | relid=0 | w=20
  715. en:papillary thyroid carcinoma (rare) --- r_associated #0: 20 --> en:Hodgkin lymphoma
    n1=en:papillary thyroid carcinoma (rare) | n2=en:Hodgkin lymphoma | rel=r_associated | relid=0 | w=20
  716. en:papillary transitional cell carcinoma --- r_associated #0: 20 --> en:Hodgkin lymphoma
    n1=en:papillary transitional cell carcinoma | n2=en:Hodgkin lymphoma | rel=r_associated | relid=0 | w=20
  717. en:paraganglioma --- r_associated #0: 20 --> en:Hodgkin lymphoma
    n1=en:paraganglioma | n2=en:Hodgkin lymphoma | rel=r_associated | relid=0 | w=20
  718. en:paraganglioma and/or glomus tumor --- r_associated #0: 20 --> en:Hodgkin lymphoma
    n1=en:paraganglioma and/or glomus tumor | n2=en:Hodgkin lymphoma | rel=r_associated | relid=0 | w=20
  719. en:paragangliomas, head and neck (31%) --- r_associated #0: 20 --> en:Hodgkin lymphoma
    n1=en:paragangliomas, head and neck (31%) | n2=en:Hodgkin lymphoma | rel=r_associated | relid=0 | w=20
  720. en:paraneoplastic sps is associated with autoantibodies to amphiphysin (amph, 600418) --- r_associated #0: 20 --> en:Hodgkin lymphoma
    n1=en:paraneoplastic sps is associated with autoantibodies to amphiphysin (amph, 600418) | n2=en:Hodgkin lymphoma | rel=r_associated | relid=0 | w=20
  721. en:paraneoplastic sps is associated with breast cancer and other malignancies --- r_associated #0: 20 --> en:Hodgkin lymphoma
    n1=en:paraneoplastic sps is associated with breast cancer and other malignancies | n2=en:Hodgkin lymphoma | rel=r_associated | relid=0 | w=20
  722. en:paraneoplastic syndrome --- r_associated #0: 20 --> en:Hodgkin lymphoma
    n1=en:paraneoplastic syndrome | n2=en:Hodgkin lymphoma | rel=r_associated | relid=0 | w=20
  723. en:parasitology --- r_associated #0: 20 --> en:Hodgkin lymphoma
    n1=en:parasitology | n2=en:Hodgkin lymphoma | rel=r_associated | relid=0 | w=20
  724. en:parathyroid disease rare --- r_associated #0: 20 --> en:Hodgkin lymphoma
    n1=en:parathyroid disease rare | n2=en:Hodgkin lymphoma | rel=r_associated | relid=0 | w=20
  725. en:parathyroid gland adenoma --- r_associated #0: 20 --> en:Hodgkin lymphoma
    n1=en:parathyroid gland adenoma | n2=en:Hodgkin lymphoma | rel=r_associated | relid=0 | w=20
  726. en:parathyroid gland carcinoma --- r_associated #0: 20 --> en:Hodgkin lymphoma
    n1=en:parathyroid gland carcinoma | n2=en:Hodgkin lymphoma | rel=r_associated | relid=0 | w=20
  727. en:parkinsonism --- r_associated #0: 20 --> en:Hodgkin lymphoma
    n1=en:parkinsonism | n2=en:Hodgkin lymphoma | rel=r_associated | relid=0 | w=20
  728. en:parosteal osteosarcoma --- r_associated #0: 20 --> en:Hodgkin lymphoma
    n1=en:parosteal osteosarcoma | n2=en:Hodgkin lymphoma | rel=r_associated | relid=0 | w=20
  729. en:parotid gland monomorphic adenoma --- r_associated #0: 20 --> en:Hodgkin lymphoma
    n1=en:parotid gland monomorphic adenoma | n2=en:Hodgkin lymphoma | rel=r_associated | relid=0 | w=20
  730. en:parotid oncocytomas --- r_associated #0: 20 --> en:Hodgkin lymphoma
    n1=en:parotid oncocytomas | n2=en:Hodgkin lymphoma | rel=r_associated | relid=0 | w=20
  731. en:pediatric adverse events terminology --- r_associated #0: 20 --> en:Hodgkin lymphoma
    n1=en:pediatric adverse events terminology | n2=en:Hodgkin lymphoma | rel=r_associated | relid=0 | w=20
  732. en:pediculosis/other skin infestation --- r_associated #0: 20 --> en:Hodgkin lymphoma
    n1=en:pediculosis/other skin infestation | n2=en:Hodgkin lymphoma | rel=r_associated | relid=0 | w=20
  733. en:pelvic inflammatory disease --- r_associated #0: 20 --> en:Hodgkin lymphoma
    n1=en:pelvic inflammatory disease | n2=en:Hodgkin lymphoma | rel=r_associated | relid=0 | w=20
  734. en:perinatal mortality --- r_associated #0: 20 --> en:Hodgkin lymphoma
    n1=en:perinatal mortality | n2=en:Hodgkin lymphoma | rel=r_associated | relid=0 | w=20
  735. en:periosteal chondrosarcoma --- r_associated #0: 20 --> en:Hodgkin lymphoma
    n1=en:periosteal chondrosarcoma | n2=en:Hodgkin lymphoma | rel=r_associated | relid=0 | w=20
  736. en:periosteal fibrosarcoma --- r_associated #0: 20 --> en:Hodgkin lymphoma
    n1=en:periosteal fibrosarcoma | n2=en:Hodgkin lymphoma | rel=r_associated | relid=0 | w=20
  737. en:periosteal osteosarcoma --- r_associated #0: 20 --> en:Hodgkin lymphoma
    n1=en:periosteal osteosarcoma | n2=en:Hodgkin lymphoma | rel=r_associated | relid=0 | w=20
  738. en:peripheral primitive neuroectodermal tumor --- r_associated #0: 20 --> en:Hodgkin lymphoma
    n1=en:peripheral primitive neuroectodermal tumor | n2=en:Hodgkin lymphoma | rel=r_associated | relid=0 | w=20
  739. en:pernicious/folate deficiency anemias --- r_associated #0: 20 --> en:Hodgkin lymphoma
    n1=en:pernicious/folate deficiency anemias | n2=en:Hodgkin lymphoma | rel=r_associated | relid=0 | w=20
  740. en:phagocytic cell --- r_associated #0: 20 --> en:Hodgkin lymphoma
    n1=en:phagocytic cell | n2=en:Hodgkin lymphoma | rel=r_associated | relid=0 | w=20
  741. en:pheochromocytomas, adrenal (28%) --- r_associated #0: 20 --> en:Hodgkin lymphoma
    n1=en:pheochromocytomas, adrenal (28%) | n2=en:Hodgkin lymphoma | rel=r_associated | relid=0 | w=20
  742. en:phyllodes tumor --- r_associated #0: 20 --> en:Hodgkin lymphoma
    n1=en:phyllodes tumor | n2=en:Hodgkin lymphoma | rel=r_associated | relid=0 | w=20
  743. en:pilonidal cyst/fistula --- r_associated #0: 20 --> en:Hodgkin lymphoma
    n1=en:pilonidal cyst/fistula | n2=en:Hodgkin lymphoma | rel=r_associated | relid=0 | w=20
  744. en:pituitary gland adenoma --- r_associated #0: 20 --> en:Hodgkin lymphoma
    n1=en:pituitary gland adenoma | n2=en:Hodgkin lymphoma | rel=r_associated | relid=0 | w=20
  745. en:plasma cell --- r_associated #0: 20 --> en:Hodgkin lymphoma
    n1=en:plasma cell | n2=en:Hodgkin lymphoma | rel=r_associated | relid=0 | w=20
  746. en:plasma cell neoplasm --- r_associated #0: 20 --> en:Hodgkin lymphoma
    n1=en:plasma cell neoplasm | n2=en:Hodgkin lymphoma | rel=r_associated | relid=0 | w=20
  747. en:plasma cell neoplasms (all subtypes) --- r_associated #0: 20 --> en:Hodgkin lymphoma
    n1=en:plasma cell neoplasms (all subtypes) | n2=en:Hodgkin lymphoma | rel=r_associated | relid=0 | w=20
  748. en:plasmacytoma --- r_associated #0: 20 --> en:Hodgkin lymphoma
    n1=en:plasmacytoma | n2=en:Hodgkin lymphoma | rel=r_associated | relid=0 | w=20
  749. en:pleomorphic liposarcoma --- r_associated #0: 20 --> en:Hodgkin lymphoma
    n1=en:pleomorphic liposarcoma | n2=en:Hodgkin lymphoma | rel=r_associated | relid=0 | w=20
  750. en:pleurisy with pleural effusion --- r_associated #0: 20 --> en:Hodgkin lymphoma
    n1=en:pleurisy with pleural effusion | n2=en:Hodgkin lymphoma | rel=r_associated | relid=0 | w=20
  751. en:pneumonia --- r_associated #0: 20 --> en:Hodgkin lymphoma
    n1=en:pneumonia | n2=en:Hodgkin lymphoma | rel=r_associated | relid=0 | w=20
  752. en:poisoning by medical agent --- r_associated #0: 20 --> en:Hodgkin lymphoma
    n1=en:poisoning by medical agent | n2=en:Hodgkin lymphoma | rel=r_associated | relid=0 | w=20
  753. en:polyembryoma --- r_associated #0: 20 --> en:Hodgkin lymphoma
    n1=en:polyembryoma | n2=en:Hodgkin lymphoma | rel=r_associated | relid=0 | w=20
  754. en:polymorphous low grade adenocarcinoma --- r_associated #0: 20 --> en:Hodgkin lymphoma
    n1=en:polymorphous low grade adenocarcinoma | n2=en:Hodgkin lymphoma | rel=r_associated | relid=0 | w=20
  755. en:poorly differentiated carcinoma --- r_associated #0: 20 --> en:Hodgkin lymphoma
    n1=en:poorly differentiated carcinoma | n2=en:Hodgkin lymphoma | rel=r_associated | relid=0 | w=20
  756. en:possibly increased risk for other cancers --- r_associated #0: 20 --> en:Hodgkin lymphoma
    n1=en:possibly increased risk for other cancers | n2=en:Hodgkin lymphoma | rel=r_associated | relid=0 | w=20
  757. en:possibly increased risk of cancer --- r_associated #0: 20 --> en:Hodgkin lymphoma
    n1=en:possibly increased risk of cancer | n2=en:Hodgkin lymphoma | rel=r_associated | relid=0 | w=20
  758. en:precursor lymphoblastic leukemia/lymphoma (all subtypes) --- r_associated #0: 20 --> en:Hodgkin lymphoma
    n1=en:precursor lymphoblastic leukemia/lymphoma (all subtypes) | n2=en:Hodgkin lymphoma | rel=r_associated | relid=0 | w=20
  759. en:predisposition to uv-induced malignancies --- r_associated #0: 20 --> en:Hodgkin lymphoma
    n1=en:predisposition to uv-induced malignancies | n2=en:Hodgkin lymphoma | rel=r_associated | relid=0 | w=20
  760. en:pregnancy complications, neoplastic --- r_associated #0: 20 --> en:Hodgkin lymphoma
    n1=en:pregnancy complications, neoplastic | n2=en:Hodgkin lymphoma | rel=r_associated | relid=0 | w=20
  761. en:premature birth of newborn --- r_associated #0: 20 --> en:Hodgkin lymphoma
    n1=en:premature birth of newborn | n2=en:Hodgkin lymphoma | rel=r_associated | relid=0 | w=20
  762. en:primary malignant germ cell neoplasm --- r_associated #0: 20 --> en:Hodgkin lymphoma
    n1=en:primary malignant germ cell neoplasm | n2=en:Hodgkin lymphoma | rel=r_associated | relid=0 | w=20
  763. en:primary malignant neoplasm of back --- r_associated #0: 20 --> en:Hodgkin lymphoma
    n1=en:primary malignant neoplasm of back | n2=en:Hodgkin lymphoma | rel=r_associated | relid=0 | w=20
  764. en:primary malignant neoplasm of bone --- r_associated #0: 20 --> en:Hodgkin lymphoma
    n1=en:primary malignant neoplasm of bone | n2=en:Hodgkin lymphoma | rel=r_associated | relid=0 | w=20
  765. en:primary malignant neoplasm of ear, nose and/or throat --- r_associated #0: 20 --> en:Hodgkin lymphoma
    n1=en:primary malignant neoplasm of ear, nose and/or throat | n2=en:Hodgkin lymphoma | rel=r_associated | relid=0 | w=20
  766. en:primary malignant neoplasm of head --- r_associated #0: 20 --> en:Hodgkin lymphoma
    n1=en:primary malignant neoplasm of head | n2=en:Hodgkin lymphoma | rel=r_associated | relid=0 | w=20
  767. en:primary malignant neoplasm of ill-defined site --- r_associated #0: 20 --> en:Hodgkin lymphoma
    n1=en:primary malignant neoplasm of ill-defined site | n2=en:Hodgkin lymphoma | rel=r_associated | relid=0 | w=20
  768. en:primary malignant neoplasm of independent multiple sites --- r_associated #0: 20 --> en:Hodgkin lymphoma
    n1=en:primary malignant neoplasm of independent multiple sites | n2=en:Hodgkin lymphoma | rel=r_associated | relid=0 | w=20
  769. en:primary malignant neoplasm of lower limb --- r_associated #0: 20 --> en:Hodgkin lymphoma
    n1=en:primary malignant neoplasm of lower limb | n2=en:Hodgkin lymphoma | rel=r_associated | relid=0 | w=20
  770. en:primary malignant neoplasm of respiratory tract --- r_associated #0: 20 --> en:Hodgkin lymphoma
    n1=en:primary malignant neoplasm of respiratory tract | n2=en:Hodgkin lymphoma | rel=r_associated | relid=0 | w=20
  771. en:primary malignant neoplasm of spleen --- r_associated #0: 20 --> en:Hodgkin lymphoma
    n1=en:primary malignant neoplasm of spleen | n2=en:Hodgkin lymphoma | rel=r_associated | relid=0 | w=20
  772. en:primary malignant neoplasm of unknown site --- r_associated #0: 20 --> en:Hodgkin lymphoma
    n1=en:primary malignant neoplasm of unknown site | n2=en:Hodgkin lymphoma | rel=r_associated | relid=0 | w=20
  773. en:primary malignant neoplasm of upper limb (disorder) --- r_associated #0: 20 --> en:Hodgkin lymphoma
    n1=en:primary malignant neoplasm of upper limb (disorder) | n2=en:Hodgkin lymphoma | rel=r_associated | relid=0 | w=20
  774. en:primary undifferentiated large cell carcinoma --- r_associated #0: 20 --> en:Hodgkin lymphoma
    n1=en:primary undifferentiated large cell carcinoma | n2=en:Hodgkin lymphoma | rel=r_associated | relid=0 | w=20
  775. en:propensity to tumor development --- r_associated #0: 20 --> en:Hodgkin lymphoma
    n1=en:propensity to tumor development | n2=en:Hodgkin lymphoma | rel=r_associated | relid=0 | w=20
  776. en:prostate neoplasm --- r_associated #0: 20 --> en:Hodgkin lymphoma
    n1=en:prostate neoplasm | n2=en:Hodgkin lymphoma | rel=r_associated | relid=0 | w=20
  777. en:prostatitis/seminal vesiculitis --- r_associated #0: 20 --> en:Hodgkin lymphoma
    n1=en:prostatitis/seminal vesiculitis | n2=en:Hodgkin lymphoma | rel=r_associated | relid=0 | w=20
  778. en:psammomatous melanotic schwannomas --- r_associated #0: 20 --> en:Hodgkin lymphoma
    n1=en:psammomatous melanotic schwannomas | n2=en:Hodgkin lymphoma | rel=r_associated | relid=0 | w=20
  779. en:pseudoglandular squamous cell carcinoma --- r_associated #0: 20 --> en:Hodgkin lymphoma
    n1=en:pseudoglandular squamous cell carcinoma | n2=en:Hodgkin lymphoma | rel=r_associated | relid=0 | w=20
  780. en:psoriasis --- r_associated #0: 20 --> en:Hodgkin lymphoma
    n1=en:psoriasis | n2=en:Hodgkin lymphoma | rel=r_associated | relid=0 | w=20
  781. en:psychological aspect of cancer --- r_associated #0: 20 --> en:Hodgkin lymphoma
    n1=en:psychological aspect of cancer | n2=en:Hodgkin lymphoma | rel=r_associated | relid=0 | w=20
  782. en:puerperal infection/sepsis --- r_associated #0: 20 --> en:Hodgkin lymphoma
    n1=en:puerperal infection/sepsis | n2=en:Hodgkin lymphoma | rel=r_associated | relid=0 | w=20
  783. en:pulmonary emphysema --- r_associated #0: 20 --> en:Hodgkin lymphoma
    n1=en:pulmonary emphysema | n2=en:Hodgkin lymphoma | rel=r_associated | relid=0 | w=20
  784. en:pulmonary tuberculosis --- r_associated #0: 20 --> en:Hodgkin lymphoma
    n1=en:pulmonary tuberculosis | n2=en:Hodgkin lymphoma | rel=r_associated | relid=0 | w=20
  785. en:radiation-related neoplasm --- r_associated #0: 20 --> en:Hodgkin lymphoma
    n1=en:radiation-related neoplasm | n2=en:Hodgkin lymphoma | rel=r_associated | relid=0 | w=20
  786. en:rarely malignant --- r_associated #0: 20 --> en:Hodgkin lymphoma
    n1=en:rarely malignant | n2=en:Hodgkin lymphoma | rel=r_associated | relid=0 | w=20
  787. en:recurrent hodgkin's disease lymphocyte predominance type --- r_associated #0: 20 --> en:Hodgkin lymphoma
    n1=en:recurrent hodgkin's disease lymphocyte predominance type | n2=en:Hodgkin lymphoma | rel=r_associated | relid=0 | w=20
  788. en:recurrent malignant neoplasm --- r_associated #0: 20 --> en:Hodgkin lymphoma
    n1=en:recurrent malignant neoplasm | n2=en:Hodgkin lymphoma | rel=r_associated | relid=0 | w=20
  789. en:reed-sternberg cell --- r_associated #0: 20 --> en:Hodgkin lymphoma
    n1=en:reed-sternberg cell | n2=en:Hodgkin lymphoma | rel=r_associated | relid=0 | w=20
  790. en:refractory anemia --- r_associated #0: 20 --> en:Hodgkin lymphoma
    n1=en:refractory anemia | n2=en:Hodgkin lymphoma | rel=r_associated | relid=0 | w=20
  791. en:refractory anemia with ring sideroblasts --- r_associated #0: 20 --> en:Hodgkin lymphoma
    n1=en:refractory anemia with ring sideroblasts | n2=en:Hodgkin lymphoma | rel=r_associated | relid=0 | w=20
  792. en:refractory cytopenia with multilineage dysplasia and ring sideroblasts --- r_associated #0: 20 --> en:Hodgkin lymphoma
    n1=en:refractory cytopenia with multilineage dysplasia and ring sideroblasts | n2=en:Hodgkin lymphoma | rel=r_associated | relid=0 | w=20
  793. en:refractory hodgkin's disease lymphocyte predominance type --- r_associated #0: 20 --> en:Hodgkin lymphoma
    n1=en:refractory hodgkin's disease lymphocyte predominance type | n2=en:Hodgkin lymphoma | rel=r_associated | relid=0 | w=20
  794. en:refractory malignant neoplasm --- r_associated #0: 20 --> en:Hodgkin lymphoma
    n1=en:refractory malignant neoplasm | n2=en:Hodgkin lymphoma | rel=r_associated | relid=0 | w=20
  795. en:regressing melanoma --- r_associated #0: 20 --> en:Hodgkin lymphoma
    n1=en:regressing melanoma | n2=en:Hodgkin lymphoma | rel=r_associated | relid=0 | w=20
  796. en:renal cell carcinoma --- r_associated #0: 20 --> en:Hodgkin lymphoma
    n1=en:renal cell carcinoma | n2=en:Hodgkin lymphoma | rel=r_associated | relid=0 | w=20
  797. en:renal cell carcinoma, solitary papillary type 2 (about 20% of patients) --- r_associated #0: 20 --> en:Hodgkin lymphoma
    n1=en:renal cell carcinoma, solitary papillary type 2 (about 20% of patients) | n2=en:Hodgkin lymphoma | rel=r_associated | relid=0 | w=20
  798. en:renal cell carcinoma, usually clear cell type --- r_associated #0: 20 --> en:Hodgkin lymphoma
    n1=en:renal cell carcinoma, usually clear cell type | n2=en:Hodgkin lymphoma | rel=r_associated | relid=0 | w=20
  799. en:reported colon and other abdominal cancer in relatives --- r_associated #0: 20 --> en:Hodgkin lymphoma
    n1=en:reported colon and other abdominal cancer in relatives | n2=en:Hodgkin lymphoma | rel=r_associated | relid=0 | w=20
  800. en:reproductive and genitourinary neoplasms gender unspecified nec --- r_associated #0: 20 --> en:Hodgkin lymphoma
    n1=en:reproductive and genitourinary neoplasms gender unspecified nec | n2=en:Hodgkin lymphoma | rel=r_associated | relid=0 | w=20
  801. en:reproductive neoplasms female malignant and unspecified --- r_associated #0: 20 --> en:Hodgkin lymphoma
    n1=en:reproductive neoplasms female malignant and unspecified | n2=en:Hodgkin lymphoma | rel=r_associated | relid=0 | w=20
  802. en:respiratory and mediastinal neoplasms benign (excl mesotheliomas) --- r_associated #0: 20 --> en:Hodgkin lymphoma
    n1=en:respiratory and mediastinal neoplasms benign (excl mesotheliomas) | n2=en:Hodgkin lymphoma | rel=r_associated | relid=0 | w=20
  803. en:reticuloendothelial system --- r_associated #0: 20 --> en:Hodgkin lymphoma
    n1=en:reticuloendothelial system | n2=en:Hodgkin lymphoma | rel=r_associated | relid=0 | w=20
  804. en:retinoblastoma --- r_associated #0: 20 --> en:Hodgkin lymphoma
    n1=en:retinoblastoma | n2=en:Hodgkin lymphoma | rel=r_associated | relid=0 | w=20
  805. en:retinopathy --- r_associated #0: 20 --> en:Hodgkin lymphoma
    n1=en:retinopathy | n2=en:Hodgkin lymphoma | rel=r_associated | relid=0 | w=20
  806. en:rhabdoid tumor --- r_associated #0: 20 --> en:Hodgkin lymphoma
    n1=en:rhabdoid tumor | n2=en:Hodgkin lymphoma | rel=r_associated | relid=0 | w=20
  807. en:rhabdomyosarcoma --- r_associated #0: 20 --> en:Hodgkin lymphoma
    n1=en:rhabdomyosarcoma | n2=en:Hodgkin lymphoma | rel=r_associated | relid=0 | w=20
  808. en:rubella infection --- r_associated #0: 20 --> en:Hodgkin lymphoma
    n1=en:rubella infection | n2=en:Hodgkin lymphoma | rel=r_associated | relid=0 | w=20
  809. en:sarcomatoid squamous cell carcinoma --- r_associated #0: 20 --> en:Hodgkin lymphoma
    n1=en:sarcomatoid squamous cell carcinoma | n2=en:Hodgkin lymphoma | rel=r_associated | relid=0 | w=20
  810. en:sarcomatoid transitional cell carcinoma --- r_associated #0: 20 --> en:Hodgkin lymphoma
    n1=en:sarcomatoid transitional cell carcinoma | n2=en:Hodgkin lymphoma | rel=r_associated | relid=0 | w=20
  811. en:scabies and other acariases --- r_associated #0: 20 --> en:Hodgkin lymphoma
    n1=en:scabies and other acariases | n2=en:Hodgkin lymphoma | rel=r_associated | relid=0 | w=20
  812. en:schizophrenia --- r_associated #0: 20 --> en:Hodgkin lymphoma
    n1=en:schizophrenia | n2=en:Hodgkin lymphoma | rel=r_associated | relid=0 | w=20
  813. en:screening for prostate cancer --- r_associated #0: 20 --> en:Hodgkin lymphoma
    n1=en:screening for prostate cancer | n2=en:Hodgkin lymphoma | rel=r_associated | relid=0 | w=20
  814. en:sebaceous cyst --- r_associated #0: 20 --> en:Hodgkin lymphoma
    n1=en:sebaceous cyst | n2=en:Hodgkin lymphoma | rel=r_associated | relid=0 | w=20
  815. en:sebaceous epithelioma --- r_associated #0: 20 --> en:Hodgkin lymphoma
    n1=en:sebaceous epithelioma | n2=en:Hodgkin lymphoma | rel=r_associated | relid=0 | w=20
  816. en:seborrheic dermatitis --- r_associated #0: 20 --> en:Hodgkin lymphoma
    n1=en:seborrheic dermatitis | n2=en:Hodgkin lymphoma | rel=r_associated | relid=0 | w=20
  817. en:second primary malignant neoplasm --- r_associated #0: 20 --> en:Hodgkin lymphoma
    n1=en:second primary malignant neoplasm | n2=en:Hodgkin lymphoma | rel=r_associated | relid=0 | w=20
  818. en:secondary central nervous system hodgkin lymphoma --- r_associated #0: 20 --> en:Hodgkin lymphoma
    n1=en:secondary central nervous system hodgkin lymphoma | n2=en:Hodgkin lymphoma | rel=r_associated | relid=0 | w=20
  819. en:secondary malignant neoplasm --- r_associated #0: 20 --> en:Hodgkin lymphoma
    n1=en:secondary malignant neoplasm | n2=en:Hodgkin lymphoma | rel=r_associated | relid=0 | w=20
  820. en:secretory otitis media --- r_associated #0: 20 --> en:Hodgkin lymphoma
    n1=en:secretory otitis media | n2=en:Hodgkin lymphoma | rel=r_associated | relid=0 | w=20
  821. en:seizure disorder --- r_associated #0: 20 --> en:Hodgkin lymphoma
    n1=en:seizure disorder | n2=en:Hodgkin lymphoma | rel=r_associated | relid=0 | w=20
  822. en:seminoma --- r_associated #0: 20 --> en:Hodgkin lymphoma
    n1=en:seminoma | n2=en:Hodgkin lymphoma | rel=r_associated | relid=0 | w=20
  823. en:seromucinous carcinoma --- r_associated #0: 20 --> en:Hodgkin lymphoma
    n1=en:seromucinous carcinoma | n2=en:Hodgkin lymphoma | rel=r_associated | relid=0 | w=20
  824. en:sertoli cell carcinoma --- r_associated #0: 20 --> en:Hodgkin lymphoma
    n1=en:sertoli cell carcinoma | n2=en:Hodgkin lymphoma | rel=r_associated | relid=0 | w=20
  825. en:sertoli-leydig cell ovarian tumors may occur --- r_associated #0: 20 --> en:Hodgkin lymphoma
    n1=en:sertoli-leydig cell ovarian tumors may occur | n2=en:Hodgkin lymphoma | rel=r_associated | relid=0 | w=20
  826. en:sertoli-leydig cell tumor, poorly differentiated --- r_associated #0: 20 --> en:Hodgkin lymphoma
    n1=en:sertoli-leydig cell tumor, poorly differentiated | n2=en:Hodgkin lymphoma | rel=r_associated | relid=0 | w=20
  827. en:sex cord-stromal tumor --- r_associated #0: 20 --> en:Hodgkin lymphoma
    n1=en:sex cord-stromal tumor | n2=en:Hodgkin lymphoma | rel=r_associated | relid=0 | w=20
  828. en:signet ring cell carcinoma --- r_associated #0: 20 --> en:Hodgkin lymphoma
    n1=en:signet ring cell carcinoma | n2=en:Hodgkin lymphoma | rel=r_associated | relid=0 | w=20
  829. en:skeletal neoplasms malignant and unspecified --- r_associated #0: 20 --> en:Hodgkin lymphoma
    n1=en:skeletal neoplasms malignant and unspecified | n2=en:Hodgkin lymphoma | rel=r_associated | relid=0 | w=20
  830. en:skin appendage tumors may show malignant transformation --- r_associated #0: 20 --> en:Hodgkin lymphoma
    n1=en:skin appendage tumors may show malignant transformation | n2=en:Hodgkin lymphoma | rel=r_associated | relid=0 | w=20
  831. en:skin basosquamous cell carcinoma --- r_associated #0: 20 --> en:Hodgkin lymphoma
    n1=en:skin basosquamous cell carcinoma | n2=en:Hodgkin lymphoma | rel=r_associated | relid=0 | w=20
  832. en:skin fibroepithelial basal cell carcinoma --- r_associated #0: 20 --> en:Hodgkin lymphoma
    n1=en:skin fibroepithelial basal cell carcinoma | n2=en:Hodgkin lymphoma | rel=r_associated | relid=0 | w=20
  833. en:skin metatypical carcinoma --- r_associated #0: 20 --> en:Hodgkin lymphoma
    n1=en:skin metatypical carcinoma | n2=en:Hodgkin lymphoma | rel=r_associated | relid=0 | w=20
  834. en:small cell carcinoma --- r_associated #0: 20 --> en:Hodgkin lymphoma
    n1=en:small cell carcinoma | n2=en:Hodgkin lymphoma | rel=r_associated | relid=0 | w=20
  835. en:small cell carcinoma carcinomatosis --- r_associated #0: 20 --> en:Hodgkin lymphoma
    n1=en:small cell carcinoma carcinomatosis | n2=en:Hodgkin lymphoma | rel=r_associated | relid=0 | w=20
  836. en:small cell carcinoma of the ovary, hypercalcemic type --- r_associated #0: 20 --> en:Hodgkin lymphoma
    n1=en:small cell carcinoma of the ovary, hypercalcemic type | n2=en:Hodgkin lymphoma | rel=r_associated | relid=0 | w=20
  837. en:small cell carcinoma, fusiform cell type --- r_associated #0: 20 --> en:Hodgkin lymphoma
    n1=en:small cell carcinoma, fusiform cell type | n2=en:Hodgkin lymphoma | rel=r_associated | relid=0 | w=20
  838. en:small cell intermediate cell carcinoma --- r_associated #0: 20 --> en:Hodgkin lymphoma
    n1=en:small cell intermediate cell carcinoma | n2=en:Hodgkin lymphoma | rel=r_associated | relid=0 | w=20
  839. en:small cell osteosarcoma --- r_associated #0: 20 --> en:Hodgkin lymphoma
    n1=en:small cell osteosarcoma | n2=en:Hodgkin lymphoma | rel=r_associated | relid=0 | w=20
  840. en:small cell sarcoma --- r_associated #0: 20 --> en:Hodgkin lymphoma
    n1=en:small cell sarcoma | n2=en:Hodgkin lymphoma | rel=r_associated | relid=0 | w=20
  841. en:small intestine carcinoid --- r_associated #0: 20 --> en:Hodgkin lymphoma
    n1=en:small intestine carcinoid | n2=en:Hodgkin lymphoma | rel=r_associated | relid=0 | w=20
  842. en:soft tissue sarcoma --- r_associated #0: 20 --> en:Hodgkin lymphoma
    n1=en:soft tissue sarcoma | n2=en:Hodgkin lymphoma | rel=r_associated | relid=0 | w=20
  843. en:solid papillary carcinoma with invasion --- r_associated #0: 20 --> en:Hodgkin lymphoma
    n1=en:solid papillary carcinoma with invasion | n2=en:Hodgkin lymphoma | rel=r_associated | relid=0 | w=20
  844. en:spindle cell melanoma --- r_associated #0: 20 --> en:Hodgkin lymphoma
    n1=en:spindle cell melanoma | n2=en:Hodgkin lymphoma | rel=r_associated | relid=0 | w=20
  845. en:spindle cell sarcoma --- r_associated #0: 20 --> en:Hodgkin lymphoma
    n1=en:spindle cell sarcoma | n2=en:Hodgkin lymphoma | rel=r_associated | relid=0 | w=20
  846. en:spiradenocarcinoma --- r_associated #0: 20 --> en:Hodgkin lymphoma
    n1=en:spiradenocarcinoma | n2=en:Hodgkin lymphoma | rel=r_associated | relid=0 | w=20
  847. en:splenic hodgkin lymphoma --- r_associated #0: 20 --> en:Hodgkin lymphoma
    n1=en:splenic hodgkin lymphoma | n2=en:Hodgkin lymphoma | rel=r_associated | relid=0 | w=20
  848. en:splenomegaly --- r_associated #0: 20 --> en:Hodgkin lymphoma
    n1=en:splenomegaly | n2=en:Hodgkin lymphoma | rel=r_associated | relid=0 | w=20
  849. en:spongioneuroblastoma --- r_associated #0: 20 --> en:Hodgkin lymphoma
    n1=en:spongioneuroblastoma | n2=en:Hodgkin lymphoma | rel=r_associated | relid=0 | w=20
  850. en:spontaneous abortion --- r_associated #0: 20 --> en:Hodgkin lymphoma
    n1=en:spontaneous abortion | n2=en:Hodgkin lymphoma | rel=r_associated | relid=0 | w=20
  851. en:sprain and strain of ankle --- r_associated #0: 20 --> en:Hodgkin lymphoma
    n1=en:sprain and strain of ankle | n2=en:Hodgkin lymphoma | rel=r_associated | relid=0 | w=20
  852. en:squamous cell carcinoma --- r_associated #0: 20 --> en:Hodgkin lymphoma
    n1=en:squamous cell carcinoma | n2=en:Hodgkin lymphoma | rel=r_associated | relid=0 | w=20
  853. en:squamous cell carcinoma in area of palmoplantar keratoderma (rare) --- r_associated #0: 20 --> en:Hodgkin lymphoma
    n1=en:squamous cell carcinoma in area of palmoplantar keratoderma (rare) | n2=en:Hodgkin lymphoma | rel=r_associated | relid=0 | w=20
  854. en:squamous cell neoplasm --- r_associated #0: 20 --> en:Hodgkin lymphoma
    n1=en:squamous cell neoplasm | n2=en:Hodgkin lymphoma | rel=r_associated | relid=0 | w=20
  855. en:squamous epitheliomas, multiple --- r_associated #0: 20 --> en:Hodgkin lymphoma
    n1=en:squamous epitheliomas, multiple | n2=en:Hodgkin lymphoma | rel=r_associated | relid=0 | w=20
  856. en:stage i hodgkin lymphoma --- r_associated #0: 20 --> en:Hodgkin lymphoma
    n1=en:stage i hodgkin lymphoma | n2=en:Hodgkin lymphoma | rel=r_associated | relid=0 | w=20
  857. en:stage i lymphocyte-depleted classical hodgkin lymphoma --- r_associated #0: 20 --> en:Hodgkin lymphoma
    n1=en:stage i lymphocyte-depleted classical hodgkin lymphoma | n2=en:Hodgkin lymphoma | rel=r_associated | relid=0 | w=20
  858. en:stage ii subdiaphragmatic hodgkin lymphoma --- r_associated #0: 20 --> en:Hodgkin lymphoma
    n1=en:stage ii subdiaphragmatic hodgkin lymphoma | n2=en:Hodgkin lymphoma | rel=r_associated | relid=0 | w=20
  859. en:stage iii hodgkin's disease lymphocyte predominance type --- r_associated #0: 20 --> en:Hodgkin lymphoma
    n1=en:stage iii hodgkin's disease lymphocyte predominance type | n2=en:Hodgkin lymphoma | rel=r_associated | relid=0 | w=20
  860. en:stage iv hodgkin lymphoma --- r_associated #0: 20 --> en:Hodgkin lymphoma
    n1=en:stage iv hodgkin lymphoma | n2=en:Hodgkin lymphoma | rel=r_associated | relid=0 | w=20
  861. en:stage iv lymphocyte-depleted classical hodgkin lymphoma --- r_associated #0: 20 --> en:Hodgkin lymphoma
    n1=en:stage iv lymphocyte-depleted classical hodgkin lymphoma | n2=en:Hodgkin lymphoma | rel=r_associated | relid=0 | w=20
  862. en:starry sky pattern --- r_associated #0: 20 --> en:Hodgkin lymphoma
    n1=en:starry sky pattern | n2=en:Hodgkin lymphoma | rel=r_associated | relid=0 | w=20
  863. en:steroid cell tumor, malignant --- r_associated #0: 20 --> en:Hodgkin lymphoma
    n1=en:steroid cell tumor, malignant | n2=en:Hodgkin lymphoma | rel=r_associated | relid=0 | w=20
  864. en:strabismus --- r_associated #0: 20 --> en:Hodgkin lymphoma
    n1=en:strabismus | n2=en:Hodgkin lymphoma | rel=r_associated | relid=0 | w=20
  865. en:strep throat/scarlet fever --- r_associated #0: 20 --> en:Hodgkin lymphoma
    n1=en:strep throat/scarlet fever | n2=en:Hodgkin lymphoma | rel=r_associated | relid=0 | w=20
  866. en:stromal sarcoma --- r_associated #0: 20 --> en:Hodgkin lymphoma
    n1=en:stromal sarcoma | n2=en:Hodgkin lymphoma | rel=r_associated | relid=0 | w=20
  867. en:suicide attempt --- r_associated #0: 20 --> en:Hodgkin lymphoma
    n1=en:suicide attempt | n2=en:Hodgkin lymphoma | rel=r_associated | relid=0 | w=20
  868. en:superficial injury of ear --- r_associated #0: 20 --> en:Hodgkin lymphoma
    n1=en:superficial injury of ear | n2=en:Hodgkin lymphoma | rel=r_associated | relid=0 | w=20
  869. en:surgical aspects --- r_associated #0: 20 --> en:Hodgkin lymphoma
    n1=en:surgical aspects | n2=en:Hodgkin lymphoma | rel=r_associated | relid=0 | w=20
  870. en:swallowed foreign body in digestive system --- r_associated #0: 20 --> en:Hodgkin lymphoma
    n1=en:swallowed foreign body in digestive system | n2=en:Hodgkin lymphoma | rel=r_associated | relid=0 | w=20
  871. en:sweat gland adenocarcinoma --- r_associated #0: 20 --> en:Hodgkin lymphoma
    n1=en:sweat gland adenocarcinoma | n2=en:Hodgkin lymphoma | rel=r_associated | relid=0 | w=20
  872. en:symptom blood/lymph organs --- r_associated #0: 20 --> en:Hodgkin lymphoma
    n1=en:symptom blood/lymph organs | n2=en:Hodgkin lymphoma | rel=r_associated | relid=0 | w=20
  873. en:synovial neoplasm --- r_associated #0: 20 --> en:Hodgkin lymphoma
    n1=en:synovial neoplasm | n2=en:Hodgkin lymphoma | rel=r_associated | relid=0 | w=20
  874. en:synovial-like neoplasm --- r_associated #0: 20 --> en:Hodgkin lymphoma
    n1=en:synovial-like neoplasm | n2=en:Hodgkin lymphoma | rel=r_associated | relid=0 | w=20
  875. en:syphilis male --- r_associated #0: 20 --> en:Hodgkin lymphoma
    n1=en:syphilis male | n2=en:Hodgkin lymphoma | rel=r_associated | relid=0 | w=20
  876. en:t lymphoblastic leukemia/lymphoma --- r_associated #0: 20 --> en:Hodgkin lymphoma
    n1=en:t lymphoblastic leukemia/lymphoma | n2=en:Hodgkin lymphoma | rel=r_associated | relid=0 | w=20
  877. en:taxonomic --- r_associated #0: 20 --> en:Hodgkin lymphoma
    n1=en:taxonomic | n2=en:Hodgkin lymphoma | rel=r_associated | relid=0 | w=20
  878. en:telangiectatic osteosarcoma --- r_associated #0: 20 --> en:Hodgkin lymphoma
    n1=en:telangiectatic osteosarcoma | n2=en:Hodgkin lymphoma | rel=r_associated | relid=0 | w=20
  879. en:teratoid medulloepithelioma --- r_associated #0: 20 --> en:Hodgkin lymphoma
    n1=en:teratoid medulloepithelioma | n2=en:Hodgkin lymphoma | rel=r_associated | relid=0 | w=20
  880. en:teratoid tumor, atypical --- r_associated #0: 20 --> en:Hodgkin lymphoma
    n1=en:teratoid tumor, atypical | n2=en:Hodgkin lymphoma | rel=r_associated | relid=0 | w=20
  881. en:testicular sertoli cell tumor --- r_associated #0: 20 --> en:Hodgkin lymphoma
    n1=en:testicular sertoli cell tumor | n2=en:Hodgkin lymphoma | rel=r_associated | relid=0 | w=20
  882. en:testicular sertoli cell tumor, calcified --- r_associated #0: 20 --> en:Hodgkin lymphoma
    n1=en:testicular sertoli cell tumor, calcified | n2=en:Hodgkin lymphoma | rel=r_associated | relid=0 | w=20
  883. en:therapy-related malignant neoplasm --- r_associated #0: 20 --> en:Hodgkin lymphoma
    n1=en:therapy-related malignant neoplasm | n2=en:Hodgkin lymphoma | rel=r_associated | relid=0 | w=20
  884. en:therapy-related myelodysplastic syndrome --- r_associated #0: 20 --> en:Hodgkin lymphoma
    n1=en:therapy-related myelodysplastic syndrome | n2=en:Hodgkin lymphoma | rel=r_associated | relid=0 | w=20
  885. en:throat cancer --- r_associated #0: 20 --> en:Hodgkin lymphoma
    n1=en:throat cancer | n2=en:Hodgkin lymphoma | rel=r_associated | relid=0 | w=20
  886. en:thymoma type b3 --- r_associated #0: 20 --> en:Hodgkin lymphoma
    n1=en:thymoma type b3 | n2=en:Hodgkin lymphoma | rel=r_associated | relid=0 | w=20
  887. en:thymus neoplasm --- r_associated #0: 20 --> en:Hodgkin lymphoma
    n1=en:thymus neoplasm | n2=en:Hodgkin lymphoma | rel=r_associated | relid=0 | w=20
  888. en:thyroglossal duct cyst --- r_associated #0: 20 --> en:Hodgkin lymphoma
    n1=en:thyroglossal duct cyst | n2=en:Hodgkin lymphoma | rel=r_associated | relid=0 | w=20
  889. en:thyroid cancer (follicular cell) --- r_associated #0: 20 --> en:Hodgkin lymphoma
    n1=en:thyroid cancer (follicular cell) | n2=en:Hodgkin lymphoma | rel=r_associated | relid=0 | w=20
  890. en:thyroid gland carcinoma --- r_associated #0: 20 --> en:Hodgkin lymphoma
    n1=en:thyroid gland carcinoma | n2=en:Hodgkin lymphoma | rel=r_associated | relid=0 | w=20
  891. en:thyroid gland medullary carcinoma --- r_associated #0: 20 --> en:Hodgkin lymphoma
    n1=en:thyroid gland medullary carcinoma | n2=en:Hodgkin lymphoma | rel=r_associated | relid=0 | w=20
  892. en:thyroid gland neoplasm --- r_associated #0: 20 --> en:Hodgkin lymphoma
    n1=en:thyroid gland neoplasm | n2=en:Hodgkin lymphoma | rel=r_associated | relid=0 | w=20
  893. en:thyroid gland oncocytic adenoma --- r_associated #0: 20 --> en:Hodgkin lymphoma
    n1=en:thyroid gland oncocytic adenoma | n2=en:Hodgkin lymphoma | rel=r_associated | relid=0 | w=20
  894. en:thyroid gland oncocytic neoplasm --- r_associated #0: 20 --> en:Hodgkin lymphoma
    n1=en:thyroid gland oncocytic neoplasm | n2=en:Hodgkin lymphoma | rel=r_associated | relid=0 | w=20
  895. en:thyrotoxicosis [hyperthyroidism] --- r_associated #0: 20 --> en:Hodgkin lymphoma
    n1=en:thyrotoxicosis [hyperthyroidism] | n2=en:Hodgkin lymphoma | rel=r_associated | relid=0 | w=20
  896. en:toxemia of pregnancy --- r_associated #0: 20 --> en:Hodgkin lymphoma
    n1=en:toxemia of pregnancy | n2=en:Hodgkin lymphoma | rel=r_associated | relid=0 | w=20
  897. en:toxoplasmosis --- r_associated #0: 20 --> en:Hodgkin lymphoma
    n1=en:toxoplasmosis | n2=en:Hodgkin lymphoma | rel=r_associated | relid=0 | w=20
  898. en:transaminase cell carcinoma --- r_associated #0: 20 --> en:Hodgkin lymphoma
    n1=en:transaminase cell carcinoma | n2=en:Hodgkin lymphoma | rel=r_associated | relid=0 | w=20
  899. en:transient cerebral ischemia --- r_associated #0: 20 --> en:Hodgkin lymphoma
    n1=en:transient cerebral ischemia | n2=en:Hodgkin lymphoma | rel=r_associated | relid=0 | w=20
  900. en:transitional cell carcinoma --- r_associated #0: 20 --> en:Hodgkin lymphoma
    n1=en:transitional cell carcinoma | n2=en:Hodgkin lymphoma | rel=r_associated | relid=0 | w=20
  901. en:trichoepitheliomas may rarely show malignant transformation to basal cell carcinoma --- r_associated #0: 20 --> en:Hodgkin lymphoma
    n1=en:trichoepitheliomas may rarely show malignant transformation to basal cell carcinoma | n2=en:Hodgkin lymphoma | rel=r_associated | relid=0 | w=20
  902. en:trophoblastic tumor --- r_associated #0: 20 --> en:Hodgkin lymphoma
    n1=en:trophoblastic tumor | n2=en:Hodgkin lymphoma | rel=r_associated | relid=0 | w=20
  903. en:tumor cells, benign --- r_associated #0: 20 --> en:Hodgkin lymphoma
    n1=en:tumor cells, benign | n2=en:Hodgkin lymphoma | rel=r_associated | relid=0 | w=20
  904. en:tumor necrosis factor receptor superfamily member 8 --- r_associated #0: 20 --> en:Hodgkin lymphoma
    n1=en:tumor necrosis factor receptor superfamily member 8 | n2=en:Hodgkin lymphoma | rel=r_associated | relid=0 | w=20
  905. en:tumors of the sympathetic nervous system (5 to 10%) --- r_associated #0: 20 --> en:Hodgkin lymphoma
    n1=en:tumors of the sympathetic nervous system (5 to 10%) | n2=en:Hodgkin lymphoma | rel=r_associated | relid=0 | w=20
  906. en:type 2 autoimmune lymphoproliferative syndrome --- r_associated #0: 20 --> en:Hodgkin lymphoma
    n1=en:type 2 autoimmune lymphoproliferative syndrome | n2=en:Hodgkin lymphoma | rel=r_associated | relid=0 | w=20
  907. en:type b lymphomatoid papulosis --- r_associated #0: 20 --> en:Hodgkin lymphoma
    n1=en:type b lymphomatoid papulosis | n2=en:Hodgkin lymphoma | rel=r_associated | relid=0 | w=20
  908. en:type b spindle cell melanoma --- r_associated #0: 20 --> en:Hodgkin lymphoma
    n1=en:type b spindle cell melanoma | n2=en:Hodgkin lymphoma | rel=r_associated | relid=0 | w=20
  909. en:uncomplicated hypertension --- r_associated #0: 20 --> en:Hodgkin lymphoma
    n1=en:uncomplicated hypertension | n2=en:Hodgkin lymphoma | rel=r_associated | relid=0 | w=20
  910. en:undifferentiated (embryonal) sarcoma --- r_associated #0: 20 --> en:Hodgkin lymphoma
    n1=en:undifferentiated (embryonal) sarcoma | n2=en:Hodgkin lymphoma | rel=r_associated | relid=0 | w=20
  911. en:undifferentiated malignant neoplasm --- r_associated #0: 20 --> en:Hodgkin lymphoma
    n1=en:undifferentiated malignant neoplasm | n2=en:Hodgkin lymphoma | rel=r_associated | relid=0 | w=20
  912. en:undifferentiated pleomorphic sarcoma with osteoclast-like giant cells --- r_associated #0: 20 --> en:Hodgkin lymphoma
    n1=en:undifferentiated pleomorphic sarcoma with osteoclast-like giant cells | n2=en:Hodgkin lymphoma | rel=r_associated | relid=0 | w=20
  913. en:undifferentiated sarcoma, not otherwise specified --- r_associated #0: 20 --> en:Hodgkin lymphoma
    n1=en:undifferentiated sarcoma, not otherwise specified | n2=en:Hodgkin lymphoma | rel=r_associated | relid=0 | w=20
  914. en:unresectable malignant neoplasm --- r_associated #0: 20 --> en:Hodgkin lymphoma
    n1=en:unresectable malignant neoplasm | n2=en:Hodgkin lymphoma | rel=r_associated | relid=0 | w=20
  915. en:urinary system neoplasm --- r_associated #0: 20 --> en:Hodgkin lymphoma
    n1=en:urinary system neoplasm | n2=en:Hodgkin lymphoma | rel=r_associated | relid=0 | w=20
  916. en:uterovaginal prolapse --- r_associated #0: 20 --> en:Hodgkin lymphoma
    n1=en:uterovaginal prolapse | n2=en:Hodgkin lymphoma | rel=r_associated | relid=0 | w=20
  917. en:uveal melanoma --- r_associated #0: 20 --> en:Hodgkin lymphoma
    n1=en:uveal melanoma | n2=en:Hodgkin lymphoma | rel=r_associated | relid=0 | w=20
  918. en:vaccine-induced fibrosarcoma --- r_associated #0: 20 --> en:Hodgkin lymphoma
    n1=en:vaccine-induced fibrosarcoma | n2=en:Hodgkin lymphoma | rel=r_associated | relid=0 | w=20
  919. en:vaginitis/vulvitis nos --- r_associated #0: 20 --> en:Hodgkin lymphoma
    n1=en:vaginitis/vulvitis nos | n2=en:Hodgkin lymphoma | rel=r_associated | relid=0 | w=20
  920. en:vagus nerve paraganglioma --- r_associated #0: 20 --> en:Hodgkin lymphoma
    n1=en:vagus nerve paraganglioma | n2=en:Hodgkin lymphoma | rel=r_associated | relid=0 | w=20
  921. en:varicose vein of lower extremities --- r_associated #0: 20 --> en:Hodgkin lymphoma
    n1=en:varicose vein of lower extremities | n2=en:Hodgkin lymphoma | rel=r_associated | relid=0 | w=20
  922. en:verrucous carcinoma --- r_associated #0: 20 --> en:Hodgkin lymphoma
    n1=en:verrucous carcinoma | n2=en:Hodgkin lymphoma | rel=r_associated | relid=0 | w=20
  923. en:vertiginous syndrome --- r_associated #0: 20 --> en:Hodgkin lymphoma
    n1=en:vertiginous syndrome | n2=en:Hodgkin lymphoma | rel=r_associated | relid=0 | w=20
  924. en:vibrissae --- r_associated #0: 20 --> en:Hodgkin lymphoma
    n1=en:vibrissae | n2=en:Hodgkin lymphoma | rel=r_associated | relid=0 | w=20
  925. en:viral hepatitis --- r_associated #0: 20 --> en:Hodgkin lymphoma
    n1=en:viral hepatitis | n2=en:Hodgkin lymphoma | rel=r_associated | relid=0 | w=20
  926. en:virus-related lymphoma --- r_associated #0: 20 --> en:Hodgkin lymphoma
    n1=en:virus-related lymphoma | n2=en:Hodgkin lymphoma | rel=r_associated | relid=0 | w=20
  927. en:well differentiated liposarcoma --- r_associated #0: 20 --> en:Hodgkin lymphoma
    n1=en:well differentiated liposarcoma | n2=en:Hodgkin lymphoma | rel=r_associated | relid=0 | w=20
  928. en:well differentiated malignant neoplasm --- r_associated #0: 20 --> en:Hodgkin lymphoma
    n1=en:well differentiated malignant neoplasm | n2=en:Hodgkin lymphoma | rel=r_associated | relid=0 | w=20
  929. en:white blood cell abnormality --- r_associated #0: 20 --> en:Hodgkin lymphoma
    n1=en:white blood cell abnormality | n2=en:Hodgkin lymphoma | rel=r_associated | relid=0 | w=20
  930. en:whooping cough due to unspecified organism --- r_associated #0: 20 --> en:Hodgkin lymphoma
    n1=en:whooping cough due to unspecified organism | n2=en:Hodgkin lymphoma | rel=r_associated | relid=0 | w=20
  931. en:x-linked dyskeratosis congenita --- r_associated #0: 20 --> en:Hodgkin lymphoma
    n1=en:x-linked dyskeratosis congenita | n2=en:Hodgkin lymphoma | rel=r_associated | relid=0 | w=20
  932. granulomatose --- r_associated #0: 20 --> en:Hodgkin lymphoma
    n1=granulomatose | n2=en:Hodgkin lymphoma | rel=r_associated | relid=0 | w=20
  933. granulome de hodgkin --- r_associated #0: 20 --> en:Hodgkin lymphoma
    n1=granulome de hodgkin | n2=en:Hodgkin lymphoma | rel=r_associated | relid=0 | w=20
  934. hématologie --- r_associated #0: 20 --> en:Hodgkin lymphoma
    n1=hématologie | n2=en:Hodgkin lymphoma | rel=r_associated | relid=0 | w=20
  935. hémopathie maligne --- r_associated #0: 20 --> en:Hodgkin lymphoma
    n1=hémopathie maligne | n2=en:Hodgkin lymphoma | rel=r_associated | relid=0 | w=20
  936. lymphocytes B --- r_associated #0: 20 --> en:Hodgkin lymphoma
    n1=lymphocytes B | n2=en:Hodgkin lymphoma | rel=r_associated | relid=0 | w=20
  937. lymphome --- r_associated #0: 20 --> en:Hodgkin lymphoma
    n1=lymphome | n2=en:Hodgkin lymphoma | rel=r_associated | relid=0 | w=20
  938. lymphome de hodgkin --- r_associated #0: 20 --> en:Hodgkin lymphoma
    n1=lymphome de hodgkin | n2=en:Hodgkin lymphoma | rel=r_associated | relid=0 | w=20
  939. lymphome hodgkinien --- r_associated #0: 20 --> en:Hodgkin lymphoma
    n1=lymphome hodgkinien | n2=en:Hodgkin lymphoma | rel=r_associated | relid=0 | w=20
  940. lymphome hodgkinien médiastinal --- r_associated #0: 20 --> en:Hodgkin lymphoma
    n1=lymphome hodgkinien médiastinal | n2=en:Hodgkin lymphoma | rel=r_associated | relid=0 | w=20
  941. lymphome hodgkinien, sai --- r_associated #0: 20 --> en:Hodgkin lymphoma
    n1=lymphome hodgkinien, sai | n2=en:Hodgkin lymphoma | rel=r_associated | relid=0 | w=20
  942. lymphome malin hodgkinien --- r_associated #0: 20 --> en:Hodgkin lymphoma
    n1=lymphome malin hodgkinien | n2=en:Hodgkin lymphoma | rel=r_associated | relid=0 | w=20
  943. lymphome malin non hodgkinien --- r_associated #0: 20 --> en:Hodgkin lymphoma
    n1=lymphome malin non hodgkinien | n2=en:Hodgkin lymphoma | rel=r_associated | relid=0 | w=20
  944. lymphome malin non-hodgkinien --- r_associated #0: 20 --> en:Hodgkin lymphoma
    n1=lymphome malin non-hodgkinien | n2=en:Hodgkin lymphoma | rel=r_associated | relid=0 | w=20
  945. lymphome malin à cellules à noyaux non encochés --- r_associated #0: 20 --> en:Hodgkin lymphoma
    n1=lymphome malin à cellules à noyaux non encochés | n2=en:Hodgkin lymphoma | rel=r_associated | relid=0 | w=20
  946. lymphome non hodgkinien --- r_associated #0: 20 --> en:Hodgkin lymphoma
    n1=lymphome non hodgkinien | n2=en:Hodgkin lymphoma | rel=r_associated | relid=0 | w=20
  947. lymphomes hodgkiniens --- r_associated #0: 20 --> en:Hodgkin lymphoma
    n1=lymphomes hodgkiniens | n2=en:Hodgkin lymphoma | rel=r_associated | relid=0 | w=20
  948. lymphomes non hodgkiniens --- r_associated #0: 20 --> en:Hodgkin lymphoma
    n1=lymphomes non hodgkiniens | n2=en:Hodgkin lymphoma | rel=r_associated | relid=0 | w=20
  949. maladie --- r_associated #0: 20 --> en:Hodgkin lymphoma
    n1=maladie | n2=en:Hodgkin lymphoma | rel=r_associated | relid=0 | w=20
  950. maladie d'hodgkin --- r_associated #0: 20 --> en:Hodgkin lymphoma
    n1=maladie d'hodgkin | n2=en:Hodgkin lymphoma | rel=r_associated | relid=0 | w=20
  951. maladie de --- r_associated #0: 20 --> en:Hodgkin lymphoma
    n1=maladie de | n2=en:Hodgkin lymphoma | rel=r_associated | relid=0 | w=20
  952. maladie de hodgkin, sai --- r_associated #0: 20 --> en:Hodgkin lymphoma
    n1=maladie de hodgkin, sai | n2=en:Hodgkin lymphoma | rel=r_associated | relid=0 | w=20
  953. maladie de hodgkin, site non précisé --- r_associated #0: 20 --> en:Hodgkin lymphoma
    n1=maladie de hodgkin, site non précisé | n2=en:Hodgkin lymphoma | rel=r_associated | relid=0 | w=20
  954. maladie
    (médecine)
     --- r_associated #0: 20 --> en:Hodgkin lymphoma
    n1=maladie
    (médecine)
    | n2=en:Hodgkin lymphoma | rel=r_associated | relid=0 | w=20
  955. maladies --- r_associated #0: 20 --> en:Hodgkin lymphoma
    n1=maladies | n2=en:Hodgkin lymphoma | rel=r_associated | relid=0 | w=20
  956. maladies d'hodgkin --- r_associated #0: 20 --> en:Hodgkin lymphoma
    n1=maladies d'hodgkin | n2=en:Hodgkin lymphoma | rel=r_associated | relid=0 | w=20
  957. médecine spécialisée --- r_associated #0: 20 --> en:Hodgkin lymphoma
    n1=médecine spécialisée | n2=en:Hodgkin lymphoma | rel=r_associated | relid=0 | w=20
  958. paragranulome de hodgkin --- r_associated #0: 20 --> en:Hodgkin lymphoma
    n1=paragranulome de hodgkin | n2=en:Hodgkin lymphoma | rel=r_associated | relid=0 | w=20
  959. paragranulome nodulaire --- r_associated #0: 20 --> en:Hodgkin lymphoma
    n1=paragranulome nodulaire | n2=en:Hodgkin lymphoma | rel=r_associated | relid=0 | w=20
  960. processus pathologique --- r_associated #0: 20 --> en:Hodgkin lymphoma
    n1=processus pathologique | n2=en:Hodgkin lymphoma | rel=r_associated | relid=0 | w=20
  961. sarcome de hodgkin --- r_associated #0: 20 --> en:Hodgkin lymphoma
    n1=sarcome de hodgkin | n2=en:Hodgkin lymphoma | rel=r_associated | relid=0 | w=20
  962. sarcome hodgkinien (obs) --- r_associated #0: 20 --> en:Hodgkin lymphoma
    n1=sarcome hodgkinien (obs) | n2=en:Hodgkin lymphoma | rel=r_associated | relid=0 | w=20
  963. spécialités médicales --- r_associated #0: 20 --> en:Hodgkin lymphoma
    n1=spécialités médicales | n2=en:Hodgkin lymphoma | rel=r_associated | relid=0 | w=20
  964. stade d'un cancer (détermination du) --- r_associated #0: 20 --> en:Hodgkin lymphoma
    n1=stade d'un cancer (détermination du) | n2=en:Hodgkin lymphoma | rel=r_associated | relid=0 | w=20
  965. tumeur de la rate --- r_associated #0: 20 --> en:Hodgkin lymphoma
    n1=tumeur de la rate | n2=en:Hodgkin lymphoma | rel=r_associated | relid=0 | w=20
  966. tumeur maligne de la rate --- r_associated #0: 20 --> en:Hodgkin lymphoma
    n1=tumeur maligne de la rate | n2=en:Hodgkin lymphoma | rel=r_associated | relid=0 | w=20
  967. tumeur maligne splénique --- r_associated #0: 20 --> en:Hodgkin lymphoma
    n1=tumeur maligne splénique | n2=en:Hodgkin lymphoma | rel=r_associated | relid=0 | w=20
  968. tumeurs de la rate --- r_associated #0: 20 --> en:Hodgkin lymphoma
    n1=tumeurs de la rate | n2=en:Hodgkin lymphoma | rel=r_associated | relid=0 | w=20
  969. type de cancer --- r_associated #0: 20 --> en:Hodgkin lymphoma
    n1=type de cancer | n2=en:Hodgkin lymphoma | rel=r_associated | relid=0 | w=20
  970. type non précisé maladie de hodgkin --- r_associated #0: 20 --> en:Hodgkin lymphoma
    n1=type non précisé maladie de hodgkin | n2=en:Hodgkin lymphoma | rel=r_associated | relid=0 | w=20
  971. adénocarcinome --- r_associated #0: 15 --> en:Hodgkin lymphoma
    n1=adénocarcinome | n2=en:Hodgkin lymphoma | rel=r_associated | relid=0 | w=15
  972. adénome malin --- r_associated #0: 15 --> en:Hodgkin lymphoma
    n1=adénome malin | n2=en:Hodgkin lymphoma | rel=r_associated | relid=0 | w=15
  973. cancer de la vulve --- r_associated #0: 15 --> en:Hodgkin lymphoma
    n1=cancer de la vulve | n2=en:Hodgkin lymphoma | rel=r_associated | relid=0 | w=15
  974. cancer épidermoïde --- r_associated #0: 15 --> en:Hodgkin lymphoma
    n1=cancer épidermoïde | n2=en:Hodgkin lymphoma | rel=r_associated | relid=0 | w=15
  975. lymphome malin diffus --- r_associated #0: 15 --> en:Hodgkin lymphoma
    n1=lymphome malin diffus | n2=en:Hodgkin lymphoma | rel=r_associated | relid=0 | w=15
  976. lymphome à cellules b --- r_associated #0: 15 --> en:Hodgkin lymphoma
    n1=lymphome à cellules b | n2=en:Hodgkin lymphoma | rel=r_associated | relid=0 | w=15
  977. Adénocarcinome --- r_associated #0: 10 --> en:Hodgkin lymphoma
    n1=Adénocarcinome | n2=en:Hodgkin lymphoma | rel=r_associated | relid=0 | w=10
  978. Lymphocytes B --- r_associated #0: 10 --> en:Hodgkin lymphoma
    n1=Lymphocytes B | n2=en:Hodgkin lymphoma | rel=r_associated | relid=0 | w=10
  979. anémie aplasique --- r_associated #0: 10 --> en:Hodgkin lymphoma
    n1=anémie aplasique | n2=en:Hodgkin lymphoma | rel=r_associated | relid=0 | w=10
  980. aplasie médullaire --- r_associated #0: 10 --> en:Hodgkin lymphoma
    n1=aplasie médullaire | n2=en:Hodgkin lymphoma | rel=r_associated | relid=0 | w=10
  981. aplasie érythrocytaire --- r_associated #0: 10 --> en:Hodgkin lymphoma
    n1=aplasie érythrocytaire | n2=en:Hodgkin lymphoma | rel=r_associated | relid=0 | w=10
  982. arythmie cardiaque --- r_associated #0: 10 --> en:Hodgkin lymphoma
    n1=arythmie cardiaque | n2=en:Hodgkin lymphoma | rel=r_associated | relid=0 | w=10
  983. asthme --- r_associated #0: 10 --> en:Hodgkin lymphoma
    n1=asthme | n2=en:Hodgkin lymphoma | rel=r_associated | relid=0 | w=10
  984. balanitis --- r_associated #0: 10 --> en:Hodgkin lymphoma
    n1=balanitis | n2=en:Hodgkin lymphoma | rel=r_associated | relid=0 | w=10
  985. balloon cell melanoma --- r_associated #0: 10 --> en:Hodgkin lymphoma
    n1=balloon cell melanoma | n2=en:Hodgkin lymphoma | rel=r_associated | relid=0 | w=10
  986. biopsie --- r_associated #0: 10 --> en:Hodgkin lymphoma
    n1=biopsie | n2=en:Hodgkin lymphoma | rel=r_associated | relid=0 | w=10
  987. cancer de l'estomac --- r_associated #0: 10 --> en:Hodgkin lymphoma
    n1=cancer de l'estomac | n2=en:Hodgkin lymphoma | rel=r_associated | relid=0 | w=10
  988. cancer de l'oeil --- r_associated #0: 10 --> en:Hodgkin lymphoma
    n1=cancer de l'oeil | n2=en:Hodgkin lymphoma | rel=r_associated | relid=0 | w=10
  989. cancer de l'ovaire --- r_associated #0: 10 --> en:Hodgkin lymphoma
    n1=cancer de l'ovaire | n2=en:Hodgkin lymphoma | rel=r_associated | relid=0 | w=10
  990. cancer de la prostate --- r_associated #0: 10 --> en:Hodgkin lymphoma
    n1=cancer de la prostate | n2=en:Hodgkin lymphoma | rel=r_associated | relid=0 | w=10
  991. cancer des os --- r_associated #0: 10 --> en:Hodgkin lymphoma
    n1=cancer des os | n2=en:Hodgkin lymphoma | rel=r_associated | relid=0 | w=10
  992. cancer prostatique --- r_associated #0: 10 --> en:Hodgkin lymphoma
    n1=cancer prostatique | n2=en:Hodgkin lymphoma | rel=r_associated | relid=0 | w=10
  993. carcinome glandulaire --- r_associated #0: 10 --> en:Hodgkin lymphoma
    n1=carcinome glandulaire | n2=en:Hodgkin lymphoma | rel=r_associated | relid=0 | w=10
  994. carcinome spinocellulaire --- r_associated #0: 10 --> en:Hodgkin lymphoma
    n1=carcinome spinocellulaire | n2=en:Hodgkin lymphoma | rel=r_associated | relid=0 | w=10
  995. en:angiomatous meningioma --- r_associated #0: 10 --> en:Hodgkin lymphoma
    n1=en:angiomatous meningioma | n2=en:Hodgkin lymphoma | rel=r_associated | relid=0 | w=10
  996. en:in situ cancer --- r_associated #0: 10 --> en:Hodgkin lymphoma
    n1=en:in situ cancer | n2=en:Hodgkin lymphoma | rel=r_associated | relid=0 | w=10
  997. en:malignant neoplasm of stomach --- r_associated #0: 10 --> en:Hodgkin lymphoma
    n1=en:malignant neoplasm of stomach | n2=en:Hodgkin lymphoma | rel=r_associated | relid=0 | w=10
  998. glycosurie rénale --- r_associated #0: 10 --> en:Hodgkin lymphoma
    n1=glycosurie rénale | n2=en:Hodgkin lymphoma | rel=r_associated | relid=0 | w=10
  999. hamartoma --- r_associated #0: 10 --> en:Hodgkin lymphoma
    n1=hamartoma | n2=en:Hodgkin lymphoma | rel=r_associated | relid=0 | w=10
  1000. herpès zoster --- r_associated #0: 10 --> en:Hodgkin lymphoma
    n1=herpès zoster | n2=en:Hodgkin lymphoma | rel=r_associated | relid=0 | w=10
  1001. hémoglobinopathie --- r_associated #0: 10 --> en:Hodgkin lymphoma
    n1=hémoglobinopathie | n2=en:Hodgkin lymphoma | rel=r_associated | relid=0 | w=10
  1002. hépatomégalie --- r_associated #0: 10 --> en:Hodgkin lymphoma
    n1=hépatomégalie | n2=en:Hodgkin lymphoma | rel=r_associated | relid=0 | w=10
  1003. impétigo --- r_associated #0: 10 --> en:Hodgkin lymphoma
    n1=impétigo | n2=en:Hodgkin lymphoma | rel=r_associated | relid=0 | w=10
  1004. kyste du canal thyréoglosse --- r_associated #0: 10 --> en:Hodgkin lymphoma
    n1=kyste du canal thyréoglosse | n2=en:Hodgkin lymphoma | rel=r_associated | relid=0 | w=10
  1005. kyste du tractus thyréoglosse --- r_associated #0: 10 --> en:Hodgkin lymphoma
    n1=kyste du tractus thyréoglosse | n2=en:Hodgkin lymphoma | rel=r_associated | relid=0 | w=10
  1006. kyste sébacé --- r_associated #0: 10 --> en:Hodgkin lymphoma
    n1=kyste sébacé | n2=en:Hodgkin lymphoma | rel=r_associated | relid=0 | w=10
  1007. kyste thyréoglosse --- r_associated #0: 10 --> en:Hodgkin lymphoma
    n1=kyste thyréoglosse | n2=en:Hodgkin lymphoma | rel=r_associated | relid=0 | w=10
  1008. leucémie aiguë myéloïde --- r_associated #0: 10 --> en:Hodgkin lymphoma
    n1=leucémie aiguë myéloïde | n2=en:Hodgkin lymphoma | rel=r_associated | relid=0 | w=10
  1009. leucémie aiguë non lymphoblastique --- r_associated #0: 10 --> en:Hodgkin lymphoma
    n1=leucémie aiguë non lymphoblastique | n2=en:Hodgkin lymphoma | rel=r_associated | relid=0 | w=10
  1010. lupus erythematosus --- r_associated #0: 10 --> en:Hodgkin lymphoma
    n1=lupus erythematosus | n2=en:Hodgkin lymphoma | rel=r_associated | relid=0 | w=10
  1011. lymphome de Hodgkin --- r_associated #0: 10 --> en:Hodgkin lymphoma
    n1=lymphome de Hodgkin | n2=en:Hodgkin lymphoma | rel=r_associated | relid=0 | w=10
  1012. léiomyosarcome --- r_associated #0: 10 --> en:Hodgkin lymphoma
    n1=léiomyosarcome | n2=en:Hodgkin lymphoma | rel=r_associated | relid=0 | w=10
  1013. mélanome à cellules fusiformes --- r_associated #0: 10 --> en:Hodgkin lymphoma
    n1=mélanome à cellules fusiformes | n2=en:Hodgkin lymphoma | rel=r_associated | relid=0 | w=10
  1014. méningiome --- r_associated #0: 10 --> en:Hodgkin lymphoma
    n1=méningiome | n2=en:Hodgkin lymphoma | rel=r_associated | relid=0 | w=10
  1015. naevocarcinome à cellules fusiformes de type b --- r_associated #0: 10 --> en:Hodgkin lymphoma
    n1=naevocarcinome à cellules fusiformes de type b | n2=en:Hodgkin lymphoma | rel=r_associated | relid=0 | w=10
  1016. neuroépithéliome --- r_associated #0: 10 --> en:Hodgkin lymphoma
    n1=neuroépithéliome | n2=en:Hodgkin lymphoma | rel=r_associated | relid=0 | w=10
  1017. non précisée, tumeur maligne du col de l'utérus --- r_associated #0: 10 --> en:Hodgkin lymphoma
    n1=non précisée, tumeur maligne du col de l'utérus | n2=en:Hodgkin lymphoma | rel=r_associated | relid=0 | w=10
  1018. néoplasme bénin --- r_associated #0: 10 --> en:Hodgkin lymphoma
    n1=néoplasme bénin | n2=en:Hodgkin lymphoma | rel=r_associated | relid=0 | w=10
  1019. ostéoporose --- r_associated #0: 10 --> en:Hodgkin lymphoma
    n1=ostéoporose | n2=en:Hodgkin lymphoma | rel=r_associated | relid=0 | w=10
  1020. otite séromuqueuse --- r_associated #0: 10 --> en:Hodgkin lymphoma
    n1=otite séromuqueuse | n2=en:Hodgkin lymphoma | rel=r_associated | relid=0 | w=10
  1021. palud
    (paludisme)
     --- r_associated #0: 10 --> en:Hodgkin lymphoma
    n1=palud
    (paludisme)
    | n2=en:Hodgkin lymphoma | rel=r_associated | relid=0 | w=10
  1022. rhabdomyosarcome --- r_associated #0: 10 --> en:Hodgkin lymphoma
    n1=rhabdomyosarcome | n2=en:Hodgkin lymphoma | rel=r_associated | relid=0 | w=10
  1023. splénomégalie --- r_associated #0: 10 --> en:Hodgkin lymphoma
    n1=splénomégalie | n2=en:Hodgkin lymphoma | rel=r_associated | relid=0 | w=10
  1024. strabisme --- r_associated #0: 10 --> en:Hodgkin lymphoma
    n1=strabisme | n2=en:Hodgkin lymphoma | rel=r_associated | relid=0 | w=10
  1025. syndrome adéno-cutanéo-muqueux --- r_associated #0: 10 --> en:Hodgkin lymphoma
    n1=syndrome adéno-cutanéo-muqueux | n2=en:Hodgkin lymphoma | rel=r_associated | relid=0 | w=10
  1026. système immunitaire --- r_associated #0: 10 --> en:Hodgkin lymphoma
    n1=système immunitaire | n2=en:Hodgkin lymphoma | rel=r_associated | relid=0 | w=10
  1027. toxoplasmose --- r_associated #0: 10 --> en:Hodgkin lymphoma
    n1=toxoplasmose | n2=en:Hodgkin lymphoma | rel=r_associated | relid=0 | w=10
  1028. trouble du rythme cardiaque --- r_associated #0: 10 --> en:Hodgkin lymphoma
    n1=trouble du rythme cardiaque | n2=en:Hodgkin lymphoma | rel=r_associated | relid=0 | w=10
  1029. tumeur bénigne --- r_associated #0: 10 --> en:Hodgkin lymphoma
    n1=tumeur bénigne | n2=en:Hodgkin lymphoma | rel=r_associated | relid=0 | w=10
  1030. tumeur cancéreuse --- r_associated #0: 10 --> en:Hodgkin lymphoma
    n1=tumeur cancéreuse | n2=en:Hodgkin lymphoma | rel=r_associated | relid=0 | w=10
  1031. tumeur de l'oeil --- r_associated #0: 10 --> en:Hodgkin lymphoma
    n1=tumeur de l'oeil | n2=en:Hodgkin lymphoma | rel=r_associated | relid=0 | w=10
  1032. tumeur de la vulve --- r_associated #0: 10 --> en:Hodgkin lymphoma
    n1=tumeur de la vulve | n2=en:Hodgkin lymphoma | rel=r_associated | relid=0 | w=10
  1033. tumeur du système nerveux central --- r_associated #0: 10 --> en:Hodgkin lymphoma
    n1=tumeur du système nerveux central | n2=en:Hodgkin lymphoma | rel=r_associated | relid=0 | w=10
  1034. tumeur maligne de l'oeil --- r_associated #0: 10 --> en:Hodgkin lymphoma
    n1=tumeur maligne de l'oeil | n2=en:Hodgkin lymphoma | rel=r_associated | relid=0 | w=10
  1035. tumeur maligne du col de l'utérus --- r_associated #0: 10 --> en:Hodgkin lymphoma
    n1=tumeur maligne du col de l'utérus | n2=en:Hodgkin lymphoma | rel=r_associated | relid=0 | w=10
  1036. tumeur maligne du col utérin --- r_associated #0: 10 --> en:Hodgkin lymphoma
    n1=tumeur maligne du col utérin | n2=en:Hodgkin lymphoma | rel=r_associated | relid=0 | w=10
  1037. tumeur maligne oesophagienne --- r_associated #0: 10 --> en:Hodgkin lymphoma
    n1=tumeur maligne oesophagienne | n2=en:Hodgkin lymphoma | rel=r_associated | relid=0 | w=10
  1038. tumeur maligne vulvaire --- r_associated #0: 10 --> en:Hodgkin lymphoma
    n1=tumeur maligne vulvaire | n2=en:Hodgkin lymphoma | rel=r_associated | relid=0 | w=10
  1039. vibrisses --- r_associated #0: 10 --> en:Hodgkin lymphoma
    n1=vibrisses | n2=en:Hodgkin lymphoma | rel=r_associated | relid=0 | w=10
  1040. épithélioma spinocellulaire --- r_associated #0: 10 --> en:Hodgkin lymphoma
    n1=épithélioma spinocellulaire | n2=en:Hodgkin lymphoma | rel=r_associated | relid=0 | w=10
  1041. Cancer osseux --- r_associated #0: 5 --> en:Hodgkin lymphoma
    n1=Cancer osseux | n2=en:Hodgkin lymphoma | rel=r_associated | relid=0 | w=5
  1042. Hématologie --- r_associated #0: 5 --> en:Hodgkin lymphoma
    n1=Hématologie | n2=en:Hodgkin lymphoma | rel=r_associated | relid=0 | w=5
  1043. Spécialités médicales --- r_associated #0: 5 --> en:Hodgkin lymphoma
    n1=Spécialités médicales | n2=en:Hodgkin lymphoma | rel=r_associated | relid=0 | w=5
  1044. Type de cancer --- r_associated #0: 5 --> en:Hodgkin lymphoma
    n1=Type de cancer | n2=en:Hodgkin lymphoma | rel=r_associated | relid=0 | w=5
  1045. aVf --- r_associated #0: 5 --> en:Hodgkin lymphoma
    n1=aVf | n2=en:Hodgkin lymphoma | rel=r_associated | relid=0 | w=5
  1046. anomalie congénitale --- r_associated #0: 5 --> en:Hodgkin lymphoma
    n1=anomalie congénitale | n2=en:Hodgkin lymphoma | rel=r_associated | relid=0 | w=5
  1047. anémie aplasique non précisée --- r_associated #0: 5 --> en:Hodgkin lymphoma
    n1=anémie aplasique non précisée | n2=en:Hodgkin lymphoma | rel=r_associated | relid=0 | w=5
  1048. anémie aplastique --- r_associated #0: 5 --> en:Hodgkin lymphoma
    n1=anémie aplastique | n2=en:Hodgkin lymphoma | rel=r_associated | relid=0 | w=5
  1049. aplasie de globules rouges purs --- r_associated #0: 5 --> en:Hodgkin lymphoma
    n1=aplasie de globules rouges purs | n2=en:Hodgkin lymphoma | rel=r_associated | relid=0 | w=5
  1050. aplasie des globules rouges purs --- r_associated #0: 5 --> en:Hodgkin lymphoma
    n1=aplasie des globules rouges purs | n2=en:Hodgkin lymphoma | rel=r_associated | relid=0 | w=5
  1051. aplasie isolée de la lignée rouge --- r_associated #0: 5 --> en:Hodgkin lymphoma
    n1=aplasie isolée de la lignée rouge | n2=en:Hodgkin lymphoma | rel=r_associated | relid=0 | w=5
  1052. arythmie --- r_associated #0: 5 --> en:Hodgkin lymphoma
    n1=arythmie | n2=en:Hodgkin lymphoma | rel=r_associated | relid=0 | w=5
  1053. astrocytome --- r_associated #0: 5 --> en:Hodgkin lymphoma
    n1=astrocytome | n2=en:Hodgkin lymphoma | rel=r_associated | relid=0 | w=5
  1054. cancer cutané --- r_associated #0: 5 --> en:Hodgkin lymphoma
    n1=cancer cutané | n2=en:Hodgkin lymphoma | rel=r_associated | relid=0 | w=5
  1055. cancer d'une glande salivaire --- r_associated #0: 5 --> en:Hodgkin lymphoma
    n1=cancer d'une glande salivaire | n2=en:Hodgkin lymphoma | rel=r_associated | relid=0 | w=5
  1056. cancer de la peau --- r_associated #0: 5 --> en:Hodgkin lymphoma
    n1=cancer de la peau | n2=en:Hodgkin lymphoma | rel=r_associated | relid=0 | w=5
  1057. cancer médullaire de la thyroïde --- r_associated #0: 5 --> en:Hodgkin lymphoma
    n1=cancer médullaire de la thyroïde | n2=en:Hodgkin lymphoma | rel=r_associated | relid=0 | w=5
  1058. carcinome acineux --- r_associated #0: 5 --> en:Hodgkin lymphoma
    n1=carcinome acineux | n2=en:Hodgkin lymphoma | rel=r_associated | relid=0 | w=5
  1059. carcinome adéno-squameux --- r_associated #0: 5 --> en:Hodgkin lymphoma
    n1=carcinome adéno-squameux | n2=en:Hodgkin lymphoma | rel=r_associated | relid=0 | w=5
  1060. carcinome adénosquameux --- r_associated #0: 5 --> en:Hodgkin lymphoma
    n1=carcinome adénosquameux | n2=en:Hodgkin lymphoma | rel=r_associated | relid=0 | w=5
  1061. carcinome gastrique --- r_associated #0: 5 --> en:Hodgkin lymphoma
    n1=carcinome gastrique | n2=en:Hodgkin lymphoma | rel=r_associated | relid=0 | w=5
  1062. carcinome glandulaire et malpighien --- r_associated #0: 5 --> en:Hodgkin lymphoma
    n1=carcinome glandulaire et malpighien | n2=en:Hodgkin lymphoma | rel=r_associated | relid=0 | w=5
  1063. carcinome intra-épithélial --- r_associated #0: 5 --> en:Hodgkin lymphoma
    n1=carcinome intra-épithélial | n2=en:Hodgkin lymphoma | rel=r_associated | relid=0 | w=5
  1064. carcinome malpighien --- r_associated #0: 5 --> en:Hodgkin lymphoma
    n1=carcinome malpighien | n2=en:Hodgkin lymphoma | rel=r_associated | relid=0 | w=5
  1065. carcinome mixte glandulaire et spinocellulaire --- r_associated #0: 5 --> en:Hodgkin lymphoma
    n1=carcinome mixte glandulaire et spinocellulaire | n2=en:Hodgkin lymphoma | rel=r_associated | relid=0 | w=5
  1066. carcinome mixte glandulaire et épidermoïde --- r_associated #0: 5 --> en:Hodgkin lymphoma
    n1=carcinome mixte glandulaire et épidermoïde | n2=en:Hodgkin lymphoma | rel=r_associated | relid=0 | w=5
  1067. carcinome squameux --- r_associated #0: 5 --> en:Hodgkin lymphoma
    n1=carcinome squameux | n2=en:Hodgkin lymphoma | rel=r_associated | relid=0 | w=5
  1068. carcinome épidermoïde --- r_associated #0: 5 --> en:Hodgkin lymphoma
    n1=carcinome épidermoïde | n2=en:Hodgkin lymphoma | rel=r_associated | relid=0 | w=5
  1069. chalazodermie granulomateuse --- r_associated #0: 5 --> en:Hodgkin lymphoma
    n1=chalazodermie granulomateuse | n2=en:Hodgkin lymphoma | rel=r_associated | relid=0 | w=5
  1070. emphysème du poumon --- r_associated #0: 5 --> en:Hodgkin lymphoma
    n1=emphysème du poumon | n2=en:Hodgkin lymphoma | rel=r_associated | relid=0 | w=5
  1071. emphysème pulmonaire --- r_associated #0: 5 --> en:Hodgkin lymphoma
    n1=emphysème pulmonaire | n2=en:Hodgkin lymphoma | rel=r_associated | relid=0 | w=5
  1072. en:congenital anomaly --- r_associated #0: 5 --> en:Hodgkin lymphoma
    n1=en:congenital anomaly | n2=en:Hodgkin lymphoma | rel=r_associated | relid=0 | w=5
  1073. en:malignant neoplasm of salivary gland --- r_associated #0: 5 --> en:Hodgkin lymphoma
    n1=en:malignant neoplasm of salivary gland | n2=en:Hodgkin lymphoma | rel=r_associated | relid=0 | w=5
  1074. en:malignant neoplasm of skin --- r_associated #0: 5 --> en:Hodgkin lymphoma
    n1=en:malignant neoplasm of skin | n2=en:Hodgkin lymphoma | rel=r_associated | relid=0 | w=5
  1075. en:malignant neoplasm of vulva --- r_associated #0: 5 --> en:Hodgkin lymphoma
    n1=en:malignant neoplasm of vulva | n2=en:Hodgkin lymphoma | rel=r_associated | relid=0 | w=5
  1076. en:malignant tumor of cervix --- r_associated #0: 5 --> en:Hodgkin lymphoma
    n1=en:malignant tumor of cervix | n2=en:Hodgkin lymphoma | rel=r_associated | relid=0 | w=5
  1077. en:serous otitis media --- r_associated #0: 5 --> en:Hodgkin lymphoma
    n1=en:serous otitis media | n2=en:Hodgkin lymphoma | rel=r_associated | relid=0 | w=5
  1078. fibrillation et flutter auriculaires --- r_associated #0: 5 --> en:Hodgkin lymphoma
    n1=fibrillation et flutter auriculaires | n2=en:Hodgkin lymphoma | rel=r_associated | relid=0 | w=5
  1079. hamartome --- r_associated #0: 5 --> en:Hodgkin lymphoma
    n1=hamartome | n2=en:Hodgkin lymphoma | rel=r_associated | relid=0 | w=5
  1080. la à granulocytes --- r_associated #0: 5 --> en:Hodgkin lymphoma
    n1=la à granulocytes | n2=en:Hodgkin lymphoma | rel=r_associated | relid=0 | w=5
  1081. lam --- r_associated #0: 5 --> en:Hodgkin lymphoma
    n1=lam | n2=en:Hodgkin lymphoma | rel=r_associated | relid=0 | w=5
  1082. lanl --- r_associated #0: 5 --> en:Hodgkin lymphoma
    n1=lanl | n2=en:Hodgkin lymphoma | rel=r_associated | relid=0 | w=5
  1083. leucémie aiguë granulocytaire --- r_associated #0: 5 --> en:Hodgkin lymphoma
    n1=leucémie aiguë granulocytaire | n2=en:Hodgkin lymphoma | rel=r_associated | relid=0 | w=5
  1084. leucémie aiguë myéloblastique --- r_associated #0: 5 --> en:Hodgkin lymphoma
    n1=leucémie aiguë myéloblastique | n2=en:Hodgkin lymphoma | rel=r_associated | relid=0 | w=5
  1085. leucémie aiguë myélocytaire --- r_associated #0: 5 --> en:Hodgkin lymphoma
    n1=leucémie aiguë myélocytaire | n2=en:Hodgkin lymphoma | rel=r_associated | relid=0 | w=5
  1086. leucémie aiguë non lymphocytaire --- r_associated #0: 5 --> en:Hodgkin lymphoma
    n1=leucémie aiguë non lymphocytaire | n2=en:Hodgkin lymphoma | rel=r_associated | relid=0 | w=5
  1087. leucémie aigüe myéloblastique --- r_associated #0: 5 --> en:Hodgkin lymphoma
    n1=leucémie aigüe myéloblastique | n2=en:Hodgkin lymphoma | rel=r_associated | relid=0 | w=5
  1088. leucémie aigüe myéloïde --- r_associated #0: 5 --> en:Hodgkin lymphoma
    n1=leucémie aigüe myéloïde | n2=en:Hodgkin lymphoma | rel=r_associated | relid=0 | w=5
  1089. leucémie granuleuse aiguë --- r_associated #0: 5 --> en:Hodgkin lymphoma
    n1=leucémie granuleuse aiguë | n2=en:Hodgkin lymphoma | rel=r_associated | relid=0 | w=5
  1090. leucémie granulocytaire aiguë --- r_associated #0: 5 --> en:Hodgkin lymphoma
    n1=leucémie granulocytaire aiguë | n2=en:Hodgkin lymphoma | rel=r_associated | relid=0 | w=5
  1091. leucémie myéloblastique aiguë --- r_associated #0: 5 --> en:Hodgkin lymphoma
    n1=leucémie myéloblastique aiguë | n2=en:Hodgkin lymphoma | rel=r_associated | relid=0 | w=5
  1092. leucémie myéloblastique aigüe --- r_associated #0: 5 --> en:Hodgkin lymphoma
    n1=leucémie myéloblastique aigüe | n2=en:Hodgkin lymphoma | rel=r_associated | relid=0 | w=5
  1093. leucémie myélocytaire aiguë --- r_associated #0: 5 --> en:Hodgkin lymphoma
    n1=leucémie myélocytaire aiguë | n2=en:Hodgkin lymphoma | rel=r_associated | relid=0 | w=5
  1094. leucémie myélogène aiguë --- r_associated #0: 5 --> en:Hodgkin lymphoma
    n1=leucémie myélogène aiguë | n2=en:Hodgkin lymphoma | rel=r_associated | relid=0 | w=5
  1095. leucémie myéloïde aiguë --- r_associated #0: 5 --> en:Hodgkin lymphoma
    n1=leucémie myéloïde aiguë | n2=en:Hodgkin lymphoma | rel=r_associated | relid=0 | w=5
  1096. leucémie non lymphoblastique aiguë --- r_associated #0: 5 --> en:Hodgkin lymphoma
    n1=leucémie non lymphoblastique aiguë | n2=en:Hodgkin lymphoma | rel=r_associated | relid=0 | w=5
  1097. leucémies myéloïdes aiguës --- r_associated #0: 5 --> en:Hodgkin lymphoma
    n1=leucémies myéloïdes aiguës | n2=en:Hodgkin lymphoma | rel=r_associated | relid=0 | w=5
  1098. lipome --- r_associated #0: 5 --> en:Hodgkin lymphoma
    n1=lipome | n2=en:Hodgkin lymphoma | rel=r_associated | relid=0 | w=5
  1099. lupus érythémateux --- r_associated #0: 5 --> en:Hodgkin lymphoma
    n1=lupus érythémateux | n2=en:Hodgkin lymphoma | rel=r_associated | relid=0 | w=5
  1100. lymphocyte mature --- r_associated #0: 5 --> en:Hodgkin lymphoma
    n1=lymphocyte mature | n2=en:Hodgkin lymphoma | rel=r_associated | relid=0 | w=5
  1101. lymphocyte néoplasique --- r_associated #0: 5 --> en:Hodgkin lymphoma
    n1=lymphocyte néoplasique | n2=en:Hodgkin lymphoma | rel=r_associated | relid=0 | w=5
  1102. lymphome de Hodgkin classique pauvre en lymphocytes de stade IV --- r_associated #0: 5 --> en:Hodgkin lymphoma
    n1=lymphome de Hodgkin classique pauvre en lymphocytes de stade IV | n2=en:Hodgkin lymphoma | rel=r_associated | relid=0 | w=5
  1103. lymphome de Hodgkin classique à déplétion lymphocytaire de stade I --- r_associated #0: 5 --> en:Hodgkin lymphoma
    n1=lymphome de Hodgkin classique à déplétion lymphocytaire de stade I | n2=en:Hodgkin lymphoma | rel=r_associated | relid=0 | w=5
  1104. lymphome de hodgkin classique pauvre en lymphocytes --- r_associated #0: 5 --> en:Hodgkin lymphoma
    n1=lymphome de hodgkin classique pauvre en lymphocytes | n2=en:Hodgkin lymphoma | rel=r_associated | relid=0 | w=5
  1105. lymphome de hodgkin classique riche en lymphocytes --- r_associated #0: 5 --> en:Hodgkin lymphoma
    n1=lymphome de hodgkin classique riche en lymphocytes | n2=en:Hodgkin lymphoma | rel=r_associated | relid=0 | w=5
  1106. lymphome t cutané --- r_associated #0: 5 --> en:Hodgkin lymphoma
    n1=lymphome t cutané | n2=en:Hodgkin lymphoma | rel=r_associated | relid=0 | w=5
  1107. maladie de Kawasaki --- r_associated #0: 5 --> en:Hodgkin lymphoma
    n1=maladie de Kawasaki | n2=en:Hodgkin lymphoma | rel=r_associated | relid=0 | w=5
  1108. maladies immunoprolifératives --- r_associated #0: 5 --> en:Hodgkin lymphoma
    n1=maladies immunoprolifératives | n2=en:Hodgkin lymphoma | rel=r_associated | relid=0 | w=5
  1109. malformation congénitale --- r_associated #0: 5 --> en:Hodgkin lymphoma
    n1=malformation congénitale | n2=en:Hodgkin lymphoma | rel=r_associated | relid=0 | w=5
  1110. mélanome à cellules fusiformes de type b --- r_associated #0: 5 --> en:Hodgkin lymphoma
    n1=mélanome à cellules fusiformes de type b | n2=en:Hodgkin lymphoma | rel=r_associated | relid=0 | w=5
  1111. méningiome angiomateux --- r_associated #0: 5 --> en:Hodgkin lymphoma
    n1=méningiome angiomateux | n2=en:Hodgkin lymphoma | rel=r_associated | relid=0 | w=5
  1112. méningiomes --- r_associated #0: 5 --> en:Hodgkin lymphoma
    n1=méningiomes | n2=en:Hodgkin lymphoma | rel=r_associated | relid=0 | w=5
  1113. naevocarcinome à cellules fusiformes --- r_associated #0: 5 --> en:Hodgkin lymphoma
    n1=naevocarcinome à cellules fusiformes | n2=en:Hodgkin lymphoma | rel=r_associated | relid=0 | w=5
  1114. neuro-épithéliome --- r_associated #0: 5 --> en:Hodgkin lymphoma
    n1=neuro-épithéliome | n2=en:Hodgkin lymphoma | rel=r_associated | relid=0 | w=5
  1115. parkinsonisme --- r_associated #0: 5 --> en:Hodgkin lymphoma
    n1=parkinsonisme | n2=en:Hodgkin lymphoma | rel=r_associated | relid=0 | w=5
  1116. peau relâchée granulomateuse --- r_associated #0: 5 --> en:Hodgkin lymphoma
    n1=peau relâchée granulomateuse | n2=en:Hodgkin lymphoma | rel=r_associated | relid=0 | w=5
  1117. rhabdomyosarcomes --- r_associated #0: 5 --> en:Hodgkin lymphoma
    n1=rhabdomyosarcomes | n2=en:Hodgkin lymphoma | rel=r_associated | relid=0 | w=5
  1118. sarcome à petites cellules --- r_associated #0: 5 --> en:Hodgkin lymphoma
    n1=sarcome à petites cellules | n2=en:Hodgkin lymphoma | rel=r_associated | relid=0 | w=5
  1119. syndrome de Kawasaki --- r_associated #0: 5 --> en:Hodgkin lymphoma
    n1=syndrome de Kawasaki | n2=en:Hodgkin lymphoma | rel=r_associated | relid=0 | w=5
  1120. syndrome lymphoprolifératif avec autoimmunité --- r_associated #0: 5 --> en:Hodgkin lymphoma
    n1=syndrome lymphoprolifératif avec autoimmunité | n2=en:Hodgkin lymphoma | rel=r_associated | relid=0 | w=5
  1121. trouble de la conduction du coeur --- r_associated #0: 5 --> en:Hodgkin lymphoma
    n1=trouble de la conduction du coeur | n2=en:Hodgkin lymphoma | rel=r_associated | relid=0 | w=5
  1122. tumeur bénigne de la peau --- r_associated #0: 5 --> en:Hodgkin lymphoma
    n1=tumeur bénigne de la peau | n2=en:Hodgkin lymphoma | rel=r_associated | relid=0 | w=5
  1123. tumeur bénigne des organes urinaires --- r_associated #0: 5 --> en:Hodgkin lymphoma
    n1=tumeur bénigne des organes urinaires | n2=en:Hodgkin lymphoma | rel=r_associated | relid=0 | w=5
  1124. tumeur de bénignité ou de malignité non assurée --- r_associated #0: 5 --> en:Hodgkin lymphoma
    n1=tumeur de bénignité ou de malignité non assurée | n2=en:Hodgkin lymphoma | rel=r_associated | relid=0 | w=5
  1125. tumeur de la glande salivaire --- r_associated #0: 5 --> en:Hodgkin lymphoma
    n1=tumeur de la glande salivaire | n2=en:Hodgkin lymphoma | rel=r_associated | relid=0 | w=5
  1126. tumeur de la prostate --- r_associated #0: 5 --> en:Hodgkin lymphoma
    n1=tumeur de la prostate | n2=en:Hodgkin lymphoma | rel=r_associated | relid=0 | w=5
  1127. tumeur maligne d'un ovaire --- r_associated #0: 5 --> en:Hodgkin lymphoma
    n1=tumeur maligne d'un ovaire | n2=en:Hodgkin lymphoma | rel=r_associated | relid=0 | w=5
  1128. tumeur maligne de l'estomac --- r_associated #0: 5 --> en:Hodgkin lymphoma
    n1=tumeur maligne de l'estomac | n2=en:Hodgkin lymphoma | rel=r_associated | relid=0 | w=5
  1129. tumeur maligne de l'ovaire --- r_associated #0: 5 --> en:Hodgkin lymphoma
    n1=tumeur maligne de l'ovaire | n2=en:Hodgkin lymphoma | rel=r_associated | relid=0 | w=5
  1130. tumeur maligne de la peau --- r_associated #0: 5 --> en:Hodgkin lymphoma
    n1=tumeur maligne de la peau | n2=en:Hodgkin lymphoma | rel=r_associated | relid=0 | w=5
  1131. tumeur maligne de la prostate --- r_associated #0: 5 --> en:Hodgkin lymphoma
    n1=tumeur maligne de la prostate | n2=en:Hodgkin lymphoma | rel=r_associated | relid=0 | w=5
  1132. tumeur maligne de la vulve --- r_associated #0: 5 --> en:Hodgkin lymphoma
    n1=tumeur maligne de la vulve | n2=en:Hodgkin lymphoma | rel=r_associated | relid=0 | w=5
  1133. tumeur maligne des glandes salivaires --- r_associated #0: 5 --> en:Hodgkin lymphoma
    n1=tumeur maligne des glandes salivaires | n2=en:Hodgkin lymphoma | rel=r_associated | relid=0 | w=5
  1134. tumeur maligne ovarienne --- r_associated #0: 5 --> en:Hodgkin lymphoma
    n1=tumeur maligne ovarienne | n2=en:Hodgkin lymphoma | rel=r_associated | relid=0 | w=5
  1135. tumeur maligne prostatique --- r_associated #0: 5 --> en:Hodgkin lymphoma
    n1=tumeur maligne prostatique | n2=en:Hodgkin lymphoma | rel=r_associated | relid=0 | w=5
  1136. tumeur neuroectodermique périphérique primitive --- r_associated #0: 5 --> en:Hodgkin lymphoma
    n1=tumeur neuroectodermique périphérique primitive | n2=en:Hodgkin lymphoma | rel=r_associated | relid=0 | w=5
  1137. tumeur non classée de bénignité ou de malignité incertaine --- r_associated #0: 5 --> en:Hodgkin lymphoma
    n1=tumeur non classée de bénignité ou de malignité incertaine | n2=en:Hodgkin lymphoma | rel=r_associated | relid=0 | w=5
  1138. tumeurs diverses --- r_associated #0: 5 --> en:Hodgkin lymphoma
    n1=tumeurs diverses | n2=en:Hodgkin lymphoma | rel=r_associated | relid=0 | w=5
Le service Rézo permet d'énumérer les relations existant pour un terme. Ce service est interrogeable par programme.
Projet JeuxDeMots - url: http://www.jeuxdemots.org
contact: mathieu.lafourcade@lirmm.fr